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ABSTRACT 
 
 
Schizotypy is traditionally conceptualised as a personality trait reflecting vulnerability 
to the development of psychosis. This thesis introduces the concept of schizotypal 
symptoms as state phenomena, related to both the development of psychotic symptoms, 
and to long-term recovery from the disorder. It is argued that schizotypal symptoms 
may be at the core of psychosis, occurring both prior to onset and following the 
remission of an acute psychotic episode. Schizotypal symptoms may therefore provide a 
bridge for the symptom-disability gap which has long been established in psychosis. 
 
The first study in this thesis reports on the psychometric properties of the Schizotypal 
Symptoms Inventory (SSI), a modified schizotypy assessment tool designed to measure 
current low-level positive psychotic symptoms in clinical and non-clinical populations. 
Levels of schizotypal symptoms are then compared in clinical and non-clinical samples. 
Following this, differential relationships between schizotypal symptom types and 
emotional, psychological, and neuropsychological variables are investigated. 
Schizotypal symptoms are then examined in relation to existing psychosis outcomes, 
before being integrated into a dimensional model of recovery. The final study of this 
thesis investigates the role of schizotypal symptoms as mediators of social recovery 
from psychosis, in the context of a randomised controlled trial.  
 
The findings of this thesis suggest that social anxiety schizotypal symptoms are highly 
prevalent in individuals recovering from acute psychosis. Moreover, differential 
relationships exist between schizotypal symptom types and emotional, psychological, 
and neuropsychological variables. Anomalous experiences are associated with a visual 
processing perceptual anomaly, whereas social anxiety and paranoid schizotypal 
symptoms are associated with emotional processing. Differential relationships also exist 
between schizotypal symptom types and recovery dimensions. Social anxiety mediates 
social recovery from psychosis, whereas anomalous experiences are associated with 
positive symptoms. Paranoid schizotypal symptoms are associated with both 
symptomatic and social recovery. These findings are combined in a psychological 
model of recovery in the discussion chapter.  
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CHAPTER ONE: INTRODUCTION 
 
1.1 GENERAL OVERVIEW 
 
There is evidence to suggest that low-level psychotic, or schizotypal, signs are common 
both in the general population and in the prodromal stages of psychosis (e.g. van Os, 
2003). Thus, schizotypy is often considered as an index of an individual’s underlying 
vulnerability to developing psychosis (Meehl, 1990). Although little research has been 
conducted into the area, schizotypal phenomena may also be important in the recovery 
phase of psychosis. Rather than a complete and immediate resolution of all symptoms 
following an acute psychotic episode, the frequency and intensity of experiences and 
beliefs gradually reduce (Drury, 1992). This often results in the presence of residual, 
low-level traces of symptoms which could be argued to resemble schizotypal-like 
experiences. These phenomena may not be highlighted by traditional assessment tools 
but are nonetheless important as could influence an individual’s social and functional 
recovery from the effects of psychosis; and also leave them vulnerable to potential 
relapse.  
 
It could be argued that given their similarities with schizotypal phenomena and in line 
with the psychosis continuum hypothesis, the prodromal and residual symptoms of 
psychosis may be most effectively assessed using a measure of schizotypy. However, 
current assessment tools in this domain perceive schizotypy as a personality trait as 
opposed to a subclinical manifestation of psychosis (i.e. a mental state). As such they 
are not reflective of fluctuations in schizotypal symptoms over time. Introducing a trait-
state distinction to the schizotypy concept would allow it to be used to assess not only 
an individual’s underlying vulnerability but also the presence of current low-level 
psychotic symptomatology.  
 
This thesis examines and compares the prevalence and frequency of low-level psychotic 
phenomena in both clinical and non-clinical populations using a modified measure of 
schizotypal symptoms. It further aims to examine the potential underlying mechanisms 
associated with different types of such phenomena, with particular reference to the 
domain of social disability. This opening chapter addresses key issues concerning the 
context in which the research that follows is set. First, the major concepts of interest – 
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predominantly psychosis and schizotypy – are defined, and an overview of the current 
theories proposed for these concepts is provided. The importance of assessing 
schizotypal symptoms following an episode of psychosis is then discussed. Finally, the 
studies to be conducted in this thesis are outlined, along with their associated aims.  
 
1.2 DEFINITION OF PSYCHOSIS 
 
Psychosis is a broadly defined concept relating to a set of symptoms which exist across 
a range of diagnostic categories; including schizophrenia, schizo-affective disorder, and 
bipolar disorder (Sims, 2002). Psychotic symptoms can also occur outside of these 
diagnoses and, furthermore, secondary psychotic symptoms (i.e. those not occurring 
from psychiatric conditions) have been found to exist in a range of other disorders, 
including dementia and in individuals with brain tumours (Cummings, 1988). A 
psychotic episode is often described as involving a “loss of contact with reality” 
(Overall & Gorham, 1962) and this can be taken as a reflection of the level of disruption 
occurring to an individual’s perceptual and thought processes. Characteristic symptoms 
of psychosis include hallucinations, delusional ideation, and disordered thoughts and 
speech. In addition, these symptoms are frequently accompanied by impaired social 
interaction, poor functioning, and a lack of insight (Cassano, Pini, Saettoni, Rucci, & 
Dell'Oso, 1998; Pini, Cassano, Dell'Oso, & Amador, 2001). When occurring in 
conjunction with disorders of mood (i.e. affective psychosis), the content of symptoms 
is also generally influenced by the nature of the mood (S. Jones & Bentall, 2006). 
 
There are a number of different ways of conceptualising psychosis including the 
diagnostic approach, in which psychotic disorders are studied as single entities; and the 
single symptom approach, which argues that there is utility in investigating the 
individual symptoms of psychosis separately. In contrast to these symptom-focused 
approaches, and due to the varied nature of outcome from psychosis, it may also be 
useful to investigate different types of recovery from psychosis. These three different 
approaches will now be outlined and discussed.  
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1.2.1 Diagnostic Approach 
 
The term psychosis is often used interchangeably with diagnostic terms for psychotic 
disorders, such as schizophrenia, schizoaffective disorder and bipolar disorder (Cutting, 
1985). Traditional psychiatric assessment instruments are used to diagnose these 
disorders and are designed to assess the presence of clinically definable symptoms, 
outlined in psychiatric diagnostic criteria such as the Diagnostic Statistical Manual of 
Mental Disorders (DSM; American Psychiatric Association, 1994) and the International 
Classification of Diseases (ICD; World Health Organisation, 1990). Using these criteria, 
the occurrence of symptoms is viewed as a deviation from an individual’s habitual 
mode of behaviour, i.e. their presence is “abnormal”.  
 
A range of diagnostic tools exist, including the Structured Clinical Interview for DSM 
(SCID; First, Spitzer, Gibbon, & Williams, 1996; Spitzer, Williams, & Gibbon, 1987); 
the Present State Examination (PSE; Wing, Cooper, & Sartorius, 1974); the Schedules 
for Clinical Assessment in Neuropsychiatry (SCAN; Wing et al., 1990); and the Brief 
Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962). These general 
psychopathology measures assess a range of clinically defined disorders and have a 
wider remit than the assessment of psychotic symptoms. Conversely, the Diagnostic 
Interview for Psychosis Diagnostic Module (DIP-DM; Jablensky et al., 1999) is a 
semistructured interview specifically designed for the assessment of psychosis in 
epidemiological and clinical settings. Items are derived and adapted from the SCAN, 
and diagnoses are generated from the Operational Criteria Checklist for Psychotic 
Illness (OPCRIT; McGuffin, Farmer, & Harvey, 1991).  
 
Measures such as those outlined above have been used to examine the epidemiology of 
psychotic disorders and also to investigate their underlying aetiology. These studies will 
now be outlined. 
 
1.2.1.1 Epidemiology 
 
Prevalence rates of psychosis vary depending on the diagnostic category under 
investigation (e.g. schizophrenia, schizoaffective disorder, bipolar disorder, etc).  The 
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lifetime prevalence of schizophrenia and bipolar disorder is approximately 0.7-1% 
(Kendler, Gallagher, Abelson, & Kessler, 1996; Woods, 2000), although individual 
psychotic symptoms have been found to be present in as much as 10-15% of the general 
population (Tien, 1991). The incidence of schizophrenia and other psychotic disorders 
is highest in late adolescence to early adulthood and at this time point, it is males who 
are most affected (Riecher et al., 1989). However, the gender distribution of bipolar 
disorder is more equal (Walden & Grunze, 2004). The incidence of psychosis has been 
found to be associated with a lower socio-economic status; although it is arguable as to 
whether this is a cause or an effect of the disorder (Dohrewend et al., 1992). 
Psychosocial stress is thought to be a prominent trigger factor in psychosis, with 
numerous studies highlighting an association between trauma, significant life events and 
the onset of psychosis (Bebbington et al., 1993; Read & Ross, 2003; Ventura, 
Nuechterlein, Lukoff, & Hardesty, 1989). Social isolation, migration, and victimisation 
are also thought to be important risk factors (Bebbington et al., 2004; Cantor-Graae & 
Selten, 2005; Thornicroft, Bisoffi, de Salva, & Tansella, 1993). 
 
1.2.1.2 Aetiology 
 
The aetiology of psychosis is somewhat debatable, with no singular theory providing a 
definitive account of its occurrence. In the psychiatric literature, there is argument for a 
large organic component to psychosis, focusing particularly on the neurotransmitter 
dopamine (Davis, Kahn, Ko, & Davidson, 1991). Furthermore, neurodevelopmental and 
genetic hypotheses for psychosis have been suggested (Gottesman & Shields, 1982; 
Murray & Lewis, 1987), as well as theories relating to psychological processes (Garety, 
Kuipers, Fowler, Freeman, & Bebbington, 2001). These will now be outlined in more 
detail. 
 
Dopamine Hypothesis. The dopamine hypothesis attempts to explain the 
biological processes accompanying the onset of psychosis. An over-activity of 
dopamine systems in the mesolimbic pathway has been argued to have an influence on 
the positive symptoms of psychosis. Conversely, problems with dopaminergic function 
in the mesocortical pathway have been thought to play a role in the occurrence of 
negative symptoms (Davis et al., 1991). Evidence for the dopamine hypothesis initially 
came from the finding that medications reducing excess levels of dopamine proved 
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successful in reducing psychotic symptoms (Carlsson & Lindquist, 1963). 
Complementary support was provided by the occurrence of amphetamine-induced 
psychosis; a psychotic episode experienced under the influence of amphetamines, which 
act by increasing dopamine levels in the brain (J. A. Lieberman, Kane, & Alvir, 1987). 
Furthermore, neuroimaging studies have shown that when psychotic, patients with 
schizophrenia show a heightened synthesis of dopamine (Reith et al., 1994). 
 
Kapur (2003) further developed the dopamine hypothesis in an attempt to clarify the 
role of the neurotransmitter in psychosis. Mesolimbic dopamine is argued to be 
involved in attributing salience or significance to affectively neutral stimuli, 
transforming them to be either aversive or attractive (Berridge & Robinson, 1998). 
Kapur (2003) suggests that in psychosis there is an increased, often stimulus-
independent release of dopamine, resulting in the aberrant attribution of salience to 
relatively innocuous events and stimuli. It is postulated that this induces a “somewhat 
novel and perplexing state marked by exaggerated importance of certain percepts and 
ideas” (p. 15), leaving individuals confused and searching for an explanation. This is 
argued to form the basis for the development of symptoms such as hallucinations and 
delusions.  
 
Neurodevelopmental Hypothesis. The neurodevelopmental theory of psychosis 
suggests that aberrant brain development; occurring due to the influence of faulty genes 
and/or early neurological insults; leads to a predisposition to the later development and 
onset of the disorder (Murray & Lewis, 1987). The nature of this aberrant brain 
development has been proposed to stem from excessive cortical pruning during 
postnatal development, resulting in a loss of neural elements (Keshavan, Anderson, & 
Pettegrew, 1994). Evidence for this approach comes from studies which have 
demonstrated a higher level of developmental delays in children who later go on to 
develop psychosis (Cannon et al., 2002). Further evidence of a neurological basis to 
psychosis comes from studies demonstrating anomalies of brain structure and function 
in individuals suffering from psychotic disorder (e.g. Chua & McKenna, 1995). More 
recent elaborations of the neurodevelopmental hypothesis postulate the incorporation of 
social factors, such as social isolation and urban upbringing, into the model (e.g. 
Boydell, van Os, McKenzie, & Murray, 2004). This suggests the possibility of an 
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exacerbation of aberrant neurodevelopment due to the interaction of environmental 
influences with biological factors. 
 
Genetic Theories. Genetic theories of psychosis propose an underlying genetic 
component to the disorder, perhaps resulting in a vulnerability to the biological and 
neurological disturbances outlined above. Evidence for this comes from twin studies 
which suggest that a high proportion of the variance in liability to psychosis is genetic 
(Gottesman & Shields, 1982). Individual genes, including neuregulin and dysbindin, 
have recently been highlighted as playing an explicit role in increasing the risk of 
schizophrenia (P. J. Harrison & Owen, 2003). The exact function of these genes is 
unclear but it is suggested that they may have an impact upon dopamine regulation. It 
must be remembered however that genetic predisposition is unlikely to be sufficient for 
the expression of psychosis and that an interaction with environmental factors is most 
probably also required (van Os & Sham, 2003).  
 
Psychological models of psychosis. These models consider the role that 
psychological processes may play in the formation and maintenance of psychotic 
symptoms, and how these can be modified in a therapeutic context. The cognitive model 
of psychosis proposed by Garety, Kuipers, Fowler, Freeman, and Bebbington (2001) 
suggests that a “basic cognitive dysfunction” results in the occurrence of anomalous 
experiences, which are then interpreted and appraised in the context of an individual’s 
life experiences and affective state. Cognitive biases are also argued to influence the 
interpretation of such anomalous experiences. However, rather than one inclusive 
psychological model of psychosis, differential hypotheses exist for the role of 
psychological processes in the development and maintenance of different psychotic 
symptom types. As such, psychological models will be discussed in more detail in a 
later section of this chapter.  
 
Summary. Research has highlighted an underlying biological or organic basis to 
psychosis which, via an influence on early development, creates an individual level of 
vulnerability to the experience of psychotic symptoms in later life; usually in 
adolescence or early adulthood. This vulnerability may be triggered by stress, emotional 
factors, and/or the occurrence of major life events. In addition to this, psychological 
processes play a role in the interpretation of the product of basic biological disturbances, 
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and thus the formation of more specific symptoms. The aetiology of psychosis appears 
to be multi-factorial, with each factor having a variable level of impact amongst 
different individuals, depending on their vulnerability threshold. 
 
1.2.1.3 Treatments for psychosis 
 
Pharmacological treatment. Treatment for psychosis can take a variety of 
forms but the dominant approach often involves the use of antipsychotic medication to 
respond to the excess levels of dopamine thought to be responsible for psychotic 
symptoms (Hirsch & Weinberger, 2003). Pharmacological treatments for psychosis 
were first developed in the 1950s, with the discovery of “typical” antipsychotic 
medications such as chlorpromazine (Cole, Klerman, & Goldberg, 1969). As opposed to 
targeting specific areas of the brain, the action of these medications is somewhat 
generalised. As such, their benefits are accompanied by a range of side effects that can 
cause equal amounts of distress as the psychosis itself. To some extent these problems 
have been overcome by the introduction of “atypical” and more specific antipsychotic 
medications, which only target the parts of the brain thought to be important in the 
occurrence of psychotic illnesses, such as the limbic system (Moghaddam & Bunney, 
1990). These medications include clozapine, olanzapine and risperidone and large scale 
randomised controlled trials have suggested that as well as producing less side-effects, 
they are also more effective than typical antipsychotic drugs in reducing psychotic 
symptoms (Kane, Honigfield, Singer, & Meltzer, 1988).   
 
Although there are distinct benefits to the use of medication in psychosis, drugs are not 
a cure for the disorder, but instead alleviate the associated symptoms (Gitlin et al., 
2001). Due to unpleasant side effects, such as involuntary movements, weight gain, 
drowsiness, physical health problems and sexual dysfunction; compliance with 
medication is often problematic (Coldham, Addington, & Addington, 2002; Kampman 
et al., 2002). Furthermore, some individuals are found to be unresponsive to medication 
altogether (Garety, Fowler, & Kuipers, 2000; Whitaker, 2004).   
 
Psychological treatment. Psychological treatments have recently been 
utilised in addition to drugs in an attempt to successfully target the symptoms and 
impact of psychosis.  Although medication may reduce the intensity and frequency of 
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experiences such as voices by reducing dopamine release; it cannot alter the 
interpretation or psychological impact of these symptoms (Kapur, 2003). Similarly, 
whilst psychological therapies may not directly affect dopaminergic activity; they can 
change the way an individual views themselves and the world, and therefore how they 
interpret their psychotic experiences. Psychosocial interventions can also reduce the 
distress associated with psychotic experiences; promote awareness of early warning 
signs; and provide coping strategies to be used when these signs occur (Rector & Beck, 
2001). Thus, it is increasingly recognised that psychological treatments can reduce the 
probability of psychotic relapse (Kuipers et al., 1997). Cognitive-behaviour therapy 
(CBT) is perhaps the most well-documented psychological approach in psychosis 
although other interventions include family therapy and social, cognitive and 
occupational rehabilitation approaches (Pilling, Bebbington, Kuipers, Garety, Geddes, 
Martindale et al., 2002; Pilling, Bebbington, Kuipers, Garety, Geddes, Orbach et al., 
2002). Many of these therapies are evidence-based, utilising research highlighting the 
importance of particular psychological processes in psychosis (Brenner & Pfammatter, 
2000).   
 
1.2.1.4 Problems with the diagnostic approach 
 
Psychiatric diagnoses provide a way of labelling certain types of behaviour and 
experiences and are also useful in terms of deciding the appropriate course of treatment 
for a given disorder. However, despite highlighting the presence of psychotic disorder, 
the diagnostic approach does not provide an explanation of the causes of psychotic 
symptoms (Bentall, 2004). In addition it does not reflect the variability present within 
psychotic disorders. Indeed, two individuals may have the same diagnosis but yet have 
both completely different presentations and outcomes (Bentall, Jackson, & Pilgrim, 
1988). Moreover, studies have suggested that clinicians often disagree about diagnostic 
classification, and that diagnostic practices can differ cross-culturally (Brockington, 
1992; van Os, Gilvarry et al., 1999). These flaws have led researchers to suggest that a 
“single symptom” approach may provide a better way of investigating the underlying 
mechanisms responsible for the development and maintenance of psychotic phenomena 
(Persons, 1986). This approach will be discussed in the next section.  
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1.2.2 Single Symptom Approach  
 
The single symptom approach to psychosis proposes the importance of studying single 
symptoms of psychosis in their own right (e.g. Freeman, Garety, Kuipers, Fowler, & 
Bebbington, 2002; Oltmanns & Maher, 1988; Slade & Bentall, 1988). This method of 
study combats the flaws of the diagnostic approach and also enables the isolation of 
single elements of pathology for study (Persons, 1986). Using this approach, individuals 
with psychosis can be classified in terms of their current problems, and treated 
accordingly, rather than being considered as a homogenous group (Allardyce, Suppes, 
& van Os, 2007). 
 
1.2.2.1 Types of psychotic symptoms 
 
Despite the idiosyncratic nature of psychotic symptoms, common themes have been 
highlighted. This has enabled the broad categorisation of psychotic phenomena into 
three different types: “positive symptoms”, “negative symptoms”, and “disorganised 
symptoms”. This idea was first proposed by Strauss, Carpenter, and Bartko (1974) who 
built upon Crow’s (1980) positive and negative dimensions of psychosis, and has since 
been supported by numerous factor analytic studies (e.g. Arndt, Alliger, & Andreasen, 
1991; Liddle, 1987; Peralta, de Leon, & Cuesta, 1992). The different symptom types 
present in psychosis will now be discussed further. It is important to note that there is 
great variability both within and between patients. Thus, not all of types of symptoms 
will be experienced by every individual suffering with psychosis and some symptoms 
may be more prominent than others. 
 
Positive Symptoms. Positive psychotic symptoms reflect the presence of 
experiences in the individual suffering with psychosis which are not present in the 
experiences of a non-psychotic individual (Cutting, 2003). Positive symptoms include 
hallucinations and delusions (Sims, 2002). Hallucinations are defined as sensory 
perceptions occurring in the absence of external stimuli. Delusions are defined as fixed 
false beliefs which are held with strong conviction and not shared by the individual’s 
social environment. As with all types of human experience, the form and content of 
hallucinations and delusions varies considerably between individuals. Hallucinations 
can occur across a range of sensory modalities, including visual, auditory, gustatory, 
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olfactory and tactile domains (Bentall, 1990). Similarly, delusions can adopt numerous 
themes and fall into a variety of categories; including persecutory, religious and 
grandiose ideation (Garety & Hemsley, 1994). Other forms of positive psychotic 
symptoms include the so-called first-rank symptoms of schizophrenia, as defined by 
Schneider (1959). These are symptoms once thought to be particularly characteristic of 
schizophrenia. In addition to auditory hallucinations and delusions, first-rank symptoms 
include phenomena such as thought insertion, thought withdrawal and thought 
broadcast.  
 
Negative Symptoms. In contrast to positive symptoms, negative symptoms refer 
to abilities that are “lost” or diminished in sufferers of psychosis (Cutting, 2003). 
Negative symptoms may remain even in periods of remission from positive symptoms 
and can be very debilitating (Ellenbroek & Cools, 2000). They are often linked with a 
poor outcome and problems with functioning (Blanchard, Mueser, & Bellack, 1998). 
These symptoms include a lack of motivation, flattened affect, social withdrawal, 
poverty of speech, and reduced emotion. Furthermore it may appear that an individual is 
unable to experience pleasure and this is referred to as physical and social anhedonia 
(Kirkpatrick & Buchanan, 1990). 
 
Disorganised Symptoms. These symptoms refer to the disordered behaviour, 
speech and thought, often displayed by individuals suffering with conditions such as 
schizophrenia (Cutting, 2003). It could be argued that disorganised symptoms are a 
reflection of the broader cognitive disorganisation which potentially underlies psychosis 
(Basso, Nasrallah, Olson, & Bornstein, 1998). Disordered thought is often indicated by 
abnormal spoken language, whereby conversation may erratically jump from one topic 
to another. Alternatively, there may be a breakdown in grammatical structure such that 
speech appears illogical (Sims, 2002). Disorganised behaviour may include that which 
is considered inappropriate according to social norms, or abnormalities in mannerisms 
or posture (M. F. Green, 2001). These phenomena may appear objectively bizarre and 
as such can lead to problems in conducting the activities of daily life. Despite this, 
disorganised symptoms are not thought to be a predictor for subsequent quality of life 
following a psychotic episode (Ho, Nopoulos, Flaum, Arndt, & Andreasen, 1998). 
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1.2.2.2 Assessing single symptoms of psychosis 
 
Single symptoms of psychosis can be assessed using a range of measures, including the 
Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987). Rather 
than a diagnostic tool, the PANSS is designed to assess the presence and severity of 
positive, negative and general features of schizophrenia, based on items adapted from 
the BPRS. Operational criteria are provided for each item and ratings are made on the 
basis of both an interview and observations made by care staff and relatives. The 
authors have reported acceptable inter-rater, test-retest and internal reliability and the 
measure is often used to rate psychotic symptoms both clinically and for research 
purposes. Scales of a similar nature to the PANSS include the Scale for the Assessment 
of Negative Symptoms and the Scale for the Assessment of Positive Symptoms 
(SANS/SAPS; Andreasen, 1981, 1984). Devised as part of the Comprehensive 
Assessment of Symptoms and History (CASH; Andreasen, Flaum, & Arndt, 1992), 
these scales rate the presence and severity of negative and positive symptoms of 
schizophrenia using both interview and observational techniques. Both scales provide 
detailed clinical definitions for a large number of symptoms; have been demonstrated to 
have good internal reliability and validity; and are widely used in psychosis research 
(Grube, Bilder, & Goldman, 1998; Malla, Norman, & Williamson, 1993). 
 
1.2.2.3 Aetiology of single symptoms of psychosis 
 
Rather than proposing an all-inclusive explanation of the occurrence of psychosis, the 
single symptom approach aims to outline how specific psychological (or biological) 
processes may be involved in the development and maintenance of specific symptoms. 
Research in this area has mostly focused on the positive symptoms of psychosis. The 
finding that there are differential associations between psychological processes and 
different symptom types suggests that there may be independent mechanisms, and thus 
causal pathways, underlying the symptoms of psychosis. These will now be discussed in 
more detail.  
 
Hallucinations. Hallucinations have been argued to stem from both 
difficulties integrating information into its temporal and spatial context (Hemsley, 
1993); and problems with self-monitoring, such that the individual’s own actions are 
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experienced as external and alien (Frith, 1992). In addition, other cognitive deficits have 
been highlighted in psychosis, including problems with executive function, memory and 
attention (M. F. Green, 1992). It is suggested that subtle deficits in information 
processing may leave individuals vulnerable to hallucinatory experiences, potentially 
via an increased sensitivity to stress (Cosway et al., 2000; McEwen & Sapolsky, 1995; 
Myin-Germeys, Krabbendam, Jolles, Delespaul, & van Os, 2002). Morrison (2001) 
builds on this notion of increased stress sensitivity, suggesting that hallucinations may 
be intrusions, similar to those occurring in anxiety disorders, but which have been 
misinterpreted as external events.  
 
Whilst the presence of hallucinations has been attributed to a cognitive dysfunction, 
their content and associated distress have been linked to core beliefs that an individual 
holds about themselves and others based on their previous experiences (Smith et al., 
2006). This fits with the cognitive model of psychosis (Garety et al., 2001) which 
suggests that psychotic symptoms are often personally meaningful and can be 
understood in the context of the individual’s personal history. 
 
Delusions. Delusions have been conceptualised as interpretations of 
anomalous experiences, arising as a result of normal cognitive processes (Garety et al., 
2001). Maher (1988) suggests that extreme emotional reactions to anomalous 
experiences may trigger a search for explanation and meaning, potentially resulting in 
delusion formation. Furthermore, Garety et al. (2001) describe the role of cognitive 
biases in the development and maintenance of delusions. These are hypothesised to 
include a “jumping to conclusions” data gathering bias, which acts by prematurely 
terminating the search for meaning before full evidence has been acquired, often 
resulting in the adoption of a delusional appraisal (Garety & Hemsley, 1994). An 
externalising attribution bias has also been found to exist in individuals with psychosis, 
such that negative events are often attributed to an external source, e.g. other people or a 
conspiracy (Bentall, Kinderman, & Kaney, 1994). This may fuel the development of 
persecutory beliefs. Furthermore, Frith (1992) suggests that people with psychosis may 
suffer from a “theory of mind” deficit, such that they find it difficult to understand the 
mental representations of others (i.e. what another person is thinking based on clues 
from their actions and conversation). This could potentially result in a paranoid 
misinterpretation of the intentions of other people. 
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The cognitive model of psychosis suggests that cognitive biases operate in the context 
of an individual’s core beliefs about both themselves and the world around them, also 
known as schema (Fowler, Freeman, Smith et al., 2006). Schematic beliefs develop 
based on life experiences and may in turn have an effect on the way any anomalous 
experiences are interpreted (Garety et al., 2001). For example, if events in an 
individual’s life have led them to believe that other people are bad and that they are 
vulnerable, for example as a result of victimisation or trauma exposure; they may have a 
tendency to feel paranoid in anxiety provoking and ambiguous situations. Different 
schematic beliefs have been found to underlie different delusion subtypes (Fowler, 
Freeman, Smith et al., 2006). 
 
1.2.2.4 Problems with the single symptom approach 
 
Although the single symptom approach is more informative than the diagnostic 
approach in terms of highlighting the potential mechanisms underlying psychotic 
phenomena, it remains focused on symptoms as the major problem in psychosis. 
Moreover, it is mainly concerned with acute psychotic symptoms, with measures such 
as the SAPS and PANSS being relatively insensitive to minor symptom fluctuations 
(Leucht et al., 2005; Santor, Ascher-Svanum, Lindenmayer, & Obenchain, 2007). As 
such, symptom approaches ignore other aspects of psychosis, such as an individual’s 
emotional response to the experience of psychosis as a major life event (Anthony, 1993; 
Gumley, White, & Power, 1999). Moreover, symptom approaches alone do not account 
for the heterogeneity of outcome present in psychotic disorders (Allardyce et al., 2007; 
Liberman & Kopelowicz, 2002). Therefore, a further way in which psychosis can be 
conceptualised is in terms of different types of recovery or outcome. This approach will 
be discussed in the next section. 
 
1.2.3 Recovery from Psychosis 
 
Psychosis is traditionally viewed as a debilitating condition with a poor outcome 
(Bleuler, 1908; Kraepelin, 1919). However, more recent studies have highlighted the 
heterogeneous nature of recovery from psychosis (Harding, Brooks, Ashikaga, Strauss, 
& Breier, 1987; G. Harrison et al., 2001). A study by Davidson and McGlashan (1997) 
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investigated the different outcomes experienced by individuals with psychotic 
diagnoses. About one third of patients were shown to experience a “good outcome”, 
involving full remission of symptoms and limited problems with social and 
occupational functioning. Many other individuals experienced continuing residual 
symptoms and a relatively high level of social disability, with a smaller proportion of 
patients suffering repeated episodes of psychosis throughout their lives. Whatever the 
outcome, experiencing an episode of psychosis can be a very traumatic life event 
affecting an individual’s confidence, self-esteem and functioning (McGorry et al., 
1991). The complex nature of recovery from psychosis is reflected heavily in the 
literature. Studies generally focus around three main aspects of recovery: symptomatic 
recovery; functional recovery; and emotional and psychological well-being. These will 
now be discussed in more detail. 
 
1.2.3.1 Positive symptom recovery 
 
Symptomatic recovery from psychosis (i.e. the remission of hallucinations and 
delusions) is an important aspect of the recovery process and often forms the initial 
phase. This is what McGorry (1992) refers to as recovering from the “primary 
impairment” of psychosis. Recovery from positive psychotic symptoms is often 
dependent on an individual’s response to medication (Johnstone, Crow, Frith, Carney, 
& Price, 1978; Kapur & Mamo, 2004), although psychological therapies have also been 
shown to be efficacious in symptom reduction (Fowler, Garety, & Kuipers, 1995; 
Kuipers et al., 1997; Wykes, Steel, Everitt, & Tarrier, 2008). Estimates vary in the 
literature, but it is suggested that around 12-50% of individuals make a full 
symptomatic recovery from an initial episode of psychosis, depending on when it was 
diagnosed and how it was treated (Jablensky et al., 1992; P. Mason et al., 1995; Rosen 
& Garety, 2005; M. Shepherd, Watt, Falloon, & Smeeton, 1989; Whitehorn, Lazier, & 
Kopala, 1998; Wiersma, Nienhuis, Slooff, & Giel, 1998). However, length of follow-up 
varies between studies and figures do not always take into account the prevalence of 
future psychotic relapse. 
 
Recovery from psychotic symptoms has been hypothesised to occur through a number 
of different stages, and these have been argued to be a mirror image of the stages 
occurring in the development of psychotic symptoms. This is known as the “rollback 
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phenomenon” (Detre & Jarecki, 1971; Fava, 1999). Symptomatic recovery is proposed 
to involve a reduction in the frequency and severity of symptoms, combined with a 
gradual increase in insight and awareness. This may be accompanied by anxiety and 
depression as the individual begins to come to terms with what has happened to them 
(Carr, 1983; Drury, 1992; Sacks, Carpenter, & Strauss, 1974). These symptom recovery 
stages have been supported by research conducted on a large sample of individuals 
following the administration of antipsychotic medication (Mizrahi, Bagby, Zipursky, & 
Kapur, 2005). In this study, participants reported less cognitive and emotional 
preoccupation with symptoms shortly after the administration of medication, e.g. the 
idea or percept “doesn’t bother me as much” (Winkelman, 1954). However, complete 
resolution of symptoms took longer to achieve and the authors suggest that, although 
antipsychotic medication may dampen the salience of psychotic phenomena, symptoms 
may require additional psychological deconstruction (Kapur, 2003). 
 
Based on the above literature, individuals in recovery from a psychotic episode may 
experience residual symptoms which are low-level and arguably subclinical in nature, 
even when full-blown psychotic symptoms have remitted. This supports the use of a 
schizotypy measure to assess such phenomena, rather than a traditional psychosis 
assessment tool such as the PANSS (Kay et al., 1987). Low-level symptoms may have 
implications for relapse (Jorgensen, 1998; Subotnik & Nuechterlein, 1988) and also for 
quality of life and social recovery; although this is less clear (Malla & Payne, 2005). 
Thus, it is important that they are monitored. However, it must be remembered that 
symptomatic recovery is only one part of the wider recovery process. Indeed, although 
psycho-education about symptom management has been shown to be important, 
particularly in terms of preventing relapse by the acknowledgement of early warning 
signs (Birchwood et al., 1989; Gumley et al., 2003; Leete, 1989); the psychological 
impact of psychosis also needs to be considered (Mueser, Corrigan et al., 2002). 
 
1.2.3.2 Functional recovery 
 
Although variable, social and functional outcome in psychosis is frequently reported as 
poor, with long-term follow-up studies suggesting that less than 50% of people with 
non-affective psychosis achieve a social recovery, and only 10-20% of people return to 
competitive employment (G. Harrison, Croudace, Mason, Glazebrook, & Medley, 1996; 
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Jablensky et al., 1992; Johnstone, Macmillan, Frith, Benn, & Crow, 1990), despite the 
majority suggesting that they wish to work (Mueser, Salyers, & Mueser, 2001). Around 
50% of people with bipolar disorder also fail to return to work and remain disabled 
(Tsai et al., 2001). Thus, many aspects of social functioning are affected by psychosis 
including employment, relationships and recreational activities (Birchwood, Smith, 
Cochrane, Wetton, & Copestake, 1990). 
 
Studies have suggested numerous predictors of poor functional recovery from 
psychosis, including poor premorbid adjustment, adolescent onset of psychosis, lack of 
social support, and high levels of negative symptoms (Addington, Young, & Addington, 
2003; Ho et al., 1998; Liberman, Kopelowicz, Ventura, & Gutkind, 2002; Schmidt, 
Blanz, Dippe, Koppe, & Lay, 1995). In addition, external societal factors have been 
hypothesised to be important, including the availability of roles in education and work 
within the local labour marker (Warner, 1985). Local economic factors, government 
policy, and individual variations in cultural values may also affect social recovery. It is 
likely that these relationships are mediated by societal effects on personal psychological 
factors, such as feelings of stigmatisation, beliefs about self and others, and the 
experience of social anxiety. Indeed, the emotional impact of psychosis has been 
postulated as a further explanation for poor social functioning (C. Jackson & Iqbal, 
2002). 
 
Published criteria state that functional improvement should be a core component when 
defining recovery from psychosis (e.g. Liberman et al., 2002; Whitehorn, Brown, 
Richard, Rui, & Kopala, 2002). However, this aspect of the recovery concept is seldom 
defined in psychiatric literature, with different studies using different measures to assess 
social outcome (Malla & Payne, 2005). For example, some studies utilise strict 
definitions when assessing functional recovery (i.e. at least ten hours per week in paid 
employment for at least a 12-month period); whereas others are much more subjective 
and define recovery as “getting back to normal” (Anthony, 1993; Hoffmann & Kupper, 
2002). A major problem with defining and assessing functional recovery in psychosis is 
the lack of appropriate measures to do so. Existing measures designed to assess this 
dimension rely heavily on whether or not people have returned to competitive 
employment (e.g. American Psychiatric Association, 2000b; Beecham & Knapp, 1992; 
Goldman, Skodol, & Lave, 1992). Although work will always be a key marker of social 
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recovery, it is not the only marker of social improvement and there is a need to consider 
engagement in other domains of activity, such as voluntary work, education, and 
structured social activity. These activities may have a positive impact on confidence and 
self-esteem and thus be an important precursor to more formal involvement in economic 
activity such as work or education. In a longitudinal study, Wing and Brown (1970) 
showed that reduced time spent doing nothing, and increased social contact were the 
most reliable predictors of improvement in psychosis. However, few social functioning 
measures for use in psychosis measure daily activity and as such are insensitive to 
change on these domains. 
 
In addition to research outlined above, service user literature suggests that “rebuilding 
life” and “reconnecting with the environment” are important aspects of recovery from 
psychosis (Chadwick, 1997; Pitt, Kilbride, Nothard, Welford, & Morrison, 2007). In a 
review of the recovery literature, Mueser et al. (2002) suggest that “recovery refers not 
only to short-term and long-term relief from symptoms, but also to social success and 
personal accomplishment in areas that the person defines as important” (p. 1273). This 
is corroborated in the service user literature and particularly by a personal account by 
Leete (1989), who states that:  
 
As I work, I become increasingly self-confident, and my self-image is bolstered. 
I feel important and grown-up, which replaces my usual sense of vulnerability, 
weakness and incompetence. Being a member of a work force decreases stigma 
and contributes to acceptance by my community, which in turn makes my life 
easier. (p. 197) 
 
Thus, although symptomatic improvement does not necessarily result in functional 
improvement following psychosis; increased activity, and particularly work, can be 
therapeutic and have a positive impact on symptoms (Burns et al., 2007). Indeed, in 
another personal account, a service user explained how increased social contact actually 
reduced their feelings of paranoia (Anonymous, 1989). Research suggests that increased 
activity promotes other aspects of recovery via its positive effects of confidence and 
self-esteem; and potentially as a result of providing distraction from persistent 
symptoms (Waddell & Burton, 2006). Thus, functional recovery is an important area for 
research which should be considered in its own right rather than as an epiphenomenon 
of psychosis. 
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1.2.3.3 Emotional and psychological well-being 
 
Psychosis has been described as an experience of sheer terror and panic (Forchuk, 
Jewell, Tweedell, & Steinnagel, 2003). Thus, encountering an episode of psychosis can 
be considered as a major life event with the potential to impact heavily upon emotional 
status and evaluative beliefs about self and others (McGorry et al., 1991; Morrison, 
Frame, & Larkin, 2003). Indeed, the experience of psychosis can be extremely 
personally threatening, particularly if the episode involved feelings of persecution 
(Shaner & Eth, 1989). This in turn can have a wider impact on long-term recovery from 
psychosis, even when symptoms have subsided (Chadwick, 1997; Fowler, 2002). 
Studies investigating the emotional and psychological impact of psychosis can be 
broadly split into two types: those examining the prevalence of emotional and 
psychological distress in large samples using standardised assessment tools; and smaller 
qualitative studies describing personal accounts of psychosis. 
 
Social anxiety has been highlighted as a common feature of psychosis, with Social 
Anxiety Disorder (SAD) proposed to be present in up to one in three individuals with a 
diagnosis of schizophrenia (Birchwood et al., 2006). Social anxiety often emerges 
during the recovery phase and is argued to be reactive to the psychotic episode (Pallanti, 
Quercieli, & Hollander, 2004). Such anxiety is hypothesised to contaminate social 
interaction, thus leading to social withdrawal and poor functioning (Birchwood et al., 
2006). Social withdrawal following psychosis is hypothesised to protect the self from 
the stigmatising views of society (Strauss, 1989). However, this may result in social 
isolation which can have devastating effects on an individual’s self-esteem and in turn 
lead to increased social withdrawal (Garety et al., 2001).  Indeed, there is evidence to 
suggest that an acute episode of psychosis is often accompanied by a reduction in social 
networks (Erickson, Beiser, & Iacono, 1999) which are very rarely replaced (H. J. 
Jackson & Edwards, 1992). 
 
Depression is a further emotional disturbance which has been found to arise in the 
recovery stages of psychosis. A prospective study of post-psychotic depression (PPD) 
found that 36% of a group of 115 participants experienced low mood following 
psychosis (Birchwood, Iqbal, Chadwick, & Trower, 2000). Moreover, PPD has been 
found to be related to more frequent psychotic relapses, poorer social functioning, and 
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even suicide (Drayton, Birchwood, & Trower, 1998; Power et al., 2003). Inextricably 
linked with anxiety and depression, low self-esteem and elevated negative beliefs about 
self have also been highlighted as common in individuals recovering from psychosis 
(Gumley, O'Grady, Power, & Schwannauer, 2004; Gureje, Harvey, & Herrman, 2004). 
Furthermore, societal stigma may contribute towards negative beliefs about others (i.e. 
feelings that other people are hostile), thus producing threat responses and exacerbating 
residual paranoia (Birchwood, 2003; Trower & Gilbert, 1989).  
 
Emotional disturbance during the recovery stages of psychosis is hypothesised to occur 
as a result of cognitive appraisals of psychosis, including loss of role, and feelings of 
hopelessness, shame and stigma (Birchwood, Mason, MacMillan, & Healy, 1993). 
Birchwood et al. (2006) illustrated that individuals experiencing social anxiety 
following an episode of psychosis, experienced greater shame attached to their 
diagnosis and also felt more socially marginalised than individuals without social 
anxiety. These associations remained even when controlling for depression. Estroff 
(1989) further postulates that social anxiety in schizophrenia may be triggered by the 
loss of social status that the stigma of “becoming a schizophrenic” often entails. 
Moreover, PPD is hypothesised to be linked with loss of autonomy and social role, 
combined with feelings of being entrapped in psychosis (Rooske & Birchwood, 1998). 
Anthony (1993) further elaborates on the concept of loss and suggests that recovery 
from the consequences of mental distress can be more difficult than recovery from 
symptom-related distress itself.  
 
Personal accounts of recovery from psychosis also describe the lack of positive emotion 
present following an episode of psychosis (e.g. Chadwick, 1997; Deegan, 1997), 
including disempowerment and a loss of hope with regard to the future (Noordsy et al., 
2002). This feeling of hopelessness is often instilled at a very early stage of the illness 
and is hypothesised to be related to the traditional idea that individuals with psychosis, 
particularly schizophrenia, will experience an inevitable and progressive downhill 
course (Corrigan, Giffort, Rashid, Leary, & Okeke, 1999). Overcoming this 
preconception is one of the main elements of recovery outlined in service user literature, 
a particular focus of which is the recovery of self-identity and regaining a sense of 
control and mastery over one’s life (Deegan, 1988; Leete, 1989; Lovejoy, 1984; Pitt et 
al., 2007; Unzicker, 1989). In a review of this literature, Anthony (1993) defines 
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recovery as “a way of living a satisfying, hopeful, and contributing life even with the 
limitations caused by mental illness” (p. 14). He also refers to “the development of new 
meaning and purpose in one’s life as one grows beyond the catastrophic effects of 
mental illness” (p. 14).  
 
1.2.3.4 Summary of recovery literature 
 
In summary, psychosis recovery literature focuses on numerous factors which are likely 
to be important when considering recovery from a psychotic episode. These include 
symptomatic recovery, functional recovery, and emotional and psychological well-
being. Most studies tend to focus on these individual components in isolation when 
investigating recovery. However, it is likely that the different dimensions of recovery 
are overlapping and that individuals will encounter elements of numerous dimensions 
but at varying levels of severity, and at different time points throughout the recovery 
process (Liberman & Kopelowicz, 2002). Despite this, social disability and emotional 
recovery have always been argued to be somewhat separate issues to symptoms in 
psychosis, with improvement in the latter not necessarily dictating improvement in the 
former (e.g. Ganev, 2000). This thesis will argue that a psychological model 
incorporating low-level psychotic or schizotypal symptoms, which exist after the 
remission of the acute phase, may help to bridge this symptom-disability gap. The 
concept of schizotypal symptoms will be defined and discussed in the next section. 
 
1.3 DEFINITION OF SCHIZOTYPY 
 
Schizotypy is traditionally viewed as a non-pathological personality trait, akin to 
Schizotypal Personality Disorder (SPD) but occurring at a much lower level of severity; 
with lower levels of distress; and where social and occupational functioning are 
unaffected (Claridge, 1997b). Schizotypal symptoms resemble those outlined in DSM-
IV criteria for SPD (e.g. social isolation, odd behaviour and thinking, and unusual 
perceptual experiences; see Table 1.1) and can also be thought of as being 
phenomenologically similar to low-level psychotic symptoms. Indeed, the presence of 
schizotypy is thought to denote an underlying genetic or biological vulnerability to 
psychosis (Meehl, 1990). Evidence for this approach comes from studies highlighting 
the increased presence of schizotypal personality traits in the relatives of patients with 
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psychotic disorders (Grove et al., 1991). In addition to this, longitudinal studies have 
suggested that transition rates to psychosis are higher in schizotypal than non-
schizotypal individuals (Morrison et al., 2002). Whether or not an individual goes on to 
develop psychosis is thought to depend upon the interaction of their schizotypal 
predisposition with social and environmental conditions (Meehl, 1990). For example, if 
adverse life events occur, the individual may make the transition to psychosis. However, 
if environmental conditions are benign then it is likely that the individual will remain 
schizotypal, displaying characteristics which are reminiscent of psychosis but where the 
disorder itself is not present. Thus, it is argued that schizotypy exists on a continuum 
with psychosis (Meehl, 1990).  
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Table 1.1  
DSM-IV Diagnostic Criteria for Schizotypal Personality Disorder (American 
Psychiatric Association, 1994) 
 
 
 
A. A pervasive pattern of social and interpersonal deficits marked by acute 
discomfort with, and reduced capacity for, close relationships as well as by 
cognitive or perceptual distortions and eccentricities of behaviour, beginning by 
early adulthood and present in a variety of contexts, as indicated by five (or 
more) of the following: 
1. ideas of reference (excluding delusions of reference) 
2. odd beliefs or magical thinking that influences behaviour and is 
inconsistent with subcultural norms (e.g. superstitiousness, belief in 
clairvoyance, telepathy, or “sixth sense”; in children and adolescents, 
bizarre fantasies or preoccupations 
3. unusual perceptual experiences, including bodily illusions 
4. odd thinking and speech (e.g. vague, circumstantial, metaphorical, 
overelaborate, or stereotyped) 
5. suspiciousness or paranoid ideation 
6. inappropriate or constricted affect 
7. behaviour or appearance that is odd eccentric or peculiar 
8. lack of close friends or confidants, other than first-degree relatives 
9. excessive social anxiety that does not diminish with familiarity and tends 
to be associated with paranoid fears rather than negative judgments about 
self 
 
B. Does not occur exclusively during the course of Schizophrenia, a Mood Disorder 
with Psychotic Features, another Psychotic Disorder, or a Pervasive 
Developmental Disorder. 
 
Note: If criteria are met prior to the onset of Schizophrenia, add “Premorbid”, e.g. 
“Schizotypal Personality Disorder (Premorbid)” 
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1.3.1 Epidemiology of Schizotypy 
 
The prevalence of SPD is approximately 0.06-2.4%, depending on how it is assessed 
(Torgersen, Kringlen, & Cramer, 2001). Although this suggests that SPD is rare, a study 
conducted by Tien, Costa, and Eaton (1992) has proposed that personality traits in this 
domain are not. Forty percent of individuals surveyed were found to display DSM-III-R 
schizotypal personality traits without meeting full diagnostic criteria for personality 
disorder itself. This finding has since been replicated in other studies (e.g. Goulding, 
2005; Johns & van Os, 2001; Joseph & Diduca, 2001; Verdoux et al., 1998). 
 
Epidemiologically, the characteristics of individuals displaying schizotypal traits have 
been shown to be similar to those of individuals with psychosis. For example, gender 
and age differences found in schizophrenia have also been found to be reflected in 
dimensions of schizotypy (Spauwen, Krabbendam, Lieb, Wittchen, & van Os, 2003; 
Venables & Bailes, 1994). Furthermore, the social and environmental risk factors 
associated with schizophrenia, such as urbanicity and childhood trauma, have also been 
shown to be associated with increased levels of schizotypy (Krabbendam, Myin-
Germeys, & van Os, 2004).  
 
1.3.2 Aetiology of Schizotypy 
 
The aetiology of schizotypy remains largely unknown, although it is argued that the 
construct shares similar aetiological mechanisms to those found in psychosis (e.g. 
Barkus, Stirling, Hopkins, & Lewis, 2006). Indeed, individuals with increased 
schizotypy scores have been shown to have increased levels of dopamine (Mohr, 
Landis, Sandor, Fathi, & Brugger, 2004), and to carry the COMT gene; a gene 
postulated to be important in the expression of schizophrenia (Avramopoulos et al., 
2002). Moreover, schizotypal individuals show similar deficits in brain structure and 
function as individuals diagnosed with psychosis (Byrne, Hodges, Grant, Owens, & 
Johnstone, 1999; Raine, Sheard, Reynolds, & Lencz, 1992). On an individual symptom 
level, processes thought to underlie hallucinations and delusions in psychosis have also 
been shown to be related to anomalous experiences and low-level paranoia in non-
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clinical samples (e.g. Freeman, Garety et al., 2005; Morrison, Wells, & Nothard, 2000). 
Individual schizotypal symptoms will now be discussed in more detail. 
 
1.3.3 Types of Schizotypal Symptoms 
 
Factor analytical studies of schizotypal phenomena in non-clinical populations have 
highlighted that they broadly fit into the same categories as psychotic symptoms (e.g. 
Bentall, Claridge, & Slade, 1989). The exact number of factors deemed to constitute 
schizotypy varies between studies, as do the labels attributed to them (Claridge, 1997a). 
Furthermore, there are methodological limitations in that different studies use different 
populations and measures of schizotypy to assess underlying factor structure (Suhr & 
Spitznagel, 2001). However, major reviews of factor analytic studies suggest that there 
is general evidence for “positive”, “negative”, and “disorganised” symptom dimensions 
of schizotypy (Claridge et al., 1996; Venables, 1995; Vollema & van den Bosch, 1995).  
 
1.3.3.1 Positive schizotypal symptoms 
 
The positive schizotypal symptoms factor is the most common factor emerging from 
factor analysis studies (Vollema & van den Bosch, 1995). It relates to unusual 
perceptual experiences and magical thinking styles and beliefs; arguably analogous to 
hallucinatory and delusional psychotic experiences. Unusual perceptual experiences do 
not specifically refer to hallucinatory-like occurrences, but also to perceptual distortions 
and hypersensitivities to sounds and smells, potentially forming the basis for later 
hallucinations (V. Bell, Halligan, & Ellis, 2006). Feelings of “de ja vu” and “presque 
vu” are other experiences included in this category (McCreery & Claridge, 2002). Odd 
beliefs and magical ideation may include extreme religious beliefs or conviction in ideas 
such as telepathy, ESP, and clairvoyancy (Chequers, Joseph, & Diduca, 1997; Clarke, 
1991). It is important to remember that positive schizotypal symptoms are not 
necessarily pathological in themselves. Many individuals are not distressed by their 
experiences and can successfully integrate them into their lives (M. Jackson, 1997). 
However, these phenomena could be considered as analogous to the “anomalous 
conscious experiences” which feature in Garety et al’s (2001) cognitive model of 
psychosis.  
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Some studies have renamed this factor the “cognitive-perceptual” component of 
schizotypy, reflecting the nature of the phenomena included in this domain and creating 
some ideological distance from psychotic symptomatology (Bergman et al., 1996; Raine 
et al., 1994). Furthermore, others have separated positive schizotypal symptoms into 
two factors, usually distinguishing unusual perceptual experiences from paranoid-like 
beliefs (Suhr & Spitznagel, 2001). 
 
1.3.3.2 Negative schizotypal symptoms 
 
Negative schizotypal symptoms refer to phenomena relating to social withdrawal and 
anhedonia (Bergman et al., 1996). It could be argued that these symptoms are 
reminiscent of the notion of the reduced ability or expectation of psychotic individuals 
to experience pleasure from social and physical stimulation. However, other studies 
suggest that in schizotypy, this factor has a more specific social anxiety and social 
impairment connotation rather than referring to physical anhedonia (Gruzelier, 1996; 
Venables & Rector, 2000). Indeed, Raine et al. (1994) labelled this factor “Interpersonal 
Schizotypy”, with loadings from schizotypal symptom types such as excessive social 
anxiety, constricted affect, and a lack of close friends. Moreover, O. Mason, Claridge, 
and Williams (1997) refer to this factor as a tendency towards introverted, emotionally 
flat and asocial behaviour.    
 
1.3.3.3 Disorganised schizotypal symptoms 
 
This factor refers to a tendency for thoughts and speech to become disorganised, 
perhaps reflecting the same underlying cognitive disorganisation shown to be present in 
psychotic illness (Liddle, 1987). Types of schizotypal phenomena loading on this factor 
include odd behaviour and odd speech (Raine et al., 1994; Vollema & Hoijtink, 2000) 
including symptoms such as unusual mannerisms; eccentric habits; and bizarre usage of 
words. Gruzelier (1996) has suggested a link between this factor and eccentricity. Some 
studies have argued for the existence of an “asocial” component as well as, or as an 
alternative to, the disorganised factor of schizotypy (e.g. Bentall et al., 1989). Asocial 
schizotypy is thought to reflect impulsive nonconformity and the disposition to unstable 
mood, particularly with regard to rules and social conventions (Shean & Wais, 2000). 
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However, it could be argued that asociality may be linked with disorganised symptoms, 
the latter perhaps influencing the former.  
 
 
1.3.4 Schizotypy and the Development of Psychosis 
 
There is longitudinal evidence to suggest that individuals scoring high on trait 
schizotypy may be at increased risk for the development of psychosis. Indeed, the 
Edinburgh High Risk study highlighted that individuals with increased genetic risk of 
psychosis reported higher levels of schizotypy than a control group (P. Miller, Byrne et 
al., 2002). Furthermore, within the high-risk group, baseline levels of schizotypal 
symptoms (particularly items from the ‘Social Withdrawal’ factor) were reasonably 
accurate at predicting which individuals did and did not go on to develop psychosis at a 
later time point (Johnstone, Ebmeier, Miller, Owens, & Lawrie, 2005). Morrison et al. 
(2002) have also demonstrated that individuals in a wider high-risk group score higher 
on the O-LIFE than non-clinical controls. Other longitudinal studies have suggested a 
16- to 60-fold increase in risk of transition to psychosis in individuals who reported 
having psychotic-like experiences in childhood and adolescence (van Os, Linscott, 
Myin-Germeys, Delespaul, & Krabbendam, 2009). For example, Poulton et al. (2000) 
report that 25% of children with psychotic-like experiences aged 11 had developed 
schizophreniform disorder at age 26.  
 
Despite findings from these studies, it must be remembered that not all individuals with 
high schizotypy go on to develop psychosis. In a large survey of high school students, 
McGorry et al. (1995) showed that prodromal symptoms were extremely prevalent 
among older adolescents and are therefore unlikely to be a specific indicator, or an 
accurate predictor, of subsequent schizophrenia. There is also evidence to suggest that 
the presence of schizotypy may have positive effects (e.g. creativity; O'Reilly, Dunbar, 
& Bentall, 2001). Moreover, longitudinal studies have suggested that many people 
reporting schizotypal phenomena at baseline have a good outcome and report few or no 
schizotypal phenomena at follow-up (Hanssen, Bak, Bijl, Vollebergh, & van Os, 2005; 
Wiles et al., 2006). Thus, only a small proportion (approximately 8%; Hanssen et al., 
2005) go on to develop a clinical disorder.  
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It may be the case that schizotypal symptoms reflect an underlying (and potentially 
genetic) vulnerability to psychosis which, when interacting with environmental risk 
factors, may result in the onset of psychosis. A recent review and model by van Os and 
colleagues (2009) supports this claim, suggesting that environmental risk factors such as 
trauma (Spauwen, Krabbendam, Lieb, Wittchen, & van Os, 2006), cannabis use 
(Henquet, Murray, Linszen, & van Os, 2005), and urbanicity (Spauwen, Krabbendam, 
Lieb, Wittchen, & van Os, 2004) act synergistically with underlying vulnerability to 
psychosis, potentially leading to the onset of psychotic disorder. It is argued that 
exposure to these environmental risk factors may have an impact on behavioural and 
neurotransmitter sensitisation, thus increasing both the persistence of schizotypal 
experiences and the need for care (Cougnard et al., 2007). 
 
The psychosis-proneness-persistence-impairment model outlined by van Os et al. 
(2009) has clinical implications for both early intervention and at-risk mental state 
services. Moreover, it may be useful in interpreting longitudinal findings such as those 
from the Edinburgh High Risk Study (Johnstone et al., 2005). Indeed, as a group 
individuals at genetic high-risk of psychosis scored higher on schizotypy than non-
clinical controls, whereas only a small proportion (around 12%) developed psychosis. 
The authors note that the vulnerability to schizophrenia occurs in many more people 
than will develop the illness. Thus, whilst informative, genetic risk and the mere 
presence of schizotypal symptoms are likely to be insufficient in defining transition to 
psychosis. As outlined by Morrison et al. (2002), screening for psychosis using 
schizotypy measures alone is likely to result in a high rate of false positives. 
Consideration of other environmental and psychological factors is therefore warranted.  
 
1.3.5 Trait Schizotypy vs. State Schizotypal Symptoms 
 
Schizotypy is a useful concept to measure in psychosis as it may help to illuminate the 
processes involved in the transition from a benign to disordered state (Raine & Lencz, 
1995). However, schizotypy is currently conceptualised as a stable personality trait 
which acts as a potential risk factor for the later development of psychotic disorder. In 
contrast, this thesis is interested in the somewhat novel concept of state fluctuations in 
individual schizotypal symptoms following an episode of psychosis, and their 
relationship with recovery.  
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Yue, Bidwell, and Norton (2006) outline the differences between traits and states, with 
particular reference to psychiatric disorders. Traits are defined as markers of an 
individual’s risk of developing a given disorder. Furthermore, they are thought to reflect 
the behavioural and biological processes which may play a causal role in the 
pathophysiology of the disorder. Traits are suggested to be present in the biological 
relatives of patients; to remain stable over time; and to be unresponsive to treatment, 
due to the fact that they are not overtly pathological. Conversely, states are argued to 
reflect the current clinical manifestation of a disorder in patients at a given time. States 
are suggested to vary over time and with clinical course and treatment.  
 
When considering the trait-state distinction in terms of schizotypy, trait schizotypy can 
be viewed as a relatively stable personality trait reflecting individual differences in 
psychosis proneness and the likelihood of experiencing schizotypal symptoms. Thus, a 
high-trait schizotypal individual would be more likely to develop psychosis than a low-
trait schizotypal individual (P. Miller, Byrne et al., 2002). However, high trait 
schizotypy is not sufficient for the development of psychosis. Two individuals may 
score exactly the same on a measure of trait schizotypy yet one may go on to develop 
clinically-defined psychosis whilst the other simply remains at risk. As such, a trait 
measure of schizotypy does not provide any information on the current level of 
schizotypal symptoms being experienced. Rather, trait measures focus on general 
dispositions or tendencies (Matthews & Deary, 1998).  
 
Conversely, state schizotypy would provide information on the level of schizotypal 
phenomenology being experienced in a given situation, thus enabling fluctuations in 
symptoms to be monitored over time. Rather than referring to general tendencies and 
personality characteristics, a state measure would enquire whether a specific 
phenomenon (e.g. feelings of paranoia) had occurred recently (Yue et al., 2006). As 
such, a state measure would account for the limitations of trait assessments and allow 
heterogeneity to be detected amongst high trait schizotypal individuals who would 
otherwise appear as a homogenous group. For example, an individual who has felt 
consistently paranoid for the last week (high state) would arguably be at greater risk of 
descending into a spiral of psychosis than an individual who has a general tendency to 
feel paranoid in certain situations (high trait). A measure of state schizotypal symptoms 
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could be used not only to assess risk of transition to psychosis but also low-level 
psychotic experiences occurring as residual symptoms following an episode of 
psychosis. Thus, there is great utility in the state schizotypy concept. Despite this, a 
measure of state schizotypal symptoms does not currently exist.  
 
The following section will argue for a relationship between state schizotypal symptoms 
and psychosis and thus for the development of a measure to assess their presence.  
 
1.4 THE RELATIONSHIP BETWEEN SCHIZOTYPAL SYMPTOMS 
AND PSYCHOSIS 
 
Although the notion of assessing state schizotypal symptoms is somewhat novel, trait 
schizotypy has long been linked with psychosis via the continuum hypothesis (Meehl, 
1962; Strauss, 1969). The term “continuum” is used to refer to constructs which range 
from one condition to another condition via gradual transitions as opposed to abrupt 
changes. This is in contrast to the concept of “dichotomisation” whereby a construct can 
be sharply divided into two obviously distinguishable categories (Soanes & Stevenson, 
2005).  
 
1.4.1 The Continuum Hypothesis of Psychosis 
 
The continuum hypothesis of psychosis states that “psychosis-like beliefs, perceptual 
distortions, and idiosyncrasies of thought and communication, considered the hallmark 
diagnostic criteria for psychosis, are distributed (albeit to varying degrees) throughout 
the general population” (V. Bell et al., 2006, p. 366). This is as opposed to traditional 
Kraepelinian categorical views of the disorder, which advocate the notion of a dividing 
line between sanity and madness. The concept of a continuum of psychosis was first 
suggested by Bleuler (1908) who proposed that schizophrenia was an “intensification of 
an already existing character”. Rado (1953) later coined the term schizotypal in 
reference to the schizophrenia phenotype. Meehl (1962) elaborated on this suggesting 
that both schizotypy and schizophrenia arise from the existence of schizotaxia, an 
integrative neural defect, which is inherited. A predisposed schizotaxic individual will 
develop as schizotypal if the social learning conditions are benign. However, if adverse 
environmental events occur, the individual may develop schizophrenia.  
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This theory has since been supported by a wealth of research including studies 
providing evidence that schizotypal and psychotic symptoms have a similar 
epidemiology and share similar risk factors (Arseneault, Cannon, Witton, & Murray, 
2004; Boydell et al., 2001; Johns et al., 2004; Morrison et al., 2003; van Os, Jones, 
Sham, Bebbington, & Murray, 1998; van Os, Verdoux et al., 1999; Verdoux & van Os, 
2002). Longitudinal studies also indicate that individuals with high schizotypy are at an 
increased risk of developing a clinical disorder. Chapman, Chapman, Kwapil, Eckblad, 
and Zinser (1994) reported that high scores on schizotypy measures predicted higher 
frequencies of both psychosis and mood disorders over the next ten years. These results 
have since been replicated (Kwapil, Miller, Zinser, Chapman, & Chapman, 1997; 
Verdoux et al., 1999) and provide yet further evidence for the continuum hypothesis. 
 
Yung et al. (2006) add further clarity to the continuum concept by outlining different 
dimensional stages on the psychosis continuum, i.e. different mental states (see Figure 
1.1). These include the absence of psychotic experiences at the lowest end of the 
continuum; followed by the presence of psychotic-like experiences with and without 
distress; frank psychotic symptoms; and psychiatrically defined schizophrenia at the 
upper end. An important point of this model is the consideration that individuals can 
move between different groups and thus up and down the continuum over time 
(illustrated by the arrows on Figure 1.1). Where an individual lies on the continuum at 
one particular time denotes their current risk of a psychotic episode. This adds a state 
element to the continuum model and a consideration of the fact that an individual’s 
mental state is not static but rather changes over time. 
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Note. PLE = Psychotic-like Experience 
 
 
Figure 1.1  
Theoretical model of the psychosis continuum (taken from Yung et al, 2006) 
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1.4.2 The Importance of Assessing Schizotypal Symptoms in Psychosis: 
Indictors of Recovery 
 
Adopting a continuum view of psychosis has been shown in previous research to be 
important and useful for a number of reasons. First, individuals who are schizotypal but 
not psychotic provide an analogue sample in which processes thought to be potentially 
related to psychosis can be investigated without the influence of the disease process or 
medication effects (Raine & Lencz, 1995). Second, a dimensional approach may help to 
identify individuals who are “at-risk” of developing psychosis and thus enable potential 
early intervention (Gooding, Tallent, & Matts, 2005). Finally, from a therapeutic 
perspective, the idea that psychosis exists on a continuum with normality is both 
important in assisting individuals in adopting a normalising appraisal for their 
experiences (Freeman, Garety et al., 2005); and in supporting the use of techniques 
found useful in other, more common disorders, such as anxiety and depression, to treat 
psychosis (Kuipers et al., 2006).  
 
At present, schizotypy is considered as being premorbid to psychosis and is not 
generally assessed after transition has been made. This thesis will argue that assessing 
state schizotypy in individuals already diagnosed with psychotic disorders may be 
particularly informative in relation to monitoring recovery from a psychotic episode. 
Although clinically definable psychotic symptoms dissipate following an episode of 
psychosis, individuals may still be experiencing residual psychotic symptoms of a 
subclinical nature, similar to those experienced in the prodromal phases of the disorder 
(Keitner et al., 1996). As outlined previously, there is evidence to suggest a relationship 
between residual and prodromal symptomatology via the “rollback phenomenon” (e.g. 
Detre & Jarecki, 1971; Fava, 1999). This suggests that individuals may inhabit a 
postdromal phase following the remission of an acute episode of psychosis, and 
supports the suggestion that it is possible to move up and down different points on the 
psychosis continuum over time (Yung et al., 2006). It is important that these low-level 
symptoms are measured as they may have implications for future relapse (Birchwood, 
1995). In addition, it may be postulated that particular types of low-level psychotic, or 
schizotypal, symptoms (e.g. extreme social anxiety) may be directly related to 
impairments in social functioning, thus influencing longer-term recovery from 
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psychosis. However, due to their subclinical nature, such symptoms cannot be detected 
using traditional psychiatric assessment tools for psychosis (e.g. PANSS; Kay et al., 
1987). It could therefore be argued that a measure of current schizotypal symptoms 
would be more appropriate in the assessment of these phenomena.  
 
Currently, no measures exist which specifically assess low-level psychotic symptoms 
during the recovery phase. Studies investigating residual symptoms tend to set their own 
criteria for the definition of these phenomena (e.g. Buchanan et al., 2005). This usually 
consists of a specified cut-off point on psychiatric assessment tools for psychosis (e.g. 
PANSS, BPRS), thus conceptualising residual psychotic symptoms as attenuations of 
those symptoms present during the acute episode (Strakowski et al., 1998). As such, 
these measures do not assess any emotional dysfunction occurring as a result of the 
episode itself. Other methods for assessing low-level psychotic symptoms following 
psychosis include “early warning signs” tools (Birchwood, MacMillan, & Smith, 1992). 
Early warning signs (EWS) are described as subtle changes in thought, affect and 
behaviour preceding the onset of psychosis (Birchwood, Spencer, & McGovern, 2000). 
Research undertaken in this domain suggests that EWS can be observed in 50-70% of 
individuals up to a month prior to relapse (Birchwood, 1995; A. G. Jolley, Hirsch, 
Morrison, McRink, & Wilson, 1990; A. Tait, McNay, Gumley, & O'Grady, 2002). The 
Early Signs Scale (ESS; Birchwood et al., 1989) was developed to assess the prodromal 
signs of relapse, and combines non-specific prodromal signs (e.g. dysphoria, sleep and 
appetite problems) with an idiosyncratic relapse signature based on the events of the 
previous episode. Although the EWS literature highlights the importance of assessing 
low-level symptoms in individuals recovering from acute psychosis, the ESS was 
designed specifically to investigate processes associated with psychotic relapse, rather 
than other forms of recovery from psychosis (e.g. social recovery). Thus, there is a need 
for a measure which could be used to accurately assess and monitor low-level psychotic 
symptoms, both prior to and following a psychotic episode, which could then be used to 
investigate relationships with different dimensions of recovery from psychosis. This 
will be the main focus of this thesis. 
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1.5 SUMMARY AND AIMS OF THESIS 
 
This introductory chapter has defined the major concepts of interest in this thesis, 
namely psychosis and schizotypy, and reviewed the current theories proposed for their 
existence. Moreover, the problem of social disability in psychosis has been highlighted, 
as has its potential relationship to schizotypal symptoms in the recovery phase of 
psychosis. The main focus of this thesis is the conceptualisation of schizotypal 
symptoms as both a prodromal and residual feature of psychosis. It is argued that 
schizotypal symptoms may be at the core of psychosis, potentially providing good 
predictors of prognosis. In the context of this somewhat novel approach, schizotypal 
symptoms are therefore viewed as being analogous to (or at least comparable with) low-
level or residual psychotic phenomena. As such, the terms schizotypal, low-level, and 
residual will be used interchangeably. In order to advance our understanding of 
psychosis (and recovery from), this thesis will argue that there is a need to focus on the 
nature of schizotypal symptoms, and to examine how they are associated with 
psychological processes. These self-reported minor variations may provide a greater 
insight into the nature of psychosis than acute symptoms themselves, which may be a 
transient “flare-up” of a long-standing underlying problem. It is predicted that akin to 
research conducted on psychotic symptoms, and in line with the continuum hypothesis, 
different schizotypal symptoms will be associated with different psychological 
processes.  
 
In order to investigate the nature of schizotypal symptoms and social recovery from 
psychosis, this thesis compares a recovering early psychosis sample and a non-clinical 
student sample on a variety of variables. As all current measures of schizotypy utilise a 
personality trait approach, the development of a tool which also enables state schizotypy 
to be assessed is required. Therefore, the initial aim of this thesis is to modify an 
existing self-report measure of trait schizotypy for use to assess state schizotypal 
symptoms in both clinical and non-clinical populations. The following chapter reviews 
existing measures of schizotypy and tools for the assessment of low-level psychotic 
symptoms. The modification of a self-report measure of schizotypy to assess both state 
and trait schizotypy is then described, and psychometric data on the scale are reported. 
Following this, the prevalence of schizotypal symptoms in clinical and non-clinical 
samples is reported and compared.  
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Cognitive models of psychosis utilise a single symptom approach and stress the 
importance of separate but interacting aetiologies underlying different types of 
symptoms (Garety et al., 2001). Therefore, a further aim of this thesis is to investigate 
the associations between different types of schizotypal symptoms and a number of 
psychological and neuropsychological variables. A dissociation between the correlates 
of different types of symptoms is predicted and it is hypothesised that distinct 
underlying mechanisms are responsible for different kinds of symptoms. In the second 
study, associations between schizotypal symptoms and neuropsychological variables are 
examined in the clinical sample. It is predicted that where present, symptoms relating to 
anomalies of experience (e.g. low-level hallucinations) will be associated with specific 
neuropsychological and neurological variables, namely anomalies in visual processing. 
Conversely, it is hypothesised that low-level paranoia and social anxiety will not be 
associated with these variables. Thus, it is argued that there is a more organic and 
biological basis to anomalous symptoms. In the third study, associations between 
schizotypal symptoms and psychological and emotional variables are investigated in the 
non-clinical sample. It is predicted that social anxiety and paranoid schizotypal 
symptoms will be strongly associated with emotional and psychological variables, with 
anomalous schizotypal experiences being associated with these variables to a lesser 
extent. Following on from this, in the fourth study, relationships between schizotypal 
symptoms and trauma will be examined in the non-clinical sample. Hypothesised routes 
from trauma exposure to schizotypal symptomatology are discussed. 
 
Following these studies examining the differential relationships between different 
schizotypal symptom types and emotional, psychological, and neuropsychological 
variables, the relationship between schizotypal symptoms and outcome is examined and 
a hypothesised dimensional model of recovery is discussed. The final chapter of this 
thesis will then experimentally test the hypothesised associations between schizotypal 
symptoms and social recovery. This investigation will be conducted using longitudinal 
data from a randomised controlled trial. The trial aims to examine the impact of a social 
recovery focused therapeutic intervention on schizotypal symptoms and time spent in 
structured activity. 
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CHAPTER TWO: 
STUDY ONE: DEVELOPMENT AND PSYCHOMETRIC PROPERTIES OF 
THE SCHIZOTYPAL SYMPTOMS INVENTORY (SSI) 
 
 
2.1 RATIONALE AND CONTEXT FOR THE STUDY 
 
Traditional measures of the symptoms of psychosis (e.g. PANSS; Kay et al., 1987) are 
designed in relation to frank psychosis, and lack the sensitivity needed to detect 
subclinical psychotic phenomena. However, subclinical phenomena may be important 
in both the transition to, and recovery from, psychotic disorders. Early subclinical and 
anomalous experiences may later develop into full-blown psychotic symptoms, 
particularly if occurring very frequently, and thus it is important that they are measured 
and not missed (Hodges, Byrne, Grant, & Johnstone, 1989). Likewise, when they are 
recovering, many people with schizophrenia report a reversion to subthreshold 
psychotic symptoms. For example, a persecutory delusion may fade into an anxious 
feeling of being “noticed” or “standing out” in social situations. In the wrong 
conditions, these subclinical phenomena may once more escalate into a further episode 
of psychosis (Birchwood, Spencer et al., 2000). 
 
Due to the overlap between schizotypal phenomena and subclinical psychotic symptoms 
(Bedwell & Donnelly, 2005), schizotypy measures could be used to assess the residual 
and prodromal symptoms of psychosis. However, a major problem is that existing 
measures (L. J. Chapman & Chapman, 1980; O. Mason et al., 1997; Venables, Wilkins, 
Mitchell, Raine, & Bailes, 1990) tend to assess schizotypy as a personality trait, rather 
than a mental state. While such measures can be used to highlight underlying 
vulnerability, they provide little information about current symptom profiles. Moreover, 
well-formulated theories now exist linking anxiety with the development of schizotypal 
phenomena (Birchwood, 2003; Fowler, 2000b), and there are therefore arguments for 
including measures of anxiety, particularly social anxiety, in an instrument designed to 
evaluate the ebb and flow of quasi-psychotic experience. 
 
The specific aim of the first part of this chapter is to review existing measures for use in 
the assessment of schizotypal phenomena and low-level psychotic symptoms. Many of 
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the measures discussed have been used to assess the prevalence of schizotypal and low-
level psychotic symptoms in the general population (e.g. Myin-Germeys, Krabbendam, 
& van Os, 2003). The suitability of these measures for assessing schizotypal symptoms 
in clinical samples will be considered. Following this review, the need for a new 
measure for use in this domain will be outlined and discussed. 
 
2.2 REVIEW OF MEASURES TO ASSESS SCHIZOTYPY AND LOW-
LEVEL PSYCHOTIC SYMPTOMS 
 
This section will review four types of measures for the assessment of schizotypy and 
low-level psychotic symptoms. These include: measures designed to assess borderline 
conditions; measures designed to assess personality types related to psychosis; measures 
designed to assess schizotypy and schizotypal traits; and measures designed to assess 
the prodromal symptoms of psychosis.  
 
2.2.1 Measures Designed to Assess Borderline Conditions 
 
Tools designed to assess schizotypal personality originate from studies detecting 
borderline psychotic symptoms in the first-degree relatives of individuals diagnosed 
with psychosis (e.g. Kety, Rosenthal, Wender, Schulsinger, & Jacobsen, 1974). These 
findings led to the suggestion that psychosis exists on a continuum, ranging from 
normality to a clinically-definable disorder. As such, early schizotypy measures took the 
form of structured and semistructured interviews designed to highlight borderline 
phenomenology. Such measures are predominantly based on diagnostic criteria for 
Schizotypal Personality Disorder (SPD), as devised by Spitzer, Endicott, and Gibbon 
(1979).  
 
Tools designed to assess borderline symptoms are outlined in more detail in Table 2.1. 
Such measures include the Diagnostic Interview for Borderlines (DIB; Kolb & 
Gunderson, 1980); the Symptom Schedule for the Diagnosis of Borderline 
Schizophrenia (Khouri, Haier, Rieder, & Rosenthal, 1980); and the Schedule for 
Schizotypal Personalities (SSP; M. Baron, Asnis, & Gruen, 1981). Perhaps the most 
well-known measure in this area is the Structured Interview for Schizotypy (SIS; 
Kendler, Liebermann, & Walsh, 1989). The SIS was developed from a large family 
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study of schizophrenia. It differs from other interviews in this domain as is not solely 
based on diagnostic criteria but includes coverage of other, potentially relevant signs 
and symptoms of at-risk mental state. The SIS has been shown by an independent pilot 
study to discriminate significantly between the relatives of individuals with 
schizophrenia and the relatives of controls, and thus demonstrates a high level of 
validity (Tsuang, Stone, Tarbox, & Faraone, 2002). Furthermore, the SIS has been used 
to identify “high-risk” individuals (e.g. P. Miller, Byrne et al., 2002). However, due to 
the fact that it is a semistructured interview, the SIS is reasonably lengthy and resource-
heavy to administer.  
 
A problem common to the majority of borderline assessment tools is that they assess 
personality disorders as opposed to personality types. Furthermore, rather than being 
necessarily specific to schizotypy, some measures assess all borderline personality 
disorders (e.g. DIB). Although there is evidence to suggest an overlap between 
personality disorders and psychosis, the extent of this overlap is unclear and forms part 
of a controversial debate which is still unresolved (Pope, Jonas, Hudson, Cohen, & 
Tohen, 1985). Therefore, interviews designed to assess borderline conditions could be 
argued to be somewhat limited in their usage in assessing the prodromal and/or residual 
signs of psychosis.  
 
2.2.2 Measures Designed to Assess Personality Types Related to Psychosis 
 
Studies have suggested that factors indicative of liability to the development of 
psychosis are broader than those included in SPD criteria (Tsuang et al., 2002). Broader, 
non-specific personality assessment measures have also been used to assess psychosis-
like characteristics. These include general personality inventories, such as the 
Minnesota Multiphasic Personality Inventory (MMPI; Hathaway & McKinley, 1951), 
which has “paranoia” and “schizophrenia” subscales; and the Sixteen Personality Factor 
Questionnaire (16 PF;  Cattell, Eber, & Tatsuoka, 1970) which has a “trust-
suspiciousness” factor. However, these measures could be argued to lack adequate 
specificity when trying to identify individuals who may be at-risk (Muntaner, Garcia-
Sevilla, Fernandez, & Torrubia, 1988). 
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A more specific psychosis-related personality measure is the Psychotism, or P-scale, 
designed by Eysenck and Eysenck (1976). Psychoticism is considered to be a dimension 
of normal personality which includes criminality, psychopathy, and manic-depressive 
disorder; with schizophrenia residing at the most extreme end. The P-scale was 
designed to assess this construct and the earliest form of the measure was included as 
part of the Eysenck Personality Questionnaire (EPQ; H. J. Eysenck & Eysenck, 1975). 
The initial P-scale contained several items with psychotic content (e.g. paranoid 
ideation and anhedonia) but also included items which tapped antisocial, impulsive and 
non-conformist traits. The inclusion of these items was influenced by research 
conducted by the authors suggesting that such traits were elevated in the relatives of 
individuals with psychosis. However, many studies have shown that anti-social and 
non-conforming individuals (who may or may not also experience psychotic symptoms) 
also have elevated scores on this scale (Farrell, 1992; Rahman, 1992). Several criticisms 
have been made against the measure in relation to this point, and also regarding the 
internal validity of the scale (e.g. Claridge, 1983). As a result of these criticisms, the P-
scale was revised (S. B. Eysenck, Eysenck, & Barrett, 1985) but problems with the 
measure still remain. Zuckerman (1989) labelled the P-scale as a tool for assessing 
psychoticism as opposed to psychosis proneness. Furthermore, even in its revised form, 
the scale been shown to have weak predictive reliability in terms of diagnosing future 
psychosis (J. P. Chapman, Chapman, & Kwapil, 1994). Moreover, in factor analytic 
studies, rather than loading on psychotic-like symptom factors, the P-scale has a 
tendency to load on factors reflecting impulsive non-conformity, thus further 
questioning the validity of the scale for use in psychosis research (Bentall et al., 1989; 
Claridge et al., 1996; Raine & Allbutt, 1989).  
 
General personality tools do not have adequate specificity to detect schizotypal 
symptoms. This has resulted in the development of measures devoted to the assessment 
of schizotypy, which will be discussed in the next section. 
 
2.2.3 Measures Designed to Assess Schizotypal Personality Traits 
 
These measures attempt to detect experiences occurring outside of clinically-defined 
psychosis, but which may highlight a predispositional vulnerability to the disorder. 
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They can be split into two types: those assessing schizotypy as a fully dimensional 
personality trait; and those assessing schizotypy as attenuated psychotic symptoms.  
 
2.2.3.1 Measures designed to assess schizotypy as a fully dimensional trait 
 
The conceptualisation of schizotypy as a fully dimensional personality trait can be 
explained using an extrapolation of Reich, James, and Morris’ (1972) multiple-
threshold liability model. This model suggests that SPD is a milder and more prevalent 
expression of the schizophrenia genotype. With this theory in mind, it could be argued 
that schizotypal traits are an even milder expression of schizophrenia genotype, with a 
lower liability than SPD, and a greater prevalence in the general population. A complete 
absence of schizotypal traits may occupy the lowest end of this dimension. Measures in 
this domain include those assessing individual schizotypal traits and others which assess 
schizotypy in a multidimensional manner. A summary of these measures is provided in 
Tables 2.2 and 2.3. 
 
Measures assessing individual schizotypal traits. Most of the scales 
belonging to this group were created and validated using non-clinical populations. Items 
are based on phenomena thought to be linked to psychosis, but their content focuses on 
personal experience rather than diagnostic criteria. Each scale taps a different type of 
schizotypal phenomena, with many items used to assess each trait. The most commonly 
used scales in this domain include the Perceptual Aberration Scale (PER; L. J. 
Chapman, Chapman, & Raulin, 1978) which measures the tendency to perceptual 
distortion; and the Magical Ideation Scale (MIS; Eckblad & Chapman, 1983) which 
asks about superstitions and magical beliefs (e.g. experiences of precognition, mind-
reading, etc). Other scales assess negative-type phenomena, such as loss of pleasure, as 
assessed by the Physical and Social Anhedonia Scales (PhA and SoA; L. J. Chapman, 
Chapman, & Raulin, 1976); and social isolation and social anxiety, as measured by the 
Revised Social Anhedonia Scale (Eckblad, Chapman, Chapman, & Mishlove, 1982) and 
the Social Fear Scale (Raulin & Wee, 1984). All of the scales demonstrate an 
impressive range of content, and have been shown to be reliable and valid (L. J. 
Chapman, Chapman, & Miller, 1982). However, the fact that the scales were validated 
using only non-clinical individuals does restrict their usage; although one study reports 
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successful use of the PhA scale in an acute psychosis population (Kontaxakis et al., 
2006). 
 
Other scales in this domain assess personality traits which are not obviously psychotic 
but which have been suggested to be characteristic of schizotypy (Meehl, 1962, 1990). 
These include the Intense Ambivalence Scale (IAS; Raulin, 1984), later revised to 
become the Schizotypal Ambivalence Scale (SAS; Kwapil, Mann, & Raulin, 2002); the 
Cognitive Slippage Scale (Miers & Raulin, 1985), designed to assess subtle thought 
disorder; and the Impulsive Nonconformity Scale (ImpNon; L. J. Chapman et al., 1984), 
designed to measure impulsive anti-social behaviour. Although these scales are not as 
well-used as other measures, they have been shown by their respective authors to have 
good psychometric properties and to have validity in assessing psychosis proneness.  
 
The Chapman scales have been widely used in research into schizotypy and psychosis 
proneness; both in investigating the correlates of schizotypy, and in assessing the 
predictive reliability of schizotypy and the later development of psychosis (e.g. 
Gooding, Tallent, & Hegyi, 2001; Raine & Manders, 1988). However, some studies 
have questioned the stability of the scales in assessing psychosis proneness over time 
(Meyer & Hautzinger, 1999). Although the measures do predict onset of other 
schizotypal symptoms and psychotic-like experiences, their predictive reliability in 
diagnosing psychotic disorders has been shown to be low  (J. P. Chapman et al., 1994; 
Kwapil, Raulin, & Midthun, 2000). 
 
Although there is some value in using scales devoted to specific types of schizotypal 
traits, a multidimensional measure of schizotypy may be more accurate in reflecting an 
individual’s symptom profile. This idea is reinforced by the suggestion that it is the 
range of schizotypal symptoms, rather than the symptoms themselves, which is 
indicative of an individual’s risk of transition to psychosis (P. Miller, Byrne et al., 
2002). As such, the use of multiple as opposed to single measures may preferable in the 
detection of schizotypic subjects (G. W. Barnes, Rhinewine, & Docherty, 2000). 
Measures assessing different aspects of schizotypy have different psychometric 
properties, and may also have different response formats (e.g. forced choice vs. Likert) 
and time scales (e.g. lifetime vs. recent prevalence). Therefore, their comparability and 
amalgamation is somewhat questionable. It is potentially more appropriate to use 
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measures which assess a range of schizotypal symptoms, as opposed to a range of 
measures which each assess an individual schizotypal symptom.  
 
Multidimensional schizotypy measures. In order to ensure comprehensive 
measurement of schizotypal phenomena, Bentall, Claridge, and Slade (1989) developed 
the Combined Schizotypal Traits Questionnaire (CSTQ); a lengthy 420-item scale 
combining 18 of the previously discussed schizotypy assessment tools (e.g. PER, MIS, 
PhA, SoA). Although comprehensive, the CTSQ is not very practical for use in 
experimental research as administration is time-consuming and highly repetitive. A 
factor analysis of the CSTQ revealed four factors: “Unusual Experiences”, “Cognitive 
Disorganisation”, “Introvertive Anhedonia”, and “Impulsive Nonconformity” (Bentall 
et al., 1989). New scales were developed using items which most accurately measured 
these four factors and as a result of this process, the Oxford-Liverpool Inventory of 
Feelings and Experiences (O-LIFE; O. Mason, Claridge, & Jackson, 1995) was 
developed. The O-LIFE addresses the problems of the CSTQ and provides a 
comprehensive, normally distributed measure of schizotypy which is suitable for use in 
the general population. The measure has good internal reliability and a comparable 
relationship of scores with age and gender to that found in psychosis samples. Despite 
these strengths, it is still quite a lengthy measure to administer and could be argued to 
retain the weaknesses of those scales combined in its creation. Nevertheless, the O-LIFE 
remains a widely used tool in schizotypy research (O. Mason & Claridge, 2006).  
 
The Schizophrenism and Anhedonia Scale (Venables et al., 1990) is a further measure 
created by combining items from existing self-report schizotypy assessment tools. 
Developed in a non-clinical sample, the scale was designed to assess both positive (i.e. 
schizophrenism – cognitive-perceptual and attentional dysfunction) and negative (i.e. 
anhedonia – social dysfunction and anhedonia) aspects of schizotypy. Validation of the 
scale involved investigating the responses of high scorers on a variety of experimental 
tasks theoretically related to psychosis. These included reaction time measurement and 
skin conductance orienting (e.g. Hazlett, Dawson, Filion, Schell, & Nuechterlein, 1997). 
The results showed that associations between scores on the scale and performance on 
the tasks were in the same direction as those highlighted in a schizophrenic sample, and 
thus the validity of the scale was confirmed (Venables et al., 1990). Despite being fairly 
inclusive, the Schizophrenism and Anhedonia Scales do not explicitly cover items 
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relating to social anxiety, but rather social anhedonia. This is arguably problematic 
given the increasing evidence for the role of social anxiety in psychosis (Birchwood, 
2003). 
 
Summary. This section has discussed measures designed to assess schizotypy 
as a fully dimensional personality trait. These measures specifically assess psychosis-
like personality traits, thus separating them from broader personality inventories. 
However, conceptualising schizotypy as a personality trait only allows an individual’s 
underlying predisposition to psychosis to be assessed, and not their current risk of 
transition. More specifically, it can be assumed that all individuals at high-risk of 
psychosis would achieve similarly high scores on a schizotypal trait measure, and thus 
would appear as a homogenous group (Claridge & Beech, 1995). Heterogeneity in 
current experiences would not be detected by a trait measure alone. 
 
As they are not based on diagnostic criteria, fully dimensional schizotypy measures 
support the continuum hypothesis and thus the notion that some individuals experience 
psychotic-like symptoms without associated distress (V. Bell et al., 2006). However, not 
being based on diagnostic criteria also reduces the clinical relevance of the scale. The 
aim of this thesis is to utilise a measure of schizotypy in the assessment of the 
prodromal and residual symptoms of psychosis. As such, items included in the measure 
should ideally bear some resemblance to clinically-defined psychotic symptoms and this 
is questionable for the above schizotypy assessment tools. The following section will 
review schizotypy measures which utilise diagnostic criteria in their construction, and 
conceptualise schizotypal phenomena as attenuated psychotic symptoms. 
 
2.2.3.2 Measures assessing schizotypy as attenuated psychotic symptoms  
 
These scales adopt a similar philosophy to measures based on diagnostic criteria (i.e. 
that symptoms represent a deviation from “normal” behaviour or experiences), but at 
the same time are grounded in the assumption that attenuated psychotic symptoms are 
distributed throughout the general population, only becoming a clinical problem when 
occurring above a certain level of severity and/or resulting in distress. Therefore, whilst 
not necessarily pathological, the presence of such symptoms may denote someone as 
being at-risk of developing a diagnosable disorder at a later stage. Many measures in 
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this domain assess single symptoms (e.g. hallucinations, delusional ideation) although 
others assess a range of symptoms. A summary of these measures is provided in Tables 
2.4, 2.5, and 2.6. 
 
Hallucinations. The Structured Interview for Assessing Perceptual 
Anomalies (SIAPA; Bunney et al., 1999) is an interview-based assessment tool 
designed to measure the frequency of sensory anomalies, or low-level hallucinations, 
across the five senses. Rather than assessing hallucinatory phenomena directly, the 
SIAPA focuses on changes in sensory intensity, attention and flooding. However, as a 
structured interview it is fairly resource-intensive to administer. The Launay-Slade 
Hallucination Scale (LSHS; Launay & Slade, 1981) is a self-report measure of 
hallucinatory predisposition and as such is easier to administer than the SIAPA. The 12-
item questionnaire includes a combination of overtly pathological/clinical items as well 
as other items which represent a subclinical form of hallucinatory experience (e.g. 
intrusive thoughts and daydreams). The scale has been shown to adequately 
discriminate between clinical and non-clinical populations and also has validity in 
assessing hallucinatory experiences in non-clinical populations (Feelgood & Rantzen, 
1994; Morrison et al., 2000).  
 
A further scale assessing hallucinatory predisposition is the Cardiff Anomalous 
Perceptions Scale (CAPS; V. Bell et al., 2006). The CAPS is a 32-item self-report scale 
assessing lifetime frequency of anomalous experiences as well as associated distress and 
intrusiveness. Items included in the scale were taken from a variety of other measures, 
including those related to psychosis proneness, temporal lobe disturbance, and the 
clinical assessment of psychosis. Although designed to assess attenuated clinical 
symptoms, the scale uses neutral language and does not assume that people perceive 
their experiences as “unusual”. The CAPS has been shown by the authors to adequately 
discriminate between clinical and non-clinical populations, and also has good test-retest 
and internal reliability. 
 
Delusions. Measures devised to assess low-level delusional ideation include 
the Peters Delusion Inventory (PDI; Peters, Joseph, & Garety, 1999), a 40-item self-
report assessment tool of delusional ideation for use in the general population. The PDI 
assesses lifetime prevalence of beliefs, interpretations and experiences using a 5-point 
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Likert scale to assess conviction, distress and frequency. Scale items are derived from 
the Present State Examination (PSE; Wing et al., 1974) and thus have a clinical basis. 
The scale has been shown by the authors to have good internal consistency and 
concurrent validity. Furthermore, it has been widely used in a range of studies assessing 
the psychosis continuum (e.g. Peters, Day, McKenna, & Orbach, 1999).  
 
Whereas the PDI measures a range of delusional ideation, other measures have been 
developed to assess specific types of delusional thought. These measures have mostly 
focused on paranoia, and include the Paranoia Scale (Fenigstein & Vanable, 1992), a 
20-item self-report scale based on items from the MMPI. Items refer mostly to public 
self-consciousness as opposed to persecution and are thus not overtly clinical in nature. 
However, the scale has been successfully applied to a schizophrenic population (Smári, 
Stefánsson, & Thorgilsson, 1994). Rawlings and Freeman (1996) developed a further 
measure to assess paranoia and suspiciousness in the general population. The 
Paranoia/Suspiciousness Questionnaire (PSQ) consists of questions modified from 
several established scales assessing paranoia and related concepts. The scale was shown 
by the authors to have good internal and test-retest reliability. However, due to its 
development in a non-clinical sample, the use of the PSQ in a psychiatric setting is 
somewhat questionable.  
 
It has been argued that scales assessing paranoia do not contain adequate reference to 
persecutory phenomena and this prompted the development of the Paranoia Checklist 
(Freeman, Garety et al., 2005). The Paranoia Checklist was devised to investigate 
paranoid thoughts of a more clinical and distressing nature than those assessed by the 
Paranoia Scale. It provides a multidimensional assessment of paranoid ideation, with 
each of the 18 items being rated on a 5-point scale for frequency, degree of conviction, 
and distress. It has been shown by the authors to display good internal and convergent 
reliability, although it has not been validated in a clinical sample.  
 
Measures assessing a range of symptoms. In terms of the wider concept of 
schizotypy and psychosis proneness, the measures discussed above each assess one 
domain of experience. This allows specific and detailed investigations into different 
types of symptoms but does not allow the co-occurrence of multiple symptom types to 
be examined. Measures which are more inclusive in their approach include the 
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Schizotypal Traits Questionnaire (STQ; Claridge & Broks, 1984); the King’s 
Schizotypy Questionnaire (KSQ; L. A. Jones et al., 2000); the Scales for Rating 
Psychotic and Psychotic-like Experiences as Continua (L. J. Chapman & Chapman, 
1980); and the Community Assessment of Psychic Experiences (CAPE; Stefanis et al., 
2002). Items included in these measures are based on attenuated versions of symptoms 
outlined by diagnostic criteria for psychosis and SPD. Other measures in this group, 
such as the Schizophrenism Scale (Nielsen & Petersen, 1976), are based on attributes 
outlined by studies investigating early stage schizophrenia (e.g. J. P. Chapman, 1966) 
and thus tap aspects which are phenomenologically related to schizophrenia. The Rust 
Inventory of Schizotypal Cognitions (RISC; Rust, 1987; 1988) assesses a range of 
bizarre and eccentric thought patterns which may be indicative of increased risk of 
developing psychosis. Indeed, Miller, Lawrie, Byrne, Cosway, and Johnstone (2002) 
have suggested that high scores on the RISC are strongly associated with the presence 
of psychotic symptoms. 
 
The only scale to assess all nine aspects of SPD, and thus arguably all of the attenuated 
symptoms of psychosis, is the Schizotypal Personality Questionnaire (SPQ; Raine, 
1991). Although the SPQ is based on diagnostic criteria for SPD, it is not specific to 
diagnosing personality disorder and can also be used to assess attenuated symptoms of 
psychosis. The SPQ is a 74-item questionnaire with a dichotomous (yes/no) response 
format. It was developed using DSM-III-R criteria (American Psychiatric Association, 
1987) and has been shown by the author to be an appropriately valid and reliable scale 
for use in both clinical and non-clinical populations for the identification of individuals 
with schizotypal traits. A factor analytic study conducted on the SPQ highlighted a 
three-factor structure encompassing “Cognitive-perceptual”, “Interpersonal”, and 
“Disorganised” schizotypy (Raine et al., 1994). This finding corresponds with other 
studies which have detected analogous factor structures in both schizotypal and 
psychotic phenomena (Bentall et al., 1989; Strauss et al., 1974). Moreover, findings 
from a study in which the SPQ was completed by first-episode schizophrenia patients 
and their first-degree relatives, suggest that the positive dimension of the questionnaire 
can be used to reflect the presence of a genetic vulnerability to schizophrenia (Vollema, 
Sitskoorn, Appels, & Kahn, 2002). The SPQ has also been used in numerous other 
studies examining the correlates of schizotypy (e.g. Dinn, Harris, Aycicegi, Greene, & 
Andover, 2002; Skosnik, Spatz-Glenn, & Park, 2001). 
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 Summary. This section has discussed measures designed to assess 
schizotypal phenomena as attenuated symptoms of psychosis. Some of these measures 
assess individual symptoms (i.e. hallucinations or delusions), whereas others assess a 
range of psychotic-like phenomena simultaneously. A definite strength of these 
measures is that they are either based on diagnostic criteria for psychosis; or on 
concepts which are theoretically related to the disorder. As such, these measures view 
schizotypal experiences as analogous to (and on a continuum with) low-level psychotic 
experiences. Use of these measures would be advantageous in assessing the prodromal 
and residual symptoms of psychosis, which may not be detected by traditional 
psychiatric assessment tools. Despite these strengths, the majority of measures in this 
domain have been developed for use in non-clinical populations and are not suitable for 
use in clinical samples. The next section considers measures used to assess low-level 
psychotic symptoms in clinical populations. 
 
2.2.4 Measures Designed to Assess Prodromal Psychotic Symptoms  
 
Prodromal symptoms occur prior to the onset of clinically diagnosable psychosis (H. J. 
Jackson, McGorry, & Dudgeon, 1995). Measures designed to assess clinically-defined 
prodromal symptoms are relatively new in their development. Like other psychiatric 
assessment tools, they assess deviations from “normal” behaviour, but also take into 
account duration, severity and frequency of symptoms, as well any decline in general 
functioning.  
 
Measures designed to assess prodromal symptoms of psychosis are broadly based on 
one of two approaches. The first is the Attenuated Positive Symptoms (APS) which is 
thought to characterise a late prodromal phase. APS measures include the 
Comprehensive Assessment of At-Risk Mental States  (CAARMS; Yung et al., 2002) 
and the Structured Interview of Prodromal Syndromes (SIPS; McGlashan et al., 2003). 
Both the CAARMS and the SIPS are interviews which follow specific criteria in order 
to potentially define an individual as being at-risk of developing psychosis. The second 
approach to assessing prodromal symptoms is the Basic Symptoms (BS) approach. This 
is based on a detailed phenomenological way of describing disturbances occurring prior 
to the onset of psychosis, including low-level changes in perception, cognition, 
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language and motor function. The BS approach is thought to characterise an early 
prodromal phase. BS measures include the Bonn Scale for the Assessment of Basic 
Symptoms (BSABS; Gross, Huber, & Klosterkötter, 1987) and the Schizophrenia 
Prediction Instrument – Adult version (SPI-A; Klösterkotter, Schultze-Lutter, Wieneke, 
Picker, & Steinmeyer, 2001). Both of these scales are clinician-rated interviews 
designed to establish the presence or absence of basic symptoms. Other measures 
adopting a combination of the APS and BS approaches also exist as do numerous 
checklists for subthreshold psychotic symptoms (e.g. Heinimaa et al., 2003; Loewy, 
Bearden, Johnson, Raine, & Cannon, 2005). A more detailed description of each 
measure is summarised in Tables 2.7, 2.8, and 2.9. 
 
Although APS and BS measures possess positive predictive value in determining the 
onset of psychotic disorder, and in highlighting those individuals who may be at-risk; 
there is wide variability in the approaches utilised. Some measures assess the presence 
or absence of particular phenomena (e.g. CAARMS, SIPS) whereas others investigate 
transformations in the structure or form of experience (e.g. EASE). In a recent review, 
Olsen and Rosenbaum (2006) outline the need for an investigation into the convergence 
and divergence of these various approaches. Many of the measures require clinician-
administered interviews, making their administration time consuming and resource-
heavy. Furthermore, the validity of many prodromal instruments is still under 
investigation and those which have been validated are mostly limited to clinical 
populations, resulting in difficulties in administering the measures to the general 
population. More research is required in order to isolate those symptoms which are 
particularly predictive of psychosis and which can be measured in both clinical and non-
clinical populations. Moreover, these measures have been specifically designed to 
assess the prodromal symptoms of psychosis. As such, their ability to adequately 
measure residual psychotic phenomena is unknown.  
 
 
 
 
  
 Table 2.1 Measures Designed to Assess Borderline Conditions 
 
Measure Description How items created Reliability and Validity 
 
Diagnostic Interview for 
Borderline (DIB; Kolb & 
Gunderson, 1980) 
 
Semistructured interview schedule for 
assessing borderline patients. 
Assesses all borderline conditions – 
borderline schizophrenia and borderline 
personality 
 
Authors abstracted major 
characteristics of borderline patients 
from interviews 
 
Adequate inter-rater reliability reported by authors. 
Not a specific measure of schizotypal personality 
but rather all borderline personality disorders. 
 
The Symptom Schedule for the 
Diagnosis of Borderline 
Schizophrenia (Khouri et al., 
1980) 
 
Structured interview containing eight 
items relating to perceptual, thought and 
behavioural changes 
Based on schizotypal-like features 
found among relatives of 
schizophrenics in Danish adoption 
study (Kety et al., 1974) 
 
Reported by authors to be a reliable measure of 
schizotypy 
The Schedule for Schizotypal 
Personalities (SSP; M. Baron et 
al., 1981) 
Structured interview designed to improve 
diagnostic reliability for borderline 
syndromes related specifically to 
schizophrenia.  
10 scales: Illusions, Depersonalisation, 
Ideas of Reference, Suspiciousness, 
Magical Thinking, Inadequate Rapport, 
Odd Communication, Social Isolation, 
Social Anxiety, and 
Delusions/hallucinations, each consisting 
of 1-8 items rated on a 4-point scale of 
severity. 
 
Based on DSM-III item set for SPD. 
Specific questions were derived from a 
review of the literature and a survey of 
clinical vignettes relevant to the 
concept of SPD. 
In a reliability study conducted by the authors, 
diagnostic agreement on the presence or absence 
of SPD was found in 49 of 53 cases.  
The Structured Interview for 
Schizotypy (SIS; Kendler et al., 
1989) 
Structured interview assessment with two 
parts: 
1.Use of structured probes to elicit self-
report information on symptoms such as 
magical ideation, social isolation, etc 
2. Observation of behaviour and 
interviewer judgements on rapport, 
attention, etc 
 
Items developed from a large family 
study of schizophrenia conducted by 
the authors 
The SIS has been shown by three independent 
pilot studies to discriminate between relatives of 
individuals with schizophrenia and relatives of 
controls (Tsuang et al., 2002). 
 
 
Note: SPD = Schizotypal Personality Disorder
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Table 2.2 Measures Designed to Assess Schizotypy as a Fully Dimensional Personality Trait – Individual Schizotypal Attributes 
 
Measure Description How items created Reliability and Validity 
 
Perceptual Aberration Scale 
(PER; L. J. Chapman et al., 
1978) 
 
35-item scale measuring cognitive 
perceptual psychotic-like experiences 
(i.e. bodily discontinuities and unusual 
sensory experiences) in the general 
population, e.g. “I have felt that 
something outside my body was a part of 
my body”. 
 
 
Items are based on experiences of 
somatic distortions and hallucinations, 
as reported in the clinical literature on 
schizophrenia and associated diagnoses. 
 
Good internal consistency (α = .85) 
College students scoring high on this measure 
exceeded control subjects on psychotic-like 
experiences (L. J. Chapman & Chapman, 1980) 
No association with scores on physical and social 
anhedonia scales – discriminant validity. 
 
Magical Ideation Scale (MIS; 
Eckblad & Chapman, 1983) 
30-item scale designed to measure 
unconventional beliefs (i.e. low-level 
delusions), such as thought transmission, 
psychokinetic effects, precognition and 
the transfer of psychic energies between 
people. 
Covers a range of beliefs and 
experiences from first-rank symptoms 
of schizophrenia and ideas of reference 
to popular paranormal and conspiracy 
theory themes. 
 
Good internal consistency (α = .80). 
Good convergent validity: correlation of .70 with 
PER. 
Subjects with high scores on the MIS showed more 
psychotic like and schizotypal symptoms than 
control subjects (L. J. Chapman & Chapman, 
1980). 
 
Physical and Social Anhedonia 
Scales (PhA & SoA; L. J. 
Chapman et al., 1976) 
 
 
PhA scale (40 items) reflects deficit in 
ability to experience physical pleasure 
(e.g. eating, touching, etc) 
SoA scale (48 items) reflects deficit in 
ability to experience interpersonal 
pleasure (e.g. being with people, talking, 
etc). 
Reflects “negative” aspects of schizotypy 
 
Based on experiences/clinical literature 
of schizophrenia. 
No association with scores on PAS or MIS, 
supporting different dimensions of positive and 
negative symptoms. 
Those with high scores on this measure were more 
socially withdrawn and had less sexual 
interest/activity. 
Revised Social Anhedonia Scale 
(Eckblad et al., 1982) 
40-item scale reflecting social isolation, 
social dysfunction and indifference  
e.g. “A car ride is much more enjoyable 
if someone is with me” (false) 
 
Based on experiences/clinical literature 
of schizophrenia. 
Good reliability and validity (Mishlove & 
Chapman, 1985) 
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Table 2.2 Contd. 
 
Measure Description How items created Reliability and Validity 
 
Social Fear Scale (Raulin & 
Wee, 1984) 
 
True/false scale developed to measure 
social fear in the general population 
 
 
Items chosen which were considered to 
be specific to social fear – suggested by 
Meehl (1962; 1990) to be characteristic 
of schizotypy 
 
Follow-up interviews confirmed the measurement 
of social fear.  
Osman, Jones, and Osman (1990) reported good 
internal and test-retest reliability. 
 
Intense Ambivalence Scale 
(IAS; Raulin, 1984) 
45-item true/false scale designed to 
measure intense ambivalence 
Based on clinical literature on 
schizophrenia and relatives of those 
with schizophrenia. 
Longitudinal study conducted by Kwapil et al. 
(2000) showed that elevated scores on the IAS 
predicted the development of psychotic illness at 
10-year follow-up. 
 
Schizotypal Ambivalence Scale 
(SAS; Kwapil et al., 2002) 
19-item revision of the Intense 
Ambivalence Scale 
Items taken from Intense Ambivalence 
Scale (Raulin, 1984) 
Good internal consistency (α = .84). 
Correlates moderately with other psychometric 
indices of schizotypy. 
High SAS scores associated with schizotypal, 
schizoid and paranoid symptoms, and poor 
functioning. 
 
Cognitive Slippage Scale (Miers 
& Raulin, 1985)  
True/false scale for use with the general 
population to assess subtle thought 
disorder. 
 
Items taken from clinical literature on 
schizophrenia and thought disorder. 
Cognitive slippage outlined by Meehl 
(1962) as one of the four characteristics 
of schizotypy. 
 
Study by Gooding et al. (2001) showed that high 
scorers on this scale had reduced cognitive 
performance – evidence of construct validity. 
Impulsive Non-Conformity 
Scale (ImpNon; L. J. Chapman 
et al., 1984) 
Scale constructed to measure impulsive 
non-conformity and anti-social 
behaviour. 
Taken from examples of anti-social 
behaviour reported in the premorbid 
adjustment phase of psychosis 
 
Correlates highly with Psychoticism scale (r = .68) 
suggesting convergent validity 
Hypomanic Personality Scale 
(HypM; Eckblad & Chapman, 
1986) 
48-item true/false scale assessing 
impulsive and manic behaviour, e.g. “I 
often get so happy and energetic that I 
am almost giddy”. 
 
Items more representative of  bipolar 
disorder or affective psychoses 
Reported by authors: 
Good internal consistency (α = .87) 
Good test-retest reliability (r = .77) 
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 Table 2.3 Measures Designed to Assess Schizotypy as a Fully Dimensional Personality Trait – Multidimensional Schizotypy Measures 
 
Measure Description How items created Reliability and Validity 
 
Combined Schizotypal Traits 
Questionnaire (CSTQ; Bentall et 
al., 1989) 
 
Combination of a large body of scales to 
measure schizotypy in the general 
population – contains 420 items and 
true/false response format 
 
 
Taken from STQ, Chapman scales, 
LSHS, Schizophrenism scale, 
Schizoidia scale, etc. Aim to capture 
multidimensionality of schizotypy 
 
Psychometrics of 14 scales included in the CSTQ 
are well-documented by the author and viewed to 
be satisfactory (Claridge, 1997a). 
Oxford-Liverpool Inventory of 
Feelings and Experiences (O-
LIFE; O. Mason et al., 1995) 
Made up of four scales each containing 
24-30 items: Unusual Experiences 
(positive symptoms), Cognitive 
Disorganisation (attention, concentration 
and decision making), Introvertive 
Anhedonia (lack of enjoyment from 
social sources, dislike of intimacy), and 
Impulsive Non-conformity (violent, self-
abuse) 
Yes/No response format 
 
Reduction of CSTQ via factor analysis 
of scales. 
Items selected on the basis of factor 
loading size, endorsement rate and 
avoidance of repetition (unless question 
appeared highly relevant).  
 
All scales have highly adequate internal 
consistency (α = .77-.89).  
Relationships with age and sex mirror those found 
in psychotic samples with psychotic symptoms. 
Schizophrenism and Anhedonia 
Scales (Venables et al., 1990)  
27-item yes/no scale developed for the 
measurement of the positive –
(cognitive/perceptual/attentional function) 
and negative (social dysfunction and 
ahedonia) aspects of schizotypy 
14 items measuring schizophrenism (SZ)  
13 items measuring anhedonia (AH) 
 
Initial questionnaire included 250 items 
taken from other scales – selections 
were made based on theory. Items were 
also chosen for having normal face 
value, i.e. non-pathologising  
Good construct validity – has been shown by 
authors to be related to other measures of 
schizotypy and diagnoses of SPD 
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Table 2.4 Measures Designed to Assess Schizotypy as Attenuated Psychotic Symptoms – Hallucinations 
 
Measure Description How items created Reliability and Validity 
 
The Structured Interview for 
Assessing Perceptual Anomalies 
(SIAPA; Bunney et al., 1999) 
 
Interview-based assessment method 
designed to assess the frequency of 
sensory anomalies occurring across all 
five senses 
 
 
Items assess perceptual anomalies as 
distinct from hallucinations but are 
based on schizophrenic experience. 
 
Good inter-rater reliability demonstrated by the 
authors. 
Individuals with schizophrenia scored higher than 
controls across all five modalities. 
Launay-Slade Hallucination 
Scale (LSHS; Bentall & Slade, 
1985; Launay & Slade, 1981)  
12-item forced choice (yes/no) 
questionnaire to measure hallucinatory 
disposition (includes combination of 
overt pathological items and other items 
which appear to represent a subclinical 
form of hallucinatory experience). Bentall 
and Slade added Likert scale for use in 
the general population. 
30-item questionnaire initially 
constructed containing 7 clinical items, 
20 subclinical items (vivid/intrusive 
thoughts, dreams, daydreams) and 3 
filler items. This was reduced by 
removing items which failed to 
discriminate between clinical and non-
clinical populations.  
 
Discriminates between hallucinators and non-
hallucinators in both patient and general 
population samples. 
Good test-retest reliability in non-clinical sample 
(r = .84). 
Cardiff Anomalous Perceptions 
Scale (CAPS; V. Bell et al., 
2006) 
32-item self-report questionnaire using 
dimensional subscales to assess distress, 
intrusiveness, and frequency of 
anomalous experiences  
Initial yes/no response (lifetime) and then 
5-point Likert scale to measure distress, 
intrusiveness and frequency. 
Aim was to construct a scale that would 
be selective for perceptual anomalies 
without being conceptually tied to the 
assumptions and language of previous 
clinical and psychometric scales.  
Items were taken from measures related 
to psychosis proneness, the clinical 
assessment of psychosis, delusional and 
magical ideation, and hallucinatory 
experience. 
Particular focus on anomalous 
perceptual experience rather than more 
general aspects of schizotypy.  
Completed by a clinical and non-clinical sample. 
11.3% of the non-clinical sample scored above the 
mean of the clinical sample. 
Internal consistency good (α = .87) and test-retest 
reliability acceptable (r = .77). Internal consistency 
also stayed stable over time (α = .92). 
Convergent validity with LSHS, O-LIFE unusual 
experiences subscale and PDI-21. Small or non-
significant correlations with other subscales of O-
LIFE. 
Factor analysis revealed a three factor structure 
(temporal lobe, chemosensation, and clinical 
psychosis) 
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Table 2.5 Measures Designed to Assess Schizotypy as Attenuated Psychotic Symptoms – Delusions 
 
Measure Description How items created Reliability and Validity 
 
Peters et al Delusion Inventory 
(PDI; Peters, Joseph et al., 1999) 
 
40-item measure of delusional ideation 
which asks about individuals’ beliefs, 
interpretations and experiences. Measures 
the total number of beliefs or experiences 
endorsed, but also the concurrent 
perceptions of distress, preoccupation and 
conviction. 
Measures lifetime prevalence, has initial 
yes/no response followed by Likert scale 
 
 
Items derived from Present State 
Examination (Wing et al., 1974) 
 
Good internal consistency and concurrent 
validity was confirmed with three scales 
measuring schizotypy, magical ideation and 
delusions.  
PDI scores up to 1 year later remained 
consistent 
Psychotic inpatients had significantly higher 
scores than controls 
Paranoia Scale (Fenigstein & 
Vanable, 1992) 
20-item self-report scale developed to 
measure paranoia in college students. 
Each item is rated on a 5-point scale from 
1 (not at all applicable) to 5 (extremely 
applicable) 
 
Items specific to paranoid ideation, e.g. “I 
sometimes feel as if I am being followed” 
Good test-retest reliability over six months 
(r = .70).  
Good internal consistency (α = .80) 
Paranoia/Suspiciousness 
Questionnaire (PSQ; Rawlings & 
Freeman, 1996) 
47-item scale developed to measure 
paranoia and suspiciousness in a non-
psychiatric sample 
Yes/No response format 
Developed on a non-psychiatric sample 
using modified items from several 
established scales of paranoia and related 
concepts. 
 
Factor analysis revealed five moderately 
correlated subscales. 
Full questionnaire and the subscales showed 
satisfactory internal consistency and test-
retest reliability.  
 
Paranoia Checklist (Freeman, 
Garety et al., 2005) 
Devised to investigate paranoid thoughts 
of a more clinical nature than those 
assessed in the Paranoia Scale and to 
provide a multi-dimensional assessment 
of paranoid ideation. 18-item self report 
scale with each item rated on a five-point 
scale for frequency, degree of conviction, 
and distress. 
 
Addition of more persecutory items to 
Fenigstein and Vanable’s (1992) paranoia 
scale. Based on literature and assessments 
of psychotic symptoms. 
Convergent validity with Paranoia Scale and 
good internal consistency (α = .90) 
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Table 2.6 Measures Designed to Assess Schizotypy as Attenuated Psychotic Symptoms – Measures Assessing a Range of Symptoms 
 
Measure Description How items created Reliability and Validity 
 
The Schizotypal Traits 
Questionnaire (STQ; Claridge & 
Broks, 1984) 
 
Consists of two scales 
STA – a 37-item scale assessing 
schizotypal personality 
STB – an 18-item scale assessing 
borderline personality 
Designed to specifically tap the DSM-III 
concepts of SPD and BPD  
 
 
Items devised to cover cognitive, 
attentional and perceptual disturbances 
found in the self-reports of schizophrenic 
patients 
 
STA has minimal correlation with 
Psychoticism. 
STB is significantly correlated with 
Psychoticism.  
Good reliability and validity reported by the 
authors. 
The King’s Schizotypy 
Questionnaire (KSQ; Williams, 
1993) 
Unpublished dissertation – KSQ 
reported in paper by Jones et al. 
(2000)  
63-item forced choice (yes/no) self-report 
measure of schizotypy 
Items linked with DSM-III criteria for 
SPD with many items based on verbatim 
descriptions of personal experiences by 
the relatives of individuals with 
schizophrenia. 
High internal consistency (α = .81) 
Good test-retest reliability (r = .73) in a 
sample of 100 normal subjects 
Good validity correlation with STA (r = .62) 
 
Scales for Rating Psychotic and 
Psychotic-like Experiences as 
Continua (L. J. Chapman & 
Chapman, 1980) 
Modification of the Schedule for 
Affective Disorders and Schizophrenia-
Lifetime version.(SADS-L; Endicott & 
Spitzer, 1978). 
Scores assigned between 1 and 11 on 
judgements of increasing deviancy. 
 
Modification consisted of attenuating item 
content of SADS-L to reflect lower-level 
phenomena. 
 
High internal consistency  (α = .94)  
Subjects who scored highly on magical 
ideation also scored highly on this scale. 
Community Assessment of Psychic 
Experiences (CAPE; Stefanis et al., 
2002) 
42-item self-report questionnaire designed 
to assess positive, negative, and 
depressive experiences associated with 
psychosis in non-clinical populations. 
Items rated on a 4-point scale for 
frequency and distress.  
Assesses lifetime presence/general 
tendencies (i.e. Do you ever…) 
 
Positive items derived from the PDI; 
negative/depressive items derived from 
the Scale for the Assessment of Negative 
Symptoms (SANS; Andreasen, 1981) and 
Subjective Experience of Negative 
Symptoms scale (SENS; Selten, Gernaat, 
Nolen, Wiersma, & van den Bosch, 1998) 
All dimensions shown by authors to be 
stable, reliable, and valid in a large general 
population sample. Cross-validated with 
interview measures of schizotypy (Konings, 
Bak, Hanssen, van Os, & Krabbendam, 
2006). 
 
 
 
 
Note: SPD = Schizotypal Personality Disorder; BPD = Borderline Personality Disorder
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Table 2.6 Contd. 
 
Measure Description How items created Reliability and Validity 
 
Schizophrenism Scale (Nielsen & 
Petersen, 1976) 
 
Taps cognitive/perceptual aspects of 
behaviour 
 
Pool of items drawn from  study reporting 
phenomenology of early stage 
schizophrenia (J. P. Chapman, 1966)  
 
Good reliability and validity reported by 
authors.  
High scorers performed worse on 
neuropsychological tasks (Asarnow, 
Nuechterlein, & Marder, 1983) suggesting 
the scale does tap cognitive aspects. 
 
Rust Inventory of Schizotypal 
Cognitions (RISC; Rust, 1987; Rust, 
1988) 
26 statements assessing schizotypal 
cognitions associated with the positive 
symptoms of acute schizophrenia. Scale 
aims to identify bizarre and eccentric 
thought patterns phenomenologically 
related to acute schizophrenia. 
 
Based on symptomatology of 
schizophrenia 
Good reliability and validity. Has been 
shown by authors to discriminate between 
individuals with acute schizophrenia and 
controls. 
 
Schizotypal Personality 
Questionnaire (SPQ; Raine, 1991) 
 
Brief SPQ (SPQ-B; Raine & 
Benishay, 1995) 
Designed with aim to develop a 
questionnaire closely modelled on DSM-
III-R criteria that could provide an overall 
measure of schizotypal personality and 
attenuated psychotic symptoms. 
Contains nine subscales to assess each of 
the nine schizotypal features (ideas of 
reference, excessive social anxiety, odd 
beliefs/magical thinking, unusual 
perceptual experiences, odd/eccentric 
behaviour, no close friends, odd speech, 
constricted affect, suspiciousness). 
74-item Yes/No response format, assesses 
lifetime prevalence. 
Shorter, 22-item instrument based on the 
SPQ consisting on the most reliable items. 
Items generated from existing interview 
schedules for schizophrenia and 
schizotypal personality (e.g. PSE, SANS, 
SCID, SADS) and generation of new 
items to fill gaps in the item pool. 
Good internal consistency (α = .90 for total 
scale and .66-.81 for subscales). 
High test-retest reliability (r = .82). 
Good convergent validity with STA and 
schizophrenism scales and divergent validity 
with scales not tapping DSM-III-R 
schizotypal features. 
Kremen, Farone, Toomey, Seidman, and 
Tsuang (1998) showed that relatives of 
individuals with schizophrenia had higher 
scores on the cognitive perceptual factor of 
the SPQ than controls. 
Factor analysis of the scale resulted in a 
three-factor solution (Raine et al., 1994) 
which has been replicated (cognitive-
perceptual, interpersonal, and disorganised). 
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 Table 2.7 Measures Designed to Assess Prodromal Symptoms – Attenuated Symptoms Measures 
 
Measure Description How items created Reliability and Validity 
 
Comprehensive Assessment of At-
Risk Mental States (CAARMS; 
Yung et al., 2002) 
 
Semistructured interview to diagnose at-risk 
mental state. 
Seven subscales (positive symptoms, 
cognitive change, emotional disturbance, 
negative symptoms, behavioural change, 
motor physical change, general 
psychopathology).  
Dimensions of intensity, frequency/duration, 
and fluctuation of symptoms are scored 
separately.  
A person is defined as being at-risk mental 
state when meeting one or more of the Ultra-
High Risk (UHR) criteria based on positive 
symptoms of CAARMS (Yung et al., 2002). 
 
 
Designed in conjunction with ultra-
high risk criteria 
 
A 6-month follow-up of 150 non-psychotic, 
help-seeking individuals demonstrated that 
meeting the CAARMS-defined UHR criteria 
significantly predicted psychosis (Yung et 
al., 2002). 
Good discriminant validity – 48 controls 
scored significantly lower than 49 
individuals in a BPRS defined UHR state 
Structured Interview for Prodromal 
Symptoms (SIPS) and Scale of 
Prodromal Symptoms (SOPS) (T. J. 
Miller et al., 1999) 
Clinician-administered semistructured 
interview. The SIPS determines presence or 
absence of prodromal state and SOPS 
determines the severity. 
Consists of 5 positive symptom items, 6 
negative symptom items, 4 disorganisation 
symptom items, and 4 general symptom 
items. Each item has a severity rating scale 
from 0 (never/absent) to 6 (severe/extreme). 
Interview contains probes for positive items, 
GAF, family interview and SPD checklist. 
 
Based on PANSS (Kay, 1991) with 
modification of the positive symptom 
scales to provide more breadth of 
scoring within the lower, prepsychotic 
ranges of severity.  
Designed to rate the existence and 
severity of prodromal symptoms along 
dimensions between normalcy and 
lower levels of pathology as defined by 
conventional rating scales (e.g. BPRS, 
PANSS, SAPS, SANS, etc) 
 
Factor structure shown to be similar to that 
of symptoms of schizophrenia (Hawkins et 
al., 2004), suggesting evidence for a 
psychosis continuum. 
Shown by authors to have good predictive 
validity. 
 
Note: BPRS = Brief Psychiatric Rating Scale; SAPS = Scale for the Assessment of Positive Symptoms; SANS = Scale for the Assessment of Negative Symptoms
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Table 2.8 Measures Designed to Assess Prodromal Symptoms – Basic Symptoms Measures 
 
Measure Description How items created Reliability and Validity 
 
Bonn Scale for the Assessment of Basic 
Symptoms (BSABS; Gross et al., 1987) 
 
Scale consists of six subscales of basic 
symptoms (two scales of dynamic deficits, 
cognitive disturbances, coenesthetic 
experiences, central vegetative 
experiences, and autoprotective 
behaviour). Each basic symptom is rated 
as either present or absent. 
 
 
Created from research conducted by the 
authors into the basic symptoms of 
schizophrenia. These are subtle, 
subjectively experienced disturbances in 
the domains of perception, cognition, 
language, motor function, will, initiative, 
and level of energy and stress tolerance. 
 
 
Specific disturbances of cognition, 
speech and perception have shown a 
significant predictive value in 
developing schizophrenia. Ten 
symptoms predicted schizophrenia with 
a probability of 71-91% (Klosterkötter, 
Hellmich, Steinmeyer, & Schultze-
Lutter, 2001). 
Schizophrenia Prediction Instrument – 
Adult version (SPI-A; Klosterkötter, 
Schultze-Lutter et al., 2001) 
 
Shorter 40-item version of the Bonn Scale 
to assess basic symptoms. 
Developed as a supplement to 
SIPS/CAARMS and PANSS. 
Shown by authors to be predictive of 
later psychosis 
Early Recognition Inventory (ERIraos; 
Häfner et al., 2004; Maurer, Hörrmann, 
Schmidt, Trendler, & Häfner, 2004)  
Two-step inventory.  
1. 17-item checklist, constructed as a 
screening instrument for application in 
primary care settings.  
2. 110-item symptom list for incipient 
schizophrenia. 
 
110-item symptom list compiled from 
other measures, including: Interview for 
the Retrospective Assessment of the 
Onset and Course of Schizophrenia and 
other Psychosis (IRAOS), BSABS, SIPS, 
CAARMS 
Successfully used in a study to screen for 
individuals in prodromal states 
(Bechdolf et al., 2005) 
Examination of Anomalous Experience 
(EASE; Parnas et al., 2005) 
Semistructured symptom checklist, 
exploring phenomena regarded as 
important in the preonset phase which is 
also manifest in schizophrenia and 
schizotypy 
Interview consists of 57 items divided into 
five subscales (cognition and stream of 
consciousness, disorders of self-awareness 
and presence, bodily experience, 
transitivism, and existential re-
orientation). Symptoms are rated in terms 
of frequency/severity and as to specific 
patterns 
 
Items focus on experiential anomalies of 
self-awareness 
Many items overlap with BSABS but only 
items relating to self-experience are 
included. Other items are based on the 
authors own experience and 
phenomenological orientation. 
Authors demonstrated good inter-rater 
reliability on the basis of video 
interviews. 
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 Table 2.9 Measures Designed to Assess Prodromal Symptoms – Screening Tools 
 
Measure Description How items created Reliability and Validity 
 
PRODscreen – a screen for 
prodromal symptoms of psychosis 
(Heinimaa et al., 2003) 
 
Screen to detect elevated risk of 
psychosis. Interview or self-rating. 
Includes: 7 items for general functioning, 
10 items for general symptoms and 12 
items of more specific psychosis-like 
character. The main focus of the measure 
is attenuated positive symptoms. 
 
 
Based on items from SIPS, IRAOS and 
BSABS 
 
Authors demonstrated that the measure 
correctly defined a SIPS-defined prodromal 
state in 77% of cases from a mixed sample. 
Inclusion of qualitative data has shown to 
enhance the validity of the screening 
procedure.  
Prodromal Questionnaire (PQ; 
Loewy et al., 2005) 
Contains 92 true/false statements 
including subscales for positive, negative, 
disorganised and general symptoms. 
Based on SIPS, SPQ and a few original 
items based on the authors’ experience 
Good concurrent validity of positive 
subscale with SIPS. Validated by authors in 
a large non-clinical population of students. 
 
Youth Psychosis At-Risk 
Questionnaire (Y-PARQ; Ord & 
Myles-Worsley, 2004)  
Consists of 92 yes/no items for self-rating 
Includes items on positive, affective and 
negative symptoms of prodromal 
schizophrenia 
Based on CAARMS Tested by authors on 648 high school 
students with elevated rates of familial 
schizophrenia. Positive predictive value of a 
CAARMS-defined at risk mental state of 
82.4%. 
 
SIPS Screen (T. J. Miller, Cicchetti, 
Markovich, McGlashan, & Woods, 
2004) 
Brief self-report screen consisting of 12 
items covering positive symptoms only. 
Each item rated between 0 (definitely 
disagree) and 6 (definitely agree) 
Covers same items as SIPS SIPS screen was administered before SIPS 
interview on a sample of 36 subjects 
referred for prodromal evaluation. Screening 
instrument showed a sensitivity of .90 and 
indicated perfect specificity. 
 
Basel Screening Instrument for 
Psychosis (BSIP; Gschwandtner et 
al., 2003; Riecher-Rössler et al., 
2006) 
46-item screening checklist to identify 
those at risk, developed for the FEPSY 
early detection study (Gschwandtner et 
al., 2003). Used in combination with the 
BPRS to rate psychotic phenomena. 
 
Based on DSM-III-R prodromal 
symptoms and other risk factors as 
derived from the literature (social decline, 
drug abuse, previous psychiatric disorders 
and genetic risk) 
Higher inter-rater reliability (Kappa = .87) 
Validated using longitudinal study assessing 
transition to psychosis. 32% of individuals 
classified at-risk by BSIP made transition 
within 2-5 years (Riecher-Rössler et al., 
2008).   
 
 
 Note: BPRS = Brief Psychiatric Rating Scale
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2.2.5 Summary of Review  
 
This section has reviewed a wide range of measures for use in assessing schizotypy and 
low-level psychotic phenomena. The review was conducted in the context of the aim of 
this thesis: using a measure of schizotypal symptoms to assess the prodromal and 
residual symptoms of psychosis. Some measures are too broad in their scope to 
adequately address this aim (i.e. borderline personality measures); whereas others assess 
only specific types of psychotic-like phenomena and as such are too narrow (e.g. PDI, 
PAS). Moreover, many of the measures reviewed have been validated in non-clinical 
populations only, making their transferability to clinical groups questionable. Most tools 
also assess schizotypy as a fully dimensional personality trait; reflecting either lifetime 
prevalence of schizotypal symptoms, or underlying predisposition to the development of 
psychosis. As a result, state heterogeneity in psychotic-like experiences is not picked up 
by these measures. Assessment tools which do assess current low-level psychotic 
phenomena (i.e. prodromal symptom measures) often require resource-intensive 
structured interviews and were specifically developed for clinical groups, making them 
unsuitable for use in non-clinical samples.  
 
As a result of this review, a need has been highlighted for the development of a self-
report measure suitable for use in assessing current (i.e. mental state) levels of 
subclinical psychotic symptoms in both clinical and non-clinical populations. Such a 
measure could be used to detect both prodromal and residual symptoms of psychosis 
and also to investigate the associations of these symptoms with a range of other 
variables. The measure should aim to encompass the strengths of assessment tools 
described in the preceding review but also address the weaknesses. Therefore its content 
should be linked to diagnostic criteria, yet at the same time comprise adequate 
sensitivity for the detection of phenomena analogous to the symptoms of psychosis, but 
which occur outside of a psychiatric framework (i.e. prior to the onset of psychosis and 
in the recovery phase). Moreover, as the exact symptoms predictive of the development 
of psychosis or psychotic relapse are presently unclear (Gunderson, Siever, & 
Spaulding, 1983; Widiger, Frances, & Trull, 1987); the measure should cover a range of 
psychotic-like symptoms, as opposed to focusing on one symptom type in isolation.  
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The rest of this chapter reports on the development and psychometric properties of the 
Schizotypal Symptoms Inventory (SSI), a modified version of the Schizotypal 
Personality Questionnaire (SPQ; Raine, 1991). The SSI aims to assess schizotypal 
experiences in a more dimensional manner, taking account of the current frequency of 
symptoms, rather than their lifetime presence or absence. The SPQ was used as the 
basis for the new instrument because it is based on DSM-III-R criteria (American 
Psychiatric Association, 1987) and is impressively inclusive in the range of phenomena 
it assesses. In particular, it includes social anxiety, paranoia, and anomalous experiences 
dimensions. This means that the distributions of different psychotic-like symptom types 
can be examined using the same scale. The SPQ is also suitable for use in both clinical 
and non-clinical populations. The modifications made to the SPQ in this study allow 
schizotypal experiences to be assessed in a state- as opposed to trait-like manner, thus 
aligning schizotypal experiences more closely with clinical measures of 
symptomatology. 
 
The distribution of psychotic-like experiences has been shown to be highly dependent 
on the instrument used to assess them (Johns & van Os, 2001). The SPQ has been 
shown to have an approximately normal distribution, suggesting that it takes a 
normalised approach towards the assessment of schizotypy (i.e. it measures normal 
variation in personality). This fits with the original design aim of the SPQ to assess 
schizotypal traits and tendencies, rather than attenuated psychotic symptoms (Raine, 
1991); and also with findings that schizotypy measured by the SPQ may be an 
endophenotype of psychosis; i.e. a quantitative trait reflecting genetic liability to the 
disorder (Avramopoulos et al., 2002; Vollema et al., 2002). Conversely, measures 
which assess schizotypy as a more pathological construct, such as the Peters Delusion 
Inventory (PDI; Peters, Joseph et al., 1999), have been shown to have a skewed 
distribution, mirroring that of other psychopathologies, e.g. affective symptoms 
(Melzer, Tom, Brugha, Fryers, & Meltzer, 2002). 
 
A state measure of schizotypal symptoms, such as the SSI, is arguably more clinical in 
its approach than a trait measure, such as the SPQ. In measuring state quasi-psychotic 
experiences, the SSI is likely to provide a more accurate assessment of current symptom 
profiles, and thus immediate risk of psychosis. Moreover, the SSI assesses recent 
frequency of schizotypal symptoms as well as their presence. This is important based on 
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suggestions from previous research that the experience of psychotic-like symptoms per 
se is not necessarily pathological, and that other dimensions of experience may be more 
predictive of risk (Lincoln, 2007). Increased frequency of experience is highlighted as a 
particular indicator of pathology, as it may lead to heightened emotional responses and 
increased distress (Birchwood, 1996). Given its more clinical focus, symptoms 
measured by the SSI may follow a more skewed distribution that that of schizotypal 
traits measured by the SPQ, which is normally distributed. This will be investigated in 
the current study. 
 
2.3 STUDY AIMS AND RESEARCH QUESTIONS 
 
The main aim of this study is to report the psychometric properties of the SSI, in both a 
clinical and non-clinical sample. In both groups, internal consistency, test-retest 
reliability and the underlying factor structure of the scale are reported. Furthermore, in 
order to investigate convergent validity of the modified scale, associations between the 
subscales of the SSI and assessments of psychotic symptoms are provided for the 
clinical sample. Moreover, to test the discriminative abilities of the SSI, schizotypy 
scores are compared in the clinical and non-clinical groups. It is hypothesised that the 
clinical sample will experience more schizotypal phenomena (i.e. have higher SSI 
scores), than the non-clinical sample; and that within the clinical sample, higher PANSS 
Positive scores will be associated with higher scores on the SSI.  
 
Following on from these analyses, the most reliable items are taken from the SSI and 
used to create a shortened 20-item version of the measure. Psychometric analyses of the 
brief SSI are reported for the clinical and non-clinical samples. It is argued that a short 
version of the SSI may be useful for longitudinal research to assess changes in 
symptoms over time without asking individuals to repeatedly complete the full 74-item 
version.  
 
Finally, in order to examine the ability of the scale to assess current low-level psychotic 
symptoms, rather than schizotypal traits and tendencies, distributions of item counts on 
the original SPQ and the new SSI are plotted using histograms and dot plots. The shape 
of these distributions is then examined and compared. It is predicted that schizotypal 
symptoms measured by the SSI will follow a skewed distribution (i.e. many people will 
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experience a few symptoms some of the time but only a few people will experience 
many symptoms a lot of the time). In contrast, it is hypothesised that the lifetime 
presence or absence assessment of schizotypy (as measured by the original SPQ 
questions) will be normally distributed.  
 
2.4 METHODOLOGY 
 
This section will provide a detailed description of the methodology used in this study. 
 
2.4.1 Design 
 
A non-clinical sample of university students and a clinical sample of patients diagnosed 
with early psychosis were surveyed in a cross-sectional design. A repeated measures 
design was used with a smaller subsample of participants to examine the test-retest 
reliability of the SSI. A between-subjects design was used to compare scores in the 
clinical and non-clinical populations. Within the clinical sample, a correlational design 
was used to investigate the hypothesised relationships between scores on the SSI and 
psychopathology measured by the PANSS.  
 
2.4.2 Participants 
 
2.4.2.1 Non-clinical sample 
 
One thousand and one students were recruited for an anonymous internet survey from 
the University of East Anglia, Norwich; and King’s College, London. A student sample 
was approached as their age group was thought to match that of an early psychosis 
sample and the typical age range at which individuals are thought to be most at risk of 
developing psychosis (Hodges et al., 1989). Convenience sampling, via a circular e-mail 
inviting individuals to participate, was used to recruit individuals into the study. A copy 
of the circular e-mail is included in Appendix A. The circular e-mail was distributed to a 
population of over 10,000 students and thus a conservative estimate of the response rate 
is approximately 10%. 
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There were no inclusion or exclusion criteria for this sample, other than individuals had 
to be registered students at either of the participating institutions. In addition to this, 
participants who incorrectly completed or missed more than 10% of items on the 
questionnaires (i.e. completion rate less than 90%) were excluded from the analysis. 
This left a total of 808 participants in the final analysis. Consequently, the percentage of 
SSI data that was prorated was minimal (0.54%).  
 
2.4.2.2 Clinical sample 
 
One hundred and twenty-six individuals with affective or non-affective psychosis 
(diagnoses of schizophrenia, schizoaffective disorder and bipolar disorder) also 
participated in the study. This sample consisted of 58 patients from the Norfolk Early 
Intervention Service (Norfolk and Waveney Mental Health Partnership); and 68 patients 
from the first cohort of participants recruited for the “Improving Social Recovery in 
Early Psychosis” (ISREP) Study – a randomised controlled trial of social recovery 
oriented cognitive-behavioural therapy (see Appendix B). All participants had been 
assessed with the Diagnostic Interview for Psychosis (DIP; Jablensky et al., 1999). 
 
All participants had been diagnosed with psychosis in the last eight years but were not 
yet classified as belonging to a chronic and enduring psychosis population. 
Furthermore, all patients were not currently experiencing an acute episode of psychosis. 
Patients recruited from the Norfolk Early Intervention Service were assessed three 
months after entry into the service, by which time, their episode of psychosis had 
stabilised. Similarly, in order to take part in the ISREP study, patients must not have 
been experiencing any positive symptoms above moderate severity as defined by the 
PANSS.  
 
2.4.2.3 Demographic characteristics of the sample 
 
Demographic characteristics of the two samples are shown in Table 2.10. As can be 
seen, the mean ages of the clinical and non-clinical samples were similar. However, 
using an independent samples t-test, the clinical group was shown to be significantly 
older than the non-clinical group, t(932) = 3.83, p <.001. There is also a gender bias 
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towards females in the non-clinical sample and males in the clinical sample. In both 
samples, ethnicity was predominantly White and British.    
 
Table 2.10  
Demographic Characteristics of the Non-clinical and Clinical Samples  
 
 Non-Clinical (N = 808) Clinical (N = 126) 
 
Mean Age (SD) in years 
 
23.0 (6.6) 
 
25.5 (6.2) 
 
Gender (%): 
Male 
Female 
Did not disclose 
 
192 (23.8) 
515 (63.7) 
101 (12.5) 
 
88 (69.8) 
38 (30.2) 
- 
 
Ethnicity (%): 
White 
Asian 
African 
Afro-Caribbean  
Other 
Did not disclose 
 
621 (76.9) 
42 (5.2) 
6 (0.7) 
2 (0.3) 
34 (4.2) 
103 (12.7) 
 
119 (94.4) 
1 (0.8) 
1 (0.8) 
1 (0.8) 
4 (3.2) 
- 
 
Diagnosis (%): 
Affective Psychosis 
Non-affective Psychosis 
 
- 
- 
 
36 (28.6) 
90 (71.4) 
 
2.4.2.4 Sample size and power analysis 
 
Between-groups analysis. In order to compare differences in SSI scores 
between clinical and non-clinical populations, a power analysis calculation revealed that 
to achieve 90% power with a significance level of .05 and an estimated moderate 
critical effect size of .50, a minimum sample size of 85 participants per group was 
required (Cohen, 1988). 
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Correlational analysis. In order to examine the relationship between 
psychopathology and scores on the SSI within each group, a power analysis calculation 
revealed that to achieve 90% power with a significance level of .05 and an estimated 
small to moderate critical effect size of .40, a minimum sample size of 62 participants 
was required in each group (Cohen, 1988).  
 
2.4.3 Ethical Considerations 
 
The study was reviewed and approved by the ethics committees of all participating 
institutions, including the Institute of Psychiatry Research Ethics Committee, the 
University of East Anglia’s Faculty of Health Ethics Committee, and Norfolk Local 
Research Ethics Committee. All letters of approval are located in Appendix C. 
 
2.4.3.1 Informed consent 
 
Non-clinical sample. An explanation of the nature of the research and what 
participation in the study would involve was included both in the circular e-mail 
inviting individuals to participate, and on the initial page of the website containing the 
questionnaires (see Appendix A). Participants were required to tick a box on the web 
page signifying that they had read and understood the instructions before they could 
progress to the questionnaires. Informed consent was assumed if participants visited the 
website and completed the questionnaires. If individuals decided not to take part after 
reading the instructions, they were free to leave the website. The instructions stated that 
participants did not have to answer any questions they felt uncomfortable with and 
could leave the website at any point, even if they had already started to complete the 
questionnaires.  
 
Clinical sample. In the clinical sample, assessments were conducted as part of 
routine clinical assessments in the Norfolk Early Intervention Service; or as part of the 
baseline assessment process in the ISREP study. All patients were asked to sign a 
consent form stating that they were agreeable to their data being used for research 
purposes. They were also provided with information regarding the nature of the research 
and how their responses would be used. Examples of patient information sheets and 
consent forms are included in Appendix D. Data for any participant who did not wish 
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their responses to be used for research purposes was not included in the sample. Patients 
were given as much time as they wanted in order to make the decision as to whether 
they wanted to be involved in the research. A minimum of 72 hours was allowed 
between giving information about the research and taking informed consent. Any 
patient who was considered by a clinician as unable to give informed consent was not 
approached to take part in the research.  
 
2.4.3.2 Confidentiality and anonymity 
 
Non-clinical sample. No identifying details were recorded about the 
individuals participating in the internet survey. Circular e-mails were distributed by 
administrative staff at each institution and thus the researchers did not have access to 
individual e-mail addresses. Demographic details were requested but participants did 
not have to supply these if they did not wish to do so.  
 
Following participation in the study, participants were assigned a code so that their 
responses to each questionnaire could be matched for analysis, whilst remaining 
anonymous. Following completion of the questionnaires, participant data was stored on 
the website until the end of the study. The web-page was developed with appropriate 
security measures by the Information Technology department at the Institute of 
Psychiatry. This ensured that no persons or organisations outside of the research team 
were able to gain access to the data collected. Storage of all data also complied with the 
terms of the Data Protection Act (1998).  
 
Participants were informed at the beginning and end of their participation that if they 
would like feedback on the research or had any queries regarding their participation, this 
would be provided on an individual basis via e-mail with the researcher. This happened 
on several occasions but no problems were highlighted and contacts with the researcher 
mostly related to personal interest and individuals requesting more information about 
the study and its aims.   
 
Clinical Sample. Each participant was allocated a code so that their 
responses to questionnaires and assessments could be matched without using their 
names. The names of participants were known only to the researcher and were not used 
  68 
 
at any other point following the end of the individual’s participation in the research. 
Participants were informed that all of their responses were confidential, unless 
something arose that resulted in the researcher becoming concerned about the personal 
safety of the participant or the safety of others. If any concerns did arise, the participant 
was always informed about who was to be contacted and what was going to happen. In 
the case of patients recruited from Norfolk Early Intervention Service, the assessments 
formed part of routine clinical practice and thus information was shared on a clinical 
basis. Participants were made aware of this at the beginning of their participation in the 
study.  
 
2.4.4 Measures 
 
2.4.4.1 Schizotypal Personality Questionnaire (SPQ; Raine, 1991) 
 
The SPQ is a 74-item questionnaire with a dichotomous (yes/no) response format, 
designed to assess schizotypal traits in both clinical and non-clinical populations. The 
measure is based on DSM-III-R criteria for Schizotypal Personality Disorder (SPD) and 
is the only published scale reflecting all aspects of the disorder. The SPQ consists of 
nine subscales, each reflecting individual SPD criteria: Ideas of Reference (9 items), 
Excessive Social Anxiety (8 items), Magical Ideation (7 items), Unusual Perceptual 
Experience (9 items), Eccentric Behaviour (7 items), No Close Friends (9 items), Odd 
Speech (9 items), Constricted Affect (8 items), and Suspiciousness (8 items). The scale 
has been shown to fit into a three factor structure: Interpersonal Schizotypy, Cognitive-
Perceptual Schizotypy, and Disorganised Schizotypy (Raine et al., 1994), mirroring the 
three types of symptoms seen in psychosis: negative, positive and disorganised (Strauss 
et al., 1974). Scores on the SPQ range from 0 to 74 with one point being given for every 
item endorsed. 
 
The SPQ has been shown to have good psychometric properties. The author reports 
Cronbach’s alpha internal consistency coefficients of .90 for the total scale and .71 to 
.78 (M = .74) for the individual subscales (Raine, 1991). Furthermore, two-month test-
retest reliability is reported at .82. In addition to this, the SPQ has been shown to 
correlate at .81 with the STA subscale of the Schizotypal Traits Questionnaire (STQ; 
Claridge & Broks, 1984); and from .59 to .65 with the Schizophrenism Scale (Venables 
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et al., 1990). Both of these scales assess several of the DSM-III-R traits for schizotypal 
personality. Conversely, low correlations have been found between the SPQ and scales 
which assess constructs related to psychosis-proneness but which are not included in 
DSM criteria for schizotypal personality, e.g. .19 with Anhedonia (Venables et al., 
1990) and .27 with Psychoticism (S. B. Eysenck et al., 1985). Thus the SPQ is shown to 
have good convergent and divergent validity. Moreover, 55% of individuals scoring in 
the top 10% of SPQ total scores have been reported by Raine (1991) to display a 
clinical diagnosis of SPD, as diagnosed by the SCID. Similar findings have been 
reported more recently by Kremen et al. (1998). 
 
2.4.4.2 Modifications to the SPQ: creation of the Schizotypal Symptoms Inventory 
(SSI)  
 
In its current form, the SPQ assesses a combination of lifetime occurrence of psychotic-
like experiences (e.g. “Have you ever seen things invisible to other people?”); and the 
presence of schizotypal traits which may be argued to predispose someone to psychosis 
(e.g. “Do you often feel that other people have got it in for you?”). As such, the SPQ 
does not assess recent occurrence of schizotypal phenomena (i.e. mental state). In order 
to address this, the Schizotypal Symptoms Inventory (SSI) was created by altering items 
so that they enquired about symptom presence in the previous two weeks, rather than at 
any point in the respondent’s lifetime. In addition, the original dichotomous response 
format of the SPQ was replaced with a 5-point Likert scale to assess the recent 
frequency of occurrence of each item. All of the 74 original questions and their wording 
were retained in order to retain the psychometric properties of the measure. Thus, 
individuals were asked how often, in the past two weeks, they had experienced each of 
the 74 schizotypal symptoms (0 = not at all, 1 = occasionally, 2 = sometimes, 3 = often, 
4 = all of the time). Scores on the SSI range from 0 to 296. A copy of the SSI is 
provided in Appendix E. 
 
2.4.4.3 Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987) 
 
The PANSS was used to assess the presence and severity of psychotic symptoms in the 
clinical sample, and to investigate the validity of the SSI as a self-report measure of 
low-level psychotic phenomena. The PANSS is a 30-item scale developed for the 
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assessment of phenomena associated with schizophrenia. It involves a semistructured 
psychiatric interview, used in combination with a detailed rating manual. Items are rated 
on a seven-point scale of increasing severity, from 1 (absent) to 7 (extreme). In the 
current study, symptoms were rated over the past 72 hours. Seven items are used to rate 
the positive symptoms of psychosis (e.g. delusional ideation, hallucinations, 
suspiciousness). A further seven items are used to rate the negative symptoms of 
psychosis (e.g. blunted affect, emotional withdrawal, poor rapport). There is also 16-
item subscale assessing general symptomatology (e.g. anxiety, depression, motor 
retardation). High inter-rater reliability and test-retest reliability have been demonstrated 
for the scale by Kay et al. (1987) and these have also been replicated more recently 
(Peralta & Cuesta, 1994). 
 
2.4.5 Procedure 
 
2.4.5.1 Non-clinical sample 
 
Participants were e-mailed the address of a website where they could complete the SSI 
online. The e-mail invited individuals to take part in a student project investigating how 
different aspects of emotion were associated with characteristics of personality. There 
was no mention of the term schizotypy as it was decided that this may be potentially 
stigmatising to some participants who may misinterpret the term and thus bias the 
sample. Completion of the questionnaires took approximately 30 minutes and there was 
no payment or other incentive offered for taking part in the research. The website was 
“open” for a period of two months following the initial e-mail. After completion of the 
questionnaires, participants were asked if they were agreeable to take part in a test-retest 
procedure for the SSI. Those who responded to this request were invited to complete the 
SSI two weeks after initial completion of the measure. One hundred and two 
participants responded to this request, thus enabling an assessment of the SSI’s 
reliability over time to be carried out. 
 
An internet survey design was chosen as it was thought that this provided a safe 
environment for participants to disclose anomalous experiences and unusual thoughts 
and feelings. The internet is becoming an increasingly popular method of conducting 
survey research, mostly because it offers many advantages over older surveying 
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techniques such as mail-outs and telephone interviews (Kaye & Johnson, 1999). Internet 
surveys reduce the time and cost normally associated with carrying out such research. 
They also remove the need for data entry as data is automatically saved as participants 
fill in the survey online. Research into internet-based surveying has shown that once 
individuals have consented to take part, the method is at least as effective as other 
modes of surveying. Birnbaum (2001) provides evidence that internet research reaches 
the same conclusions as laboratory-based research. Furthermore, it has been suggested 
that web surveys produce less item non-response than telephone surveys (Fricker, 
Galesic, Tourangeau, & Yan, 2005). Internet surveys may also be more desirable than 
face-to-face or telephone surveying methods, as they are potentially less intrusive and 
an individual may feel less pressurised into taking part.  
 
2.4.5.2 Clinical sample 
 
Measures for this study were completed as part of routine clinical assessments in the 
Early Intervention Service sample; and as part of the baseline assessment process for 
participants recruited for the ISREP study. The PANSS interviews were carried out by 
trained researchers who met regularly to ensure reliability and quality control. In the 
case of Early Intervention Service patients, interviews took place three months after 
entry into the service. This enabled stabilisation of the psychotic episode. In the case of 
the patients recruited from the ISREP study, assessments took place approximately one 
week after consent to enter into the study and before randomisation to either the control 
or treatment arm of the trial. Following the interview, patients self-completed the self-
report questionnaires (i.e. SPQ, SSI). These were completed on a laptop using a 
specially designed database which stored responses as they were entered. This was done 
in order to make the response format of the SSI as identical as possible to that utilised 
by the non-clinical sample in the internet survey. The self-report questionnaires and the 
symptom interviews were completed within two weeks of one another.  
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2.4.6 Data Analysis Plan 
 
2.4.6.1 Initial treatment of the data 
 
Non-clinical sample. Raw data from the internet survey were screened and 
cleaned prior to analyses. The data set was screened for any missing data. For each 
participant, where answers to more than 10% of items in individual questionnaires were 
missing, data for that questionnaire was removed. For those participants with less than 
10% of responses missing for each questionnaire, prorating was used to replace missing 
responses. This involved replacing missing variables with the participants’ mean scores 
for the particular subscale in the particular questionnaire in which they occurred. This 
was considered a valid procedure to use as only a small number of missing variables 
were prorated (0.54%). Missing data analyses showed that missing data points were 
randomly distributed across the data set. 
 
Clinical sample. Following entry, data were screened for any anomalous 
values and these were amended accordingly. Missing data were treated in the same way 
as for the non-clinical sample. After completion of the interviews and self-report 
questionnaires, researchers went through the raw data and pointed out any missing 
responses to the participant. This resulted in a low level of missing data (less than 
0.50%).  
 
2.4.6.2 Analyses of the data 
 
All data were analysed using SPSS for Windows, version 14 (SPSS, 2005). In the first 
stage of the analysis, descriptive statistics and data distributions were calculated for all 
measures in both samples. Psychometric analyses were then conducted. Internal 
consistency for the total SSI and its subscales were measured for both samples using 
Cronbach’s alpha internal consistency coefficients. Test-retest reliability was assessed 
for the total SSI and subscales in the clinical sample using Pearson’s product moment 
correlations. Furthermore, a Principal Components Analysis with varimax rotation was 
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performed on the combined scale of 74 state schizotypy items for both groups in order 
to examine the internal factor structure of the scale.  
 
Comparisons of mean scores in clinical and non-clinical samples on the total SSI and its 
subscales were conducted using a series of independent samples t-tests for normally 
distributed data. Where data were skewed, non-parametric statistics were used to 
compare differences between groups. Pearson’s product moment correlations were also 
conducted to investigate the hypothesised relationships between psychotic 
symptomatology and scores on the SSI in the clinical sample. Where data were skewed, 
Spearman’s Rho correlations were used. These relationships were also taken as a 
measure of the convergent validity of the scale.  
 
In order to create a shortened version of the SSI consisting of the most reliable items, 
findings from the factor analyses conducted on the clinical and non-clinical sample data 
were used. Items loading on the same factors in both groups were selected and scores on 
each combined factor compared between groups in order to ensure adequate 
discrimination between clinical and non-clinical populations. The six items with the 
highest loadings on each factor between the two samples were chosen for the brief 
scale. Cronbach’s alphas for each factor were then calculated for both samples. Where 
alphas were low, item-total correlations were conducted and items with the highest 
correlations were selected. Items thought to have particular clinical relevance were 
retained even if this was not supported by statistical analysis. Psychometric analyses 
outlined above were then repeated for the brief scale in both samples. Finally, 
distributions of symptom counts on the SPQ and SSI were plotted using histograms and 
dot plots. The shape of these distributions was compared. 
 
2.5 RESULTS 
 
This section reports the results of the statistical analyses outlined above. First, 
descriptive data is provided for both the clinical and non-clinical populations. This is 
followed by results of the psychometric analysis of the SSI, including internal 
consistency, test-retest reliability, convergent validity, and the factor analysis. The most 
reliable items are then used to create a shorter, easier to use, version of the SSI and the 
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psychometric analyses of this brief scale are reported. Finally, the distributions of 
symptom counts provided by the SPQ and SSI are compared. 
 
2.5.1 Descriptive Data 
 
2.5.1.1 Non-clinical sample 
 
Table 2.11 provides descriptive data for the SPQ and the SSI in the non-clinical sample. 
SPQ scores are similar to non-clinical norms reported by other papers (e.g. Raine, 
1991). 
 
Table 2.11  
Descriptive Data for the Non-Clinical Sample 
 
 N Min-Max Median Mean  
(SD) 
Skewness 
(SE) 
 
SPQ Total 
 
808 
 
0-68 
 
27.50 
 
28.59 (14.51) 
 
0.43 (0.09) 
 
SSI Total 
 
808 
 
0-202 
 
33.00 
 
42.23 (33.93) 
 
1.32 (0.09) 
 
2.5.1.2 Clinical sample 
 
Table 2.12 provides descriptive data for the SPQ, the SSI, and the PANSS for the 
clinical sample. Individuals in the clinical sample displayed relatively low levels of 
psychotic symptomatology as defined by the PANSS, but appear to experience higher 
levels of schizotypal phenomena than the non-clinical sample.  
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Table 2.12  
Descriptive Data for the Clinical Sample 
 
 N Min-
Max 
Median Mean  
(SD) 
Skewness 
(SE) 
 
SPQ Total 
 
126 
 
0-74 
 
40.50 
 
39.60 (16.19) 
 
-0.16 (0.22) 
 
SSI Total 
 
126 
 
0-251 
 
63.00 
 
67.64 (49.03) 
 
1.44 (0.22) 
 
PANSS Positive 
 
118 
 
7-28 
 
12.00 
 
12.36 (4.33) 
 
0.86 (0.22) 
 
PANSS Negative 
 
118 
 
7-29 
 
13.00 
 
13.56 (4.21) 
 
0.82 (0.22) 
 
PANSS General  
 
118 
 
18-58 
 
31.00 
 
30.71 (7.33) 
 
0.54 (0.22) 
 
2.5.1.3 Normality of the distributions and transforms 
 
 
In both samples, the distributions of scores were positively skewed for most variables, 
with the majority of participants scoring in the lower range. This can be seen by the 
levels of skewness shown for each measure in Tables 2.11 and 2.12. Data are thought to 
be particularly skewed when the skewness value exceeds +/- 1. Although this is not the 
case for all variables, Shapiro-Wilk tests showed the distributions for most variables to 
be significantly different from normal. The one exception to this is SPQ scores, which 
appear to be normally distributed, in line with Raine et al’s (1994) findings. The data 
were resistant to transformation using both log and square root techniques. Therefore, 
where data is skewed, non-parametric statistics will be used to investigate relationships 
and differences between variables. Parallel parametric analyses did however reveal 
similar findings. 
 
2.5.2 Comparison of SSI Scores in Clinical and Non-Clinical Samples 
 
Independent samples t-tests were used to compare SPQ scores between the clinical and 
non-clinical samples. The clinical sample displayed significantly higher SPQ scores 
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than the non-clinical sample, t(932) = 7.20, p <.001. Independent samples Mann-
Whitney U tests were used to compare SSI scores between the two samples. The clinical 
sample displayed significantly higher SSI scores than the non-clinical sample (U = 
33224.00, p <.001). This suggests that, like the SPQ, the SSI can adequately 
discriminate between clinical and non-clinical populations. 
 
2.5.3 Psychometric Analysis of the SSI 
 
2.5.3.1 Internal consistency of the SSI 
 
Cronbach’s alpha coefficients for the SSI were .96 for the non-clinical sample and .97 
for the clinical sample. Cronbach alphas should ideally be between .80 and .90 (Streiner 
& Norman, 2003). Coefficients for the SSI are therefore high, suggesting that there may 
be some item redundancy in the measure.  
 
2.5.3.2 Test-retest reliability 
 
To assess the stability of the scale over time, a sample of 103 participants in the non-
clinical sample completed the SSI on two occasions, approximately two weeks apart. 
Mean test-retest response latency was 20.3 days (SD = 7.7 days). Test-retest reliability 
for the total scale was shown to be good, r(103) = .87, p <.001. 
 
2.5.3.3 Convergent and construct validity of the SSI 
 
Convergent validity of the SSI was examined in the clinical sample using Spearman’s 
Rho correlations with scores on the SPQ. Total SPQ scores correlated with state 
schizotypy at r(808) = .89, p <.001 in the non-clinical sample, and r(126) = .73, p <.001 
in the clinical sample. This suggests that the SSI is assessing the same construct as was 
intended to be measured by the original SPQ. In order to further investigate the validity 
of the SSI, associations with PANSS symptoms scores were investigated in the clinical 
sample. Total SSI scores were significantly correlated with PANSS positive symptoms, 
r(118) = .60, p <.001; and PANSS general psychopathology scores, r(118) = .55, p 
<.001. PANSS negative symptoms scores did not correlate with total SSI scores, r(118) 
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= .14, p = .14. This suggests that the predominant focus of the SSI is low-level positive 
psychotic phenomena. 
 
2.5.4 Factor Structure of the SSI 
 
In order to investigate the underlying factor structure of the SSI, Principal Components 
Analysis (PCA) with varimax rotation was performed on the combined scale of 74 state 
schizotypy items for both the clinical and non-clinical samples. The outcomes of these 
analyses are reported here. PCA is a data reduction technique often used in scale 
construction to reduce a larger set of observed variables to a smaller, more manageable 
number for use in subsequent analyses (Brown, 2006). Varimax rotation is an 
orthogonal rotation technique designed to maximise the independence of different 
factors (i.e. factors are constrained to be uncorrelated). 
 
PCA in the non-clinical sample revealed the presence of 16 factors with eigenvalues 
exceeding one (Kaiser criterion), explaining a cumulative total of 61.13% of the 
variance. PCA in the clinical sample revealed the presence of 20 factors with 
eigenvalues exceeding one (Kaiser criterion), explaining a cumulative total of 76.28% 
of the variance. However, closer inspection of the scree plots (Cattell, 1966) indicated a 
break in both samples after the fourth component. See Figures 2.1 and 2.2 for scree 
plots for the non-clinical and clinical samples. Thus, a further PCA was conducted for 
both groups using a four factor solution. This solution accounted for 40% of the 
variance in the non-clinical sample and 43.4% of the variance in the non-clinical 
sample. Eigenvalues from the analysis are shown in Table 2.13. 
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Figure 2.1  
Scree plot for the non-clinical sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2  
Scree plot for the clinical sample 
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Table 2.13  
Dimensionality of the SSI Items: Initial Eigenvalues from a Principal Components 
Analysis 
 
 
The same four factors were highlighted in both the non-clinical and the clinical sample. 
Each factor will now be briefly discussed. Items were considered to “load” on a factor if 
it had a loading of .30 or above (Tabachnick & Fidell, 2001). 
 
2.5.4.1 Factor 1 
 
The first factor was labelled “Interpersonal Schizotypy” and could be argued to mirror 
Raine et al’s (1994) Interpersonal factor in the original measure. It contains items 
concerning social anxiety and constricted affect and could be said to be analogous to 
some of the negative symptoms of psychosis, e.g. withdrawal, flattened affect, blunting, 
etc. This factor contained 25 items in the non-clinical sample, had an eigenvalue of 
18.17, and accounted for 24.5% of the variance. In the clinical group, this factor 
contained 22 items, had an eigenvalue of 22.13, and accounted for 29.9% of the 
variance. Nineteen items loaded on this factor in both the clinical and the non-clinical 
samples and these are shown in Table 2.14. 
 
 
Non-Clinical Sample (N = 808) Clinical Sample (N = 126)  
 
Component 
 
Total 
% 
variance 
Cumulative 
% 
 
Total 
% 
variance 
Cumulative 
% 
 
1 (Interpersonal) 
 
18.2 
 
24.5 
 
24.5 
 
22.1 
 
29.9 
 
29.9 
2 (Disorganised) 4.7 6.4 30.9 3.07 4.1 34.0 
3 (Paranoid) 3.2 5.4 36.3 4.1 5.6 39.6 
4 (Anomalous) 2.7 3.7 40.0 2.8 3.8 43.4 
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Table 2.14  
Factor Loadings for Factor 1 in Non-clinical and Clinical Samples 
 
Factor Loading  
Non-
Clinical 
Clinical 
 
I tend to keep in the background on social occasions. (SSI 57) 
 
 
.72 
 
.69 
I feel very uneasy talking to people I do not know well. (SSI 71) 
 
.75 .67 
I am mostly quiet when with other people. (SSI 24) 
 
.71 .65 
I get anxious when meeting people for the first time. (SSI 29) 
 
.63 .64 
I have little interest in getting to know other people. (SSI 6) 
 
.36 .63 
Do you often feel nervous when you are in a group of unfamiliar 
people?  (SSI 38) 
 
.72 .62 
I prefer to keep myself to myself. (SSI 15) 
 
.62 .62 
I get very nervous when I have to make polite conversation. (SSI 11) 
 
.62 .59 
I feel very uncomfortable in social situations involving unfamiliar 
people. (SSI 46) 
 
.75 .59 
I find it hard to be emotionally close to other people. (SSI 33) 
 
.63 .58 
I rarely laugh and smile. (SSI 26) 
 
.48 .56 
My non-verbal conversation is poor. (SSI 35) 
 
.55 .55 
I do not have an expressive and lively way of speaking. (SSI 68) 
 
.52 .55 
Do you feel that you are unable to get close to people?  (SSI 66) 
 
.69 .53 
I tend to keep my feelings to myself. (SSI 73) 
 
.62 .52 
I find it hard to communicate with other people. (SSI 69) 
 
.56 .50 
I am poor at expressing my true feelings by the way I talk and look. 
(SSI 17) 
 
.57 .50 
I sometimes avoid going to places where there will be many people 
because I will get anxious. (SSI 2) 
 
.57 .47 
Have you found that it is best not to let other people know too much 
about you?  (SSI 52) 
 
.56 .46 
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2.5.4.2 Factor 2 
 
The second factor was labelled “Disorganised Schizotypy” and mirrors Raine at al’s 
(1994) Disorganised factor in the original measure. It contains items concerning 
oddities of behaviour and speech and could be said to be analogous to symptoms such 
as thought disorder in psychotic conditions. This factor contained 13 items in the non-
clinical sample, had an eigenvalue of 4.72, and accounted for 6.4% of the variance. In 
the clinical sample, this factor contained ten items, had an eigenvalue of 3.07, and 
accounted for 4.1% of the variance. Nine items loaded on this factor in both the clinical 
and the non-clinical samples and these are shown in Table 2.15. 
 
 
Table 2.15  
Factor Loadings for Factor 2 in Non-clinical and Clinical Samples 
 
Factor Loading  
Non-
Clinical 
Clinical 
 
I sometimes jump quickly from one topic to another when speaking. 
(SSI 16) 
 
 
.52 
 
.76 
I often ramble on too much when speaking. (SSI 34) 
 
.56 .71 
People sometimes comment on my unusual mannerisms and habits. 
(SSI 14) 
 
.62 .68 
Other people see me as slightly eccentric. (SSI 5) 
 
.70 .67 
Do you tend to wander off the topic when having a conversation?  
(SSI 58) 
 
.59 .57 
Sometimes other people think that I am a little strange. (SSI 23) 
 
.71 .54 
People occasionally comment that my speech is confusing. (SSI 72) 
 
.62 .52 
I sometimes use words in unusual ways. (SSI 50) 
 
.60 .49 
People sometimes find it hard to understand what I am saying. (SSI 7) 
 
.52 .47 
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2.5.4.3 Factor 3 
 
The third factor was labelled “Paranoid Schizotypy” and mirrors one half of Raine et 
al’s (1994) Cognitive-Perceptual factor in the original measure. It contains items 
concerning suspiciousness and some ideas of reference. Some of the excessive social 
anxiety subscale also loaded on this factor, which could be said to be analogous to the 
paranoid symptoms of psychosis. This factor contained 13 items in the non-clinical 
sample, had an eigenvalue of 3.23, and accounted for 4.4% of the variance. In the 
clinical sample, this factor contained nine items, had an eigenvalue of 4.11, and 
accounted for 5.6% of the variance. Seven items loaded on this factor in both the 
clinical and the non-clinical samples and these are shown in Table 2.16. 
 
 
Table 2.16  
Factor Loadings for Factor 3 in Non-clinical and Clinical Samples 
 
Factor Loading  
Non-
Clinical 
Clinical 
 
Do you sometimes feel that people are talking about you?  (SSI 63) 
 
 
.76 
 
.77 
When you see people talking to each other, do you often wonder if 
they are talking about you?  (SSI 53) 
 
.62 .74 
Do you sometimes feel that other people are watching you?  (SSI 
60) 
 
.59 .65 
I often feel that others have it in for me. (SSI 59) 
 
.63 .62 
When shopping, do you get the feeling that other people are taking 
notice of you?  (SSI 45) 
 
.57 .51 
Do you often feel that other people have got it in for you?  (SSI 18) 
 
.64 .50 
I am sure I am being talked about behind my back. (SSI 9) 
 
.72 .50 
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2.5.4.4 Factor 4  
 
The fourth factor was labelled “Anomalous Schizotypy” and mirrors the other half of 
Raine et al’s (1994) Cognitive-Perceptual factor in the original measure. It contains 
items concerning magical ideation and unusual perceptual experiences and could be said 
to be analogous to some of the positive symptoms of psychosis, e.g. hallucinations and 
delusions. This factor contained 12 items in the non-clinical sample, had an eigenvalue 
of 2.74, and accounted for 3.7% of the variance. In the clinical sample, this factor 
contained 15 items, had an eigenvalue of 2.82, and accounted for 3.8% of the variance. 
Eleven items loaded on this factor in both the clinical and the non-clinical samples and 
these are shown in Table 2.17. 
 
2.5.4.5 Other items 
 
Other SSI items either did not load on any of the factors (i.e. loading less than .30) or 
cross-loaded between different factors (i.e. difference of less than .10 between 
loadings). They were therefore not considered to be assessing any specific type of 
symptom and were excluded from further stages of the analysis (Tabachnick & Fidell, 
2001). 
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Table 2.17  
Factor Loadings for Factor 4 in Non-clinical and Clinical Samples 
 
Factor Loading  
Non-
Clinical 
Clinical 
 
Have you ever felt that you are communicating with another 
person telepathically (by mind-reading)?  (SSI 55) 
 
 
.62 
 
.67 
Do you believe in telepathy?  (SSI 12) 
 
.68 .64 
Do you believe in clairvoyancy (psychic forces, fortune telling, 
etc)?  (SSI 30) 
 
.65 .60 
Have you ever had the sense that some person or force is around 
you, even though you cannot see anyone?  (SSI 13) 
 
.55 .55 
Can other people feel your feelings when they are not there?  
(SSI 39) 
 
.58 .55 
When you look at a person, or yourself in a mirror, have you 
ever seen the face change right before your eyes?  (SSI 22) 
 
.32 .53 
Have you had experiences with the supernatural?  (SSI 3) 
 
.50 .52 
Have you ever noticed a common event or object that seemed to 
contain a special sign for you?  (SSI 28) 
 
.45 .49 
Have you ever seen things invisible to other people?  (SSI 40) 
 
.56 .44 
I often hear a voice speaking my thoughts aloud. (SSI 31) 
 
.30 .44 
Have you ever had experiences with astrology, seeing the future, 
UFOs, ESP, or a sixth sense?  (SSI 47) 
 
.64 .37 
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2.5.5 Descriptive Statistics of Factors 
 
Descriptive data for each of the factors are provided in Table 2.18 for both the non-
clinical and clinical samples. 
 
Table 2.18  
Descriptive Data for Factors of the SSI 
 
 
 N Min-Max Median Mean  
(SD) 
Skewness 
(SE) 
 
Interpersonal 
Non-Clinical 
Clinical 
 
 
808 
126 
 
 
0-64 
0-76 
 
 
9.00 
23.00 
 
 
13.03 (13.22) 
24.75 (16.49) 
 
 
1.32 (0.09) 
0.67 (0.22) 
 
Disorganised 
Non-Clinical 
Clinical 
 
 
808 
126 
 
 
0-33 
0-34 
 
 
6.00 
6.00 
 
 
7.56 (6.56) 
7.98 (7.62) 
 
 
1.12 (0.09) 
1.23 (0.22) 
 
Paranoid 
Non-Clinical 
Clinical 
 
 
808 
126 
 
 
0-25 
0-28 
 
 
2.00 
5.00 
 
 
3.44 (4.17) 
6.90 (7.13) 
 
 
1.77 (0.09) 
1.20 (0.22) 
 
Anomalous 
Non-Clinical 
Clinical 
 
 
808 
126 
 
 
0-31 
0-38 
 
 
1.00 
2.00 
 
 
2.74 (4.16) 
5.04 (6.78) 
 
 
2.67 (0.09) 
2.13 (0.22) 
 
 
 
As can be seen from the descriptive data, all distributions of the different factors are 
positively skewed and thus non-parametric statistics will be used in the following 
analyses. 
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2.5.6 Correlations between Different Factors 
 
Spearman’s Rho correlations between the different SSI factors are shown in Tables 2.19 
and 2.20 for the non-clinical and clinical samples respectively. 
 
Table 2.19  
Correlations between SSI Factors in the Non-clinical Sample (N = 808) 
 
 Disorganised Paranoid Anomalous 
 
Interpersonal 
 
.47*** 
 
.46*** 
 
.32*** 
 
Disorganised 
 
 
 
.44*** 
 
.39*** 
 
Paranoid 
  
 
 
.33*** 
 
*p <.05, **p <.01, ***p <.001 
 
 
Table 2.20  
Correlations between SSI Factors in the Clinical Sample (N = 126) 
 
 Disorganised Paranoid Anomalous 
 
Interpersonal 
 
.43*** 
 
.49*** 
 
.36*** 
 
Disorganised 
 
 
 
.50*** 
 
.45*** 
 
Paranoid 
  
 
 
.57*** 
 
*p <.05, **p <.01, ***p <.001 
 
All factors have low to moderate correlations with one another in both samples. This 
suggests that the factors are not completely independent from one another and 
somewhat overlap.  
  87 
 
 
2.5.7 Creation of the Brief SSI 
 
A brief version of the SSI was created using the most reliable items from the full scale, 
based on the factor analysis described above. The Cronbach’s alphas for the full scale 
were high, suggesting that the measure is over-determined and highlighting item 
redundancy. Shortening the scale will remove redundancy and maximise both coherence 
and discrimination of items. In addition, most current measures of schizotypy are 
relatively long and thus a quick and easy-to-use tool for use in this domain is well 
needed. 
 
2.5.7.1 Initial factor selection 
 
In order to create a shortened version of the SSI, independent samples Mann-Whitney U 
tests were initially conducted to compare scores on each of the factors outlined above 
between the clinical and non-clinical samples. This was to ensure that the brief scale 
would adequately discriminate between clinical and non-clinical populations. As each 
factor contained a different number of items, factor scores were scaled prior to this 
analysis. Significant differences were found between Interpersonal (U = 27835.00, p 
<.001), Paranoid (U = 36473.50, p <.001), and Anomalous (U = 40724.50, p <.001) 
factor scores in the two samples, with the clinical sample scoring significantly higher 
than the non-clinical sample. However, there was no significant difference between the 
two samples on scores on the Disorganised factor (U = 50763.50, p = .96). These 
differences are further illustrated in Figure 2.3. It was therefore decided to remove 
Disorganised items from the brief version of the SSI, due to their lack of discriminative 
specificity. Thus, no items from the Odd Speech and Odd Behaviour subscales were 
included in the brief SSI. 
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Figure 2.3   
Comparison of mean SSI scores in clinical and non-clinical samples 
 
2.5.7.2 Item Selection 
 
Item-total correlations were calculated for all items loading on the remaining three 
factors in both samples. Item-total correlations for the Interpersonal Schizotypy factor 
ranged from .43 to .70 in the clinical sample and from .34 to .74 in the non-clinical 
sample. For the Paranoid Schizotypy factor, item-total correlations ranged from .48 to 
.80 in the clinical sample and from .50 to .76 in the non-clinical sample. Finally, for the 
Anomalous Schizotypy factor, item-total correlations ranged from .31 to .62 in the 
clinical sample and .30 to .55 in the non-clinical sample.  A combination of the highest 
factor loadings and highest item-total correlations were used to select the final items for 
the Brief SSI. To maximise separation between subscales, items which loaded high on 
the factor of interest and low on other factors were selected.  
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This resulted in an 18-item scale made up of three subscales: a “Social Anxiety” scale 
consisting exclusively of items from the Excessive Social Anxiety subscale of the 
original SPQ; a “Paranoia” scale consisting of items from the Suspiciousness and Ideas 
of Reference subscales of the original SPQ; and an “Anomalous Experiences” scale 
consisting of items from the Odd Beliefs, Ideas of Reference and Unusual Perceptual 
Experiences subscales from the original SPQ. An additional two items (items 31 and 
40) were added to the Anomalous Experiences subscale even though they were not the 
highest loadings for that factor. These items were retained as they were thought to be of 
important clinical relevance, reflecting low-level hallucinatory experience. Items 
included in the Brief SSI are shown in Table 2.21. 
 
  90 
 
 
Table 2.21  
Items Included in the Brief SSI 
 
Scale Item 
Number 
Question 
 
2 
 
I sometimes avoid going to places where there will be many 
people because I will get anxious. 
11 I get very nervous when I have to make polite conversation. 
29 I get anxious when meeting people for the first time. 
38 Do you often feel nervous when you are in a group of 
unfamiliar people? 
46 I feel very uncomfortable in social situations involving 
unfamiliar people. 
 
Social Anxiety 
71 I feel very uneasy talking to people I do not know well. 
 
9 
 
I am sure I am being talked about behind my back. 
18 Do you often feel that other people have it in for you? 
 
Paranoia 
53 When you see people talking to each other, do you often 
wonder if they are talking about you? 
59 I often feel that others have it in for me. 
60 Do you sometimes feel that other people are watching you? 
 
63 Do you sometimes feel that other people are talking about 
you? 
 
12 
 
Do you believe in telepathy (mind-reading)? 
13 Have you ever had the sense that some person or force is 
around you, even though you could not see anyone? 
28 Have you ever noticed a common event or object that 
seemed to be a special sign for you? 
30 Do you believe in clairvoyancy (psychic forces, fortune 
telling, etc)? 
31 I often hear a voice speaking my thoughts aloud. 
39 Can other people feel your feelings when they are not there? 
40 Have you ever seen things invisible to other people? 
 
Anomalous 
55 Have you ever felt that you are communicating with another 
person telepathically (by mind-reading)? 
 
  91 
 
 
2.5.7.3 Description of the Brief SSI 
 
The Brief SSI is a 20-item scale assessing state symptoms of schizotypy over three 
domains: Anomalous Experiences (8 items); Social Anxiety (6 items); and Paranoia (6 
items). All items have the same 5-point Likert scale as the full scale in order to 
determine recent frequency of occurrence of each symptom, ranging from 0 (not at all) 
to 4 (all of the time). Therefore the total possible score on the scale as a whole is 80 
(made up of 24 possible points each for the Social Anxiety and Paranoia subscales and 
32 possible points for the Anomalous Experiences subscale). Items were ordered 
randomly to avoid clusters of questions asking about the same types of symptoms. A 
copy of the Brief SSI is provided in Appendix E. 
 
2.5.8 Descriptive Data for the Brief SSI 
 
Descriptive statistics and norms of schizotypy scores for both the total Brief SSI and 
each of the subscales in the clinical and non-clinical samples are shown in Table 2.22. 
All distributions were positively skewed and could not be corrected via transformation 
of the data. Thus non-parametric statistics were used in all analyses. All between-group 
differences were shown to be significant at the p = .001 level using independent samples 
Mann-Whitney U tests. All mean scores in the clinical group were equivalent to scores 
in the 75th percentile or above in the non-clinical sample, suggesting that all types of 
schizotypal symptoms are more prevalent in clinical samples. However, the largest 
differences between the two populations were on the Social Anxiety and Paranoia 
subscales, with Anomalous Experiences acting as a weaker discriminator. 
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 Table 2.22  
 Norms and Descriptive Data for Brief SSI  
 Min-
Max 
Median Mean  
(SD) 
Skewness 
(SE) 
U p 25th 
centile 
50th 
centile 
75th 
centile 
90th 
centile 
 
SSI Brief Total 
Non-clinical (N = 808) 
Clinical (N = 126) 
 
 
0-53 
0-80 
 
 
7.00 
15.00 
 
 
9.54 (9.22) 
18.67 (15.70) 
 
 
1.46 (0.09) 
1.31 (0.22) 
 
 
31589.00 
 
 
<.001 
 
 
3.00 
7.00 
 
 
7.00 
15.00 
 
 
14.00 
27.00 
 
 
23.00 
39.30 
Social Anxiety 
Non-clinical (N = 808) 
Clinical (N = 126) 
 
0-24 
0-24 
 
3.00 
7.50 
 
4.41 (5.14) 
8.56 (6.65) 
 
1.46 (0.09) 
0.50 (0.22) 
 
30961.00 
 
<.001 
 
0.00 
3.00 
 
3.00 
7.50 
 
7.00 
13.25 
 
12.00 
19.30 
Paranoia 
Non-Clinical (N = 808) 
Clinical (N = 126) 
 
0-21 
0-24 
 
2.00 
4.00 
 
2.85 (3.63) 
5.99 (6.41) 
 
1.88 (0.09) 
1.24 (0.22) 
 
36126.00 
 
<.001 
 
0.00 
1.00 
 
2.00 
4.00 
 
4.00 
9.00 
 
7.00 
16.60 
Anomalous Experiences 
Non-Clinical (N = 808) 
Clinical (N = 126) 
 
0-23 
0-32 
 
1.00 
2.00 
 
2.28 (3.43) 
4.12 (5.69) 
 
2.45 (0.09) 
2.35 (0.22) 
 
41525.50 
 
.001 
 
0.00 
0.00 
 
1.00 
2.00 
 
4.00 
6.00 
 
6.00 
11.30 
               92
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2.5.9 Endorsement Frequencies 
 
The average frequency of endorsement for each schizotypal symptom included in the 
Brief SSI is shown in Table 2.23. Endorsement was defined as a symptom having 
occurred often or all of the time in the last two weeks. Social Anxiety symptoms were 
the most common phenomena in the clinical sample, with 52.4% of the sample 
experiencing at least one symptom of social anxiety often or all of the time in the past 
two weeks. This is compared to 24.1% in the non-clinical sample. Thirty-five per cent 
of the clinical sample had experienced at least one symptom of paranoia often or all of 
the time in the past two weeks, compared with 13.5% of the non-clinical sample. Thirty-
two per cent of the clinical sample had experienced at least one anomalous experience 
often or always in the past two weeks, compared with 18.7% of the non-clinical sample. 
Endorsement frequencies were compared between the clinical and non-clinical samples 
using chi-square tests. Social Anxiety and Paranoid symptoms were the strongest 
discriminators between clinical and non-clinical samples. Anomalous Experiences were 
the weakest discriminator. 
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Table 2.23  
Average Endorsement of Brief SSI Items in Non-clinical and Clinical Samples 
 
 
 
 
 
 
 
*p <.05 adjusted for multiple comparisons (α/20 = 0.0025) 
Endorsement (%)  
Non-
Clinical 
Clinical 
 
χ2 
Social 
Anxiety 
I sometimes avoid going to places where there will be 
many people because I will get anxious. 
6.4 26.2 51.4* 
 I get very nervous when I have to make polite 
conversation 
8.8 19.8 14.4* 
 I get anxious when meeting people for the first time 12.5 25.4 14.8* 
 Do you often feel nervous when you are in a group of 
unfamiliar people? 
13.1 31.0 26.4* 
 I feel very uncomfortable in social situations 
involving unfamiliar people 
8.3 24.6 30.9* 
 I feel very uneasy talking to people I do not know 
well 
8.4 27.0 38.6* 
Paranoia I am sure I am being talked about behind my back. 7.5 21.4 24.6* 
 Do you often feel that other people have it in for you? 3.2 16.7 41.3* 
 When you see people talking to each other, do you 
often wonder if they are talking about you? 
4.0 13.5 19.9* 
 I often feel that others have it in for me. 2.2 11.9 29.9* 
 Do you sometimes feel that other people are watching 
you? 
3.7 19.0 47.1* 
 Do you sometimes feel that other people are talking 
about you? 
3.3 16.7 39.7* 
Do you believe in telepathy? 2.1 8.7 16.5* Anomalous 
Experiences Have you had the sense that some person or force is 
around you, even though you could not see anyone? 
6.9 11.9 3.8 
 Have you noticed a common event or object that 
seemed to be a special sign for you? 
2.6 4.8 1.8 
 Do you believe in clairvoyancy? 3.5 7.1 4.3 
 I often hear a voice speaking my thoughts aloud. 8.5 13.5 3.2 
 Can other people feel your feelings when they are not 
there? 
1.4 7.9 21.4* 
 Have you seen things invisible to other people? 0.9 5.6 16.2* 
 Have you felt that you were communicating with 
another person telepathically? 
1.5 4.8 6.2 
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2.5.10 Psychometric Analysis of the Brief SSI  
 
2.5.10.1 Internal consistency  
 
Cronbach’s alpha coefficients for the total brief scale were .87 for the non-clinical 
sample and .92 for the clinical sample. Coefficients for each of the subscales for the 
non-clinical and clinical samples respectively were: .89 (.89) for Social Anxiety; .85 
(.90) for Paranoia; and .72 (.83) for Anomalous Experiences. These coefficients are 
more acceptable than those for the full scale and suggest that the Brief SSI has good 
internal validity but is not over-determined.  
 
2.5.10.2 Test-retest reliability 
 
Test-retest reliability for the shorter version of the scale was calculated using Pearson’s 
correlations on the data used to calculate test-retest reliability for the longer version of 
the scale. A test-retest correlation of r(103) = .86, p <.001 was shown for the total brief 
scale and test-retest correlations ranged from .62 to .86 for the subscales (p <.001). Thus 
the scale shows good reliability over time. 
 
2.5.10.3 Convergent and construct validity  
 
Correlations between the brief and long versions of the SSI were r(808) = .87, p <.001 
for the non-clinical sample and r(126) = .90, p <.001 for the clinical sample. This 
suggests that the shorter scale adequately reflects the content of the longer instrument. 
Correlations between the brief SSI and the original SPQ are shown in Tables 2.24 and 
2.25 for the non-clinical and clinical samples respectively.  
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Table 2.24  
Correlations between Brief SSI and SPQ Scores in the Non-clinical Sample (N = 808) 
 
 
*p <.05, **p <.01, ***p <.001 
 
Table 2.25  
Correlations between Brief SSI and SPQ Scores in the Clinical Sample (N = 126) 
 
 
 
*p <.05, **p <.01, ***p <.001 
 
In order to further investigate the validity of the Brief SSI, scores on the measure were 
correlated with PANSS scores in the clinical sample. These correlations are shown in 
Table 2.26. 
 
 Total SSI 
Brief Score 
Social 
Anxiety 
Paranoia Anomalous 
Experiences 
SPQ 
- Total 
- Cognitive Perceptual 
- Interpersonal 
- Disorganised 
 
.78*** 
.70*** 
.75*** 
.52*** 
 
.63*** 
.39*** 
.75*** 
.39*** 
 
.63*** 
.66*** 
.58*** 
.42*** 
 
.50*** 
.60*** 
.29*** 
.37*** 
 Total SSI 
Brief Score 
Social 
Anxiety 
Paranoia Anomalous 
Experiences 
SPQ 
- Total 
- Cognitive Perceptual 
- Interpersonal 
- Disorganised 
 
.67*** 
.65*** 
.62*** 
.47*** 
 
.59*** 
.45*** 
.64*** 
.44*** 
 
.58*** 
.60*** 
.53*** 
.42*** 
 
.50*** 
.58*** 
.38*** 
.32*** 
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Table 2.26  
Correlations between Brief SSI and PANSS Scores in the Clinical Sample (N = 118) 
 
 Total SSI 
Brief Score 
Social 
Anxiety 
Paranoia Anomalous 
Experiences 
PANSS Positive  .58*** .33*** .56*** .67*** 
PANSS Negative  .11 .03 .18* .09 
PANSS General  .48*** .40*** .44*** .40*** 
 
 
*p <.05, **p <.01, ***p <.001 
 
The correlations suggest a bias of the brief SSI towards positive symptoms. There were 
little to no correlations with measures of negative symptoms. 
 
2.5.11 Distributions of Trait and State Symptom Counts 
 
Distributions of trait and state schizotypy symptom counts (number of items endorsed) 
were plotted for the non-clinical and clinical samples using histograms and dot plots. 
Trait distributions were plotted on a histogram using total scores on the SPQ (i.e. 
number of “yes” responses). These are shown in Figures 2.4 and 2.5 and can be seen to 
broadly fit a normal distribution, in line with previous findings (e.g. Johns & van Os, 
2001). 
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Figure 2.4  
Frequency distribution of SPQ (trait schizotypy) 
scores in the non-clinical sample with fitted 
Gaussian curve 
Figure 2.5  
Frequency distribution of SPQ (trait schizotypy) 
scores in the clinical sample with fitted Gaussian 
curve 
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In order to investigate the distribution of state schizotypy scores, the number of brief 
SSI items endorsed by each participant for the total scale and each of the subscales was 
calculated for both the clinical and non-clinical samples. Endorsement was defined as a 
symptom having occurred often or all of the time in the last two weeks. This produced a 
symptom count for each participant which ranged from 0-20 for the total scale; 0-6 for 
Social Anxiety and Paranoia subscales; and 0-8 for the Anomalous Experiences 
subscale. These symptom counts were then plotted against sample frequency to obtain a 
symptom count distribution. Distributions of state symptom counts for the non-clinical 
and clinical samples are shown in Figures 2.6 to 2.9. These distributions are shown to 
be extremely skewed. Furthermore, Shapiro-Wilk tests demonstrated that distributions 
of state schizotypal symptoms were significantly different from normal in both the non-
clinical (Total Scale: w = 0.62, p <.001; Social Anxiety: w = 0.52, p <.001; Paranoia: w 
= 0.36, p <.001; Anomalous: w = 0.43, p <.001) and clinical (Total Scale: w = 0.77, p 
<.001; Social Anxiety: w = 0.76, p <.001; Paranoia: w = 0.62, p <.001; Anomalous: w = 
0.55, p <.001) samples.  
 
The deviation from the normal distribution suggests that the SSI may be assessing 
phenomena which are less common than phenomena assessed by the SPQ (Lyoo, Youn, 
Ha, Park, & Kwon, 2003). Indeed, in the non-clinical sample, only 44% of individuals 
scoring above the median on the SPQ also scored above the 75th percentile on the SSI. 
Similarly, in the clinical sample, only 43% of individuals scoring above the mean on the 
SPQ also scored above the 75th percentile on the SSI. This suggests that there are a large 
group of individuals (56% and 57% in the non-clinical and clinical samples 
respectively) who score high on trait schizotypy but not on state schizotypy (bottom 
right corner on Figures 2.10 and 2.11). It is the group of individuals who score high on 
both state and trait schizotypy (top right corner on Figures 2.10 and 2.11) who may be 
most at risk. The SSI would identify these individuals whereas the SPQ would not. 
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Figure 2.6  
Distribution of total state schizotypal symptom counts (often/all of the time in the last 
two weeks) in the non-clinical and clinical samples 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7  
Distribution of state Social Anxiety schizotypal symptom counts (often/all of the time in 
the last two weeks) in the non-clinical and clinical samples 
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Figure 2.8  
Distribution of state Paranoid schizotypal symptom counts (often/all of the time in the 
last two weeks) in the non-clinical and clinical samples 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9  
Distribution of state Anomalous schizotypal symptom counts (often/all of the time in 
the last two weeks) in the non-clinical and clinical samples 
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Note. Reference line on the X axis refers to median SPQ score. Reference line on the Y axis refers to 75th percentile SSI score. 
 
Figure 2.11  
Scatter plot of SPQ and Brief SSI scores in the clinical 
sample (N = 126) 
Figure 2.10 
Scatter plot of SPQ and Brief SSI scores in the non-
clinical sample (N = 808) 
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2.6 DISCUSSION 
 
This chapter has reported on the modification of a self-report measure, originally 
designed to assess schizotypal personality traits, so that it can be used to assess the 
current (i.e. state) presence and frequency of low-level psychotic symptomatology in 
both clinical and non-clinical populations. Such a scale could be used to detect the 
prodromal and residual symptoms of psychosis. This section will review the results of 
the current study. The findings will be discussed in relation to the current literature and 
the clinical implications will be examined. Following on from this, potential weaknesses 
of the study will be outlined, as will possibilities for future research.  
 
2.6.1 Summary and Discussion of the Psychometric Properties of the SSI 
 
The current study suggests that both long and brief versions of the SSI have robust 
psychometric properties. The analyses indicate good internal consistency (particularly in 
the brief version) and stability of the scale over time, in both clinical and non-clinical 
samples. Moreover, a Principal Components Analysis has highlighted a four-factor 
structure, resembling that of the SPQ (Raine et al., 1994), but where the Cognitive-
Perceptual factor is divided into two separate but related components: Paranoia and 
Anomalous Experiences. This split may be important in differentiating between clinical 
and non-clinical populations.  
 
In addition, the SSI has been found to adequately discriminate between clinical and 
non-clinical samples. It was hypothesised that the clinical sample would score more 
highly on the SSI than the non-clinical sample. A series of independent samples Mann-
Whitney U tests showed that the clinical sample had higher scores on all of the factors, 
apart from the Disorganised factor which did not discriminate between the two samples. 
This was later removed to create the brief version of the SSI. Chi square tests revealed 
that social anxiety symptoms were the largest discriminator between clinical and non-
clinical samples, suggesting that social anxiety may be an important clinical problem 
during the recovery stages of psychosis. Anomalous experiences were the weakest 
discriminator, suggesting that these may be the first symptoms to remit after a psychotic 
episode. 
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Analyses also suggest that the SSI is valid in assessing psychotic-like experiences, due 
to associations with the PANSS. It was hypothesised that within the clinical sample, 
higher scores on measures of psychopathology would be associated with higher scores 
on the SSI. Spearman’s Rho correlations showed positive relationships between SSI 
scores and scores on the Positive and General subscales of the PANSS. However, little 
to no associations were shown between SSI scores and the Negative subscale of the 
PANSS. Similar findings were shown for the Brief SSI which was found to be 
associated with measures of positive psychotic symptoms but not with measures of 
negative psychotic symptoms. These findings suggest that the SSI is more sensitive and 
specific to the assessment of low-level positive psychotic symptoms, as opposed to 
negative or disorganised symptoms. It could be argued that negative and disorganised 
symptoms are better assessed in an objective as opposed to self-report manner 
(Andreasen, 1981). For example, an individual’s social anxiety or paranoia may lead 
them to believe that they exhibit traits similar to those described by criteria for thought 
disorder (e.g. getting words mixed up, rambling, etc). However, in reality, and when 
measured objectively, these may not be present.  
 
Based on its assessment of the presence and frequency of current schizotypal symptoms, 
it was hypothesised that the SSI would have a more clinical focus than the SPQ, which 
takes normality as its reference point. This hypothesis was supported by the differing 
distributions of symptom counts from the SPQ and the SSI. In both the clinical and non-
clinical samples, distributions of symptom counts on the SPQ were shown to fit a 
normal Gaussian distribution, suggesting that schizotypy assessed by the measure is a 
quantitative trait reflecting normal variation in personality. Conversely, distributions of 
state schizotypal symptom counts using the SSI (i.e. the number of symptoms 
experienced often or always in the last two weeks) were extremely skewed and 
significantly different from normal. The half-normal distribution of SSI symptom 
counts mirrors that of other measures designed to assess schizotypal experiences as 
attenuated symptoms of psychosis (e.g. V. Bell et al., 2006; Peters, Joseph et al., 1999). 
Thus, the difference in distributions between the SPQ and the SSI from normal to half-
normal could be taken as a form of validity that the SSI is assessing quasi-psychotic 
experiences, rather than personality traits (Johns & van Os, 2001).  
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A deviation from the normal distribution suggests that the SSI is assessing phenomena 
which are less common than schizotypal traits (Lyoo et al., 2003). Moreover, the 
finding that not all high-trait schizotypy individuals had high scores on state schizotypy 
could be taken as further evidence to suggest that the SSI provides a more accurate 
reflection of an individual’s current symptom profile. Indeed, two individuals could 
score the same on a measure of trait schizotypy and yet have totally different state 
presentations. The SSI would allow discrimination of these two individuals, whereas the 
SPQ would not – they would both score in the right-hand tail of the Gaussian 
distribution. 
 
2.6.2 Clinical Implications of Findings 
 
The use of a state measure of schizotypy is extremely clinically relevant and has many 
advantages in that it allows the presence of current symptoms and their frequency to be 
assessed. This is in contrast to the assessment of general tendencies and lifetime 
experience as measured by trait schizotypy tools. Assessing dimensional concepts such 
as frequency is particularly important when thinking about transition to a psychotic 
episode. Indeed, a large proportion of people appear to experience a few schizotypal 
symptoms occasionally; but only a minority of people experience many of these 
symptoms frequently. It is this latter group of individuals who could be considered at 
greater risk of making the transition to a psychotic episode. Birchwood (1996) suggests 
that increased frequency of initial, low-level, anomalous or schizotypal experiences, 
may result in an extreme emotional reaction and drive a “search for meaning”, 
potentially leading to the delusional systems characteristic of psychosis. In addition to 
this, the fact that low-level psychotic symptoms remain following recovery from acute 
psychosis is of important clinical relevance and could have implications in terms of 
defining early warning signs and relapse (A. Tait et al., 2002).  
 
The SSI can be used to assess symptomatology in both clinical and non-clinical 
populations, thus enabling comparisons to be made between the two samples. Such a 
measure is relatively novel in its development as many other measures of schizotypy are 
validated using only community samples (J. P. Chapman, Chapman, & Kwapil, 1995). 
Conversely, most traditional measures of psychotic phenomena are only suitable for use 
with clinical populations and are often not sensitive enough to assess low-level 
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symptomatology (e.g. Kay et al., 1987). The SSI is could be argued to bridge this gap in 
assessment tools. Furthermore, although the SSI assesses symptom frequency over the 
past two weeks, this time scale could be changed in order to assess symptom change 
over longer or shorter periods dependent on the demands of the investigation, e.g. 
“Have you experienced X in the last month/week/24 hours?” The Brief SSI may be 
particularly useful in longitudinal studies and clinical practice in order to assess changes 
in symptoms over time. Most current measures of schizotypy are relatively long and 
thus a quick and easy-to-use tool for use in this domain is much needed.  
 
2.6.3 Relevance to the Literature and Theoretical Significance of the SSI 
 
As well as providing evidence for the reliability and validity of the SSI, the results from 
this study could be taken as support for the continuum hypothesis of psychosis (e.g. 
Johns & van Os, 2001).  Indeed, the distributions of both schizotypal traits and state 
schizotypal symptoms in the non-clinical sample are continuous (rather than bimodal), 
suggesting that schizotypal phenomena may exist on a continuum. Moreover, although 
the clinical sample experienced significantly more schizotypal experiences, they were 
not uncommon in the non-clinical sample, with 20% of individuals surveyed having had 
an anomalous experience often or all of the time in the last two weeks. This is quite 
staggering when considering that the frequency of psychotic disorder is 0.5% (Robins & 
Regier, 1991) and supports other prevalence studies in this area (Johns, Nazroo, 
Bebbington, & Kuipers, 1998; Myin-Germeys et al., 2003; Ohayon, 2000; Olfson et al., 
2002; van Os, Hanssen, Bijl, & Ravelli, 2000; Verdoux & van Os, 2002). In line with 
previous research, it appears that it is not the experience of psychotic-like symptoms per 
se which is unique to psychosis. Recent studies have suggested that it may be the 
interpretation of the experience which separates normality from pathology (Lincoln, 
2007).  
 
The presence of high levels of low-level schizotypal symptomatology in a clinical 
sample defined as having “recovered” from acute psychosis could be argued to support 
the rollback phenomenon. This is an idea which suggests that as an illness remits; many 
of the stages and symptoms that were seen during the early stages of its development 
are repeated, but in the reverse order (Detre & Jarecki, 1971; Fava, 1999). However, 
longitudinal research would need to be conducted over the entire course of psychosis in 
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order to fully examine this hypothesis (i.e. to investigate whether there similarities exist 
between prodromal and residual symptoms). Social anxiety appears to be particularly 
prevalent in individuals recovering from psychosis, with over half of the participants in 
the clinical sample reporting experiencing at least one symptom of social anxiety often 
or all of the time in the previous two weeks. This supports literature suggesting that 
social anxiety is an important clinical problem following psychosis (Birchwood et al., 
2006). 
 
2.6.4 Weaknesses of the Current Study 
 
There are a number of considerations which should be borne in mind when interpreting 
the results of this study. First, it could be argued that the non-clinical sample was not 
epidemiologically representative due to the fact that they were university students 
(Prescott, 2002). However, in terms of a comparison sample for an early psychosis 
population, students are matched in terms of age, although not necessarily social status 
(Hodges et al., 1989). It could also be argued that the way in which participants in the 
non-clinical sample were recruited (i.e. via opportunity sampling) may have biased the 
sample, with individuals with a personal interest in or personal experience of this area 
choosing to take part (Freeman, Garety et al., 2005). Furthermore, it is unknown 
whether any of the participants had received treatment for a psychiatric disorder, and 
what the level of substance abuse was in the group. These weaknesses can only be 
overcome by the use of  standardised and epidemiologically representative sampling 
methodology, as used in other prevalence studies (Johns & van Os, 2001). This was not 
feasible for the current study.  
 
Despite the attractiveness of internet research, there are some concerns attached to its 
usage. Indeed, the generalisability of findings from such studies has been questioned 
due to the fact that participation is restricted to those who have access to computer 
networks (Best, Krueger, Hubbard, & Smith, 2001). However, as the current study was 
aiming to recruit participants from student populations, where internet access is 
extremely high, coverage bias was not thought to be a problem. Furthermore, using a 
web-based technique allowed the specific population under investigation to be targeted 
more easily, i.e. by using year group e-mailing lists. Web-based surveys have also been 
criticised for having lower response rates than other modes of data collection in this 
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domain (Couper, Blair, & Triplett, 1999; Fricker et al., 2005). However, this was 
overcome in the current study by sampling a large number of people. A strength of web-
based methodology is that it is not significantly more resource-intensive to send an e-
mail to 10,000 individuals than to 100 individuals.  
 
A further weakness of the current study is that participants in the clinical sample were 
relatively recovered and as such may not have been experiencing symptomatology 
which may otherwise have discriminated between a clinical and non-clinical population, 
e.g. disorganised symptoms (McGlashan, 1987; Torgersen, 1985). However, it must be 
remembered that the aim of creating the SSI was to modify it to assess low-level 
psychotic symptomatology. Such phenomena are arguably best investigated in a 
recovered sample as ceiling effects may have been observed in a more acute sample 
where symptomatology is more severe.  
 
It could be argued that although based on DSM-III-R diagnostic criteria, the SSI is 
somewhat biased towards positive psychotic phenomena and social anxiety. This is 
particularly true of the brief version of the scale where many of the negative symptom 
(e.g. Constricted Affect, No Close Friends) and disorganisation (e.g. Odd Behaviour, 
Odd Speech) subscales have been removed. However, when conducting comparisons of 
different symptom types between clinical and non-clinical samples, it was the positive-
type (i.e. paranoia and anomalous experiences) and social anxiety items which were the 
best discriminators. Furthermore, negative and disorganised symptoms are arguably 
more accurately assessed using objective as opposed to self-report methods. There are 
numerous independent tools which could be used in addition to the SSI to assess such 
phenomena if this was deemed important (e.g. SANS; Andreasen, 1981).  
 
2.6.5 Summary  
 
In summary, the SSI has been shown to be a reliable and valid measure for assessing 
current low-level psychotic phenomena, in both clinical and non-clinical populations. 
Whilst assessment tools already exist to measure the presence of paranoia (e.g. 
Freeman, Garety et al., 2005), interpersonal anxiety (e.g. Liebowitz, 1987), and even 
hallucinatory phenomena (V. Bell et al., 2006; Launay & Slade, 1981) in non-clinical 
populations; the SSI assesses a range of schizotypal phenomena simultaneously and can 
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also be used to assess quasi-psychotic experiences in individuals in recovery from 
psychosis. Thus, the current study offers a significant contribution to research in this 
area, and provides a robust tool for use in later studies in this thesis. The studies which 
follow aim to elucidate the underlying mechanisms of different schizotypal symptom 
types and examine their role in recovery from psychosis.  
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CHAPTER THREE: 
STUDY TWO: THE MCCOLLOUGH EFFECT AND POSITIVE 
SCHIZOTYPAL SYMPTOMS IN PSYCHOSIS 
 
3.1 RATIONALE AND CONTEXT FOR THE STUDY 
 
The previous chapter in this thesis highlighted the presence of schizotypal symptoms in 
a sample of individuals recovering from an acute episode of psychosis. This chapter will 
investigate associations between these symptoms, particularly those in the anomalous 
experiences domain, and the experience of a visual illusion paradigm. This section will 
first summarise the literature in relation to the occurrence of anomalous experiences in 
psychosis, before outlining the aims of the current study. 
 
Low-level anomalous experiences and perceptual disturbances are viewed as being at 
the core of psychosis (M. Shepherd, 1987). Cognitive models suggest that it is the 
interpretation of these experiences which leads to delusion formation and the 
development of full-blown psychotic symptoms (Garety et al., 2001). It is hypothesised 
that these phenomena may be caused by a cognitive dysfunction. The cognitive 
dysfunction itself is not necessarily seen as the primary cause of psychosis, but rather a 
final common pathway through which environmental and genetic influences may 
operate (Hemsley, 2005a). 
 
The nature of the cognitive dysfunction underlying anomalous experiences is a matter of 
some debate (Frith, 1979; Hemsley, 1987; Knight, 1984; Maher, 1983; Venables, 1984). 
However, key to all explanations is the notion that in the early stages of psychosis, there 
is some degree of failure in automatic processing. Hemsley (2005a) specifies this as a 
“weakening of the influence of spatial and temporal regularities on perception” (p. 979). 
This causes a disruption in processing by the intrusion of material that would normally 
remain below awareness. This theory, combined with the ideas of Gray (1982), resulted 
in the development of the Gray-Hemsley model (J. A. Gray, 1995, 1998a, 1998b; J. A. 
Gray, Feldon, Rawlins, Hemsley, & Smith, 1991; Hemsley, 1992, 1993, 1998). A 
central tenet of this model is the existence of a comparator which brings together the 
current state of an individual’s perceptual world with a predicted state (J. A. Gray, 
1993; Hemsley, 2005a). The predicted state is based on previous experience of 
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regularities occurring between different stimuli (J. A. Gray, 1995). If a mismatch occurs 
between the current perceptual state and the predicted state, attention is allocated to 
stimuli thought to be responsible for that mismatch. In psychosis, the Gray-Hemsley 
model suggests that repeated and inappropriate mismatch signals occur, which result in 
the inappropriate allocation of attention to details of the environment which would not 
normally reach awareness. This is hypothesised to result in the occurrence of anomalous 
experiences. This idea has been further developed by Corlett, Honey, and Fletcher 
(2007) who highlight the importance of increased prediction errors (i.e. a mismatch 
between expected and actual events) in the development of psychotic symptoms. 
 
Evidence to support the Gray-Hemsley model comes from a variety of sources, 
including studies investigating latent inhibition in psychosis (Lubow & Gewirtz, 1995). 
Latent inhibition (LI) is a learning process whereby if individuals are primed with a 
stimulus which has no consequence, the later formation of conditioned associations with 
that stimulus is inhibited, i.e. the stimulus loses associability due to non-reinforced pre-
exposure (Lubow & Moore, 1959). LI is thought to be adaptive as it prevents responses 
being made to irrelevant stimuli and thus allows such stimuli to be filtered out of 
awareness. In acute psychosis however, LI has been shown to be impaired: prior 
exposure to a non-reinforced stimulus does not inhibit later association formation with 
that stimulus (Baruch, Hemsley, & Gray, 1988). This supports the notion that psychosis 
may be characterised by an impaired ability to integrate the regularities of previously 
presented material with current sensory input. Similar findings have also been shown 
using other contextual processing tasks in both clinical and non-clinical samples 
(Hemsley, 2005a, 2005b; Steel, Hemsley, & Pickering, 2002). It should be noted that 
low LI is a phenomenon paired with acute psychosis only. When LI experiments have 
been conducted with individuals following remission of psychotic symptoms, 
performance has been shown to be similar to that of non-clinical individuals (Baruch et 
al., 1988). This suggests that low LI, and indeed the Gray-Hemsley model, may apply 
specifically to state fluctuations in low-level anomalous experiences and perceptual 
disturbances and not to the more general syndrome of schizophrenic illness. However, it 
is unknown whether the reinstatement of LI following the remission of acute psychosis 
is a result of antipsychotic medication, or due to factors intrinsic to the evolution of 
schizophrenic illness (Barak & Weiner, 2007; N. S. Gray, Pilowsky, Gray, & Kerwin, 
1995). 
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A strength of using LI as an investigative tool is that it provides a task in which 
individuals with psychosis perform better than non-clinical individuals. Thus, the 
outcome cannot be attributed to a generalised cognitive deficit (L. J. Chapman & 
Chapman, 1973; Hemsley, 2005b). Rather, the awareness of redundant information that 
is hypothesised to occur in psychosis, suggests that there is an increase in cognitive 
activity. However, this is problematic due to issues of limited capacity. Thus, increased 
activity and lack of inhibition in psychosis are likely to reduce the efficiency of 
processing. This fits with the early ideas of Bleuler (1950) who described sufferers of 
schizophrenia as “flooded with an undifferentiated mass of incoming sensory data”. 
 
One difficulty with the Gray-Hemsley model acknowledged by the authors (Hemsley, 
2005a) is that of “mapping constructs that have been generated to explain task 
performance, on to experiential phenomena” (p. 978). Indeed, although the LI paradigm 
supports the notion of impaired automatic processing in psychosis, it does not directly 
explain the occurrence of perceptual disturbance. One paradigm which could be 
employed with this aim in mind is the McCollough Effect (ME; McCollough, 1965). 
The ME is a visual illusion defined as an after-effect and involves the perception of 
colour when no colour is in fact present. After-effects are illusions which require a 
period of adaptation to produce them (Gregory, 1998). To produce an ME, an individual 
is alternately presented with a magenta vertical grating and a green horizontal grating 
for a few minutes. After this period of adaptation, an achromatic vertical grating appears 
green and an achromatic horizontal grating appears pink. The strength of this phantom 
colour is then assessed using a visual analogue scale, or by assessing the orientation 
over which the illusion can be perceived: the further away from 0°, the stronger the 
effect. Although no large scale population studies have been conducted, the ME is 
considered to be a phenomenon of “normal” visual perception. On average, over 90% of 
participants tested in experimental studies perceive the effect (Byth, McMahon, & King, 
2000; Logue & Byth, 1993; McCollough, 1965). 
 
Whilst the presence of the ME is considered “normal”, individual differences have been 
shown to occur in ME strength and have been used to investigate potential underlying 
mechanisms responsible for the effect (e.g. Byth, Logue, Bell, Best, & King, 1992; 
Logue & Byth, 1993; Shute, 1979). The exact physiology and function of the ME is 
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unknown (Allan & Siegel, 1993; Humphrey, 1998; Skowbo, Timney, Gentry, & 
Morant, 1975). However, it is hypothesised that the ME is a low-level visual 
phenomenon with some top-down influence (J. Barnes et al., 1999), potentially 
occurring in area V1 (Humphrey & Goodale, 1998), and is reflective of the ability of the 
visual system to recalibrate itself in the face of perceptual anomalies (Dodwell & 
Humphrey, 1990, 1993). Adaptation level theory (Helson, 1964) suggests that one of 
the main challenges in visual perception is matching the internal representation of the 
world (i.e. what we expect to perceive based on past experience) to external properties 
(i.e. what we actually perceive). In making psychophysical judgements it is 
hypothesised that the observer sets up an implicit scale based on the statistical 
properties of the set of objects being judged. There is a neutral point or adaptation level 
in relation to which perceptual judgements are made (Helson, 1964). Some external 
properties are statistical in nature and reflect properties of the world that occur in the 
long run. For example, the normal correlation of colour and orientation is zero. It is 
deemed necessary to keep such elementary dimensions of perception separate in order 
to make different types of learning possible (Barlow, 1990). If such long-term 
perceptual rules are violated, for example during a period of adaptation, a discrepancy is 
detected. In response to this, through an error correction device (ECD; Andrews, 1964), 
the visual system recalibrates in order to reduce the discrepancy. Generally speaking, 
this results in an inverse transformation on its input. 
 
During the ME adaptation phase, colour and orientation are highly correlated (i.e. green 
always occurs with the horizontal grating; and magenta always occurs with the vertical 
grating). This violates the normal zero correlation between orientation and colour. In 
response to this, the visual system recalibrates and de-correlates colour and orientation 
(Dodwell & Humphrey, 1990). As a result of this, the inverse colour to that which was 
paired with a particular orientation in the adaptation phase, is perceived upon 
presentation of the achromatic grating of that orientation. Thus, pink is perceived upon 
presentation of the achromatic horizontal grating, and green is perceived upon 
presentation of the achromatic vertical grating.  
 
The idea of an ECD in perception has many similarities to that of Gray and Hemsley’s 
comparator (J. A. Gray, 1982). Thus, it could be hypothesised that the ME would be 
altered in acute psychosis in the same way as LI has been shown to be affected. 
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Following adaptation and on presentation of the achromatic test stimulus, a large 
mismatch occurs between the current perceptual state and the predicted state. If 
individuals with psychosis have an increased sensitivity to mismatches and are more 
prone to prediction errors, they may experience a stronger ME than a non-clinical 
sample. A single case study conducted by Shute (1979) showed that an individual with 
schizophrenia exhibited a particularly strong ME during a florid psychotic episode. This 
effect was barely measurable after administration of antipsychotic medication. This is 
similar to the state dependent effect of LI in psychosis. Moreover, amphetamines have 
been shown to increase ME strength in a non-clinical population, suggesting that 
dopaminergic processes may play a role in the effect (Byth et al., 1992; Shute, 1979). 
However, no study has yet examined ME strength in a large sample of individuals with 
psychosis.  
 
3.1.1 Aims of the Study  
 
The aim of the current study is to examine the notion that the ME can be used to assess 
anomalies in automatic processing in individuals with psychosis. As previous studies 
have specifically linked such impairments with psychotic states, it is hypothesised that 
increased ME strength will be specifically associated with the presence and severity of 
low-level positive psychotic symptoms (i.e. anomalous experiences and paranoia), but 
not with other types of psychosis-related symptomatology (i.e. social anxiety, negative 
symptoms). Moreover, in line with the single case study by Shute (1979), it is 
hypothesised that antipsychotic medication will reduce ME strength. In addition to these 
hypotheses, the relationship between the ME and other aspects of neuropsychological 
functioning will be investigated. It is predicted that ME strength will be independent 
from more generic aspects of cognitive functioning.  
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3.2 RESEARCH HYPOTHESES 
 
1. Increased ME strength will be specifically associated with the presence and 
severity of low-level positive psychotic symptoms (i.e. anomalous 
experiences and paranoia) but not with other types of psychosis-related 
symptomatology (i.e. social anxiety). 
 
2. Participants receiving higher levels of antipsychotic medication will 
experience weaker MEs. 
 
3. ME strength will be independent from more generic aspects of cognitive 
functioning. 
 
3.3 METHODOLOGY 
 
Similar methodology to that outlined in the previous chapter (section 2.4) was used in 
this study. A subsample of the participants from the clinical sample outlined in the 
previous study also took part in this study. 
 
3.3.1 Design 
 
A sample of patients in recovery from acute psychosis was surveyed in a cross-sectional 
design. All participants completed a range of self-report questionnaires and clinician-
administered assessments. Participants also completed the McCollough Effect task and 
other neuropsychological assessments. 
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3.3.2 Participants 
 
3.3.2.1 Sample description 
 
A sample of 103 individuals with affective or non-affective psychosis were recruited 
from secondary mental health services in the East Anglia region of the UK and gave 
written consent to take part in the study (as outlined in Study 1, section 2.4). All 
participants had been diagnosed with psychosis in the last eight years but were not 
currently experiencing an acute episode. After assessment with the Diagnostic Interview 
for Psychosis (Castle et al., 2006), 70% of the sample met criteria for non-affective 
psychosis (predominantly schizophrenia), and 30% for affective psychosis 
(predominantly bipolar disorder). The mean age of the sample was 26.6 years (SD = 
5.6). Seventy-three per cent were male and 27% were female. 
 
3.3.2.2 Sample size and power analysis 
 
In order to examine the relationship between ME strength and psychopathology within 
the group, a power analysis calculation revealed that to achieve 80% power with a 
significance level of .05 and an estimated small critical effect size of .30, a minimum 
sample size of 85 participants was required (Cohen, 1988). Therefore the study was 
adequately powered. 
 
3.3.3 Measures and Materials 
 
3.3.3.1 Schizotypal Symptoms Inventory (SSI) 
 
As individuals in the sample were not currently experiencing an acute episode of 
psychosis, the brief Schizotypal Symptoms Inventory was administered to assess 
residual symptoms of psychosis. Moreover, as anomalies in automatic processing have 
been linked with low-level anomalous experiences and perceptual disturbances, rather 
than full-blown psychotic symptoms, it was thought that the SSI may be more sensitive 
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in detecting these phenomena than a more traditional psychosis assessment tool. The 
SSI has been described in detail in the previous chapter and as such a description will 
not be repeated here. Total and subscale scores were used in the analyses. 
 
3.3.3.2 Scale for the Assessment of Positive Symptoms (SAPS; Andreasen, 1984) 
 
The presence of any acute psychotic symptoms was assessed using the SAPS, a 35-item 
semistructured interview designed to assess the presence of positive psychotic 
symptoms. As well as the total scale score, a subscale score was calculated for each 
participant reflecting core psychotic symptoms (auditory hallucinations, voices 
commenting, voices conversing, somatic hallucinations, delusions of reference, 
delusions of being controlled, and delusions of mind reading). This subscale was taken 
from a factor analysis of the SAPS (Peralta & Cuesta, 1999) and thought to reflect the 
core symptoms of psychosis that might be attributable to impaired automatic 
processing. 
 
3.3.3.3 Client Service Receipt Inventory (CSRI; Beecham & Knapp, 1992) 
 
The CSRI is a research tool designed to collect information about the use of health and 
social care services. This was used to collect data from participants about current 
medication levels. Antipsychotic medications were converted into chlorpromazine 
equivalence so that they could be compared between individuals (Woods, 2003). 
 
3.3.3.4 McCollough Effect paradigm (ME; McCollough, 1965) 
 
The ME paradigm was presented on a computer screen. Participants were initially 
presented with adaptation stimuli for 4 minutes. These consisted of two gratings 
alternating at 5-second intervals with a 1-second interval between presentations. One 
grating was composed of vertical black stripes on a green background (0,255,0 on the 
RGB scale) and the other grating was composed of horizontal black stripes on a 
magenta background (255,0,255 on the RGB scale). See Figure 3.1 for examples of the 
adaptation stimuli. Following the adaptation phase, participants were shown an 
achromatic test stimulus, consisting of black and white horizontal and vertical gratings 
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(see Figure 3.2), and were asked to give a magnitude estimate of any phantom colour 
they perceived. This estimate was given using a visual analogue scale (VAS) with 
ratings from 0-100. Higher ratings correspond to stronger effects (i.e. 0 equal to no 
colour and 100 equal to colours observed in the adaptation period).  
 
In addition to a VAS rating of effect strength, the test stimulus was presented over a 
range of orientations from 0-180° at 5° intervals for 5 seconds each. Previous research 
has shown that the ME is strongest at 0° and cannot usually be seen at 45° intervals 
(McCollough, 1965). However, the effect has been shown to reappear when the test 
stimulus is viewed at 90° and 180°. Thus, the orientation test in the current study 
provided four additional measures of effect strength (0-45°, 45-90°, 90-135°, and 135-
180°). An average of these four measurements was then calculated to provide an 
orientation range between 0-45° over which the ME could be perceived. Higher 
orientation ranges were assumed to reflect stronger effects.  
 
All stimuli in the paradigm subtended 8.8 degrees by 8.8 degrees of visual angle at a 
viewing distance of 60cm. Gratings in both the adaptation and test stimuli had a spatial 
frequency of 2.7 cycles per degree and were of high contrast. All stimuli were displayed 
in a central position on a 15” laptop computer screen using Microsoft PowerPoint.  
 
3.3.3.5 Cambridge Neuropsychological Automated Test Battery (CANTAB; 
Sahakian & Owen, 1992) 
 
In order to examine the ME in relation to other aspects of neuropsychological 
performance, participants completed selected tasks from the CANTAB. The Intra-extra 
Dimensional Set Shifting (IED) task is a test of rule acquisition and reversal and 
assesses executive function. Performance was measured by the number of errors 
participants made on the task, with increased errors reflecting poorer performance. The 
Paired Associate Learning (PAL) task assesses episodic memory and associative 
learning. Performance on the PAL task was measured by the number of trials it took for 
participants to learn associations, with an increased number of trials reflecting poorer 
performance. The Rapid Visual Information Processing (RVP) task assesses sustained 
attention. Performance on the RVP task is measured by a sensitivity score, ranging from 
0 (poor) to 1 (good), and reflecting a participant’s accuracy at detecting the target 
  119
sequence. Finally, the Spatial Working Memory (SWM) task assesses working memory 
abilities. Performance on the SWM task was measured by the number of errors 
participants made, with increased errors reflecting poorer performance. 
 
 
 
Figure 3.1  
McCollough Effect adaptation stimuli 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2  
Test stimulus for the McCollough Effect task 
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3.3.4 Procedure 
 
A similar procedure to that outlined in the previous study was used in this study. All 
measures were administered by trained researchers who met regularly to maintain 
reliability of procedures and ratings. Self-report measures were completed 
independently by participants. Symptom assessments were completed in a separate 
session to the ME and CANTAB tasks. Neuropsychological assessments were 
conducted in a quiet and controlled environment, predominantly in a clinical setting, to 
prevent distraction. Symptom and neuropsychological assessments were completed 
within two weeks of one another. 
 
3.3.5 Data Analysis Plan 
 
All data was analysed using SPSS for Windows, version 14 (SPSS, 2005). Data was 
screened and cleaned as outlined in the previous chapter (section 2.4.6.1). In the first 
stage of the analysis, descriptive statistics were calculated for all variables. Bivariate 
Pearson’s product moment correlations were conducted to investigate relationships 
between ME strength, symptoms, medication levels, and neuropsychological 
performance. Differences between participants who perceived the effect and those who 
did not were investigated using independent samples t-tests. 
 
3.4 RESULTS 
 
3.4.1 Descriptive Data 
 
Table 3.1 shows descriptive statistics for all variables in the group. The majority of 
variables had skewed distributions which were resistant to normalising transformation 
procedures. Therefore, parametric and non-parametric analyses were conducted. 
However, both types of analyses revealed the same findings and thus parametric 
analyses are reported. 
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Table 3.1  
Descriptive Statistics for all Study Variables   
 
 N Min-Max Mean  
(SD) 
Skewness 
(SE) 
Schizotypal Symptoms  
- Total 
- Social Anxiety 
- Paranoia 
- Anomalous Experiences 
 
103 
103 
103 
103 
 
0-80 
0-24 
0-24 
0-32 
 
17.64 (15.41) 
8.09 (6.51) 
5.45 (6.23) 
4.11 (5.74) 
 
1.55 (0.24) 
0.61 (0.24) 
1.35 (0.24) 
2.39 (0.24) 
 
SAPS 
- Total 
- Core Psychotic Symptoms 
 
 
103 
103 
 
 
0-48 
0-25 
 
 
14.02 (12.51) 
4.99 (6.19) 
 
 
0.74 (0.24) 
1.44 (0.24) 
 
Antipsychotic Medication 
Dose (mg) 
 
77 
 
0-726.67 
 
216.26 (169.82) 
 
0.54 (0.27) 
 
McCollough Effect 
- Magenta estimate 
- Green estimate 
- Orientation range (°) 
 
 
103 
103 
102 
 
 
0-100 
0-100 
0-45 
 
 
7.68 (14.25) 
11.68 (17.17) 
14.04 (13.72) 
 
 
3.51 (0.24) 
2.15 (0.24) 
0.34 (0.24) 
 
Intra-Extra Dimensional Set 
Shift (number of errors) 
 
103 
 
6-201 
 
35.85 (39.52) 
 
2.63 (0.24) 
 
Paired Associate Learning 
(number of trials) 
 
102 
 
1-26 
 
12.65 (5.38) 
 
0.72 (0.24) 
 
Spatial Working Memory 
(number of errors) 
 
103 
 
0-76 
 
32.47 (20.75) 
 
0.19 (0.24) 
 
Rapid Visual Processing 
(accuracy) 
 
96 
 
0-0.97 
 
0.83 (0.18) 
 
-4.01 (0.25) 
 
Note. Descriptive statistics for ME are for the whole sample, including participants who did not 
perceive the effect 
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3.4.2 Measuring the ME in a Sample with Psychosis 
 
Magnitude estimation was significantly correlated with the orientation range over which 
the effect was perceived (magenta: r(102) = .41, p <.001; green: r(102) = .51, p <.001). 
This suggests that both measurements were tapping the same concept, i.e. ME strength. 
From this point forward, orientation range will be used as the measure of ME strength 
as this measure is unlikely to be affected by extreme responding in the same way as 
visual analogue scales. There was no significant difference in ME strength between 
individuals with affective and non-affective psychosis, t(97) = 0.90, p = .37. 
 
3.4.3 ME and Medication Effects 
 
The ME was experienced by 63% of individuals in the sample (mean orientation range 
= 22.37°, SD = 10.61°). Thus, 37% did not experience the effect at all. This is unusual 
when considering the fact that the effect is thought to be a phenomenon of normal visual 
perception. Current medication levels were known for a subsample of participants (n = 
77). Those who could perceive the ME were receiving a significantly lower dose of 
antipsychotic medication than individuals who could not perceive the effect: 178mg vs. 
279mg; t(75) = 2.62, p = .01. Moreover, there was a significant negative association 
between antipsychotic dose and ME strength, such that individuals receiving higher 
doses of antipsychotic medication perceived weaker MEs, r(76) = -.28, p = .01. 
 
3.4.4 Relationships with Other Variables 
 
ME strength was not associated with symptom scores on the SAPS (Total: r(102) = .10, 
p = .32; Core Psychotic Symptoms: r(102) = .08, p = .44). However, there was a 
correlation between ME strength and schizotypal symptoms. ME strength correlated 
with Anomalous Experiences, r(102) = .23, p = .02; and Paranoia r(102) = .21, p = .03; 
but not with Social Anxiety r(102) = .14, p = .15. Thus, those individuals reporting 
higher levels of Anomalous Experiences and Paranoia also displayed stronger MEs. 
 
Bivariate correlations showed no association between ME strength and scores on other 
neuropsychological paradigms (IED: r(102) = -.02, p = .82; PAL: r(101) = -.07, p = .48; 
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SWM: r(102) = -.02, p = .84; RVP: r(95) = .02, p = .88). Thus the ME appears to be 
independent from other domains of neuropsychological functioning. 
 
3.5 DISCUSSION 
 
This chapter has examined the experience of the ME in a large group of individuals with 
psychotic illness. Previous clinical studies conducted in this area have focused on single 
cases (e.g. Shute, 1979) and thus this study is somewhat novel in its design. This section 
will review the results of the current study in relation to the research hypotheses 
outlined at the beginning of this chapter. The findings will be discussed in relation to 
the current literature and the clinical implications will be examined. Following on from 
this, potential weaknesses of the study will be outlined, as will possibilities for future 
research.  
 
3.5.1 Overview of Findings 
 
The ME was experienced by 63% of the sample and was significantly associated with 
the presence of anomalous and paranoid schizotypal symptoms. That is, individuals 
reporting more of these phenomena also experienced significantly stronger MEs. 
However, this association did not occur for symptoms of social anxiety, or for acute 
symptoms of psychosis as measured by the SAPS. This suggests that the relationship 
between ME strength and symptomatology may be specific to core low-level positive 
psychotic phenomena (e.g. perceptual disturbance and anomalous experience). 
Moreover, there appears to be an effect of medication on ME strength, with individuals 
taking higher levels of antipsychotic medication also displaying weaker effects. The 
group of 37% participants who could not perceive the ME were found to be taking 
significantly higher levels of medication than the 63% who could. In addition to these 
findings, ME strength was shown to be independent from other domains of cognitive 
functioning, suggesting that the findings of the current study cannot be attributed to 
general cognitive factors. 
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3.5.2 Relevance to the Literature  
 
In light of the above findings it appears that the ME may be reflective of an anomaly in 
automatic processing, akin to that described in the Gray-Hemsley model, and which is 
specific to state low-level positive psychotic symptomatology. The increased strength of 
the ME in individuals who report more positive schizotypal symptoms suggests that 
individuals with psychosis may display an increased sensitivity to discrepancies 
between what is actually perceived and what is expected based on past experience. 
Moreover, unlike tasks which have previously been used to test the Gray-Hemsley 
model (e.g. latent inhibition); the ME is more directly relevant to the presence of 
perceptual aberration.  
 
The finding that MEs are not present in individuals taking high levels of antipsychotic 
medication suggests that the effect may be blocked in some way. The exact process by 
which this occurs can only be speculated. However, it is known that there is heightened 
dopamine transmission in individuals with psychosis (Davis et al., 1991; Seeman, 1987; 
Seeman & Kapur, 2000). Excess dopamine in the ventral striatum is thought to be 
responsible for anomalous experiences due to its role in the aberrant attribution of 
salience, and in turn the direction of attention, to irrelevant stimuli (Kapur, 2003). 
Antipsychotic medication is hypothesised to be effective in reducing psychotic 
symptoms due to a blockade of this dopamine transmission (Kapur & Mamo, 2004). 
However, experimental studies have shown that in normal circumstances, dopamine is 
released in the face of a discrepancy between what is predicted to occur in the 
environment and what actually occurs (Berridge & Robinson, 1998; Schultz, 1999). It is 
hypothesised that this allows attention to be directed to new stimuli to aid learning. In 
this study it is suggested that the ME is the result of a process which attempts to respond 
to a discrepancy between predicted and actual perception (Dodwell & Humphrey, 
1990). A lack of dopamine transmission in individuals taking high levels of 
antipsychotic medication may therefore disrupt the process by which the ME occurs, 
thus resulting in no effect being experienced. Conversely, via the same process, an 
excess of dopamine may result in a stronger effect being experienced.  
 
  125
Other studies investigating perceptual processing in psychosis have suggested that 
clinical populations are less susceptible to visual illusions as a result of weak contextual 
suppression (Dakin, Carlin, & Hemsley, 2005). Dakin et al. showed that individuals 
with schizophrenia were more accurate in a contrast discrimination task than controls, 
and less prone to the “contrast-contrast” illusion – a paradigm where a target appears 
lower in contrast when presented within a high-contrast surround than in isolation 
(Chubb, Sperling, & Solomon, 1989). With this in mind, it could be argued that ME 
strength would be weaker in individuals with psychosis, due to reduced influence of the 
adaptation phase (i.e. context) on the perception of colour in the test stimulus. However, 
if the contrast detection task is viewed in terms of individuals with psychosis being 
more sensitive than controls to mismatch, and thus better able to detect subtle 
differences in contrast; then it seems reasonable and consistent that they would also 
experience stronger MEs. Moreover, in line with Dakin et al. (2005), the finding that 
individuals with increased levels of psychotic-like phenomena “over-perform” on the 
ME paradigm may help to reveal underlying mechanisms of the disorder. This is in 
contrast to tasks on which individuals with psychosis show a deficit, whereby 
performance is usually explained in the context of a generalised impairment. In future 
studies it would be interesting to compare ME strength with performance on other 
visual illusion paradigms and tasks relating to contextual processing. 
 
3.5.3 Weaknesses of the Current Study 
 
There are a number of limitations to the current study which should be taken into 
account when interpreting the findings. First, the study lacks a non-clinical control 
group. As such it is unknown whether MEs experienced by individuals with psychosis 
are stronger than those experienced in the general population; or whether the lack of ME 
in 37% of participants was merely a result of the way in which the paradigm was 
administered in this study. However, in a study of ME strength in a non-clinical student 
sample using similar methodology, over 90% of participants perceived the effect 
(Thompson & Hodgekins, 2004). An analogous pattern of association between ME 
strength and schizotypal symptoms was also found in this non-clinical (and thus 
medication naïve) sample, with weaker MEs occurring in low-schizotypy individuals 
(Thompson & Hodgekins, 2004).  
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Second, although associations were found between schizotypal symptoms and ME 
strength in the current study, no associations were found between psychotic symptoms 
as rated by the SAPS. However, it must be remembered that this group were not 
currently experiencing an acute episode of psychosis and thus levels of positive 
psychotic symptoms were relatively low. It could also be argued that the SSI is a more 
sensitive measure of low-level psychotic symptoms, assessing phenomena similar to 
those which have previously been associated with anomalies in automatic processing. 
Thus it is more likely that associations between ME strength and symptoms would be 
found when using this scale, as opposed to the SAPS. In order to assess the relationship 
between ME strength and full-blown psychotic symptoms, this study would need to be 
replicated in a sample with acute psychosis.  
 
It could be argued that there are problems with using prescribed medication dosage to 
examine associations between medication use and other variables, given the high level 
of mediation non- or partial-compliance in psychotic disorders (e.g. Coldham et al., 
2002). In order to gain more accurate estimates of medication status, plasma levels of 
antipsychotic medication would ideally have been taken. However, this was beyond the 
scope of the current study. Moreover, the relationship between antipsychotic medication 
and ME strength may be confounded by other variables, including illness severity and 
duration. Thus, it may be the case that a subcategory of chronic psychosis patients (who 
also take higher levels of medication) have a reduced likelihood of perceiving the ME 
than less chronic individuals. Further research is therefore needed to unpick the nature 
of these relationships. Indeed, as this study is correlational in design, conclusions cannot 
be made with respect to causality, or the direction of relationships between ME 
perception, antipsychotic medication, and schizotypal symptoms. Future research in this 
area should focus on investigating fluctuations in ME strength over the course of a 
psychotic episode, both before and after the administration of antipsychotic medication. 
Based on the current findings, it would be predicted that perception of the ME would be 
strongest during an acute episode when anomalous experiences were at their most 
florid, and then gradually decline following the remission of these experiences, 
potentially after the administration of antipsychotic medication. 
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3.5.4 Summary 
 
Despite the above limitations, the findings of this study have some interesting clinical 
implications and add a promising dimension to the search for a basic cognitive 
dysfunction underlying the positive symptoms of psychosis. The results also support 
those of other studies which have demonstrated anomalies in both low-level and top-
down visual processes in psychosis (Giersch & Rhein, 2008; Vohs et al., 2008). 
Moreover, the findings concur with suggestions that such anomalies may be specific to 
clinical state (Johannesen, Bodkins, O'Donnell, Shekhar, & Hetrick, 2008). In addition 
to previous research, the current study also outlines how aberrant perception may be 
linked to the symptoms of psychosis. However, it must be remembered that a basic 
cognitive dysfunction resulting in anomalous experiences is only part of the story. 
Interpretation is key to the development of such experiences into later psychotic illness. 
This is likely to be a largely psychological process. In order to develop effective 
therapeutic approaches, future research must focus on examining how these two 
processes interact. The association between psychotic-like experiences and emotional 
and psychological variables will be the focus of the next chapter of this thesis. 
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CHAPTER FOUR: 
STUDY THREE: RELATIONSHIPS BETWEEN SCHIZOTYPAL SYMPTOMS, 
EMOTION, AND SCHEMA VARIABLES IN A NON-CLINICAL SAMPLE 
 
 
4.1 RATIONALE AND CONTEXT OF THE STUDY 
 
4.1.1 Overview 
 
Thus far, this thesis has demonstrated that schizotypal symptoms occur both in non-
clinical populations and in clinical populations recovering from psychosis. This study 
examines the relationship between these symptoms and emotional and psychological 
variables in a non-clinical sample.  
 
Findings from the previous chapter support theories suggesting that anomalous 
experiences may be the product of an underlying cognitive disturbance (J. A. Gray et 
al., 1991; Hemsley, 1998). The cognitive model of psychosis argues that emotional and 
psychological variables are particularly important in the appraisal of anomalous 
experiences arising from such a disturbance, and thus in the development and 
maintenance of psychotic symptoms (Garety et al., 2001). In line with the continuum 
hypothesis, it is likely that schizotypal experiences will also be accompanied by a range 
of emotional and psychological factors influencing their development and maintenance. 
However, there may be differential relationships between individual schizotypal 
symptom types and emotional and psychological variables. Indeed, interpersonal 
phenomena (e.g. social anxiety and paranoia) could be argued to have a more emotional 
and psychological basis than anomalous experiences, which have been argued to be 
more organic in nature. 
 
Although numerous studies have used a single-symptom approach (e.g. Freeman, 
Garety et al., 2005) to investigate the factors associated with specific psychotic 
phenomena (e.g. paranoia), little research has been conducted to investigate the 
differential associations between discrete symptom types and potential associated 
variables. The SSI is advantageous in this respect as it assesses a range of low-level 
psychotic symptoms simultaneously. Moreover, investigating the relationships between 
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schizotypal symptoms and emotional and psychological variables in a non-clinical 
population may inform more specifically upon the factors and processes underlying the 
development of such phenomena, without the confounding effects of the disease process 
(Raine & Lencz, 1995). Furthermore, if relationships between schizotypal symptoms 
and emotional and psychological variables in the non-clinical sample mirror those found 
in clinical samples, this could be taken as evidence to support the psychosis continuum.   
 
This chapter first reviews the literature regarding associations between positive 
psychotic symptoms and emotional and psychological processes, before investigating 
the relationships between different types of schizotypal symptoms and emotional and 
psychological variables in a non-clinical population.  
 
4.1.2 Psychosis and Emotional and Psychological Processes 
 
Birchwood (2003) argues that emotional dysfunction is pervasive in psychosis, and may 
occur pre- and post-onset, as well as during the psychotic episode itself. Several routes 
to emotional dysfunction in psychosis have been postulated. Birchwood (2003) 
proposes three overlapping pathways:  first, that emotional dysfunction is intrinsic to 
psychosis; second that emotional disorders are a psychological reaction to psychosis; 
and third, that emotional disorders arise from shared risk factors with psychosis. It is 
likely that all of these pathways are valid, accounting for different levels of emotional 
disturbance at different stages of psychotic illness. However, the finding that emotional 
disturbance occurs prior to the onset of psychosis (Häfner, Löffler, Maurer, Hambrecht, 
& an der Heiden, 1999; McGlashan, 1996), suggests that it may have a direct impact on 
the development of psychotic symptoms. Moreover, an emotional response to psychotic 
symptoms may create a vicious cycle, thus maintaining the presence of psychotic 
phenomena (Fowler, Freeman, Steel et al., 2006). 
 
In line with the cognitive model of psychosis, different aspects of emotion and self and 
other evaluation may be associated with different types of psychotic symptoms. 
Evidence for this will now be reviewed. 
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4.1.2.1 Anxiety 
 
Increased levels of anxiety have been found to be common before the onset of psychotic 
symptoms (Tien & Eaton, 1992) and in the prodromal stages of the disorder (Birchwood 
et al., 1992; McGlashan, 1996). Anxiety has also been shown to be predictive of 
transition to psychotic illness. A study by Weiser et al. (2001) showed that adolescents 
with neurotic disorders were more likely to develop psychosis than those without 
neurotic disorders. These findings have since been replicated by other researchers (P. 
Jones, Rodgers, Murray, & Marmot, 1994; P. Miller, Byrne et al., 2002). Following the 
onset of psychosis, anxiety has been highlighted as a common co-morbid feature of 
acute psychotic episodes, with studies suggesting rates of around 40-50% (Argyle, 
1990; Cosoff & Hafner, 1998; Turnbull & Bebbington, 2001). Moreover, Voges and 
Addington (2005) found that 31% of a first-episode psychosis sample met criteria for 
social phobia. 
 
Anxiety is thought to play an important role in both the development and maintenance 
of psychotic symptoms. The notion that anxiety may be partially responsible for the 
occurrence of hallucinations and delusions is an idea supported by J. A. Gray et al. 
(1991), whose neuropsychological model implicates arousal as a central process in the 
onset of psychosis. Increased arousal prior to symptom formation is thought to direct 
attention towards irrelevant stimuli and trigger a search for meaning as to why such 
stimuli feel personally meaningful. The importance of arousal also fits with the stress-
vulnerability model of psychosis (Nuechterlein & Dawson, 1984) and findings that 
symptom occurrence and psychotic relapse are often preceded by stressful life events 
and corresponding increases in arousal (Bebbington et al., 1993; Malla, Cortese, Shaw, 
& Ginsberg, 1990). In addition, studies have demonstrated that individuals with 
psychosis have greater stress sensitivities (Myin-Germeys, Delespaul, & van Os, 2005). 
 
Emotional processes are not thought to be directly responsible for causing 
hallucinations (Freeman & Garety, 2003). However, it is argued that anxiety may 
provide a trigger for the hypothesised dysfunction in cognitive processes which is 
thought to lead to the occurrence of hallucinations (Morrison, 1998; Slade, 1976; Tien 
& Eaton, 1992). The exact physiological process by which this occurs has yet to be 
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clearly defined but it has been suggested that anxiety may result in failures in self-
monitoring (Frith, 1992). Morrison (2001) further elaborates on the maintaining role of 
anxiety on hallucinatory experience, suggesting that hallucinations occur as a result of 
intrusions into awareness, governed by anxiety. The misinterpretation of these 
intrusions as external threats produces a further emotional response which leads to more 
intrusions, creating a vicious cycle. In addition, it is thought that anxiety may have an 
impact on the content and interpretation of auditory hallucinations, perhaps resulting in 
a threatening theme, e.g. “we’re after you” (Fowler, 2000a; Garety et al., 2001; 
Morrison, 2001). Thus, it appears that there is a role for anxiety in the development, 
content and maintenance of hallucinations.  
 
As well as hallucinations, Freeman and colleagues suggest that anxiety may be 
important in the development and content of delusions, particularly paranoia and 
persecutory beliefs (Freeman, 2007; Freeman & Garety, 2003). Anxiety and 
interpersonal sensitivity – a specific type of anxiety concerning social interaction – have 
been shown to predict the presence of paranoia in both clinical and non-clinical 
populations (Freeman, Dunn et al., 2005; Freeman, Garety et al., 2005), with paranoid 
thoughts (e.g. “people are out to get me”) often building upon common interpersonal 
worries and anxieties (e.g. “people are looking at me”). It is hypothesised that delusions, 
particularly those of a persecutory nature, are threat beliefs maintained by similar 
psychological processes traditionally associated with emotional disorders (Freeman et 
al., 2002). Indeed, similar processes are thought to underlie both anxiety and paranoia, 
including the anticipation of threat or danger, and the use of safety behaviours to 
prevent the feared event from taking place (Freeman, 2007; Salkovskis, 1991). The 
majority of individuals with persecutory delusions have also been shown to have a 
worry thinking style, even about matters unrelated to paranoia (Freeman & Garety, 
1999). In addition to this, increased emotional arousal in response to paranoia is 
hypothesised to induce an attentional bias, resulting in individuals becoming 
hyperaware of their surroundings. This increases vigilance for potentially threatening 
stimuli, which may in turn maintain persecutory beliefs. Evidence in support of this 
view comes from studies highlighting an attentional bias towards threat stimuli in 
individuals with psychosis (M. J. Green, Williams, & Davidson, 2003). 
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The evidence reviewed suggests that anxiety may play an important and sometimes 
causal role in the development and maintenance of psychotic symptoms, namely 
hallucinations and delusions. Individuals with psychosis may be more vulnerable to 
fluctuations in anxiety in response to daily hassles and major life events, which could in 
turn trigger symptom formation and influence its content and accompanying 
interpretation. It has been argued that anxiety is simply a consequence of psychotic 
symptoms (J. P. Chapman, 1966). Indeed, anxiety problems often remain even after the 
remission of acute psychosis (Voges & Addington, 2005). However, whilst it is 
accepted that psychotic symptoms are accompanied by increases in anxiety, the finding 
of emotional disturbance prior to the onset of full symptoms suggests that the 
relationship is circular (Freeman & Garety, 2003). That is, changes in arousal trigger the 
onset of symptoms which then have an additional impact on anxiety, in turn increasing 
vulnerability for further symptom development. 
 
4.1.2.2 Depression 
 
As with anxiety, increased levels of depression are a common feature of psychosis, both 
before and after onset.  A retrospective study by Häfner and colleagues demonstrated 
that 73% of patients with first-episode psychosis had experienced a prodromal phase 
lasting several years, which had begun with the occurrence of depressive and negative 
symptoms (Häfner et al., 1999). Furthermore, Bustamante, Maurer, Löffler, and Häfner 
(1994) suggest that 81% of the depression occurring in the early stages of psychosis 
begins an average of 4.3 years prior to diagnosis. Following onset, depression has been 
shown to be frequently co-morbid with schizophrenia (Siris, 1995), with around 45% of 
individuals experiencing depressed mood (Leff, Tress, & Edwards, 1988). A more 
recent study estimates an even higher prevalence of depression in psychosis at between 
22-75%, depending on which assessment tools and criteria are used (Koreen et al., 
1993). 
 
In the same way as anxiety, it is thought that depression may impact upon the content of 
hallucinations and the way in which they are experienced and interpreted. Most of the 
research in this domain tends to focus on auditory hallucinations, with suggestions that 
depressed mood may lead to critical content of voices, e.g. “you’re useless” (Fowler, 
2000b; Freeman & Garety, 2003; Morrison, 2001). Indeed, Smith et al. (2006) showed 
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that individuals who were more depressed, experienced voices with more negative 
content and were also more distressed by them. Thus, there is a suggestion that the 
content of hallucinations may reflect emotional concerns. However, causality is difficult 
to establish here as it is equally likely that distressing voices evoke an increased 
emotional response. For example, being called useless by a voice is likely to result in 
low mood. Chadwick and Birchwood (1994) conducted a study to investigate how 
beliefs about voices, as well as content, influenced mood. They found that emotional 
distress was most closely tied to beliefs about the voices, with increased depression 
being associated with beliefs that voices were malevolent. In 30% of cases, these beliefs 
occurred even if the voices were not negative in content. This suggests that mood may 
not just be a response to the occurrence of hallucinations, but rather play a more 
important role in their interpretation. 
 
Depression is also argued to impact upon delusion formation by providing the 
individual with a feeling of social exclusion and a sense of being a target for others 
(Freeman & Garety, 2003). Aspects of depression, such as guilt, may also feature in the 
content of delusional beliefs. For example, a depressed individual may believe that they 
deserve to be persecuted because they are a bad person. This has been defined as “bad 
me” paranoia (Trower & Chadwick, 1995). Moreover, in a cross-sectional study by C. 
Green et al. (2006), individuals with paranoid beliefs who reported feeling subordinate 
and powerless in the face of persecution, were shown to suffer from higher levels of 
depression than individuals who felt able to exert some control over their situation. 
Causality in such studies is however still an issue. Depression may result in feelings of 
powerlessness and inferiority, thus influencing delusion content, or may also occur as 
an emotional response to delusional beliefs, particularly if they are negative in nature. 
Akin to findings for hallucinations, individuals who are more distressed by their 
delusions also experience higher levels of depression (Smith et al., 2006). As with 
anxiety, the relationship between depression and psychotic phenomena is thus likely to 
be circular.  
 
Whilst depression appears to influence the content and interpretation of psychotic 
symptoms, it has been argued that anxiety may play a more central role than low mood 
in symptom development (Norman, Malla, Cortese, & Diaz, 1998). Indeed, some 
studies have found stronger links between depression and negative symptoms (e.g. 
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amotivation) rather than positive psychotic phenomena (Norman & Malla, 1991). 
Despite this, it has been hypothesised that depression in psychosis may induce a 
cognitive bias towards the processing of negatively connotated information, thus 
influencing and maintaining hallucinations and delusions (Guillem, Pampoulova, Stip, 
Lalonde, & Todorov, 2005). Moreover, it may be specific negative evaluative beliefs 
associated with depression, rather than low mood per se, which are important in the 
development of psychotic symptoms. These will be considered in the next section. 
 
4.1.2.3 Self-esteem and schematic beliefs 
 
Closely linked to depression, low self-esteem and negative self evaluation have been 
shown to be common and pervasive in psychosis, as well as in non-clinical samples who 
report psychotic-like symptoms (Bowins & Shugar, 1998; Combs & Penn, 2004; 
Freeman et al., 1998; Silverstone, 1991). In addition to a low baseline level of self-
esteem, individuals with psychosis are also hypothesised to experience increased 
fluctuations in self-esteem over time (Thewissen, Bentall, Lecomte, van Os, & Myin-
Germeys, 2008; Thewissen et al., 2007). This may be reflective of general emotional 
instability, or may be associated with fluctuations in symptoms. Low self-esteem in 
psychosis has been linked to increased illness severity and poorer outcome (Freeman et 
al., 1998). Moreover, whilst implicated in the development and maintenance of 
psychotic symptoms (Bentall et al., 1994; Garety et al., 2001; Smith et al., 2006), there 
is a consistent finding of low self-esteem in patients at varying phases of psychotic 
illness, even after symptom recovery (Gureje et al., 2004), suggesting that it may also 
be a reaction to the disorder itself. Indeed, the process of developing psychosis has 
significant implications for the development of negative self-concept (Birchwood & 
Iqbal, 1998; Laithwaite et al., 2007). 
 
There are numerous problems in assessing self-esteem in psychosis, including how the 
construct should be defined and the selection of appropriate measurement tools. Whilst 
it is generally accepted that global self-esteem is reduced in psychosis, exactly which 
aspects of low self-esteem influence symptoms, if at all, is a matter under debate. 
Bentall and colleagues argue that psychotic symptoms, particularly persecutory 
delusions, develop in individuals with low self-esteem to prevent negative thoughts and 
feelings about the self from reaching consciousness (Bentall, Corcoran, Howard, 
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Blackwood, & Kinderman, 2001; Bentall et al., 1994). That is, individuals with 
psychosis have a tendency to make external personal attributions (i.e. blame other 
people) for negative events in order to protect themselves against underlying low self-
esteem. Evidence to support this view comes from findings of externalising attribution 
biases in paranoid individuals (Krstev, Jackson, & Maude, 1999; Lyon, Kaney, & 
Bentall, 1994); and from studies highlighting reductions in self-esteem which 
immediately precede increases in paranoia (Thewissen et al., 2008). Moreover, intact 
self-esteem has been observed in some individuals with paranoia, even in cases with 
high depression (Candido & Romney, 1990). However, in the majority of cases, low 
self-esteem is directly related to paranoia and other positive symptoms of psychosis 
(Freeman & Garety, 2003). This would not be expected if paranoia served as an 
effective defence. Thus, an alternative view is that low self-esteem in psychosis occurs 
as a result of normal emotional processes and has a central, non-defensive role in the 
development of symptoms (Fowler, 2000a; Garety et al., 2001).  
 
More recent research has focused specifically on the role of extreme negative self and 
other evaluation in psychosis, as opposed to global self-esteem. Indeed, increased 
negative self evaluation has been strongly associated with the presence of positive 
symptoms of psychosis (Barrowclough et al., 2003). Moreover, Freeman and Garety 
(2003) propose that psychotic symptoms are a direct reflection of pre-existing (and 
predominantly negative) beliefs about the self, world, and others. With this in mind, 
Fowler, Freeman, Smith et al. (2006) have developed a tool with the specific aim of 
assessing core schematic beliefs (both negative and positive) about self and others. The 
Brief Core Schema Scales (BCSS) allow a distinction to be made between extreme 
negative self evaluations (e.g. “I am bad”), hypothesised to be characteristic of 
psychosis; and generic self-esteem assessments which tend to measure the absence of 
positive evaluations of self (e.g. “Other people are more successful than me”). 
 
Using the BCSS, individuals with psychosis report more extreme negative beliefs about 
self and others when compared to a non-clinical sample (Fowler, Freeman, Smith et al., 
2006). These beliefs are hypothesised to develop via adaptation and social learning, 
potentially in response to early adverse experiences (Garety et al., 2001). The triggering 
of negative schematic beliefs (e.g. “I am vulnerable”, “others are dangerous”) may lead 
to the experience of psychotic symptoms due to their influence on the appraisal of 
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anomalous experiences or ambiguous social situations. Indeed, an individual who 
believes that they are weak and vulnerable to attack, and that others are hostile and 
dangerous, may be more likely to interpret a glance from a passer-by as a threat signal. 
Equally, negative schematic beliefs about the self may be reflected in the content of 
auditory hallucinations (Freeman & Garety, 2003). Thus, it is the accessing of these 
schemas, and not just emotional disturbance alone, that is proposed to be associated 
with psychotic symptoms (Garety et al., 2001). Smith et al. (2006) demonstrated that the 
occurrence of persecutory delusions was associated with negative evaluative beliefs 
about the self and others, even when controlling for current mood and self-esteem. 
Auditory hallucinations on the other hand, were found to be associated with higher 
levels of depression and lower self-esteem, but not with negative evaluative beliefs 
about self or others. However, more distressing hallucinations, and those with more 
negative content, were associated with increased negative beliefs about self. 
 
The role of schemas in the development and maintenance of psychotic symptoms could 
be argued to date back to the work of Laing (1960; 1961). In Self and Others, Laing 
(1961) refers to the notion of an individual with psychosis feeling as though other 
people are against them: “…self attributes to others the intention to oust self from his 
position in the world, to displace and replace him” (p. 132). This is similar to what 
Fowler, Freeman, Smith et al. (2006) refer to as negative beliefs about others. Laing 
also refers to an individual with psychosis as feeling vulnerable and having an insecure 
position in the world: “what tortures him is his harrowing suspicion that he is of no 
importance to anyone” (p. 136). This is similar to what Fowler, Freeman, Smith et al. 
(2006) refer to as negative beliefs about self. A combination of beliefs that the external 
world is hostile and the self is weak and vulnerable creates a dangerous social position, 
which Laing (1961) describes as being “false and untenable” (p. 125). Such a position, 
combined with increased anxiety, may lead to the development of persecutory delusions 
and appears to be characteristic of individuals with psychosis. This is in line with 
research by Smith et al. (2006) outlined above. 
 
Whilst closely related to the more generic constructs of low self-esteem and low mood, 
it appears that negative beliefs about self and others may have a specific role in the 
formation, content, and maintenance of psychotic symptoms. These schemas seem 
particularly important in the formation of delusions and paranoia, providing the 
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foundations for delusional beliefs to be built upon. They appear to play less of a role in 
the development of hallucinatory experiences, although may have an impact on the 
content and interpretation of hallucinations, as well as associated distress. Moreover, the 
presence of psychotic symptoms is likely to feed back into and confirm pre-existing 
schematic beliefs about self, thus creating a vicious cycle (Smith et al., 2006). 
 
4.1.2.4 Summary  
 
Research into the role of emotion and psychological processes in psychosis suggests 
that anxiety, depression, and evaluative beliefs about self and others have important and 
potentially differential roles in positive symptom formation and maintenance. Whilst the 
content of both delusions and hallucinations may often be a direct representation of the 
emotional state of the individual, the role for emotion and schematic beliefs in the initial 
development of psychotic symptoms is perhaps most clear for delusions, particularly 
those of a paranoid and persecutory nature. Indeed, negative beliefs about self and 
others have been shown to be important predictors of persecutory beliefs (Smith et al., 
2006). This is in contrast to hallucinations, where emotion and psychological processes 
are thought to be more of a maintenance (as opposed to causal) factor. However, anxiety 
appears to be a core component in the development of all psychotic symptoms (Tien & 
Eaton, 1992), both influencing delusion formation and providing a trigger for 
mechanisms underlying hallucinatory experiences. 
 
4.1.3 Aims of the Study 
 
The introduction to this chapter has emphasised the importance of emotion and 
schematic beliefs about self and others in both influencing the development and shaping 
the content of psychotic symptoms. The aim of the current study is to examine 
differential associations between dimensions of positive schizotypal symptoms and 
emotional and psychological variables in a non-clinical population. Although previous 
studies have examined these associations in analogue populations (e.g. Freeman, Garety 
et al., 2005; Gracie et al., 2007), the current study has a specific focus on current low-
level psychotic symptoms rather than more generic predispositions to psychosis. It will 
also examine differential associations between different symptom types simultaneously, 
rather than focusing on one symptom type in isolation. 
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4.2 RESEARCH HYPOTHESES 
 
1. Social anxiety schizotypal symptoms will be associated with a lack of 
positive beliefs about self (i.e. low self-esteem), anxiety, and interpersonal 
sensitivity. 
 
2. Paranoid schizotypal symptoms will be associated with negative beliefs 
about self and others, anxiety, and interpersonal sensitivity. 
 
3. Anomalous schizotypal symptoms will be associated with anxiety but not 
schematic beliefs about self and others, or interpersonal sensitivity. 
 
4.3 METHODOLOGY 
 
The methodology for this study was the same as that outlined for the non-clinical 
sample in Study 1 (section 2.4). The same participants and procedures were used.  
 
4.3.1 Design 
 
A non-clinical sample of university students were surveyed in a cross-sectional design. 
All participants completed the Schizotypal Symptoms Inventory (SSI) and other 
measures via an internet survey, as described in Study 1 (section 2.4). A within-subjects 
correlational design was used to investigate the hypothesised relationships between 
schizotypal symptoms, emotion, and schema variables.  
 
4.3.2 Participants 
 
The same group of 808 non-clinical participants who were described in Study 1 (section 
2.4.2.1) also took part in this study. The sample will not therefore be described again 
here.  
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4.3.2.1 Sample size and power analysis 
 
 Correlations. In order to examine the relationship between emotion, schema, 
and scores on the SSI, a power analysis calculation revealed that to achieve 90% power 
with a significance level of .05 and an estimated small to moderate critical effect size of 
.40, a minimum sample size of 62 participants was required (Cohen, 1988). Therefore 
the study was adequately powered.  
 
 Multiple regression. In order to examine whether emotion and schema 
predict SSI scores, a multiple regression analysis with seven predictors was conducted 
for each dimension of the SSI. A power analysis calculation revealed that to achieve 
90% power with a significance level of .05, and an estimated small to moderate critical 
effect size of .15, a minimum sample size of 129 participants was required (Cohen, 
Cohen, West, & Aiken, 2003). Therefore the study was adequately powered. 
 
4.3.3 Measures 
 
4.3.3.1 Schizotypal Symptoms Inventory (SSI)  
 
The SSI was completed to provide an index of current low-level psychotic 
symptomatology. The SSI has been described in previous chapters of this thesis and as 
such will not be repeated here. In this study, the brief version of the SSI was used. Total 
and subscale scores (i.e. Social Anxiety, Paranoia, Anomalous Experiences) were used 
in analyses.  
 
4.3.3.2 Depression Anxiety Stress Scales (DASS; Lovibond & Lovibond, 1995) 
 
The depression and anxiety scales of the DASS were used to assess current (i.e. past 
week) levels of emotional distress in the sample. The depression and anxiety scales of 
the DASS each consist of 14 items rated on a 4-point Likert scale from 0 (did not apply 
to me at all) to 3 (applied to me very much). Scores on the two scales therefore range 
from 0 to 42, with higher scores indicating higher levels of emotional distress. Lovibond 
and Lovibond (1995) report results of a comparison of the DASS with the Beck Anxiety 
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Inventory (BAI; Beck & Steer, 1987) and the Beck Depression Inventory (BDI; Beck, 
Ward, Mendelson, Mock, & Erbaugh, 1961) in a non-clinical sample (N = 717). The 
DASS anxiety scale correlated at .81 with the BAI; and the DASS depression scale 
correlated at .74 with the BDI. The authors report Cronbach’s alpha internal consistency 
coefficients of .91 and .81 for the DASS depression and anxiety scales respectively. A 
principal components analysis showed a good distinction between the depression and 
anxiety factors of the DASS. The scale has also recently been shown to be reliable and 
valid in a large UK non-clinical population (Crawford & Henry, 2003). The depression 
and anxiety scales of the DASS were chosen for use in the internet survey instead of the 
BDI and BAI as they are more appropriate for use in non-clinical populations than the 
latter, which are more clinical in nature. Furthermore, unlike the BDI and BAI, the 
DASS scales are not bound by copyright and are thus freely available for use in online 
research. 
 
4.3.3.3 Brief Core Schema Scales (BCSS; Fowler, Freeman, Smith et al., 2006)  
 
The BCSS consists of 24 items concerning beliefs about the self and others that are 
assessed on a 5-point rating scale (0-4). The scale was designed to create a quick and 
easy-to-use assessment of the type of extreme positive and negative evaluations of self 
and others that have been observed clinically to be typical of people with psychosis. 
Four scores are obtained: negative self (6 items, e.g. “I am bad”), positive self (6 items, 
e.g. “I am talented”), negative others (6 items, e.g. “Other people are hostile”) and 
positive others (6 items, e.g. “Other people are accepting”). Individuals are initially 
asked to indicate in a dichotomous format whether they hold each belief. If they answer 
“Yes” to holding the belief, they are then asked to indicate their degree of belief 
conviction by choosing a number from 1 (believe it slightly) to 4 (believe it totally).  
 
The BCSS has been shown to have good psychometric properties. A Principal 
Components Analysis of the items suggested an underlying dimensional structure 
reflecting independence between the different dimensions of self and other evaluation. 
Furthermore, Fowler, Freeman, Smith et al. (2006) report good internal consistency, 
with Cronbach’s alpha internal consistency coefficients for the subscales ranging from 
.78 to .88. Moderate to strong associations were shown between the BCSS and the 
Rosenberg self-esteem questionnaire (Rosenberg, 1965). The BCSS was chosen for use 
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in this study as schema is argued to be important in the development of psychotic 
symptoms. For example, viewing the self as vulnerable and other people as bad may 
result in a tendency towards paranoid thinking and potential delusion formation. The 
BCSS was specifically designed for use in psychosis and differs from other measures of 
schema which tend to be more reflective of self-esteem, e.g. the Young Schema 
Questionnaire (Young, 1998). 
 
4.3.3.4 Interpersonal Sensitivity Measure (IPSM; Boyce & Parker, 1989) 
 
The IPSM is a 36-item self-report measure assessing excessive sensitivity to the 
interpersonal behaviour of others, to social feedback and to perceived or actual negative 
evaluation by others. The 36 items are completed on a 4-point Likert scale ranging from 
1 (very unlike me) to 4 (very like me). The measure provides a total score and five 
subscale scores: Interpersonal Awareness (8 items), Need for Approval (8 items), 
Separation Anxiety (8 items), Timidity (8 items), and Fragile Inner Self (5 items). The 
IPSM has good psychometric properties, as reported by the authors (Boyce & Parker, 
1989). Correlations between the five factors were shown to be low indicating their 
relative independence. Cronbach’s alpha internal consistency coefficients in a non-
clinical population are reported as .86 for the total scale and .55 to .76 for the individual 
subscales. Six-week test-retest reliability was reported as .70 for the total scale and .55 
to .70 for the subscales.  
 
The IPSM was selected for use in this study as the scale has been implicated in the 
assessment of the underlying mechanisms of social anxiety (Harb, Heimberg, Fresco, 
Schneier, & Liebowitz, 2002), and has also been liked with paranoia (Freeman, Dunn et 
al., 2005). Therefore, interpersonal sensitivity may also be involved in the development 
of schizotypal symptoms. This will be investigated in the current study. For the purpose 
of the current study, total IPSM scores were used in the analyses. 
 
4.3.4 Procedure 
 
The same procedure as outlined in Study 1 (section 2.4.5.1) was adopted for this study 
and as such will not be repeated here. The non-clinical sample completed the measures 
via an internet survey.  
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4.3.5 Data Analysis Plan 
 
Initial screening and cleaning of the data has been described in Study 1 (section 2.4.6.1) 
and will not be repeated here. All data was analysed using SPSS for Windows, version 
14 (SPSS, 2005). 
 
In the first stage of the analysis, descriptive statistics were calculated for all variables. 
Bivariate correlations were conducted to investigate relationships between schizotypy 
and emotional and psychological variables. Simultaneous linear multiple regression 
analyses were then conducted to further determine which variables best predicted 
different types of schizotypy. Separate regression analyses were conducted for each 
subscale of the SSI. Schizotypy scores served as the dependent variable. Anxiety, 
depression, BCSS subscales, and IPSM scores served as the independent variables. 
 
4.4 RESULTS 
 
4.4.1 Descriptive Data  
 
Table 4.1 provides descriptive data on all variables for the whole sample. As can be 
seen from the descriptive statistics, data on most variables are positively skewed. This 
could not be corrected by transforming the data. Therefore, Spearman’s Rho (i.e. non-
parametric) correlations were conducted to investigate associations between variables. 
Standard multiple regression techniques were used despite the skewness of the data. 
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Table 4.1  
Descriptive Statistics for all Study Variables  
 
 N Min-Max Mean  
(SD) 
Skewness 
(SE) 
 
Schizotypal Symptoms 
- Social Anxiety 
- Paranoia 
- Anomalous Experiences 
- Total 
 
 
808 
808 
808 
808 
 
 
0-24 
0-21 
0-23 
0-53 
 
 
4.41 (5.14) 
2.85 (3.63) 
2.28 (3.43) 
9.54 (9.22) 
 
 
1.46 (0.09) 
1.88 (0.09) 
2.45 (0.09) 
1.46 (0.09) 
 
DASS  
- Depression 
- Anxiety 
 
 
779 
779 
 
 
0-42 
0-37 
 
 
10.07 (10.12) 
5.94 (6.55) 
 
 
1.39 (0.09) 
1.74 (0.09) 
 
Brief Core Schema Scales 
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
 
 
769 
769 
769 
769 
 
 
0-24 
1-24 
0-24 
3-24 
 
 
4.29 (4.31) 
13.02 (4.84) 
4.89 (4.18) 
12.48 (3.83) 
 
 
1.51 (0.09) 
-0.19 (0.09) 
1.04 (0.09) 
-0.06 (0.09) 
 
Interpersonal Sensitivity 
 
753 
 
53-144 
 
93.85 (15.49) 
 
0.06 (0.09) 
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4.4.2 Relationships between Schizotypal Symptoms and Emotional and 
Psychological Variables 
 
4.4.2.1 Bivariate correlations 
 
Spearman’s Rho correlations between schizotypy scores and emotional and 
psychological variables are shown in Table 4.2. With reference to Cohen (1988), in both 
groups, associations between schizotypy and emotional and psychological variables 
appear to be stronger for social anxiety and paranoid schizotypal symptoms than for 
anomalous experiences. This is supported using analyses cited by Meng, Rosenthal, and 
Rubin (1992) to compare correlated correlations. The association between anxiety and 
schizotypal symptoms was shown to be significantly smaller for anomalous experiences 
than that for social anxiety (Z = 4.07, p <.001) or paranoid schizotypal symptoms (Z = 
3.45, p <.001). The latter two symptom types did not however differ in terms of the 
strength of their relationship with anxiety (Z = 0.91, p = .18). Similarly, the association 
between depression and schizotypal symptoms was shown to be significantly smaller 
for anomalous experiences than for social anxiety (Z = 3.68, p <.001) or paranoid 
schizotypal symptoms (Z = 3.88, p <.001). However, the strength of association 
between social anxiety and depression and paranoia and depression was the same. For 
interpersonal sensitivity, the relationship with schizotypy was significantly stronger for 
social anxiety when compared with both paranoia (Z = 3.64, p <.001) and anomalous 
experiences (Z = 8.41, p <.001). For negative other schema, the relationship with 
schizotypy was significantly stronger for paranoia when compared with both social 
anxiety (Z = 2.52, p = 0.01) and anomalous experiences (Z = 5.74, p <.001). The 
relationship between negative self schema and schizotypy was comparable for social 
anxiety and paranoia, but significantly smaller for anomalous experiences (Z = 6.10, p 
<.001; Z = 6.44, p <.001). 
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Table 4.2  
Correlations between Schizotypal Symptoms and Anxiety, Depression, Schema, and 
Interpersonal Sensitivity 
 
 
*p <.05, **p <.01, ***p <.001 
 Social Anxiety 
Schizotypy 
Paranoid 
Schizotypy 
Anomalous 
Schizotypy 
Total Brief 
Schizotypy 
 
Anxiety (N = 779) 
 
.46*** 
 
.43*** 
 
.30*** 
 
.54*** 
 
Depression (N = 779) 
 
.39*** 
 
.39*** 
 
.24*** 
 
.46*** 
 
Schema (N = 769) 
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
 
 
.44*** 
-.37*** 
.27*** 
-.27*** 
 
 
.44*** 
-.25*** 
.36*** 
-.31*** 
 
 
.19*** 
-.06 
.13*** 
-.13** 
 
 
.49*** 
-.33*** 
.34*** 
-.32*** 
 
Interpersonal Sensitivity 
(N = 753) 
 
.52*** 
 
.40*** 
 
.18*** 
 
.52** 
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4.4.2.2 Regression analyses 
 
In order to further investigate the associations between schizotypal symptoms and 
emotional and psychological variables, simultaneous multiple regression analyses were 
conducted. 
 
Social Anxiety schizotypal symptoms. A simultaneous multiple regression 
was undertaken with the Social Anxiety subscale of the Brief SSI as the dependent 
variable, and depression, anxiety, schema (BCSS), and interpersonal sensitivity as the 
explanatory variables. The results are shown in Table 4.3. 
 
Table 4.3  
Summary of Simultaneous Regression Analysis for Variables Predicting Social Anxiety 
Schizotypal Symptoms (N = 746) 
 
 
 
 
 
 
Note. R2 =.34 , p <.001 (unique variability = .09, shared variability = .25); Adjusted R2 = .33 
*p <.05, **p <.01, ***p <.001, †p <.10 
 
Interpersonal sensitivity was the best predictor of scores on the Social Anxiety subscale 
of the SSI, followed by anxiety and positive self schema. There was a trend for negative 
self schema as a predictor of Social Anxiety. Depression and the other BCSS scales 
contributed no unique variance to Social Anxiety scores, and apparent bivariate 
Variable B SE B β sr2 (unique) 
 
Constant 
 
-4.31 
 
1.36 
 
 
 
 
Anxiety 0.16 0.03 .20*** .02 
Depression -0.01 0.02 -.01 .00004 
Negative Self Schema 0.11 0.06 .09† .003 
Positive Self Schema -0.14 0.04 -.13** .01 
Negative Other Schema 0.04 0.04 .03 .0007 
Positive Other Schema -0.02 0.05 -.01 .0001 
Interpersonal Sensitivity 0.10 0.01 .30*** .06 
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associations between these variables and Social Anxiety scores were made redundant or 
mediated by other variables. 
 
Paranoid schizotypal symptoms. A simultaneous multiple regression was 
undertaken with the Paranoia subscale of the Brief SSI as the dependent variable, and 
depression, anxiety, schema (BCSS), and interpersonal sensitivity as the explanatory 
variables. The results are shown in Table 4.4. 
 
Table 4.4  
Summary of Simultaneous Regression Analysis for Variables Predicting Paranoid 
Schizotypal Symptoms (N = 746) 
 
 
 
 
 
 
 
Note. R2 = .36, p <.001 (unique variability = .07, shared variability =.29); Adjusted R2 = .35 
*p <.05, **p <.01, ***p <.001, †p <.10 
 
Negative other schema was the best predictor of scores on the Paranoia subscale of the 
SSI, followed by negative self schema, anxiety, interpersonal sensitivity, and positive 
other schema. Depression and positive self schema contributed no unique variance to 
Paranoia scores, and apparent bivariate associations between these variables and 
Paranoia scores were made redundant or mediated by other variables. 
 
Variable B SE B β sr2 (unique) 
 
Constant 
 
-1.74 
 
0.93 
 
 
 
 
Anxiety 0.08 0.02 .15*** .01 
Depression 0.02 0.02 .07 .002 
Negative Self Schema 0.15 0.04 .17*** .01 
Positive Self Schema 0.02 0.03 .03 .0004 
Negative Other Schema 0.18 0.03 .21*** .03 
Positive Other Schema -0.08 0.03 -.08* .005 
Interpersonal Sensitivity 0.03 0.01 .14*** .01 
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Anomalous Experiences. A simultaneous multiple regression was undertaken 
with the Anomalous Experiences subscale of the Brief SSI as the dependent variable, 
and depression, anxiety, schema (BCSS), and interpersonal sensitivity as the 
explanatory variables. The results are shown in Table 4.5. 
 
Table 4.5  
Summary of Simultaneous Regression Analysis for Variables Predicting Anomalous 
Experiences (N = 746) 
 
 
 
 
 
 
 
Note. R2 = .13, p <.001 (unique variability = .06, shared variability = .07); Adjusted R2 = .12 
*p <.05, **p <.01, ***p <.001, †p <.10 
 
Anxiety was the only predictor of scores on the Anomalous Experiences subscale of the 
SSI. Depression, the BCSS scales, and interpersonal sensitivity, contributed no unique 
variance to Anomalous Experiences scores and apparent bivariate associations between 
these variables and Anomalous Experiences were made redundant or mediated by other 
variables. 
Variable B SE B β sr2 (unique) 
 
Constant 
 
-0.31 
 
1.00 
  
Anxiety 0.15 0.02 .30*** .05 
Depression 0.03 0.02 .09 .003 
Negative Self Schema -0.01 0.05 -.01 .00004 
Positive Self Schema 0.05 0.03 .07 .002 
Negative Other Schema 0.03 0.03 .04 .001 
Positive Other Schema 0.01 0.04 .02 .0002 
Interpersonal Sensitivity 0.01 0.01 .02 .0003 
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4.5 DISCUSSION 
 
This chapter has examined the differential associations between schizotypal symptom 
types and emotional and psychological variables in a non-clinical sample. This section 
will review the findings of the current study. The results will initially be considered in 
relation to each of the research hypotheses outlined at the beginning of this chapter. 
They will then be discussed in relation to the current literature and the clinical 
implications of the findings will be examined. Following on from this, potential 
weaknesses of the study will be outlined, as will possibilities for future research. 
 
4.5.1 Evaluation of the Findings in Relation to Research Hypotheses 
 
It was hypothesised that associations between schizotypal symptoms and levels of 
emotional and psychological disturbance would be stronger for social anxiety and 
paranoia, than for anomalous experiences. This was supported by the data. Using both 
Cohen’s (1988) criteria and Meng et al’s (1992) method of comparing correlated 
correlations, associations between anomalous experiences and emotional and 
psychological variables were found to be significantly smaller than associations 
between emotional and psychological variables and other schizotypal symptom types. 
Regression analyses were then conducted to examine differential predictors of each 
schizotypal symptom type. The results of these analyses will now be discussed. 
 
4.5.1.1 Hypothesis 1 
 
It was hypothesised that social anxiety schizotypal symptoms would be associated with 
reduced positive beliefs about self, interpersonal sensitivity, and anxiety. This 
hypothesis was supported by the data. Scores on the Social Anxiety subscale of the SSI 
were found to be predicted by increased interpersonal sensitivity, increased anxiety, and 
decreased positive beliefs about self (which could also be considered as low self-
esteem). There was also a trend suggesting increased negative beliefs about self as a 
predictor of Social Anxiety scores. Thus, it appears that social anxiety is related to the 
way in which an individual feels about themselves, and may also be linked to concerns 
  150
about how others view them. These findings support the underlying mechanisms of 
social anxiety as postulated in the literature. Indeed, previous studies have suggested 
that socially anxious individuals have both reduced self-esteem and a tendency to 
anticipate negative social feedback (Clark & Wells, 1995; De Jong, 2002). 
 
4.5.1.2 Hypothesis 2 
 
It was hypothesised that paranoid schizotypal symptoms would be associated with 
negative beliefs about self and others, interpersonal sensitivity and anxiety. These 
hypotheses were also supported by the data. Scores on the Paranoia subscale of the SSI 
were found to be predicted by increased negative beliefs about others, increased 
negative beliefs about self, increased anxiety, increased interpersonal sensitivity, and 
decreased positive beliefs about others. Thus, it appears that paranoia is related to the 
way an individual feels about themselves, as well as the way in which they perceive 
other people. These findings fit with the notion that paranoid beliefs may develop from 
a combination of beliefs about the self as vulnerable and others as hostile (Fowler, 
Freeman, Smith et al., 2006; Laing, 1961). Anxiety also appears to be an important 
predictor, potentially by increasing arousal and producing a threat response. This 
supports the idea that paranoid beliefs are maintained by the same psychological 
processes that have traditionally been associated with emotional disorders (Freeman, 
2007). Moreover, the finding that interpersonal sensitivity predicts paranoia provides 
support for the hypothesis that paranoid beliefs may build upon common interpersonal 
worries (Freeman, Garety et al., 2005). 
 
4.5.1.3 Hypothesis 3 
 
It was hypothesised that anomalous experiences would be associated with anxiety, but 
not with schematic beliefs about self or others. This hypothesis was supported by the 
data. Indeed, bivariate correlations showed weak associations between scores on the 
Anomalous Experiences subscale of the SSI and emotional and psychological variables, 
apart from anxiety where the relationship was stronger. Moreover, regression analyses 
suggested that the only predictor of anomalous experiences was increased anxiety 
(specifically physiological anxiety as measured by the DASS as opposed to 
interpersonal sensitivity). The regression model including all emotional and 
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psychological variables accounted for only 12% of the variance in Anomalous 
Experiences scores. This is in contrast to models for Social Anxiety and Paranoia which 
accounted for 33% and 35% of the variance respectively. The finding that anxiety was 
the only predictor of anomalous experiences fits with research suggesting that increases 
in anxiety may be involved in the underlying physiology of such phenomena (Morrison, 
1998; Slade, 1976). Furthermore, studies investigating hallucination proneness in the 
general population have found that individuals with higher levels of anxiety display 
stronger predispositions to hallucinatory experience (Ohayon, 2000). 
 
4.5.1.4 Summary of findings 
 
The findings of this study support the notion that psychotic symptoms are the product of 
numerous interacting processes (Freeman & Garety, 2003). In particular, the current 
study has highlighted a role for emotion and psychological variables in the occurrence 
of psychotic-like phenomena. Such variables appear to have a differential influence on 
individual symptom types, being particularly important in the development of social 
anxiety and paranoia. Social anxiety has been shown to be related to the way in which 
an individual feels about themselves, as well as concerns about how other people view 
them. Negative beliefs that others are hostile, combined with negative beliefs about self 
have been implicated as being predictive of paranoia. Conversely, anomalous 
experiences appear to be influenced to a lesser extent by emotion and psychological 
variables. This supports the idea that anomalous experiences may be predominantly 
caused by cognitive dysfunction, rather than being psychologically determined. Despite 
this, anxiety has been shown to be a significant predictor of all schizotypal symptoms, 
including anomalous experiences. 
 
4.5.2 Relevance to the Literature 
 
All of the findings in this study support arguments in the literature, as outlined in the 
introductory section of this chapter. This will now be discussed in more detail. 
 
Anxiety has previously been linked to all types of positive psychotic symptoms (e.g. 
Freeman & Garety, 2003). The finding that anxiety was a significant predictor of scores 
on the Social Anxiety, Paranoia, and Anomalous Experience subscales of the SSI in the 
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current study supports such previous research. Anxiety has been hypothesised to 
increase arousal and hypervigilance, thus in turn leading to the development of both 
social anxiety and paranoid ideation (Freeman & Garety, 2003; Nuechterlein & 
Dawson, 1984). Similarly, anxiety has been implicated as a trigger for the underlying 
physiology of hallucinatory experiences (Frith, 1992; J. A. Gray et al., 1991; Morrison, 
2001). The same mechanisms may explain why anxiety was found to significantly 
predict schizotypal symptoms in this study. In addition to anxiety, interpersonal 
sensitivity was also shown to be predictive of social anxiety and paranoia. Interpersonal 
sensitivity is a specific type of anxiety related to social interaction and the way in which 
we perceive others to evaluate our behaviour (Boyce & Parker, 1989). The finding that 
this construct predicts paranoia replicates findings from previous research and supports 
the idea that paranoid beliefs may stem from common interpersonal worries (Freeman, 
Dunn et al., 2005; Gilbert, Boxall, Cheung, & Irons, 2005). 
 
Depression was not found to be a significant predictor of any type of schizotypal 
symptom in the current study. However, bivariate correlations did show an association 
between depression and all types of schizotypal symptoms. Therefore, rather than being 
involved in the development of psychotic symptoms, depressed mood may be an 
emotional response to the occurrence of psychosis and psychotic-like experiences. This 
is an idea that has been put forward in the literature (e.g. Birchwood, Iqbal et al., 2000). 
Alternatively, it may be the case that it is specific negative evaluative beliefs associated 
with depression, as opposed to low mood per se, which are important in the 
development of psychotic symptoms (Barrowclough et al., 2003). This would explain 
why in the regression analyses, depression was not associated with schizotypal 
symptoms when controlling for negative schematic beliefs. Negative schematic beliefs 
about self and others and not depression were found to be predictive of social anxiety 
and paranoia, but not anomalous experiences. 
 
A distinction should be made between extreme negative evaluative beliefs about self 
and low self-esteem, which is perhaps more clearly defined as a lack of positive beliefs 
about self (Fowler, Freeman, Smith et al., 2006). Low self-esteem has previously been 
implicated in the development of paranoia, with the suggestion that the function of 
paranoid thoughts is to prevent negative thoughts and feelings about the self from 
reaching consciousness (Bentall et al., 2001; Bentall et al., 1994). However, results 
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from the current study do not support this hypothesis. Although global self-esteem was 
not assessed in the current study, the positive self subscale of the BCSS (e.g. “I am 
successful”) has been shown to be highly correlated with measures of self-esteem 
(Fowler, Freeman, Smith et al., 2006). Increased paranoia was associated with reduced 
scores on this dimension of the BCSS, suggesting that self-esteem is decreased in 
paranoid individuals. This would not be expected if paranoia served as an effective 
defence. The findings therefore suggest that low self-esteem may arise as a result of 
normal emotional processes. Moreover, it was specifically extreme negative beliefs 
about self and others that were found to predict Paranoia scores, rather than a lack of 
positive self beliefs. Low self-esteem (i.e. reduced positive beliefs about self) was 
however found to be predictive of increased Social Anxiety scores, which may be a 
precursor to paranoia.  
 
4.5.3 Clinical Implications of Findings 
 
In line with the continuum hypothesis of psychosis, investigating relationships between 
emotional dysfunction and schizotypal symptoms in a non-clinical population enables 
the potential underlying mechanisms of positive psychotic symptoms to be investigated, 
without the confounding effects of the psychotic disease process (Raine, Lencz, & 
Mednick, 1995). Moreover, the finding that relationships between schizotypal 
symptoms and emotional and psychological disturbance mirror those occurring for 
psychotic symptoms in clinical samples (Fowler, Freeman, Smith et al., 2006; Freeman 
& Garety, 2003) can be taken as further support for the continuum hypothesis (Claridge, 
1997b). 
 
The findings of the current study combined with those of previous research suggest that 
there is a need for therapeutic approaches for psychosis to focus on the role of emotion. 
Assessing and targeting emotional disturbance in the early stages of psychosis may 
lessen the severity, or even prevent the onset of a psychotic episode (Morrison et al., 
2002). Furthermore, as previously outlined in the literature, the content of psychotic 
symptoms may highlight the emotional status of the individual (Freeman & Garety, 
2003). Thus, by reducing emotional distress, psychotic symptoms may also be reduced. 
Understanding emotional and psychological factors that may have led to the 
development of psychotic symptoms may also help to inform formulation and enhance 
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understanding of the potential processes maintaining such beliefs and experiences. 
Moreover, techniques modified from treatments for emotional disorders (e.g. Clark & 
Fairburn, 1997) may be useful in the treatment of psychosis (Freeman & Garety, 2003). 
Emotional disturbance should therefore be assessed and treated in its own right, rather 
than being assumed to be an epiphenomenon of psychotic symptoms. 
 
It must also be remembered that emotional disturbance may be a response to psychotic 
symptoms as well as a precursor (Birchwood, 2003; Morrison et al., 2003; Tarrier, 
Khan, Cater, & Picken, 2007). As such, emotional and psychological factors are likely 
to have a profound impact on the recovery of individuals who have experienced a 
psychotic episode. Indeed, even when symptoms have remitted, emotional disturbance 
has been shown to remain (Birchwood, Iqbal et al., 2000; Chadwick, 1997; Voges & 
Addington, 2005). It is important that this is not ignored as it may have implications for 
psychotic relapse, i.e. by providing a trigger for symptom recurrence (Subotnik & 
Nuechterlein, 1988; Tarrier, Barrowclough, & Bamrah, 1991); and also for long-term 
functional recovery (Birchwood et al., 2006; Pallanti et al., 2004).  
 
4.5.4 Weaknesses of the Current Study 
 
The current study is cross-sectional and thus it is difficult to know whether the 
emotional and psychological distress reported is involved in the development of 
schizotypal symptoms, or whether it occurs as a response to the symptoms themselves. 
It is likely that both of these hypotheses are correct and that the relationship between 
emotion and psychosis is reciprocal (Freeman & Garety, 2003). However, although the 
findings have highlighted a relationship between emotion, psychological variables and 
schizotypy, the direction of this relationship and the mechanism by which it occurs can 
at present only be postulated. There is also an issue concerning multicollinearity 
amongst measures used in this study, in that scores on most measures were inter-
correlated. This is a common feature of psychological research (Miles & Shevlin, 2001). 
However, clear hypotheses were put forward as to the proposed direction of 
relationships between variables, before any analyses were conducted. This is not to say 
that other models would not fit the data equally well, or indeed better, and this needs to 
be considered when interpreting the findings.  
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The sample used in this study was recruited from a student population using 
opportunistic sampling methods. Thus, it is questionable as to whether the group is 
representative of the wider population. Moreover, it is unknown if any of the sample 
have experienced, or are currently experiencing, a psychotic episode or any other mental 
health problem. The same problems of using internet-based survey methodology, as 
outlined in previous chapters (section 2.6.4), also apply here. This research has been 
conducted using an analogue population under the assumptions of the continuum 
hypothesis of psychosis. These assumptions suggest that the same mechanisms which 
underlie psychotic symptoms are also likely to be operating in schizotypal symptoms. 
This may however not be the case and as such the applicability of the findings to a 
clinical population remains to be determined. Nevertheless, this same criticism could be 
argued to apply to all psychosis research conducted on non-clinical samples. Moreover, 
the findings of the current study replicate those from similar studies conducted using 
clinical samples and fit with current theory (e.g. Fowler, Freeman, Smith et al., 2006). 
 
Despite some methodological weaknesses, the findings of the current study provide an 
estimate of the type of relationships which may occur between psychotic-like symptoms 
and emotional and psychological variables. These can be used to shape the hypotheses 
and design of future studies investigating these relationships in clinical populations and 
using longitudinal data. The current study is also very large in comparison to others in 
this field, which is a clear strength. Moreover, although potentially not representative, 
participants were matched in age to a first-episode psychosis population, thus aiding the 
applicability of findings to a clinical group. 
 
4.5.5 Summary 
 
In conclusion, this study has replicated findings of previous research arguing for a role 
for emotion and schema in the development of psychotic symptoms. However, the 
emotional route to psychosis may be more defined for social anxiety and paranoia as 
opposed to anomalous experiences. Moreover, there may be differential associations 
between individual symptoms and emotional and psychological variables. It must also 
be remembered that emotional and psychological disturbance may be a reaction to 
psychotic-like experiences, as well as being involved in their development. With this in 
mind it is likely that emotional and psychological factors will influence recovery from 
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psychosis. This will be investigated in more detail in a later chapter of this thesis. One 
way of further investigating the role of emotion and evaluative self and other beliefs in 
the formation and maintenance of psychotic symptoms, is to examine the way in which 
traumatic experiences influence the presence of psychotic-like phenomena. This will be 
the focus of the next chapter.  
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CHAPTER FIVE: 
STUDY FOUR: RELATIONSHIPS BETWEEN SCHIZOTYPAL SYMPTOMS 
AND TRAUMA EXPOSURE IN A NON-CLINICAL SAMPLE 
 
 
5.1 RATIONALE AND CONTEXT OF THE STUDY 
 
5.1.1 Overview 
 
The previous chapter in this thesis examined differential associations between 
schizotypal symptoms and emotion and schema variables. Paranoia and social anxiety 
were found to be most strongly associated with these variables, whereas anomalous 
experiences were predicted solely by anxiety. A further way of investigating the role of 
emotion and evaluative self and other beliefs in psychosis is to examine the way in 
which trauma exposure influences the presence of psychotic-like phenomena. This 
chapter first reviews the literature regarding associations between psychotic symptoms 
and trauma history, before investigating the impact of traumatic life events on 
schizotypal symptoms in a non-clinical sample.  
 
5.1.2 Trauma and Psychosis 
 
A history of trauma and victimisation has been shown to be relatively common in 
individuals with psychosis (e.g. Carmen, Rieker, & Mills, 1984; Goff, Brotman, 
Kindlon, Waites, & Amico, 1991; Masters, 1995). However, the link between psychosis 
and trauma is somewhat controversial, with reported rates of trauma being dependent on 
the assessment tools used and the criteria applied (Mueser, Rosenberg, Goodman, & 
Trumbetta, 2002). Despite this, most findings suggest that rates of trauma may be 
elevated in populations with severe mental illness (Goodman, Rosenberg, Mueser, & 
Drake, 1997). Similarly, rates of post-traumatic stress disorder (PTSD) also appear to be 
high in this group, suggesting either the presence of more severe trauma or an increased 
sensitivity to trauma (i.e. a heightened response) in individuals with psychosis (Mueser 
et al., 1998). In addition to retrospective studies with individuals diagnosed with 
psychosis, prospective studies have shown that individuals with a history of trauma are 
at increased risk of developing psychosis at a later date (Janssen et al., 2004; Spataro, 
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Mullen, Burgess, Wells, & Moss, 2004; Spauwen et al., 2006). Furthermore, 
investigations with non-clinical samples suggest increased psychosis proneness in 
individuals who have been exposed to a traumatic event (Gracie et al., 2007; Read, 
Goodman, Morrison, Ross, & Aderhold, 2004). Psychotic-like symptoms have also 
been shown to be prevalent in individuals diagnosed with PTSD, further suggesting a 
link between trauma and psychosis (R. W. Butler, Mueser, Sprock, & Braff, 1996). 
 
Psychosis occurring in the context of a trauma history has been shown to be 
characterised by more severe psychotic symptoms, particularly in relation to 
hallucinations, and a worse outcome across a variety of domains (Carmen et al., 1984; 
Greenfield, Strakowski, Tohen, Batson, & Kolbrener, 1994; Mueser, Rosenberg et al., 
2002; Ross, Anderson, & Clark, 1994). Moreover, trauma has been linked to psychosis 
in a dose-response way, with more severe traumas being associated with more severe 
symptom presentations (Read, van Os, Morrison, & Ross, 2005; Schenkel, Spaulding, 
DiLillo, & Silverstein, 2005). In particular, specific links have been made between 
interpersonal traumas, such as child sex abuse (CSA) and victimisation, and the positive 
symptoms of psychosis, rather than other types of trauma such as road traffic accidents 
(Hammersley et al., 2003; Read, Agar, Argyle, & Aderhold, 2003; Ross et al., 1994). 
Indeed, a study by Bebbington et al. (2004) suggested that individuals with psychosis 
were 15.5 times more likely to have suffered sexual abuse than individuals without any 
mental disorder.  
 
Explanations of the association between trauma and psychosis are numerous but can be 
broadly split into two categories: those suggesting a direct link between trauma and 
psychosis, and those suggesting an indirect link between trauma and psychosis (Fowler, 
Freeman, Smith et al., 2006; Morrison et al., 2003). These will now be discussed. 
 
5.1.2.1 Direct route from trauma to psychosis 
 
Direct approaches argue that psychosis and PTSD may share similar developmental 
processes, with the traumatic event acting as a trigger for the onset of psychosis. This 
view fits with traditional theories such as the stress-vulnerability model, suggesting that 
trauma may result in an augmentation in arousal, which in turn influences symptom 
formation (Zubin & Spring, 1977). In addition, it has been argued that exposure to 
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interpersonal trauma in childhood may result in over-reactivity and dysregulation of the 
hypothalamic-pituitary-adrenal (HPA) axis, thus increasing stress sensitivity and 
vulnerability to psychotic symptoms (Read, Perry, Moskowitz, & Connolly, 2001). 
Although this may be true to a certain extent, it is likely that traumatisation is linked 
with the emergence of psychotic symptoms in a more specific way. Indeed, most 
symptoms of psychosis have a content that can be meaningfully related to past and 
personally significant experiences (Fowler, Garety, & Kuipers, 1998). It is thought that 
an alternative direct link between traumatic experience and psychotic symptoms may 
relate to the notion of re-experiencing; where the content of hallucinations and delusions 
reflect the events of the traumatic experience itself. For example, in the case of CSA, 
auditory hallucinations may manifest as the voice of the abuser (Read & Argyle, 1999). 
Where this occurs, these phenomena are appraised as relating to a current threat, as 
opposed to rumination about a past experience, and thus an emotional response is 
generated. This is similar to processes thought to occur in PTSD (Brewin & Holmes, 
2003; Ehlers & Clark, 2000). Moreover, Fowler and colleagues suggest that the re-
experiencing-type symptoms of psychosis may be influenced by problems in the 
contextual processing of trauma memories (Fowler, Freeman, Steel et al., 2006; Steel, 
Fowler, & Holmes, 2005). This anomaly in processing results in memories of the event 
being stored in a manner which leaves them vulnerable to being triggered involuntarily, 
and thus experienced as intrusions into awareness. In line with this view, experimental 
studies using analogue and clinical populations suggest that vulnerability to psychosis 
(i.e. high trait schizotypy) may be associated with an information processing style 
similar to that outlined above (i.e. a weakened ability to integrate information within a 
temporal and spatial context) and thus may also act as a vulnerability factor in the 
development of intrusions following exposure to a traumatic event (Holmes & Steel, 
2004; Marzillier & Steel, 2007; Steel, Mahmood, & Holmes, 2008). 
 
5.1.2.2 Indirect route from trauma to psychosis 
 
Although the re-experiencing route may account for psychotic phenomena in a 
substantive minority of cases, many other cases exist where there is no obvious link 
between the traumatic life event and the psychotic symptomatology that is reported. 
This is reflected in a study by Hardy et al. (2005) where a direct link between 
hallucination content and past trauma was shown in only 13% of cases, with 42% of 
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cases showing no association at all. In cases without a direct link it is hypothesised that 
traumatic events may influence the development of psychosis in a more indirect and 
idiosyncratic way, by inducing emotional disturbance and synthesising negative beliefs 
about self and others (Fowler, Freeman, Steel et al., 2006; Morrison et al., 2003). 
Indeed, trauma exposure is associated with a wide variety of undesirable outcomes and 
can have severe implications upon how an individual views themselves and the external 
world. Previous studies in non-psychotic populations have found an association between 
a history of interpersonal trauma (i.e. bullying, assault, sexual abuse) and negative 
changes in evaluative beliefs about self and others (Foa, Ehlers, Clark, Tolin, & Orsillo, 
1999). Moreover, trauma history in non-psychotic individuals has been shown to be 
related to increased emotional disturbance (Mueser, Rosenberg et al., 2002) and 
increased interpersonal sensitivity (Figueroa, Silk, Huth, & Lohr, 1997). As outlined 
above, emotion and schematic beliefs about self and others are important in the 
interpretation of initial anomalous experiences occurring in the early stages of psychosis 
(Garety et al., 2001). Thus it seems likely that these same processes will influence 
psychotic symptoms occurring in the context of trauma history, where emotional 
disturbance is likely to be increased. In line with this view, a cognitive model of 
paranoia suggests that persecutory delusions are threat beliefs, potentially emerging in 
response to the experience of interpersonal stress and trauma (Freeman et al., 2002). In 
this model, trauma is hypothesised to give rise to threatening appraisals of others (i.e. 
that others are dangerous and untrustworthy), increasing the likelihood of paranoid 
interpretations of ambiguous situations or stimuli. Depression, anxiety, and low self-
esteem arising as a result of trauma exposure may also influence the content of 
psychotic symptoms and associated distress, as outlined in the previous chapter (e.g. 
Freeman & Garety, 2003). 
 
5.1.2.3 Summary 
 
It is more than likely that both direct and indirect routes linking trauma and psychosis 
account for the development of psychotic symptoms. However, it may be that they each 
offer differential explanations for individual symptom types (Fowler, Freeman, Steel et 
al., 2006). Evidence for a direct link between trauma and psychosis has tended to focus 
on auditory hallucinations, often in the context of CSA (Read et al., 2001). Conversely, 
exposure to interpersonal trauma (i.e. bullying, sexual abuse, physical victimisation) has 
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been hypothesised to influence other types of psychotic symptoms (e.g. paranoia and 
persecutory delusions) by increasing levels of anxiety and depression, and synthesising 
negative schematic beliefs about self and others (Fowler, Freeman, Steel et al., 2006; 
Garety et al., 2001; Morrison et al., 2003). Non-interpersonal trauma is not hypothesised 
to influence the development of psychosis (Mueser et al., 1998). Associations between 
trauma exposure and state schizotypal symptoms will be investigated in the current 
study using a non-clinical sample. 
 
5.1.3 Aims of the Study 
 
The introduction to this chapter has emphasised the importance of trauma exposure on 
the development and maintenance of psychotic symptoms. Exposure to a traumatic life 
event, particularly of an interpersonal nature, may impact upon symptom formation by 
increasing stress sensitivity; inducing hallucinations via a re-experiencing route; and/or 
by increasing emotional disturbance and synthesising extreme negative evaluative 
beliefs about self and others. The aim of the current study is to examine the influence of 
trauma history on the presence of schizotypal symptoms and their association with 
emotion and schema. 
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5.2 RESEARCH HYPOTHESES 
 
1. Interpersonal trauma (i.e. bullying, physical victimisation, and sexual abuse) 
will be associated with increased schizotypal symptoms and emotional 
distress, whereas non-interpersonal trauma (i.e. road traffic accidents, 
witnessing an accident, natural disaster) will not. 
 
2. The pathway between interpersonal trauma and increased schizotypal 
symptoms may be different for different symptom types: 
 
a. Exposure to interpersonal trauma may be specifically and directly 
associated with anomalous experiences (direct route) 
 
b. The relationship between interpersonal trauma and paranoia and social 
anxiety may be mediated by increased negative schematic beliefs about 
self and others (indirect route) 
 
5.3 METHODOLOGY 
 
The methodology for this study was the same as that outlined for the non-clinical 
sample in Studies 1 (section 2.4) and 3 (section 3.3). The same participants and 
procedures were used.  
 
5.3.1 Design 
 
A non-clinical sample of university students were surveyed in a cross-sectional design. 
All participants completed the Schizotypal Symptoms Inventory (SSI), a trauma screen, 
and other measures via an internet survey, as described in Study 1 (section 2.4). A 
between-subjects design was used to investigate group differences between individuals 
who had and had not been exposed to a traumatic event. A within-subjects design was 
used to examine the relationships between trauma exposure, emotion, schema, and 
schizotypal symptoms. 
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5.3.2 Participants 
 
The same group of non-clinical participants who were outlined in Study 1 also took part 
in this study (section 2.4.2.1). Sixty-one participants in the sample did not complete the 
trauma screen and therefore were not included in the current study. The demographic 
characteristics of the 747 participants who completed the trauma screen were not 
significantly different from those who did not (mean age = 23.1 years, SD = 6.7; 64% 
female, 24% male, 12% did not disclose gender). 
 
5.3.2.1 Sample size and power analysis 
 
 Between-groups analysis. In order to compare differences in SSI scores 
between those who had and had not been exposed to a traumatic event, a power analysis 
calculation revealed that to achieve 90% power with a significance level of .05 and an 
estimated moderate critical effect size of .50, a minimum sample size of 85 participants 
per group was required (Cohen, 1988). 
 
 Correlations. In order to examine the relationship between trauma exposure, 
emotion, and scores on the SSI, a power analysis calculation revealed that to achieve 
90% power with a significance level of .05 and an estimated small to moderate critical 
effect size of .40, a minimum sample size of 62 participants was required (Cohen, 
1988). 
 
 Multiple regression. In order to examine whether trauma exposure was a 
predictor of SSI scores (either directly or indirectly), a multiple regression analysis with 
eight predictors was conducted for each dimension of the SSI. A power analysis 
calculation revealed that to achieve 90% power with a significance level of .05, and an 
estimated small to moderate critical effect size of .15, a minimum sample size of 136 
participants was required (Cohen et al., 2003). 
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5.3.3 Measures 
 
5.3.3.1 Schizotypal Symptoms Inventory (SSI) 
 
As in previous chapters, the SSI was completed to provide an index of current low-level 
psychotic symptomatology. The SSI has been described in previous chapters and as 
such will not be repeated here. In this study, the brief version of the SSI was used. Total 
and subscale scores (i.e. Social Anxiety, Paranoia, Anomalous Experiences) were used 
in analyses.  
 
5.3.3.2 Trauma History Screen 
 
Participants were asked to complete a trauma history screen (see Appendix E). This 
consisted of the Trauma History Questionnaire (THQ; B. L. Green, 1996) and eight 
items selected from the Traumatic Life Events Questionnaire (TLEQ; Kubany et al., 
2000). The items enquire about experience of road traffic accidents, bullying, sexual 
abuse (at three different time points), and physical abuse (with and without a weapon). 
An additional general item was also included so that participants could report any other 
types of trauma they had experienced but which had not been specifically asked about 
(e.g. natural disaster, witnessing an accident). Items from the THQ and TLEQ measures 
have been shown to have good validity and reliability and to be suitable for research 
purposes (Norris & Hamblen, 2004). In order to reduce potential distress, specific 
details about traumas were not requested. Instead, participants were asked to state 
whether or not they had experienced the particular trauma being asked about. If a 
particular trauma was endorsed, the participant was asked to give an indication of how 
severe the incident was (i.e. “Did you think you might be killed or seriously injured?”) 
and how they felt about it now (i.e. “Do you still think about it?”; “Does it still affect 
you now?”). This information was used to decide whether the event met DSM-IV-TR 
A1 stressor criteria (American Psychiatric Association, 2000a). Traumas were split into 
interpersonal (bullying, physical victimisation, sexual abuse) and non-interpersonal 
(road traffic accident, witnessing an accident, natural disaster) subtypes. In addition, 
each type of interpersonal trauma was analysed separately.  
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5.3.3.3 Other measures 
 
In order to examine relationships between trauma, emotion, schema, and schizotypal 
symptoms; the depression and anxiety scales of the DASS (Lovibond & Lovibond, 
1995); the Brief Core Schema Scales (BCSS; Fowler, Freeman, Smith et al., 2006); and 
the Interpersonal Sensitivity Measure (IPSM; Boyce & Parker, 1989) were also 
administered. As these measures were described in detail in the previous chapter 
(section 4.3.3), they will not be discussed again here. 
 
5.3.4 Procedure 
 
The same procedure as outlined in Study 1 (section 2.4.5.1) was adopted for this study 
and will not be described again here. The non-clinical sample completed the measures 
via an internet survey. 
 
5.3.5 Data Analysis Plan 
 
All data was analysed using SPSS for Windows, version 14 (SPSS, 2005). Initial 
screening and cleaning of the data has been described in Study 1 (section 2.4.6.1). In the 
first stage of the analysis, descriptive statistics were calculated for all variables. 
Responses to the trauma history screen were also coded as to whether they met DSM-
IV-TR A1 stressor criteria (yes/no). Traumas meeting criteria included events which 
involved actual or threatened death to the self (taken from the probe question asking 
participants if they thought they were going to be killed or seriously injured); witnessing 
death or serious injury of another; and learning of the sudden death of a close friend or 
relative. For traumatic events relating to sexual victimisation, it was also ascertained as 
to whether the event included sexual penetration. In cases with a lack of detail, the 
coding was conservative. The frequency of each trauma was then calculated, as was the 
number of traumas experienced by each individual. 
 
Due to the skewed distributions of the data, independent samples Mann-Whitney U tests 
were conducted to examine differences in schizotypy scores (across different 
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dimensions) between those having experienced different trauma types and those who 
had not. Similar analyses were conducted for anxiety, depression, schema and 
interpersonal sensitivity to examine whether scores on these variables differed between 
individuals who had been exposed to a traumatic event and those who had not.  
 
Following this, hierarchical linear multiple regression analyses were conducted to 
investigate whether trauma exposure predicted schizotypal symptoms. Separate 
regression analyses were conducted for each dimension of schizotypy that was found to 
be increased in groups exposed to trauma. In each case, schizotypy served as the 
dependent variable. In the first stage of the analyses, trauma type served as the only 
independent variable. Where trauma was shown to be a significant predictor of 
schizotypal symptoms, emotion and schema were added as further independent 
variables to see if this affected the predictive value of trauma. If trauma remained a 
significant predictor of schizotypy even when controlling for emotion and schema, it 
was surmised that there was a direct association between trauma and symptoms. If 
however trauma was no longer a significant predictor of schizotypy when controlling 
for emotional and psychological variables, it was surmised that there was an indirect 
association between trauma and symptoms, potentially mediated by changes in 
schematic beliefs and emotional distress. 
 
5.4 RESULTS 
 
5.4.1 Descriptive Data  
 
Descriptive data for emotion and schema variables are shown in Table 4.1 in the 
previous chapter. 
 
Exposure to at least one traumatic event was reported by 616 participants (82.5%). 
However, when applying DSM-IV-TR A1 stressor criteria, 262 participants were found 
to have experienced a severe traumatic event (35.1%). This is lower than some other 
studies have reported (e.g. Gracie et al., 2007; Kubany et al., 2000) but may be a result 
of the strict criteria used. The mean number of severe traumas experienced by the 
sample was 0.58 (SD = 1.01), minimum = 0, maximum = 7. Frequencies of exposure to 
different types of traumatic event are shown in Table 5.1. Increased trauma exposure 
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(i.e. exposure to more traumas) was associated with higher scores on the Anomalous 
Experiences subscale of the SSI, r(747) = .09, p = .02; increased anxiety, r(747) = .08, p 
= .02); and more negative beliefs about self, r(747) = .08, p = .03) and others, r(747) = 
.11, p = .003).  
 
 
Table 5.1  
Frequency of Severe Trauma Exposure (N = 747) 
 
Type of Trauma % Yes 
 
Have you ever been in a serious car accident or serious accident at work, 
or somewhere else? 
 
 
6.2 
Has anyone ever done anything particularly nasty or cruel to you? 
 
10.0 
Did you ever have sexual contact with anyone who was at least five years 
older than you before you reached the age of thirteen? 
 
3.1 
Before you were aged eighteen, did anyone ever use pressure, coercion, or 
non-physical threats to have sexual contact with you? 
 
5.4 
At any other time in your life, has anyone ever used physical force or 
threat of force to make you have some type of unwanted sexual contact 
with them? 
 
5.2 
Has anyone ever attacked you with a gun, knife or some other weapon, 
regardless of whether you ever reported it? 
 
7.0 
Has anyone ever attacked you without a weapon but with the intent to kill 
or seriously harm you? 
 
6.2 
Have you ever experienced (or seen) any other events that were life 
threatening, caused serious injury, or were highly disturbing or 
distressing? 
 
14.9 
Endorsement of at least one traumatic experience 35.1 
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5.4.2 Between-group Differences 
 
Individuals who had experienced a severe traumatic life event and those who had not 
were compared on SSI scores and on measures of anxiety, depression, schematic 
beliefs, and interpersonal sensitivity using Mann-Whitney U tests. The results are 
shown in Table 5.2. Individuals who had been exposed to a severe traumatic event 
scored significantly higher on the Anomalous Experiences subscale of the SSI; and had 
significantly more negative beliefs about others than individuals who had not been 
exposed to a severe traumatic event. There were also trends indicating higher levels of 
anxiety and negative schematic beliefs about self in the group who had been exposed to 
a severe traumatic event. 
 
In order to further investigate which type of trauma was associated with increased 
schizotypy and emotional distress, traumas were grouped into interpersonal (sexual 
abuse, bullying, physical victimisation with and without a weapon) and non-
interpersonal (road traffic accident, natural disaster, witnessing an accident) subtypes. 
Exposure to non-interpersonal trauma was not associated with any increases in 
schizotypal symptoms, emotional distress, or negative schematic beliefs (see Table 5.3). 
Conversely, exposure to interpersonal trauma was associated with higher scores on all 
types of schizotypal symptoms (trend for Anomalous Experiences); increased anxiety, 
depression, and interpersonal sensitivity; and increased negative and decreased positive 
schematic beliefs about self and others (see Table 5.4). 
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Table 5.2  
Differences in Schizotypy, Emotional Distress and Schematic Beliefs between Groups 
who have and have not been Exposed to a Severe Traumatic Event 
 
 
 
Exposed to trauma  
Mean (SD) 
 
Yes (N = 262) No (N = 485) 
U p 
Schizotypal Symptoms 
- Total 
- Social Anxiety 
- Paranoia 
- Anomalous Experiences 
 
10.16 (9.88) 
4.67 (5.53) 
2.94 (3.78) 
2.56 (3.52) 
 
9.28 (8.83) 
4.36 (5.01) 
2.84 (3.55) 
2.08 (3.31) 
 
61520.50 
62865.50 
62981.50 
57230.50 
 
.47 
.81 
.84 
.02 
Anxiety 7.03 (7.67) 5.36 (5.82) 58115.50 .07 
Depression 11.37 (11.77) 9.54 (9.28) 61163.00 .48 
BCSS 
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
 
4.83 (4.83) 
12.88 (5.38) 
5.43 (4.48) 
12.17 (4.22) 
 
3.97 (3.91) 
13.17 (4.56) 
4.58 (4.02) 
12.64 (3.61) 
 
57568.50 
61171.00 
55580.50 
59455.00 
 
.07 
.62 
.01 
.27 
Interpersonal Sensitivity 95.00 (16.20) 93.32 (15.07) 58709.50 .12 
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Table 5.3  
Differences in Schizotypy, Emotional Distress and Schematic Beliefs between Groups 
who have and have not been Exposed to a Non-interpersonal Traumatic Event  
   
Exposed to trauma 
Mean (SD) 
 
Yes (N = 81) No (N = 666) 
U p 
Schizotypal Symptoms 
- Total 
- Social Anxiety 
- Paranoia 
- Anomalous Experiences 
 
9.30 (11.75) 
3.91 (5.12) 
2.60 (4.27) 
2.78 (4.27) 
 
9.63 (8.87) 
4.54 (5.21) 
2.90 (3.55) 
2.18 (3.27) 
 
23648.00 
24200.00 
23937.00 
25622.00 
 
.07 
.13 
.09 
.44 
Anxiety 6.60 (7.92) 5.87 (6.39) 26183.50 .71 
Depression 11.73 (12.86) 10.00 (9.89) 26476.00 .84 
BCSS 
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
 
4.63 (5.22) 
13.06 (5.73) 
5.54 (4.93) 
12.85 (4.04) 
 
4.23 (4.15) 
13.07 (4.75) 
4.80 (4.10) 
12.43 (3.81) 
 
26028.00 
26345.00 
24318.50 
24330.00 
 
.82 
.96 
.24 
.24 
Interpersonal Sensitivity 91.67 (16.59) 94.18 (15.33) 24508.50 .20 
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Table 5.4  
Differences in Schizotypy, Emotional Distress and Schematic Beliefs between Groups 
who have and have not been Exposed to an Interpersonal Traumatic Event  
 
 
 
Exposed to trauma 
Mean (SD) 
 
Yes (N = 170) No (N = 577) 
U p 
Schizotypal Symptoms 
- Total 
- Social Anxiety 
- Paranoia 
- Anomalous Experiences 
 
11.30 (10.07) 
5.25 (5.56) 
3.36 (3.98) 
2.68 (3.69) 
 
9.09 (8.89) 
4.23 (5.07) 
2.73 (3.52) 
2.12 (3.29) 
 
42388.00 
43847.00 
44299.00 
44661.50 
 
.01 
.03 
.05 
.06 
Anxiety 7.87 (8.00) 5.38 (5.98) 41114.00 .002 
Depression 11.92 (12.08) 9.67 (9.60) 45874.00 .24 
BCSS 
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
 
5.19 (4.81) 
12.21 (5.33) 
5.58 (4.51) 
11.41 (4.14) 
 
4.00 (4.06) 
13.33 (4.69) 
4.67 (4.09) 
12.79 (3.69) 
 
41611.50 
43412.00 
42880.50 
39638.00 
 
.004 
.04 
.02 
<.001 
Interpersonal Sensitivity 96.75 (15.97) 93.07 (15.25) 41503.00 .004 
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To investigate whether a particular subtype of interpersonal trauma was specifically 
associated with increased schizotypy and emotional distress; differences in schizotypy 
scores, anxiety, depression, interpersonal sensitivity, and schematic beliefs about self 
and others were compared between individuals who had and had not been exposed to 
different types of interpersonal trauma. The specific subtypes investigated were: severe 
bullying, physical attack (with and without a weapon), and sexual abuse. Sexual abuse 
was split into that occurring in childhood (before the age of 13) and that occurring at 
other times. These analyses are presented in Tables F1 to F4 in Appendix F. Exposure 
to severe bullying and physical victimisation were associated with increased scores on 
the Social Anxiety subscale of the SSI. Exposure to sexual abuse occurring in childhood 
(CSA) was associated with increased scores on the Social Anxiety and Paranoia 
subscales of the SSI. Sexual abuse occurring outside of childhood was not associated 
with any increase in schizotypy. No specific subtype of interpersonal trauma was 
associated with increased scores on the Anomalous Experiences subscale of the SSI. 
Increased emotional distress was associated with all types of interpersonal trauma apart 
from sexual abuse occurring outside of childhood. CSA was found to be associated with 
the most emotional distress and highest schizotypy scores. 
 
5.4.3 Direct and Indirect Pathways 
 
In order to examine direct and indirect pathways between exposure to interpersonal 
trauma and schizotypy, hierarchical multiple linear regression analyses were conducted. 
There were two stages to each regression analysis. In the first stage, trauma exposure 
was the only independent variable. If interpersonal trauma was found to significantly 
predict schizotypy, then emotion and schema variables were added as further 
independent variables in a second stage. All types of schizotypy were found to be 
increased in individuals who had been exposed to interpersonal trauma. Therefore, three 
regression analyses were conducted using each schizotypy subscale as the dependent 
variable. 
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5.4.3.1 Social Anxiety 
 
The results for the hierarchical regression analyses on the Social Anxiety subscale of the 
SSI are shown in Table 5.5. Exposure to interpersonal trauma was shown to be a 
significant predictor of increased Social Anxiety scores. However, when controlling for 
emotion and schema variables, interpersonal trauma was no longer a significant 
predictor. This suggests that the association between trauma and social anxiety is 
mediated by changes in anxiety, interpersonal sensitivity, and schematic beliefs about 
self. 
 
5.4.3.2 Paranoia 
 
The results for the hierarchical regression analysis on the Paranoia subscale of the SSI 
are shown in Table 5.6. Exposure to interpersonal trauma was shown to be a significant 
predictor of increased Paranoia scores. However, when controlling for emotion and 
schema variables, interpersonal trauma was no longer a significant predictor. This 
suggests that the association between trauma and paranoia is mediated by changes in 
anxiety, interpersonal sensitivity, and schematic beliefs about self and others. 
 
5.4.3.3 Anomalous Experiences 
 
The results for the hierarchical regression analysis on the Anomalous Experiences 
subscale of the SSI are shown in Table 5.7. Exposure to interpersonal trauma was 
shown to be a significant predictor of increased Anomalous Experiences scores. 
However, when controlling for emotion and schema variables, interpersonal trauma was 
no longer a significant predictor. This suggests that the association between trauma and 
Anomalous Experiences is mediated by changes in anxiety. 
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Table 5.5  
Summary of Hierarchical Regression Analysis Investigating the Prediction of Social 
Anxiety Schizotypal Symptoms by Exposure to Interpersonal Trauma, Before and After 
Controlling for Emotion and Schema Variables (N = 746) 
 
 
Note. R2 = .01, p = .03 for Step 1; ∆R2 = .32, p <.001 for Step 2  
*p < .05, **p < .01, ***p < .001, †p <.10 
Variable B SE B β 
 
Step 1 
   
 Constant  4.19 0.22  
 Interpersonal Trauma 1.01 0.45 .08* 
Step 2    
 Constant -4.11 1.37  
 Interpersonal Trauma -0.09 0.38 -.01 
 Anxiety 0.16 0.03 .20*** 
 Depression -0.01 0.02 -.02 
 Negative Self Schema 0.12 0.06 .10† 
 Positive Self Schema -0.15 0.04 -.14** 
 Negative Other Schema 0.04 0.04 .03 
 Positive Other Schema -0.02 0.05 -.02 
 Interpersonal Sensitivity 0.10 0.01 .29*** 
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Table 5.6  
Summary of Hierarchical Regression Analysis Investigating the Prediction of Paranoid 
Schizotypal Symptoms by Exposure to Interpersonal Trauma, Before and After 
Controlling for Emotion and Schema Variables (N = 746) 
 
Variable B SE B β 
 
Step 1 
   
 Constant  2.69 0.15  
 Interpersonal Trauma 0.63 0.32 .07* 
Step 2    
 Constant -1.59 0.94  
 Interpersonal Trauma -0.16 0.26 -.02 
 Anxiety 0.09 0.02 .16*** 
 Depression 0.02 0.02 .06 
 Negative Self Schema 0.15 0.04 .18*** 
 Positive Self Schema 0.02 0.03 .03 
 Negative Other Schema 0.19 0.03 .22*** 
 Positive Other Schema -0.08 0.03 -.09* 
 Interpersonal Sensitivity 0.03 0.01 .14*** 
 
Note. R2 = .01, p = .05 for Step 1; ∆R2 = .34, p <0.001 for Step 2  
*p < .05, **p < .01, ***p < .001 
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Table 5.7  
Summary of Hierarchical Regression Analysis Investigating the Prediction of 
Anomalous Schizotypal Symptoms by Exposure to Interpersonal Trauma, Before and 
After Controlling for Emotion and Schema Variables (N = 746) 
 
Variable B SE B β 
 
Step 1 
   
 Constant  2.05 0.14  
 Interpersonal Trauma 0.62 0.29 .08* 
Step 2    
 Constant -0.17 1.01  
 Interpersonal Trauma 0.22 0.28 .03 
 Anxiety 0.15 0.02 .30*** 
 Depression 0.03 0.02 .08 
 Negative Self Schema -0.01 0.05 -.01 
 Positive Self Schema 0.04 0.03 .06 
 Negative Other Schema 0.02 0.03 .03 
 Positive Other Schema 0.02 0.04 .02 
 Interpersonal Sensitivity <0.01 0.01 .02 
 
Note. R2 = .01, p = 0.03 for Step 1; ∆R2 = .11, p <0.001 for Step 2  
*p < .05, **p < .01, ***p < .001 
 
 
Similar regression analyses were also conducted for subtypes of interpersonal trauma. 
The results from these analyses are presented in Tables F5 to F8 in Appendix F. For all 
types of interpersonal trauma (i.e. CSA, bullying, and physical victimisation), the 
relationship between trauma exposure and increased schizotypal symptoms was 
mediated by changes in emotion and schema.  
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5.4.4 Summary of Findings 
 
Increased schizotypal symptoms, emotional distress, and changes in schematic beliefs 
about self and others appear to be specifically related to exposure to interpersonal (as 
opposed to non-interpersonal) traumas. When investigating the nature of the association 
between interpersonal trauma and schizotypy, it appears that rather than a direct link, 
the relationship is mediated by the influence of trauma on emotion and schematic 
beliefs. Indeed, exposure to interpersonal trauma alone predicted very little of the 
variability in schizotypy scores (approximately 1%). Moreover, when combined with 
emotional and psychological variables, trauma contributed no unique variance to 
schizotypy scores. These results are consistent with the hypothesis that changes in 
emotion and schema, brought about by interpersonal trauma exposure, may impact upon 
the development and maintenance of psychotic-like symptoms. 
 
5.5 DISCUSSION 
 
This chapter has examined the associations between schizotypal symptom types and 
exposure to a traumatic life event. This section will review the findings of the current 
study. The results will initially be considered in relation to each of the research 
hypotheses outlined at the beginning of this chapter. They will then be discussed in 
relation to the current literature and the clinical implications of the findings will be 
examined. Following on from this, potential weaknesses of the study will be outlined, as 
will possibilities for future research. 
 
5.5.1 Evaluation of the Findings in Relation to Research Hypotheses 
 
5.5.1.1 Hypothesis 1 
 
It was hypothesised that exposure to an interpersonal trauma (i.e. bullying, physical 
victimisation, sexual abuse) would be associated with increased schizotypal symptoms 
and emotional distress; whereas exposure to a non-interpersonal trauma (i.e. road traffic 
accidents, natural disaster, witnessing an accident) would not. This finding was 
supported by the data. Individuals exposed to interpersonal trauma had higher scores on 
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all dimensions of the SSI; higher levels of anxiety and depression; higher interpersonal 
sensitivity scores; and increased negative and decreased positive beliefs about self and 
others. All of these between-group differences reached statistical significance, apart 
from the Anomalous Experiences subscale of the SSI, where differences were at trend 
level. Conversely, there were no significant differences on any of these variables 
between individuals who had and had not experienced a non-interpersonal trauma. 
These findings support those from previous research (e.g. Mueser et al., 1998). 
 
Subtypes of interpersonal trauma were also found to be associated with increased 
schizotypal symptoms. Social anxiety was increased in individuals who had been 
exposed to severe bullying and physical victimisation. Social anxiety and paranoia were 
particularly elevated in individuals who had been exposed to child sex abuse. No 
specific subtype of interpersonal trauma was associated with increased anomalous 
experiences. Interestingly, sexual abuse occurring outside of childhood was not 
associated with increased schizotypal symptoms on any dimension. Similarly, emotional 
distress in this group was not as pronounced as that occurring in individuals exposed to 
CSA. These findings replicate previous research suggesting that sexual abuse occurring 
in childhood has a particularly severe and prolonged impact on mental health (Browne 
& Finkelhor, 1986). The differences between these groups could be attributed to 
differences in the nature of sexual abuse occurring in and out of childhood. In contrast 
to sexual abuse in later life, CSA is likely to occur over a prolonged period of time in 
the context of reduced social support and when coping mechanisms are not yet fully 
developed (Browne & Finkelhor, 1986).  
 
5.5.1.2 Hypothesis 2 
 
It was hypothesised that the pathway between schizotypal symptoms and exposure to 
interpersonal trauma may be different for different symptom types. In line with previous 
research on CSA and hallucinations (e.g. Read et al., 2003), it was predicted that 
exposure to interpersonal trauma may be specifically and directly associated with 
increased scores on the Anomalous Experiences subscale of the SSI. This hypothesis 
was not supported by the data. Whilst individuals who had been exposed to 
interpersonal trauma had increased scores on the Anomalous Experiences subscale of 
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the SSI (at trend level), trauma exposure was not an independent predictor of anomalous 
experiences when controlling for anxiety.  
 
In terms of social anxiety and paranoia, it was predicted that exposure to interpersonal 
trauma would be associated with increased scores on the corresponding subscales of the 
SSI, and that these relationships would be mediated by increases in both emotional 
distress and the synthesis of negative beliefs about self and others. These hypotheses 
were supported by the data. Individuals who had been exposed to interpersonal trauma 
had significantly higher scores on Social Anxiety and Paranoia dimensions of the SSI. 
Hierarchical regression analyses suggested that the relationship between trauma 
exposure and social anxiety was mediated by anxiety, interpersonal sensitivity, and a 
lack of positive beliefs about self; and that the relationship between trauma exposure 
and paranoia was mediated by anxiety, interpersonal sensitivity, and extreme negative 
schematic beliefs about self and others.    
 
5.5.2 Relevance to the Literature and Clinical Implications of Findings 
 
The finding that individuals with a history of severe interpersonal trauma experience 
increased levels of psychotic-like symptoms replicates findings of previous research 
(Gracie et al., 2007). The potential mediation of this relationship by emotional and 
psychological processes further supports the role of emotion in psychosis; and suggests 
an indirect route between trauma and psychotic symptoms, as outlined in other studies 
(Fowler, Freeman, Steel et al., 2006; Morrison et al., 2003). The findings of the current 
study also support those of the previous chapter in this thesis, highlighting the 
importance of emotion and schema in the development and maintenance of psychotic 
symptoms. 
 
The results do not provide any support for theories postulating a direct route between 
trauma and psychotic symptoms (Read et al., 2003). However, the presence of such a 
pathway cannot be ruled out on the basis of current findings. Previous studies 
investigating the direct pathway have examined re-experiencing-type symptoms of 
psychosis and hallucinations, which differ in content to items included on the 
Anomalous Experiences subscale of the SSI. Moreover, the current study did not assess 
symptoms of PTSD as has been done in other studies (Mueser, Rosenberg et al., 2002). 
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It is often a re-experiencing element of PTSD that is linked to hallucinations and 
therefore it may be this same element that would be linked to anomalous schizotypal 
phenomena (Gracie et al., 2007; Morrison et al., 2003). Previous studies have also 
analysed the content of psychotic symptoms and linked this to the content of the 
traumatic event itself (e.g. Hardy et al., 2005). Such detail was beyond the scope of the 
current study. 
 
Experimental studies proposing a direct route between trauma and psychotic symptoms 
have focused on the way in which a deficit in the contextual processing of trauma 
memories may result in the presence of intrusions (Holmes & Steel, 2004; Steel et al., 
2005). In the current study, trauma history was not found to be an independent predictor 
of anomalous experiences. Rather, the relationship was mediated by anxiety. Anxiety 
has also previously been linked with contextual processing anomalies (Frith, 1992; J. A. 
Gray, 1982). As such, it may be the case that increases in anxiety disrupt normal 
processing and provide a trigger for the occurrence of trauma-related intrusions, which 
may then be experienced as hallucinations or anomalous perceptions (Morrison, 2001; 
Steel et al., 2005). This is in contrast to social anxiety and paranoia where schema 
appears to play more of a role. However, further research would need to be conducted in 
order to confirm this hypothesis. 
 
In line with the continuum hypothesis, the associations between trauma and schizotypal 
symptoms highlighted in the current study could be generalised to a clinical sample and 
thus have implications for clinical practice. Indeed, when considered in the context of a 
history of interpersonal trauma, the symptoms of psychosis may be understood as being 
personally meaningful to the client (Fowler, 2000a). The content of psychotic symptoms 
may mirror the content of the traumatic event; or perhaps more commonly, exposure to 
a traumatic event of an interpersonal nature may provide the individual with a sense that 
they are vulnerable and that the world is a dangerous place. Fowler, Garety, and Kuipers 
(1995) suggest a role for cognitive behaviour therapy for psychosis in assisting the 
individual to make sense of their psychotic experiences in the context of psychological 
processes and previous life events. 
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5.5.3 Weaknesses of the Current Study 
 
In addition to the methodological weaknesses outlined in previous chapters, there are a 
number of limitations specific to the current study which need to be considered when 
interpreting the findings. First, the study is cross-sectional and thus it is difficult to 
establish the direction of relationships between trauma, schizotypy, and psychological 
variables. It is unknown whether trauma exposure increases predisposition to psychosis, 
or whether the predisposition was present prior to the traumatic event and influences the 
associated response (Mueser, Rosenberg et al., 2002). However, as this study was 
assessing the state presence of schizotypal symptoms rather than schizotypy as a 
personality trait, it can be assumed with reasonable certainty that the phenomena 
reported by participants occurred after the traumatic event (i.e. in the last two weeks). 
Nevertheless, state schizotypal symptoms will be influenced by underlying trait 
schizotypy which may predate trauma exposure.  
 
Second, the reporting of trauma in the current study was retrospective, which is 
problematic but somewhat unavoidable. In order to unpick the nature of relationships 
between trauma, emotion, schema, and schizotypy; longitudinal prospective studies 
would need to be conducted. This was however beyond the scope of the current study. 
Furthermore, although the findings suggest that emotional and schematic variables 
mediate the relationship between trauma and psychosis, it is possible that emotion and 
schematic beliefs have an influence on the retrospective reporting of trauma. In other 
words, regression analyses do not discriminate between confounding and mediational 
effects (Dunn & Bentall, 2007). True mediational analyses can only be conducted on 
longitudinal data. 
 
Finally, the power of the secondary analyses conducted on subtypes of interpersonal 
trauma is questionable. Power calculations revealed that at least 85 participants per 
group would be needed for between-group comparisons of schizotypal symptoms, 
emotion, and schema. Due to the strict criteria applied to the data, endorsement of 
subtypes of interpersonal traumas resulted in groups with a smaller sample size than this 
(see Tables F1 to F8 in Appendix F), and thus the results of these analyses should be 
regarded with caution. However, the primary focus of this study was exposure to 
  182
interpersonal trauma in general, rather than specific subtypes. These analyses were more 
than adequately powered. Secondary analyses were exploratory and further studies 
would need to be conducted to confirm their findings. 
 
5.5.4 Summary 
 
Despite some methodological weaknesses, the findings of the current study support 
research highlighting a role for trauma history in the presence of psychotic 
symptomatology. Indeed, the finding that exposure to a traumatic event is associated 
with increased emotional distress, negative schematic beliefs, and increased schizotypal 
symptoms provides further evidence for the role of emotion and psychological variables 
in the development and maintenance of psychotic phenomena, thus supporting the 
findings of Study 3. Moreover, if there is an emotional route into psychosis, it is likely 
that there is also an emotional route to recovery from the disorder. This will be 
examined in the next chapter.  
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CHAPTER SIX: 
STUDY FIVE: SCHIZOTYPAL SYMPTOMS AND DIMENSIONS OF 
RECOVERY FROM PSYCHOSIS 
 
 
6.1 RATIONALE AND CONTEXT FOR THE STUDY 
 
6.1.1 Overview  
 
The concept of recovery from psychosis is an area of increasing interest to both 
researchers and clinicians. Traditional views suggest that the notion of recovery from 
psychosis is somewhat paradoxical. Indeed, lack of recovery and poor outcome formed 
part of the original diagnostic criteria for the disorder (Bleuler, 1950; Kraepelin, 1919), 
and this view has long since dominated psychiatric and societal views about severe 
mental illness. However, more recent long-term follow-up studies have shown that 
approximately half of individuals diagnosed with psychosis have a favourable outcome 
(e.g. Harding, 1988; G. Harrison et al., 2001). This literature has been supplemented by 
service user accounts of the recovery process, showing that recovery from psychosis is 
in fact possible (Deegan, 1988; Leete, 1989; Lovejoy, 1984; Unzicker, 1989). This 
paradigm shift has been accompanied by changes in government policy for severe 
mental illness (Department of Health, 2001) and a move towards “recovery-oriented 
services” (Anthony, 1993; Jacobson & Greenley, 2001; Turner-Crowson & Wallcraft, 
2002).  
 
Despite advances in the understanding of positive outcomes for people diagnosed with 
psychosis, there currently exists no single agreed definition of recovery. The 
overwhelming message in the literature is that recovery from psychosis is a complex 
and arguably multidimensional construct, which can mean different things to different 
people at different points in their illness pathway (Lester & Gask, 2006). However, such 
a subjective and disparate view does not aid research into the recovery process. There is 
a need to operationalise the recovery concept in order to allow recovery-focused 
interventions to be reliably assessed (Liberman & Kopelowicz, 2002). Within 
psychiatry and the wider medical profession, recovery is still generally assessed using 
symptom-related criteria (Whitehorn et al., 2002). Whilst easily defined, this emphasis 
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on symptom remission as a marker of recovery from psychosis means that social 
outcomes and psychological well-being are often neglected, despite the fact that these 
constructs are meaningful to patients and feature heavily in the user literature (Pitt et al., 
2007). 
 
When considering recovery, McGorry (1992) proposes the need for a distinction to be 
made between primary impairments, and secondary impairments occurring as a 
consequence of psychosis. Primary impairments refer to psychotic symptoms 
themselves, whereas secondary impairments refer to the psychological effects of the 
experience of psychosis. McGorry (1992) argues that primary and secondary 
impairments occur as a result of different processes, follow a different time course of 
recovery, and may be influenced by different forms of treatment. It is suggested that 
whereas primary impairments are the direct result of psychotic illness and generally 
require biological treatments (i.e. medication); secondary impairments are the 
consequence of the impact of psychosis as a major life event (i.e. on relationships, role 
functioning, etc) and the way in which the individual interprets and makes sense of their 
illness. 
   
A distinction has also been made between symptomatic and functional recovery from 
psychosis, with studies highlighting that social outcome is often independent of 
symptomatic recovery (Davidson & McGlashan, 1997; Strauss & Carpenter, 1977; 
Tohen et al., 2000). Indeed, individuals who have recovered symptomatically from a 
psychotic episode do not always achieve a social recovery (i.e. return to work or 
education). Similarly, other individuals may have high levels of functioning and yet still 
be experiencing psychotic symptoms on a daily basis (Harding et al., 1987). This 
dissonance suggests that factors other than symptoms may influence long-term recovery 
from psychosis. These have been hypothesised to include loss of confidence and self-
esteem (Pallanti et al., 2004); feelings of entrapment and stigmatisation (Birchwood et 
al., 1993); and fear of relapse (Gumley & Schwannauer, 2006; Gumley et al., 1999). In 
addition to these so-called “internal” factors, wider external and societal factors such as 
culture (Sartorious, Jablensky, & Shapiro, 1977) and rates of employment (Warner, 
1985), have also been shown to be strongly associated with social outcome following 
psychosis.  
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Based on the complex interplay of factors outlined above, some studies have attempted 
to operationally define recovery from psychosis utilising a multidimensional approach. 
For example, Liberman, Kopelowicz, Ventura, and Gutkind (2002) suggest that full 
recovery from psychosis involves sustained improvement in positive and negative 
symptoms, role functioning (i.e. vocational activity and independent living), and social 
adjustment (i.e. meaningful peer relationships). Similarly, Whitehorn et al. (2002) 
outline “symptom control”, “autonomous daily living”, and “return to the social and 
occupational lifeline” as important dimensions of recovery. However, these studies use 
different outcome measures and cut-offs to define recovery on each dimension. 
Moreover, other operational definitions focus on more subjective aspects of the 
recovery process. For example, following a review of service user literature, Noordsy et 
al. (2002) propose “hope”, “self-responsibility”, and “getting on with life” as 
dimensional definitions of recovery; although how such aspects can be measured in a 
standardised way, if at all, remains to be ascertained. Thus, at present no single set of 
criteria for defining recovery has been universally adopted.  
 
The concept of recovery is still a relatively new area of research. Indeed, in the early 
nineties, Anthony (1993) stated that “we are nowhere near understanding the recovery 
concept” (p. 22). Since this paper, much research has been conducted into factors 
constituting recovery from psychosis, but a general consensus on exactly what recovery 
is has yet to be reached. A major reason for this is the incredibly subjective and personal 
nature of recovery. This has led to a focus on personal narratives, following suggestions 
that more formal assessment methods are “doomed to failure” (G. Shepherd, Boardman, 
& Slade, 2008). Although service user literature provides a detailed description of the 
process of recovery for individual users, how this relates to existing standardised 
assessments of outcome from psychosis, or to the wider population with psychosis, has 
yet to be established. Operationalised assessment of recovery is important, especially in 
order to examine the efficacy of recovery-focused mental health services, introduced as 
a result of government guidelines (Department of Health, 2001). However, there are 
currently numerous outcome measures used in psychosis research. This study will 
examine the dimensional structure of such outcome measures and how this may relate to 
the assessment of recovery from psychosis.  
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The focus of this thesis is schizotypal symptoms. Previous chapters have shown that 
schizotypal symptoms are common in individuals in recovery from acute psychosis, and 
that they are associated with emotional disturbance and psychological distress. This 
chapter will investigate how different types of schizotypal symptoms relate to various 
dimensions of outcome in psychosis. Schizotypal symptoms may be viewed as residual 
symptoms of psychotic illness, but may also reflect emotional and psychological 
recovery from the disorder. Although previous studies have highlighted the 
independence of symptomatic recovery (as measured by traditional symptom measures) 
and functional recovery (i.e. return to competitive employment or education), there have 
been no studies to date which have considered the impact of residual, or schizotypal 
symptoms on the wider recovery process. This chapter will investigate different 
dimensions of recovery and how these relate to different types of schizotypal symptoms. 
 
6.1.2 Aims of the Study 
 
There are two main aims of this study, the first of which is to investigate the 
multidimensionality of recovery from an episode of psychosis and to propose a 
theoretical model of the different dimensions of recovery. The second aim of this study 
is to investigate how different schizotypal symptom types are related to these 
dimensions of outcome. Both of these aims will be examined using exploratory factor 
analysis conducted on subscale scores from a range of assessment tools designed to 
assess different aspects of outcome in psychosis.    
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6.2 RESEARCH HYPOTHESES 
 
1. The exploratory factor analysis will highlight the multi-dimensional nature 
of recovery from psychosis, and suggest that outcome should be assessed 
across a number of different domains. 
 
2. Schizotypal symptom types, as measured by the SSI, will exist on different 
dimensions of recovery: 
 
a) The Anomalous Experiences subscale of the SSI may be reflective of 
residual and low-level psychotic symptoms 
 
b) The Social Anxiety subscale of the SSI may be reflective of emotional 
and psychological recovery following an episode of psychosis 
 
c) The Paranoia subscale of the SSI may be reflective of both residual 
psychotic symptoms and emotional and psychological recovery 
following an episode of psychosis 
 
6.3 METHODOLOGY 
 
6.3.1 Design 
 
A sample of patients in recovery from psychosis was surveyed in a cross-sectional 
design. All participants completed a range of self-report questionnaires and clinician-
administered assessments as part of the baseline assessment of the “Improving Social 
Recovery in Early Psychosis” (ISREP) trial (see Appendix B for trial paper).  
 
Subscales from the assessment tools were entered into an exploratory factor analysis 
using maximum likelihood estimation in Mplus (Muthén & Muthén, 1998). Factor 
analysis is a shared variance technique commonly used to identify the core 
psychological constructs evaluated by tests or scales (Delis, Jacobson, Bondi, Hamilton, 
  188
& Salmon, 2003). Shared variance techniques are based on the assumption that a 
significant correlation between two or more testing variables indicates that the variables 
are measuring a similar construct. The specific aim of factor analysis is to “determine 
the number and nature of latent variables or factors that account for the variation and 
covariation among a set of observed measures” (Brown, 2006; p. 13). A factor is 
defined as “an unobservable variable that influences more than one observed measure 
and that accounts for correlations among those observed measures” (Brown, 2006; p. 
13). EFA is an exploratory or descriptive form of factor analysis (i.e. no a priori 
restrictions are placed on the data) used in the early stages of construct validation and 
designed to “determine the appropriate number of common factors [in a set of observed 
variables] and to uncover which measured variables are reasonable indicators of the 
various latent dimensions” (Brown, 2006; p. 14). Thus in this study, outcome measures 
commonly used in psychosis research were entered into an exploratory factor analysis to 
examine the main important constructs or dimensions of recovery from psychosis. 
 
EFA differs from Principal Components Analysis (PCA) as used in Study 1. The main 
aim of PCA is data reduction, whereas the goal of EFA is to identify latent variables 
which make sense of correlations existing between measured variables. PCA is used 
mainly in scale construction, whereas EFA is used when a researcher wishes to identify 
a set of latent constructs underlying a battery of measures (Fabrigar, Wegener, 
MacCallum, & Strahan, 1999). EFA is also a useful approach for examining construct 
validation in relation to theoretical concepts. For example, within psychiatry, symptoms 
thought to be manifestations of a single mental disorder would be expected to be highly 
correlated and thus to load on the same factor. Conversely, indicators of theoretically 
distinct constructs would not be expected to be correlated and thus to load on different 
factors. EFA also accounts for measurement error, whereas PCA does not, thus 
providing arguably more accurate results. 
 
6.3.2 Participants 
 
Seventy-seven participants were recruited from secondary mental health services in the 
East Anglia Region of the UK, from a catchment area with a semirural population of 
around two million people, living in small cities, towns and rural areas. The sample 
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were in relative symptom remission from their psychosis but had high levels of social 
disability. 
 
The sample had a mean age of 29.0 years (SD = 6.8 years). Seventy-one per cent were 
male and 29% were female. Ninety-one per cent of the sample was white and 9% were 
from other ethnic origin. Sixty-five per cent had received a diagnosis of non-affective 
psychosis (predominantly schizophrenia) and 35% had a diagnosis of affective 
psychosis (predominantly bipolar disorder). Mean illness duration was 4.8 years (SD = 
2.3 years) and mean unemployment length was 209 weeks (SD = 182 weeks). See 
Appendix B for a report on the ISREP study and for a fuller description of the sample. 
 
6.3.2.1 Sample size and power analysis 
 
A sample size of 77 is satisfactory to conduct a factor analysis, although larger samples 
are recommended (Gorsuch, 1993). In EFA, between three and five participants per 
measured variable are said to be required in order to produce accurate estimates of the 
population parameters (Kline, 1993). The current study has 23 measured variables and 
thus 3.3 participants per measured variable. 
 
6.3.3 Measures 
 
All participants completed the Brief Schizotypal Symptoms Inventory (SSI) as 
described in previous chapters. A range of other measures were also completed and 
these are outlined below. 
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6.3.3.1 Social functioning measures 
 
Time Use Survey (modified from Office for National Statistics, 2003). The 
UK 2000 Time Use Survey (Short, 2006) was modified in the ISREP study in order to 
make it suitable for use in a psychosis population. The original Time Use Survey 
consists of seven daily diaries, completed by participants and accounting for every ten 
minutes of their time. This is supplemented by a structured interview administered by a 
researcher. The original time use survey has been shown to be an adequately reliable 
tool for assessing time use (Short, 2006). See Appendix E for a copy of the Time Use 
Survey. 
 
The version of the time use survey used in the current study differs from the original in 
two ways. First, the modified interview is shorter than that used by the Office of 
National Statistics. Questions were removed which did not relate to the areas of time 
use under investigation (as outlined below). Second, the seven daily self-report diaries 
were removed in order to reduce demand on participants, who were already being asked 
to complete a range of self-report instruments. However, all questions that were 
included in the modified version were taken from the original, and the same coding 
framework was applied to the data. 
 
The modified time use survey used in this study consists of a semistructured interview 
in which the participant is asked about how they have spent their time over the last 
month. Activities enquired about include: work, education, voluntary work, leisure, 
sports, hobbies, socialising, resting, housework/chores, childcare, and sleep. As a result 
of the interview, time spent on each of the activities is calculated in terms of the number 
of hours per week allocated to that activity. Two summary measures can be derived 
from the Time Use Survey: hours in Constructive Economic Activity and hours in 
Structured Activity. Constructive Economic Activity is calculated as the sum of hours 
per week over the last month spent in work, education, voluntary work, housework and 
chores, and childcare. Structured Activity is calculated as the sum of hours per week 
over the last month spent in constructive economic activity, but also includes hours 
engaged in structured leisure activity, sports and hobbies. 
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The time use survey provides a direct and objective measure of the number of hours an 
individual is spending in activity. This is contrast to other measures of social 
functioning for use in psychosis populations, which provide a more subjective 
assessment of the quality of an individual’s life (Barry & Crosby, 1996). A further 
strength of the Time Use Survey is that it has been applied and validated in a normative 
community population and thus allows the recovery of individuals with psychosis to be 
compared with societal norms, i.e. has functioning improved to a degree which is 
similar to that occurring in the general population? This comparative facility is 
something which is lacking in other outcome measures for psychosis (Liberman, 2002). 
 
Hours spent in Constructive Economic Activity and Structured Activity were found to 
be significantly associated with quality of life (r(76) = .39, p = .001; and r(76) = .43, p 
<.001 respectively) measured by the Quality of Life Scale (Heinrichs, Hanlon, & 
Carpenter, 1984); social functioning (r(77) = .27, p = .02; and r(77) = .31, p = .006 
respectively) measured by the Social and Occupational Functioning Scale (Goldman et 
al., 1992); and activity (r(77) = .53, p <.001; and r(77) = .57, p <.001 respectively) 
measured by the Time Budget (S. Jolley et al., 2006). Thus, the Time Use Survey has 
good convergent validity with other measures of functioning. Hours in activity were not 
however associated with positive, negative, or general symptoms measured by the 
PANSS (Kay et al., 1987). This is a strength of the Time Use Survey as scores on some 
functioning assessment tools have previously been shown to be confounded by negative 
symptoms (Barry & Crosby, 1996). Moreover, it supports the notion that symptomatic 
and functional recoveries are independent of one another (e.g. Tohen et al., 2000). 
 
Quality of Life Scale (QLS; Heinrichs et al., 1984). The QLS is a 21-item 
scale which utilises a semistructured interview approach. It is designed to assess the 
functional impairments associated with psychosis, including problems with 
interpersonal relationships and occupational role functioning. The measure is a 
commonly used tool for assessing deficit symptoms in psychosis and consists of four 
categories: Intrapsychic Foundations (e.g. sense of purpose, motivation, curiosity and 
empathy); Interpersonal Relations (e.g. social contact, relationships with family); 
Instrumental Role Functioning (e.g. employment, accomplishment, role satisfaction); 
and Common Objects and Activities (e.g. participation and engagement in regular 
activities). This structure was confirmed by a factor analysis conducted by the authors, 
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thus confirming the validity of the measure. The QLS has also been shown to have good 
reliability, with the authors reporting an inter-rater reliability alpha of .94 for the total 
scale and .91 to .97 for the subscales.  
 
Each of the 21 items has suggested probe questions to assist the interviewer in making a 
judgement on the level of the disability. Scores are rated on a scale of 0 (severe 
impairment) to 6 (unimpaired). The QLS is a commonly used outcome measure in 
psychosis research (Cramer et al., 2000) and was included in the current study to 
examine how it is related to other dimensions of outcome. Total QLS scores and scores 
on the Instrumental Role Functioning dimension were used in the analysis. The 
Instrumental Role Functioning dimension was chosen because it was thought that this 
may be particularly important when considering recovery. Other subscales were not 
included due to issues of power (i.e. a larger sample size would be required). 
 
Social and Occupational Functioning Assessment Scale (SOFAS; Goldman 
et al., 1992). The SOFAS is a visual analogue scale whereby the interviewer makes an 
objective rating of the individual’s current social and occupational functioning on a 
scale of 0 to 100, with higher scores indicating better functioning. The SOFAS was 
originally devised for use in Axis V assessment in DSM-IV (American Psychiatric 
Association, 1994) and is a reliable  and commonly used measure of social functioning 
in psychosis (Goldman et al., 1992; Whitehorn et al., 2002).  
 
EuroQol (Brooks, 1996; EuroQol Group, 1996). The EuroQol is a self-
report visual analogue scale on which participants rate their health state (mental and 
physical) on a 0-100 point scale. Higher ratings correspond to better quality of life. The 
scale has been used in a variety of health settings to assess quality of life and outcome 
(e.g. Dorman, Waddell, Slattery, Dennis, & Sandercock, 1997). Validity of the scale for 
use in a population with schizophrenia has also been investigated and shown to be good 
(König, Roick, & Angermeyer, 2007). In the current study this measure was used to 
gain a subjective assessment of global health status/quality of life, for use in 
combination with researcher rated quality of life scales. 
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6.3.3.2 Symptom assessments 
 
Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987). The 
PANSS has been described elsewhere in this thesis (section 2.4.4.3) and as such a 
description will not be repeated here. The PANSS is commonly used to assess symptom 
remission in operationalised criteria for recovery from psychosis (e.g. Liberman et al., 
2002; Whitehorn et al., 2002) and was used in the current study to assess the level of 
psychotic symptoms present in the sample. 
 
Scale for the Assessment of Positive Symptoms (SAPS; Andreasen, 1984) and 
Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 1981). The SAPS 
and SANS were used in addition to the PANSS. These measures provide a detailed 
description of specific positive and negative symptoms of psychosis. For both scales, 
symptoms are rated using a 6-point (0-5) rating scale, with higher scores indicating 
more severe symptoms. Symptoms are rated over the last month. In the current study, 
total scores were used for both the SAPS and the SANS. 
 
The SAPS is a 35-item rating scale for the assessment of the positive symptoms of 
psychosis. Items are rated based on patients’ responses to a clinical interview. 
Generally, higher scores on items reflect increased frequency of occurrence of that 
particular symptom. However, in some cases (e.g. delusions) conviction, preoccupation 
and severity are also included in the rating. The SAPS consists of five subscales: 
Hallucinations (e.g. auditory hallucinations, somatic hallucinations); Delusions (e.g. 
persecutory delusions, delusions of jealousy); Bizarre Behaviour (e.g. clothing and 
appearance, repetitive and stereotyped behaviour); Positive Formal Thought Disorder 
(e.g. derailment, pressure of speech); and Inappropriate Affect. Internal consistency of 
the SAPS has been shown to be good, as has inter-rater reliability for the scale 
(Andreasen, 1990). The measure is commonly used to assess positive psychotic 
phenomenology in psychosis for both clinical and research purposes (e.g. Perry & Braff, 
1994). 
 
The SANS is a 24-item rating scale for the assessment of the negative symptoms of 
psychosis. Items included in the SANS are predominantly observational in nature and 
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the rater is required to make an objective judgement about their presence or absence. 
The scale contains five subscales of negative symptoms: Alogia (e.g. poverty of speech, 
blocking); Affective Flattening (e.g. unchanging facial expression, decreased 
spontaneous movements); Avolition-Apathy (impersistence at work and school, 
physical anergia), Anhedonia-Asociality (e.g. ability to feel intimacy and closeness), 
and Attention (e.g. social inattentiveness). The SANS has been shown to have good 
internal consistency, with Cronbach’s alphas ranging from .67 to .90 for the five 
subscales. Furthermore, the measure has been found to correlate well with the negative 
symptoms items of the Brief Psychiatric Rating Scale (BPRS; Overall & Gorham, 
1962), suggesting good concurrent validity (Thiemann, Csernansky, & Berger, 1987). 
Reliability of the SANS has been confirmed by a multi-site investigation (Mueser, 
Sayers, Schooler, Mance, & Haas, 1994). 
 
Global Assessment of Symptoms Scale (GAS; American Psychiatric 
Association, 2000b). The GAS is part of the Global Assessment of Functioning scale 
(GAF; American Psychiatric Association, 2000b), a 0-100 visual analogue scale used by 
mental health clinicians to rate social, occupational, and psychological functioning. 
Symptoms and functioning can be rated separately. The scale is similar to the Global 
Assessment Scale, featuring in DSM-IV (American Psychiatric Association, 1994). For 
the purpose of this study, only the symptoms part of the measure was used to assess 
global symptoms. Higher scores on the scale correspond to lower levels of symptoms. 
The GAS was used in this study to complement the PANSS, SAPS and SANS and to 
assess general symptomatology. Both the GAF and the GAS have good reliability and 
validity and are widely used in research, thus enabling comparability with other studies 
(Endicott, Spitzer, Fleiss, & Cohen, 1976). 
 
6.3.3.3 Assessments of emotional and psychological well-being 
 
Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996). The BDI-
II is self-report measure designed to assess the symptoms of depression and their 
intensity in clinical and non-clinical samples. The BDI-II consists of 21 items rated on a 
4-point scale (0-3) of increasing severity. Symptoms are rated dependent on their 
presence in the last two weeks. Scores on the BDI-II range from 0 to 63 and specific 
cut-off scores are provided for different bands of severity. The BDI-II is an extensively 
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used measure of depression and the symptoms it enquires about are in line with DSM-
IV criteria for the disorder. The BDI-II has also been shown to correlate at .71 with the 
Hamilton Depression Rating Scale (Hamilton, 1960) and has a one-week test-retest 
reliability of .93. In addition, the scale has been shown by the authors to have good 
internal consistency, demonstrating a coefficient alpha of .91. Moreover, the BDI-II has 
been used in many studies with patients with psychosis (e.g. Fialko et al., 2006) and has 
also been shown to correlate at .91 with the interview-based Calgary Depression Scale 
for Schizophrenia (Addington, Addington, & Maticka-Tyndale, 1993). Depression has 
previously been shown to impede recovery from psychosis (Birchwood & Iqbal, 1998) 
and thus the BDI-II was included in the current study to examine how levels of 
depression were associated with other dimensions of outcome. 
 
Beck Anxiety Inventory (BAI; Beck & Steer, 1987). The BAI is a self-report 
measure designed to assess common symptoms of anxiety. The BAI includes 21 items 
which are descriptive of subjective, somatic, or panic-related symptoms of anxiety. 
Individuals are asked to rate each item on a 4-point scale dependent on how much they 
have been affected by each of the symptoms in the last week, from 0 (not at all) to 3 
(severely). Scores on the scale range from 0 to 63 and specific cut-off scores are 
provided for different bands of severity. The scale has been shown by the authors to 
have high internal consistency, with item-total correlations ranging from .30 to .71. 
Furthermore, test-retest reliability has been reported as .75. The scale has been shown to 
have validity for use with patients with panic disorder, social phobia, obsessive-
compulsive disorder and generalised anxiety. It has also been used in many studies with 
patients with psychosis (e.g. Freeman & Garety, 1999) and is suitable for use in both 
clinical and research settings. Anxiety has previously been shown to occur in the 
recovery stages of psychosis (Freeman & Garety, 2003) and thus the BAI was included 
in the current study to examine how levels of anxiety were associated with other 
dimensions of outcome. 
 
Beck Hopelessness Scale (BHS; Beck & Steer, 1988). The BHS is a 20-item 
self-report scale designed to assess three main aspects of hopelessness: feelings about 
the future; loss of motivation; and expectations. Items are rated using a dichotomous 
true/false response format. Total scores from the BHS were used in the current study. 
Higher scores reflect increased levels of hopelessness. The BHS was originally 
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designed to highlight individuals who may be at risk of committing suicide and has 
been shown to have good predictive value with respect to suicidal ideation (Beck, 
Brown, Berchick, Stewart, & Steer, 1990). However, the BHS has also been used to 
assess negative attitudes about the future (Beck & Steer, 1988). The authors report an 
internal consistency of the scale of between .82 to .93; and a six-week test-retest 
reliability of .66. BHS scores have also been found to correlate at .75 with severity of 
depression, as measured by the BDI-II (Enns, Inayatulla, Cox, & Cheyne, 1997). The 
BHS was used in the current study as hope is thought to be an important aspect of 
recovery from psychosis (Noordsy et al., 2002).  
 
Personal Beliefs about Illness Questionnaire (PBIQ; Birchwood et al., 
1993). The PBIQ is a 16-item measure designed to assess an individual’s cognitive 
appraisals about their illness. It encompasses five subscales: Loss; Humiliation; 
Shame/Stigma; Attribution of Behaviour to the Self or the Illness; and Entrapment in 
Psychosis. Total PBIQ scores were used in the current study. The scale was specifically 
designed for use in psychosis and has been shown by the authors to have good 
reliability and validity (Birchwood et al., 1993). Low scores on the scale indicate 
favourable attitudes towards the self and the psychosis, e.g. high perceived control over 
illness, positive expectations of the future, low awareness of stigma, and a view of the 
illness as being separate to the self. The PBIQ was included in the current study as 
previous quantitative and qualitative studies have shown that illness cognitions may be 
important in long-term recovery from psychosis (e.g. Anthony, 1993; Gumley & 
Schwannauer, 2006; Hoffmann & Kupper, 2002; C. Jackson & Iqbal, 2002; Lobban, 
Barrowclough, & Jones, 2003).  
 
Brief Core Schema Scales (BCSS; Fowler, Freeman, Smith et al., 2006). The 
BCSS has been described elsewhere in this thesis (section 4.3.3.3) and as such a 
description will not be repeated here. This measure was used in the current study to 
examine how individuals’ beliefs about self and others may be related to outcome.  
 
6.3.4 Procedure 
 
Participants completed all of the above measures as part of the baseline assessment 
process for the ISREP study. Self-report measures were completed independently by the 
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participants, although assistance was provided if required. All other assessments were 
conducted by a researcher. Formal training in all measures was provided and interviews 
were audio-taped for reliability and quality control. Researchers met on a regular basis 
to ensure reliability in ratings. Some qualitative data was also collected from the 
interviews and used in defining the factor structure. 
 
6.3.5 Data Analysis Plan 
 
Initial screening and cleaning of the data has been described in Study 1 (section 
2.4.6.1). In the initial stage of the analysis, descriptive statistics were calculated for all 
variables using SPSS for Windows, version 14 (SPSS, 2005). Exploratory factor 
analysis (EFA) was conducted in Mplus for Windows, version 4.1 (Muthén & Muthén, 
1998). Mplus was used rather than SPSS because EFA is a special case of structural 
equation modelling and Mplus is specialised software developed for this purpose.  
 
In order to assess the multidimensionality of recovery in psychosis, an EFA using 
maximum likelihood estimation with promax rotation was conducted using subscale 
scores for all of the assessment tools described above. A key advantage of maximum 
likelihood estimation is that it allows for a statistical evaluation of how well a factor 
solution fits the data. Promax rotation was used as it is an oblique as opposed to 
orthogonal rotation, and thus allows the factors defined to be correlated. As it is likely 
that different dimensions of recovery will be associated with one another, this was 
decided to be the most appropriate type of rotation (Costello & Osborne, 2005; Fabrigar 
et al., 1999).  
 
EFA attempts to determine the minimum number of latent variables or factors that can 
adequately describe the correlations among a set of observed variables. It is important 
that the factors be interpretable according to a recognised theory in addition to the 
model fitting the data well. For the current data set, an initial examination of 
eigenvalues and the scree plot determined the maximum number of factors a suitable 
model may contain. Models with one through to six factor solutions were then run and 
the goodness of fit of each model was established using the root mean square residuals 
provided by Mplus. Interpretation of factors was also influenced by the recovery 
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literature and qualitative data collected during the interviews. This procedure complies 
with best practice guidelines for EFA (Costello & Osborne, 2005; Fabrigar et al., 1999). 
 
6.4 RESULTS 
 
6.4.1 Descriptive Data 
 
Table 6.1 provides descriptive data for all variables in the ISREP sample. Despite being 
in relative remission from positive symptoms, the descriptive data reflect a plethora of 
other concerns reflective of poor recovery. There are moderate levels of depression and 
anxiety in the sample, as well as relatively high levels of hopelessness. Moreover, 
positive schematic beliefs are low in comparison to a normative sample. Hours in 
constructive activity are also low compared to non-clinical norms (Office for National 
Statistics, 2003). Data on some variables were skewed (e.g. SSI, Time Use Survey, 
BCSS) and the data was resistant to normalising transformation. 
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Table 6.1   
Descriptive Statistics for all Study Variables 
 
 N Min-Max Mean  
(SD) 
Skewness 
(SE) 
Schizotypal Symptoms Inventory 
- Total 
- Social Anxiety 
- Paranoia 
- Anomalous Experiences 
 
68 
68 
68 
68 
 
0-80 
0-24 
0-24 
0-32 
 
19.12 (16.02) 
8.75 (6.45) 
5.85 (6.33) 
4.51 (6.31) 
 
1.72 (0.29) 
0.48 (0.29) 
1.37 (0.29) 
2.43 (0.29) 
Time Use Survey (hours) 
- Constructive Economic 
- Structured 
 
77 
77 
 
0-94 
2.25-97 
 
12.43 (17.05) 
29.03 (19.42) 
 
3.20 (0.27) 
1.41 (0.27) 
Quality of Life Scale 
- Total 
- Instrumental Role 
 
76 
77 
 
31-110 
0-18 
 
64.54 (14.85) 
6.04 (3.96) 
 
0.53 (0.28) 
0.54 (0.27) 
SOFAS 77 35-80 50.06 (8.47) 1.06 (0.27) 
EuroQol 69 0-100 55.38 (23.50) -0.36 (0.29) 
PANSS 
- Total 
- Positive 
- Negative  
- General 
 
77 
77 
77 
77 
 
37-87 
7-24 
7-25 
19-48 
 
56.74 (10.83) 
12.22 (3.83) 
13.64 (3.67) 
30.88 (5.94) 
 
0.33 (0.27) 
0.63 (0.27) 
0.67 (0.27) 
0.23 (0.27) 
SAPS Total 77 0-55 14.71 (12.56) 0.88 (0.27) 
SANS Total 77 8-62 32.10 (11.76) 0.23 (0.27) 
Global Assessment of Symptoms 77 30-75 56.83 (9.76) -0.64 (0.27) 
Beck Depression Inventory 73 0-57 21.90 (13.75) 0.46 (0.28) 
Beck Anxiety Inventory 74 0-50 16.97 (12.56) 0.68 (0.28) 
Beck Hopelessness Scale 74 1-20 8.80 (5.74) 0.49 (0.28) 
Personal Beliefs About Illness 70 3-40 21.52 (7.53) 0.07 (0.29) 
Brief Core Schema Scales 
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
 
74 
74 
74 
74 
 
0-24 
0-21 
0-24 
0-24 
 
6.15 (5.80) 
8.83 (6.03) 
6.62 (6.41) 
10.42 (6.15) 
 
1.23 (0.28) 
0.44 (0.28) 
1.00 (0.28) 
0.29 (0.28) 
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6.4.2 Dimensions of Recovery 
 
In order to investigate the multidimensionality of recovery from psychosis, an EFA 
using maximum likelihood estimation with promax rotation was performed on the 
subscale scores of all of the measures outlined above. The analysis accounted for all 
missing data so that the full set of data from all 77 participants could be used. The 
outcome of this analysis is reported here.  
 
Factors were selected using a range of criteria from good practice guidelines for factor 
selection in EFA (Brown, 2006; Fabrigar et al., 1999). Initial analyses revealed the 
presence of six factors with eigenvalues exceeding one (i.e. Kaiser criterion). This was 
confirmed by an examination of the scree plot (see Figure 6.1) using the scree test 
(Cattell, 1966). Models with between one and six factors were then fitted to the data and 
the goodness of fit was examined using root mean square residuals provided by Mplus. 
The root mean square residual is the average of the differences between the observed 
variable correlations and the correlations estimated by the model (Brown, 2006). If a 
model provides a good fit to the data, the value of the root mean square residual should 
be below 0.05. The eigenvalues for each factor and root mean square residuals for each 
of the models are shown in Table 6.2.  
 
An item was defined as loading on a factor if it had a loading of 0.30 or above 
(Tabachnick & Fidell, 2001). Joint loadings were considered to occur if an item loaded 
on more than one factor with a difference of less than 0.10. Each factor had to have 
more than two items loading on it in order to be considered as a dimension of recovery.  
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Figure 6.1  
Scree plot from exploratory factor analysis 
 
 
Table 6.2  
Eigenvalues and Root Mean Square Residuals for Different Factor Solutions 
 
Number of factors  Eigenvalue Root Mean Square Residual 
1 7.65 0.17 
2 3.64 0.11 
3 2.07 0.09 
4 1.72 0.07 
5 1.33 0.06 
6 1.14 0.039 
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After an examination of each of the models, based on the above rules and with reference 
to the recovery literature, it was decided that the six factor model provided the best fit to 
the data. The factor loadings of this model are shown in Table 6.3. Correlations between 
each of the factors are shown in Table 6.4. Each factor will now be described.  
 
The factor structure was supported by qualitative data collected during the assessments. 
Relevant quotes are used to illustrate each factor. 
 
6.4.2.1 Factor 1: Activity Levels 
 
If I can start some voluntary work and succeed at that, then I can keep on 
moving onto the next step, and improve my confidence. I don’t want to sit on 
my backside and do nothing… Eventually I want to go back to work and get off 
benefits… Having plans in place for what I’m doing in the week definitely 
helps, rather than just thinking, “well, I’ve got a whole week ahead of me and 
nothing to do”… ‘cos that would just drive me to distraction I think. (Participant 
73) 
 
The first factor was labelled “Activity Levels” and reflects the amount of time that an 
individual is spending in structured and constructive economic activity. The two 
subscales of the Time Use Survey were the only loadings on this factor, suggesting that 
the measure reflects an independent dimension of recovery. This factor was also 
independent of symptom-related factors. 
 
6.4.2.2 Factor 2: Positive Symptoms 
 
These days, I sometimes just see things out of the corner of my eye, and when I 
look, there’s nothing there. (Participant 20) 
 
I feel mildly paranoid now… mental panics… like some days when I’m going 
around the supermarket, I’m constantly looking over my shoulder… and I don’t 
know why. (Participant 58) 
 
The second factor was labelled “Positive Symptoms” and reflects the traditional 
conceptualisation of recovery from psychosis. All measures relating to the assessment 
of positive symptoms loaded on this factor, including the SAPS; the PANSS Positive 
subscale; the GAS; and the Paranoia and Anomalous Experiences subscales of the SSI. 
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6.4.2.3 Factor 3: Clinician-rated Recovery 
 
My CPN says, “you’re ready to do more” (Participant 73) 
 
The third factor was labelled “Clinician-rated Recovery” and reflects functional 
recovery, or quality of life, as assessed by measures which are rated by clinicians or 
researchers. Measures loading on this factor include the Quality of Life Scale and the 
SOFAS. Although this factor correlates with the Activity Levels factor, the finding that 
it came out as an independent dimension of recovery suggests that the measures loading 
on it are assessing something qualitatively different from actual hours spent in activity. 
 
6.4.2.4 Factor 4: Negative Symptoms 
 
I have big problems with motivation… it can be awful, to the point that 
sometimes I haven’t gone out for days. Just couldn’t be bothered to do anything. 
I know I need to do things, but sometimes I just can’t be bothered. (Participant 
20) 
 
It’s difficult to think clearly… simple decisions sometimes feel very difficult... 
I’m stumbling over my thoughts and mumbling away… and I find that quite 
frustrating. (Participant 58) 
 
The fourth factor was labelled “Negative Symptoms” and includes those measures 
designed to assess negative symptoms – the SANS and the Negative symptoms subscale 
of the PANSS. This factor was moderately associated with both the Positive Symptoms 
factor and the Clinician-rated Recovery factor. However, it was independent of actual 
time spent in activity (i.e. the Activity Levels factor). 
 
6.4.2.5 Factor 5: Resilience and Optimism 
 
Everything I do is one step further to getting back, and that makes me feel good, 
it improves my self-esteem… It’s not until you’ve been through it that you 
know… I don’t want to fail… and I think this time, feeling positive has got me 
through. (Participant 73) 
 
The fifth factor was labelled “Resilience and Optimism” and reflects feelings of 
positivity and hope. Measures loading on this factor include positive beliefs about self 
and positive beliefs about others subscales of the BCSS, and the Beck Hopelessness 
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Scale (negative loading). Interestingly the EuroQol also loads on this factor, even 
though it is designed to be an assessment of functioning. This suggests that those 
individuals who are more positive or hopeful may rate themselves as having higher 
quality of life using this scale. High scores on this factor may be conducive to better 
recovery. 
 
6.4.2.6 Factor 6: Emotional Barriers 
 
I feel like I’m constantly having this barrage of negative thoughts and I’m 
blaming myself and just getting annoyed with the condition I’ve got… There’s 
this complete loss of control in my life. I don’t know why I was thinking like 
that then… I had this overly inflated sense of self importance then, and yet now 
I feel completely unimportant. I find it quite distressing that I could think like 
that. (Participant 58) 
 
I’m not sure I have the confidence [to work] yet… Because my life has been so 
negative in places, I find it difficult to envisage the future. …I find it difficult to 
be around other people… to explain about my illness. (Participant 36) 
 
The sixth factor was labelled “Emotional Barriers” and includes measures which may be 
considered to reflect barriers towards recovery, notably emotional dysfunction (BDI and 
BAI scores) and negative evaluative beliefs about self and others. Personal Beliefs 
about Illness scores also loaded positively on this factor suggesting that negative illness 
cognitions (i.e. feelings of stigma, etc) may be an emotional barrier to recovery. The 
Social Anxiety and Paranoia subscales of the SSI also loaded positively on this factor. A 
negative correlation was shown between this factor and the Resilience and Optimism 
factor, suggesting that they may be opposite ends of the same spectrum. 
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Table 6.3  
Rotated Factor Solution for Six-factor Recovery Model (N = 77)  
 
Note. Loadings can be higher than +/-1 in a promax rotation, as factors are not orthogonal 
Loadings above 0.30 are highlighted in bold font, dual loadings are italicised
 Activity 
Levels 
Positive 
Symptoms 
Clinician 
Rated 
Negative 
Symptoms 
Resilience 
Optimism 
Emotional 
Barriers 
Cons Economic 
Activity 
0.86 0.10 0.06 -0.01 0.11 0.04 
Structured Activity 0.83 -0.05 0.09 0.09 0.06 0.06 
QLS Total 0.04 0.05 0.87 0.09 0.02 0.05 
QLS Role Function 0.26 -0.11 0.83 -0.20 -0.17 -0.09 
GAS -0.10 0.48 0.38 <-0.01 0.12 -0.03 
BDI 0.02 0.20 -0.06 -0.03 -0.15 0.94 
BAI 0.15 -0.19 0.01 0.18 -0.07 0.62 
BHS -0.08 0.14 -0.02 0.15 -0.55 0.47 
SOFAS -0.06 0.08 0.81 0.05 0.03 -0.01 
EuroQol -0.04 0.03 -0.06 0.10 0.43 -0.31 
SAPS 0.01 -1.03 -0.04 0.07 -0.04 -0.18 
SANS -0.04 0.05 -0.27 -0.66 0.14 0.18 
PBIQ 0.09 0.09 -0.15 0.13 -0.16 0.77 
BCSS – Negative Self -0.02 0.18 0.04 -0.11 <0.01 0.95 
BCSS – Positive Self 0.12 0.02 -0.08 0.08 0.74 -0.14 
BCSS – Negative Other 0.01 -0.19 -0.04 -0.13 0.03 0.46 
BCSS – Positive Other 0.03 0.09 -0.06 0.07 0.83 0.06 
SSI – Social Anxiety  -0.13 -0.14 0.12 0.10 0.01 0.57 
SSI – Paranoia  0.03 -0.50 0.16 -0.09 0.17 0.45 
SSI – Anomalous -0.19 -0.63 0.12 0.06 0.19 0.34 
PANSS – Positive  -0.01 -0.97 -0.04 <0.01 -0.14 -0.20 
PANSS – Negative  -0.02 0.04 0.08 -1.03 -0.05 -0.09 
PANSS – General  0.06 -0.31 -0.12 -0.25 -0.40 0.19 
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  Table 6.4   
  Correlations between Recovery Factors 
 
 Activity 
Levels 
Positive 
Symptoms 
Clinician 
Rated 
Negative 
Symptoms 
Resilience/ 
Optimism 
Emotional 
Barriers 
Activity Levels 1.00      
Positive Symptoms .03 1.00     
Clinician Rated .35 .26 1.00    
Negative Symptoms .13 .34 .41 1.00   
Resilience/Optimism -.11 .27 .23 .16 1.00  
Emotional Barriers -.01 -.53 -.14 -.15 -.44 1.00 
               206
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6.5 DISCUSSION 
 
This chapter has outlined a multidimensional model of recovery based on an 
exploratory factor analysis of commonly used outcome measures for psychosis. It has 
also examined how schizotypal symptom types relate to different recovery dimensions. 
This section will review the findings of the current study. The results will initially be 
considered in relation to each of the research hypotheses outlined at the beginning of 
this chapter. They will then be discussed in relation to the current literature and the 
clinical implications of the findings will be examined. Following on from this, potential 
weaknesses of the study will be outlined, as will possibilities for future research. 
 
6.5.1 Evaluation of Findings in Relation to Research Hypotheses 
 
6.5.1.1 Hypothesis 1 
 
It was hypothesised that recovery would be a multidimensional construct. This 
hypothesis was supported by an exploratory factor analysis which highlighted six 
dimensions of recovery. These include: Activity Levels, Positive Symptoms, Negative 
Symptoms, Clinician-rated Recovery, Resilience/Optimism, and Emotional Barriers. 
This model fitted the data well, based on both good practice guidelines for EFA 
(Brown, 2006; Fabrigar et al., 1999) and in relation to current recovery literature.  
 
6.5.1.2 Hypothesis 2 
 
It was hypothesised that different schizotypal symptom types, as measured by the SSI, 
would exist on different dimensions of recovery. This hypothesis was supported by the 
findings. The Social Anxiety subscale of the SSI loaded on the Emotional Barriers 
factor, along with illness cognitions, depression, anxiety, and negative beliefs about self 
and others. The Anomalous Experiences subscale of the SSI loaded on the Positive 
Symptoms factor, along with other symptom measures including the SAPS, the positive 
symptoms subscale of the PANSS, and the Global Assessment of Symptoms scale. The 
Paranoia subscale of the SSI loaded on both the Emotional Barriers and Positive 
Symptoms factors. This suggests that the Social Anxiety subscale of the SSI may be 
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tapping emotional recovery from the episode of psychosis; whilst the Anomalous 
Experiences subscale may be tapping residual symptoms of psychosis. The Paranoia 
subscale appears to be tapping both of these constructs. 
 
6.5.2 Relevance to the Literature 
 
The outcome dimensions proposed in this study concur with literature suggesting that 
recovery from psychosis involves more than just symptom remission (Anthony, 1993; 
Liberman & Kopelowicz, 2002; J. Lieberman et al., 2008). Indeed, the model highlights 
symptomatic recovery as one dimension but also takes into account other factors, such 
as emotional disturbance and functioning. Moreover, it supports the notion that 
symptomatic and functional recovery are relatively independent of one another (e.g. 
Tohen et al., 2000) due to the loading of symptom and functioning measures on 
separate, uncorrelated factors. In addition, the factors outlined in the model correspond 
with the dimensions of outcome featured in existing operational definitions of recovery. 
For example, Whitehorn et al’s (2002) “symptom control”, “autonomous living”, and 
“return to the social and occupational lifeline” are arguably reflected in the Positive 
Symptoms, Negative Symptoms, Clinician-rated Recovery and Activity Levels factors.  
 
However, as well as supporting operational criteria, the model also provides validity for 
the use of specific measures in assessing suggested dimensions of recovery. This is an 
important addition to the literature as many previous studies have argued that recovery 
research is limited by difficulties in assessing this somewhat abstract and multifaceted 
concept (Liberman, 2002; G. Shepherd et al., 2008). Indeed, Estroff (1995) suggests: 
 
The challenge for researchers… is to develop methods and principles that reflect 
accurately the experiences, meanings and needs of people with severe, 
persistent, mental illness. The challenge is not to reduce the complexity of the 
task, but to make it understandable. The reconstitution of lives in a complex 
process, much of which we fail to find in our outcome research not necessarily 
because of the bleak course of schizophrenia, but because of conceptual and 
methodological shortcomings. (p. 87) 
 
Symptomatic recovery is often assessed by scores on the positive subscale of the 
PANSS (e.g. Liberman et al., 2002; Whitehorn et al., 2002). This subscale had a high 
and independent loading on the Positive Symptom factor in the current model, 
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suggesting that it is a valid tool for assessing the remission of full-blown positive 
psychotic symptoms. Clinician-rated measures such as the SOFAS and QLS are often 
used to assess functional recovery from psychosis (e.g. Whitehorn et al., 2002). 
However, this practice was called into question by the findings of the current study. The 
results of the factor analysis suggest that these measures may be assessing something 
qualitatively different to actual time spent in structured activity, which loaded on a 
separate and independent factor. Moreover, the Clinician-rated Recovery factor was 
highly correlated with the Negative Symptoms factor, implying that measures such as 
the QLS and SOFAS may be assessing more of a generic “deficit syndrome” rather than 
actual activity. This supports existing criticisms of the SOFAS, which argue that it does 
not capture the complexity of “real life” functioning (Wallace, Liberman, Tauber, & 
Wallace, 2000). In addition, the EuroQol, which is traditionally viewed as a measure of 
quality of life, loaded with measures assessing positivity and hopefulness. This supports 
previous literature proposing differences in objective and subjective assessment of 
quality of life (Narvaez, Twamley, McKibbin, Heaton, & Patterson, 2008); and suggests 
that careful thought needs to be given to the measures used when defining operational 
criteria for recovery. 
 
In terms of schizotypal symptoms – the main focus of this thesis – the results of the 
current study support those outlined in previous chapters and highlight the importance 
of using a measure of schizotypal symptoms in the assessment of recovery from 
psychosis. The finding that the Anomalous Experiences subscale of the SSI loaded 
strongly and independently with positive symptom measures validates the use of this 
scale in assessing the residual symptoms of psychosis. Moreover, it supports the notion 
that Anomalous Experiences are not influenced by emotion and psychological variables 
to the same extent as Paranoia and Social Anxiety. The Social Anxiety subscale loaded 
with measures tapping emotional distress, negative illness cognitions and negative 
schematic beliefs about self and others. This supports research suggesting that social 
anxiety may be reactive, arising from threats associated with the experience of 
psychosis, i.e. from feelings of shame, personal vulnerability and stigma (Birchwood et 
al., 1993). Paranoia loaded with both Anomalous Experiences (Positive Symptoms 
factor) and Social Anxiety (Emotional Barriers factor), suggesting that paranoid beliefs 
may occur as residual forms of persecutory delusions, and/or as interpersonal concerns 
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resulting from the psychological impact of psychosis, e.g. “people are looking at me and 
judging me because they know I have a mental illness”. 
 
The factors highlighted from this exploratory analysis also mirror themes outlined in 
service user literature on recovery (e.g. Anthony, 1993; Davidson, 2003; Deegan, 1988; 
Pitt et al., 2007). “Renewing hope and commitment”, “accepting illness” and 
overcoming the “interpersonal effects” of an episode of psychosis feature heavily in 
user-defined criteria for recovery from psychosis (Davidson, 2003; Noordsy et al., 
2002). Moreover, it has been proposed that these themes may be important mediators of 
functional recovery (Liberman & Kopelowicz, 2002), and argued that they should 
feature as central components in recovery oriented services (Anthony, 1993). However, 
as the majority of these concepts have emerged from qualitative research and service 
user reports of recovery, it is difficult to incorporate them into standardised assessment 
frameworks, due to their somewhat subjective nature. Despite this, service user recovery 
themes are arguably reflected in the Resilience/Optimism and Emotional Barriers 
factors of the model outlined in this study. This suggests that they can in fact be 
measured to a certain extent by standardised tools such as the SSI, BHS, BCSS and 
PBIQ. Further investigation is however required. 
 
6.5.3 Clinical Implications of Findings 
 
The current study has highlighted the complex interplay of factors involved in recovery 
from a psychotic episode. The findings suggest that focusing on one aspect of recovery 
in isolation, such as symptom remission, may be inadequate. The proposed 
multidimensional model could be agued to provide a framework for the assessment of 
recovery from psychosis, outlining which tools may be most appropriate for assessing 
particular types of outcome. This framework could also be used to create “recovery 
profiles”, tailored to the individual and outlining the relative contribution of different 
dimensions to the wider recovery process. It is likely that individuals will encounter all 
of the factors associated with recovery from a psychotic episode, but at varying levels of 
severity and at different time points along the recovery pathway. Thus, all of these 
factors need to be monitored and responded to appropriately.  
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This assessment framework may be particularly relevant for the delivery and evaluation 
of recovery-oriented services for people with severe mental health problems. Central 
features of these services include: symptom management; developing awareness of 
early warning signs/relapse plans; adjusting to the psychological impact of the episode; 
instilling hope for the future; empowering individuals to develop valued relationships 
and roles; and increasing social and occupational activity (Department of Health, 2001; 
Jacobson & Greenley, 2001; G. Shepherd et al., 2008; Tauscher-Wisniewski & 
Zipursky, 2002; Turner-Crowson & Wallcraft, 2002). Such a multidimensional 
approach supports the multidimensional nature of the model outlined in this study. 
Indeed, different types of recovery are likely to require different forms of treatment. 
Suggested interventions include: maintenance doses of medication for residual 
symptoms; social skills training, psychoeducation, and supported employment (see 
Mueser, Corrigan et al., 2002 for a review). Evaluating the efficacy of these targeted 
interventions requires the use of specific tools designed to assess the particular outcome 
of interest. For example, an intervention designed to instil hope and increase self-esteem 
would be best assessed by tools loading on the Optimism/Resilience factor outlined in 
this study (e.g. BHS, BCSS). Conversely, an intervention designed for improving social 
skills to increase functioning may be best assessed by tools loading on the Activity 
Levels factor, (i.e. the Time Use Survey). 
 
This study also highlights the importance of assessing schizotypal symptoms in the 
recovery stages of psychosis. Monitoring schizotypal symptoms may be important when 
thinking about early warning signs for psychotic relapse. Indeed, in a prospective study 
of the six-week period preceding relapse in a group of individuals with schizophrenia, 
subtle increases in “quasi-psychotic phenomena” (i.e. unusual perceptual experiences 
and unusual thought content as featuring in the Anomalous Experiences and Paranoia 
subscale of the SSI) were found to predict relapse (Subotnik & Nuechterlein, 1988). 
However, the authors noted that such slight increases were difficult to assess using 
traditional assessment tools such as the BPRS (Overall & Gorham, 1962). With this in 
mind, the Anomalous Experiences and Paranoia subscales of the SSI may be more 
sensitive in detecting these subtle changes than more traditional assessment tools. These 
subscales of the SSI may also be useful in the creation of relapse plans (Birchwood, 
Spencer et al., 2000); and for monitoring the efficacy of interventions designed for 
psychotic symptom control, for example maintenance doses of antipsychotic medication 
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(Tauscher-Wisniewski & Zipursky, 2002). Conversely, an intervention designed to 
target the interpersonal effects of an episode of psychosis, may be best assessed by the 
Social Anxiety subscale of the SSI, which appears to reflect emotional disturbance 
associated with psychosis. 
 
6.5.4 Limitations of the Current study and Future Directions 
 
Previous studies have criticised the use of factor analysis in the development of 
theoretical concepts (Delis et al., 2003). This criticism is mostly based on a study by 
Armstrong (1967) who created an artificial data set with a known structure and then 
showed that factor analysis failed to accurately represent this structure. Subsequent 
studies have however argued that it is not factor analysis per se that is problematic, but 
rather the way in which it is commonly misused by researchers (Fabrigar et al., 1999). 
EFA, rather than PCA, is suggested as the best technique for studies investigating latent 
constructs. In addition, maximum likelihood estimation is proposed as gold-standard 
methodology as it allows the goodness-of-fit of models to be established. Moreover, it is 
recommended that researchers use multiple criteria when deciding upon the number of 
factors to include in a model (e.g. eigenvalues, scree test, and descriptive fit indexes); 
and to use oblique (rather than orthogonal) rotation techniques, unless it is known a 
priori that factors are uncorrelated (Brown, 2006; Fabrigar et al., 1999). Thus, it could 
be argued that the EFA conducted in this study was appropriate and well informed in 
terms of both statistical methodology and theoretical literature on recovery. As such, the 
interpretation of the findings can be viewed with relative confidence. Despite this, some 
limitations do apply. The analysis was based on a relatively small sample size of 
individuals who were selected on the basis that they had poor social functioning. It has 
been argued that factor analyses should not be conducted on samples with less than 100 
participants (Fabrigar et al., 1999). Furthermore, some data was skewed and this can 
affect the accuracy of maximum likelihood methods (Curran, West, & Finch, 1996). As 
a result of these weaknesses, replication studies are required in order to provide further 
support for the factorial structure that has been proposed.  
 
When interpreting the results, it is important to bear in mind that factor analysis simply 
highlights correlations existing between different measures and thus any interpretation 
should be informed by current theoretical knowledge. However, the correlations 
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highlighted in this study do support an a priori hypothesis that recovery from psychosis 
is multidimensional. Nevertheless, the model proposed is not definitive and requires 
validation from further, and larger, confirmatory studies. In addition, there is a need for 
triangulation with other forms of investigation, such as treatment studies targeting 
specific dimensions of outcome (Liberman et al., 2002). If such studies showed change 
on the standardised assessment tools loading on the dimension of interest, this would 
further validate the model. There are also other outcome measures used in psychosis 
research which have not been included in this study and which should be investigated as 
part of developing a more substantive model (e.g. the Independent Living Skills Survey; 
Wallace et al., 2000). Finally, it must be remembered that psychosis, and thus recovery 
from psychosis, is extremely heterogeneous, influenced by many internal and personal 
variables. Numerous studies have identified characteristics which are predictive of 
recovery from psychosis, including marital status, premorbid functioning, and 
neuropsychological deficits (Hoffmann & Kupper, 2002; Liberman et al., 2002). These 
variables also need to be taken into account when considering the process of recovery 
from psychosis. In particular, future studies should examine how these predictors relate 
to different dimensions of outcome. 
 
Future studies should also focus on applying this dimensional outcome model to 
theoretical and explanatory research investigating the process of recovery from 
psychosis. Indeed, the current study was cross-sectional and thus no conclusions can be 
drawn regarding temporal aspects of recovery. For example, previous literature suggests 
that symptomatic improvement occurs first, followed by recovery from the 
psychological impact of psychosis as a major life event (McGorry, 1992). This could 
not be investigated in the current study. Moreover, the literature also suggests that 
certain factors may either impede or promote recovery and thus may act as mediators in 
the recovery process (Liberman & Kopelowicz, 2002). For example, personal resilience 
and hope are highlighted as important components of functional recovery from 
psychosis (Noordsy et al., 2002; Pitt et al., 2007). Conversely, negative illness 
cognitions and high levels of distress are hypothesised to impede recovery from 
psychosis (Birchwood et al., 1993). As such, it could be argued that individuals scoring 
highly on the Emotional Barriers factor may have problems with recovery, whereas 
individuals scoring highly on the Resilience/Optimism factor may have better 
recoveries. If this is the case, interventions targeting these constructs may be successful 
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in facilitating long term recovery from psychosis (see Appendix B for ISREP trial 
paper). However, longitudinal research needs to be conducted to investigate these 
potential mediational pathways further. This will be the focus of the final study in this 
thesis. 
 
6.5.5 Summary 
 
In conclusion, this study has proposed an exploratory six-factor assessment model of 
different dimensions of recovery from psychosis. This supports the notion that recovery 
is a multidimensional construct, encompassing both symptomatic and functional 
recovery, as well as emotional and psychological well-being. The importance of 
schizotypal symptoms in the recovery process has also been highlighted. The current 
study provides a useful framework for further investigations of the recovery concept. 
However, the model requires further validation and replication using confirmatory 
factor analysis in a larger sample. The final study in this thesis will examine the 
potential role of schizotypal symptoms as mediators of social recovery.  
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CHAPTER SEVEN: 
STUDY SIX: SCHIZOTYPAL SYMPTOMS AS AN OUTCOME AND 
MEDIATOR OF COGNITIVE BEHAVIOUR THERAPY FOR IMPROVING 
SOCIAL RECOVERY IN PSYCHOSIS 
 
 
7.1 RATIONALE AND CONTEXT FOR THE STUDY 
 
Previous studies in this thesis have highlighted the importance of schizotypal symptoms 
in recovery from psychosis, both in terms of the disease process itself (i.e. occurring as 
residual symptoms) and in terms of emotional and psychological recovery from the 
disorder. A model outlining a potential dimensional approach to recovery has also been 
postulated, suggesting that the presence of schizotypal symptoms may have an influence 
on long-term outcome from an episode of acute psychosis. However, thus far these 
findings have all been demonstrated using a cross-sectional design. As such, the 
temporal process by which schizotypal symptoms may influence recovery from 
psychosis is unknown. This study will adopt a longitudinal design, in the context of a 
randomised controlled trial, in order to investigate this further. It will examine whether 
an intervention designed to improve social recovery in psychosis has an impact on 
schizotypal phenomena, and whether changes in schizotypal symptoms mediate changes 
in social functioning.  
 
As outlined above, data collection for this study took place in the context of a 
randomised controlled trial. The “Improving Social Recovery in Early Psychosis” 
(ISREP) study is an MRC-funded platform trial, designed to investigate the efficacy of 
a new psychosocial intervention to improve social recovery in early psychosis and 
severe affective disorder. The intervention – Social Recovery oriented Cognitive 
Behaviour Therapy (SRCBT) – specifically focuses on improving constructive and 
structured social activity, while managing sensitivity to stress and low-level psychotic 
symptoms. Thus, it aims to target a range of different dimensions of recovery outlined 
in the previous chapter. The primary outcome of the trial was hours spent in structured 
and constructive economic activity. A range of other psychological and intrapsychic 
outcomes were also assessed, including schizotypal symptoms, hopelessness, symptoms 
of depression and anxiety, and beliefs about self and others. See Appendix B for the 
ISREP trial outcome paper.  
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Past clinical trials of interventions which have attempted to promote social activity 
without taking careful account of sensitivity to psychosis and anxiety, have shown 
increased risk of relapse, especially amongst people still experiencing psychotic 
symptoms (Hogarty, Goldberg, Schooler, & Ulrich, 1974; Hogarty et al., 1997). This 
fits with stress-vulnerability models of psychosis (Zubin & Spring, 1977) and the 
suggestion that vocational rehabilitation into competitive employment can be 
demanding and stressful for individuals with psychosis (Hoffmann, Kupper, & Kunz, 
2000; Nithsdale, Davies, & Croucher, 2008). It has been argued that in addition to 
supported employment, more emphasis should be placed on managing residual 
symptoms, inducing positive self-concepts, and instilling optimistic but realistic 
expectations (Mueser, Corrigan et al., 2002; Resnick, Rosenheck, & Lehman, 2004). 
This approach, adopted by the ISREP trial, may provide the coping strategies and self-
confidence required to produce a favourable recovery outcome. Although the main 
outcome of the ISREP study was weekly hours in constructive and structured activity, 
the present study aims to evaluate the impact of SRCBT on schizotypal phenomena, 
using the SSI. In addition, the role of schizotypal symptoms as mediators of change in 
time use will be investigated. If schizotypal symptoms do indeed play a key role in 
recovery, changes in these phenomena would arguably be accompanied by changes in 
activity.  
 
7.2 RESEARCH HYPOTHESES 
 
1. It is predicted that the provision of SRCBT added to treatment as usual 
(TAU) will have an effect on schizotypal symptoms in comparison to TAU 
alone. 
 
2. It is predicted that SRCBT but not TAU will lead to changes in levels of 
schizotypal symptoms, and that these changes may be specifically associated 
with changes in activity. 
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7.3 METHOD 
 
7.3.1 Design 
 
The study was a single blind randomised controlled treatment trial (RCT) comparing 
cases who received SRCBT in addition to TAU (treatment group) with those receiving 
TAU alone (control group). Participants were randomised to either the treatment or 
control group following a baseline assessment and initial screening for suitability. 
Randomisation was stratified for diagnosis (affective/non-affective psychosis) and 
centre (Norfolk/Cambridgeshire). It is well established that RCTs provide gold-standard 
methodology to test the effectiveness of new treatments. However, there is an increasing 
emphasis on RCT methods to examine the process of treatment as well as its outcome 
(J. Green, 2006; J. Green & Dunn, 2008). This is the focus of the current study. 
 
7.3.2 Participants 
 
Seventy-seven participants were recruited from secondary mental health services in the 
East Anglia region of the UK, localised around two sites: Norfolk and Cambridgeshire. 
 
7.3.2.1 Sample size and power analysis 
 
The ISREP trial was designed to compare the effectiveness of a new intervention 
(SRCBT) in comparison to a control condition (TAU). The sample size was predicated 
on testing the effectiveness of SRCBT on a range of outcome measures with an effect 
size of .60. A power analysis calculation revealed that to achieve 90% power with a 
significance level of .05 and an estimated effect size of .60, a minimum sample size of 
30 participants per group was required (Cohen, 1988). However, the aim was to recruit 
beyond this to account for potential drop-outs. It was known that investigations of 
hypotheses regarding mediators of change would be underpowered and would therefore 
need to be regarded with caution. However, they were still undertaken as useful 
preliminary steps in empirically informed exploratory research. 
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7.3.2.2 Inclusion and exclusion criteria 
 
Inclusion criteria for the study were: (a) a current diagnosis of affective or non-affective 
psychosis (including schizophrenia, schizoaffective disorder, bipolar disorder, and 
psychotic depression); (b) illness duration of 8 years or less (onset of illness was 
defined as the first contact with psychiatric services for psychotic symptoms, checked in 
case notes); (c) positive psychotic symptoms (hallucinations and delusions) in relative 
remission (defined by a score of 4 of less on individual symptoms on the PANSS); and 
(d) currently unemployed or engaged in less that 16 hours per week paid employment or 
education. Participants were excluded if the psychotic disorder was thought to have an 
organic basis, acute psychosis was present, or the primary diagnosis was drug 
dependency on opiates or cocaine. 
 
7.3.2.3 Participant characteristics 
 
Thirty-five participants were randomised to the treatment condition and 42 to TAU, the 
control condition. Key demographic, clinical and social characteristics of the sample are 
summarised in Table 7.1. This shows that randomisation resulted in well-balanced 
groups between treated and control cases in terms of age, gender, ethnicity, diagnosis 
and illness length, and social characteristics. There were no significant differences on 
any of these variables between the treatment and control groups. Participant flow 
throughout the trial is outlined in a CONSORT diagram in Figure 7.1. 
 
7.3.3 Ethical Considerations 
 
As outlined in Study 1 of this thesis, the study was reviewed and approved by the ethics 
committees of all participating institutions (section 2.4.3). All participants were given 
an information sheet about the trial and asked to sign a consent form (see Appendix D). 
A minimum of 72 hours was allowed between giving information about the study and 
taking informed consent. Any potential participant who was considered by a clinician as 
unable to give informed consent was not approached to take part. 
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Table 7.1  
Baseline Characteristics of ISREP Participants  
 
 
 SRCBT  
(N = 35) 
TAU  
(N = 42) 
Total  
(N = 77) 
Demographic characteristics: 
Mean Age in years (SD) 
 
Gender (% male) 
 
Ethnicity (% white) 
 
Diagnosis (% non-affective) 
 
Mean illness length in yrs (SD) 
 
Medication level in mg (SD) 
(chlorpromazine equivalence) 
 
 
27.8 (6.1) 
 
71.4% 
 
85.7% 
 
65.7% 
 
4.9 (2.2) 
 
265.1 (200.8) 
 
30.0 (7.2) 
 
71.4% 
 
95.2% 
 
64.3% 
 
4.8 (2.4) 
 
223.7 (167.0) 
 
29.0 (6.8) 
 
71.4% 
 
90.9% 
 
64.9% 
 
4.8 (2.3) 
 
242.2 (182.7) 
 
Social and Clinical characteristics   
Mean (SD): 
Unemployment length in weeks  
 
Time Use in hours per week: 
- Constructive Economic Activity 
- Structured Activity 
 
Current IQ  
 
Contacts with Secondary Mental 
Health Services in last 6 months 
 
Contacts with Voluntary Services in 
last 6 months 
 
 
202.4 (146.0) 
 
 
14.8 (20.2) 
30.4 (19.9) 
 
101.8 (11.3) 
 
32.1 (35.3) 
 
 
11.0 (18.3) 
 
 
214.8 (209.2) 
 
 
10.4 (13.9) 
27.8 (19.2) 
 
103.7 (11.3) 
 
25.9 (23.1) 
 
 
7.4 (14.4) 
 
 
209.1 (182.2) 
 
 
12.4 (17.1) 
29.0 (19.4) 
 
102.8 (11.3) 
 
32.1 (35.3) 
 
 
9.0 (16.2) 
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Figure 7.1  
CONSORT diagram of participant flow throughout the ISREP trial 
Fully Suitable N = 200 
 
Consented                     N = 88 
Did Not Consent           N = 112 
Assessed and Randomised N = 77 
 
Dropped out during baseline assessment   N=11 
 
Reasons: 
Symptomatic N = 5
Not interested N = 5 
Personal reasons N = 1 
Treatment (SRCBT) N = 35 
Location: 
Centre 1   N = 24 
Centre 2   N = 11 
 
Diagnosis: 
Affective   N = 12 
Non-affective  N = 23 
Control (TAU) N = 42 
Location: 
Centre 1   N = 26 
Centre 2   N = 16 
 
Diagnosis: 
Affective   N = 15 
Non-affective  N = 27 
 
N = 33 
Post-
intervention 
follow-up  
(9 month) 
2 drop-out 4 drop-out 
 
N = 38 
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7.3.4 Treatments 
 
Details of SRCBT and TAU conditions are outlined below. 
 
7.3.4.1 Social Recovery Cognitive Behavioural Therapy (SRCBT) 
 
Therapy was adapted from the CBT for psychosis manual (Fowler et al., 1998), 
particularly focusing on aspects promoting social recovery, and was also informed by 
manuals for cognitive therapy of depression (Beck, Rush, Shaw, & Emery, 1979); and 
social anxiety (G. Butler, 1999). Therapy in both centres was supervised by experienced 
CBT specialists. Adherence and competence were monitored using tape recordings and 
individual and group supervision. Participants received a mean of 14 sessions (SD = 7). 
For a more detailed description of SRCBT, see trial outcome paper (Appendix B) 
 
7.3.4.2 Treatment as Usual (TAU) 
 
Active case management was provided by multidisciplinary secondary care mental 
health teams as treatment as usual. This consisted of multidisciplinary case 
management, and was backed by the availability of services to provide supported 
employment for people with severe and enduring mental health problems. There were 
no significant differences in the level of support given to treated cases and controls at 
baseline (see Table 7.1), t(75) = -1.3, p = .20.   
 
7.3.5 Measures 
 
The sample completed a range of measures at both baseline and post-treatment. The 
primary outcome of the ISREP trial was weekly hours in structured and constructive 
economic activity, measured by the Time Use Survey (TUS; adapted from Short, 2006) 
as described in the previous chapter (section 6.3.3). However, for the purpose of this 
study, schizotypal symptoms measured by the brief version of the Schizotypal 
Symptoms Inventory (SSI) were the main outcome of interest. The SSI has been 
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described in detail elsewhere in this thesis and as such a description will not be repeated 
here. Total scale and subscale scores were used in the analyses. 
 
Other measures administered in the study included the Positive and Negative Syndrome 
Scale (PANSS; Kay et al., 1987); the Quality of Life Scale (QLS; Heinrichs et al., 
1984); the Beck Hopelessness Scale (BHS; Beck & Steer, 1988); the Beck Depression 
Inventory (BDI-II; Beck et al., 1996); the Beck Anxiety Inventory (BAI; Beck & Steer, 
1987); the Brief Core Schema Scales (BCSS; Fowler, Freeman, Smith et al., 2006); the 
Personal Beliefs about Illness Questionnaire (PBIQ; Birchwood et al., 1993); the 
EuroQol visual analogue scale (EQ-VAS; Brooks, 1996); the Global Assessment of 
Symptoms Scale (GAS; American Psychiatric Association, 2000b); and the Social and 
Occupational Functioning Assessment Scale (SOFAS; Goldman et al., 1992). All of 
these measures have been described in detail in previous chapters of this thesis. 
 
7.3.6 Procedure 
 
Participants were assessed at two time points by a researcher who was blind to the 
outcome of randomisation and thus did not know if the participant had received therapy 
or not.  The baseline assessment (T1) occurred after participants had consented to take 
part in the study and before randomisation. The post-treatment assessment (T2) took 
place at the end of the study, approximately nine months after the baseline assessment. 
For those individuals who did not wish to attend a post-treatment assessment 
appointment but who were willing to still be involved in the project, assessments took 
place over the telephone and were also triangulated with discussions with carers and/or 
care co-ordinators. 
 
Baseline and post-treatment assessments were conducted by research assistants who 
were independent of treatment delivery and randomisation. Every effort was made to 
ensure they were kept blind to allocation. Formal training in all measures was provided 
and interviews were audio-taped for reliability and quality control. Research assistants 
met regularly throughout the trial to maintain reliability of procedures and ratings. 
Where blindness was broken, another research assistant conducted the follow-up 
assessment. Ninety-three percent of the post-treatment assessments were completed 
blind. The research assistants made allocation guesses after post-treatment assessments. 
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These were correct for treatment (SRCBT) for 58% and for control (TAU) guessed 
correctly for 64%. This is within the levels that would be expected by chance and thus 
blindness can be considered successful. 
 
7.3.7 Data Analysis Plan 
 
Data was cleaned and screened as outlined in Study 1 (section 2.4.6.1). Descriptive 
statistics were then computed for all variables. All data was analysed using SPSS for 
Windows, version 14.0 (SPSS, 2005).  
 
Formal analyses and statistical testing were conducted on an intention-to-treat (ITT) 
basis using Analysis of Covariance (ANCOVA) models.  These analyses allow for the 
presence of missing outcome data under the assumption that the data are missing at 
random conditional on the covariates included in the regression model (i.e. allocation, 
schizotypal symptoms, length of unemployment, and baseline values of the outcome 
variables). The sensitivity of the results to departures from this assumption was checked 
for those analyses indicating a significant treatment effect. For these analyses, missing 
data at follow up was imputed using an expectation-maximisation (EM) model.  
 
7.3.7.1 Hypothesis 1 
 
ANCOVA models were used to test the significance of differences between the 
treatment and control groups for all outcome measures. This study specifically focuses 
on the effects of treatment on schizotypal symptoms. A separate ANCOVA was 
conducted for each subscale of the SSI, using the post-treatment (T2) score on the 
measure as the dependent variable. Allocation to treatment, centre and diagnosis were 
used as fixed factors; and two key variables assumed to be associated with outcome and 
predictive of drop-out were used as covariates. The covariates were: baseline (T1) score 
on the measure (e.g. schizotypal symptoms at baseline); and length of unemployment. 
Non-significant interactions were removed before testing for main effects. 
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7.3.7.2 Hypothesis 2 
 
A further set of ANCOVAs were conducted in order to examine the effect of 
schizotypal symptoms as mediators of change in social functioning in the context of 
SRCBT. For each ANCOVA, hours in structured activity at post-treatment (T2) was 
used as the dependent variable, with baseline (T1) hours in structured activity as a 
covariate. Allocation to treatment, and change in the mediating variable (i.e. T2-T1 
change in schizotypal symptoms) were then included as explanatory variables. If a 
significant interaction was found between allocation and change in schizotypal 
symptoms, this was interpreted as suggesting that schizotypal symptoms may mediate 
the effect of SRCBT on functioning (i.e. the intervention may enhance change in that 
variable). If this interaction was not significant then it was removed and the analysis 
was repeated. A significant main effect of change in schizotypal symptoms on activity 
would highlight a longitudinal relationship between these two variables (i.e. change in 
one variable influences change on another, but not specifically in the context of 
therapy). 
 
7.4 RESULTS 
 
7.4.1 Descriptive Data 
 
Outcome data on activity was available for 92% of the recruited sample. This 
information was obtained via a combination of face-to-face and telephone interview, 
conversations with case managers, and case note information. Eighty percent of the 
sample completed post-treatment face-to-face interview. Questionnaire assessments 
were available for around 75% of the sample. Descriptive statistics (means and standard 
deviations) are shown in Table 7.2 for the SSI and in Table 7.3 for all other variables. 
For the SSI, means and standard deviations are provided for baseline and post-treatment 
assessments and also for participant change scores (T2-T1). The descriptive statistics 
are broken down by treatment and diagnostic group at baseline and post-treatment (9 
months) and derive from analyses of the cases available at post-treatment assessment 
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(i.e. the completers). Data for some variables was skewed and was resistant to 
normalising transformation. 
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 Table 7.2  
 Descriptive Statistics for SSI Scores by Treatment and Diagnosis – Mean (SD) 
 
 Note. TAU = Treatment as Usual; SRCBT = Social Recovery-oriented Cognitive Behaviour Therapy  
Total Sample (N = 68) Non-Affective (N = 45) Affective (N = 23)   
TAU (N = 38) CBT (N = 30) TAU (N = 25) CBT (N = 20) TAU (N = 13) CBT (N = 10) 
 
Total 
 
0 
9 
Change 
 
21.7 (14.5) 
24.8 (16.6) 
2.1 (15.5) 
 
15.9 (17.5) 
18.6 (12.8) 
6.1 (11.5) 
 
24.8 (16.5) 
26.0 (18.4) 
-0.5 (17.6) 
 
10.5 (9.3) 
18.0 (12.3) 
10.0 (9.8) 
 
15.8 (6.7) 
22.8 (13.8) 
6.5 (10.6) 
 
26.6 (2.8) 
19.7 (14.4) 
-1.1 (11.6) 
 
Social Anxiety 0 
9 
Change 
10.8 (6.1) 
10.1 (6.3) 
-0.9 (5.6) 
6.2 (6.0) 
9.9 (6.7) 
5.2 (7.1) 
10.8 (6.4) 
9.3 (6.2) 
-1.7 (6.0) 
4.1 (4.1) 
10.3 (7.0) 
7.6 (6.3) 
10.8 (5.7) 
11.3 (6.5) 
0.5 (4.7) 
10.4 (7.1) 
9.2 (6.6) 
0.6 (6.5) 
 
Paranoia 0 
9 
Change 
6.5 (6.1) 
7.4 (5.8) 
0.8 (5.2) 
5.0 (6.6) 
5.2 (5.1) 
1.0 (4.0) 
8.0 (6.7) 
8.5 (6.4) 
0.2 (6.0) 
3.3 (3.7) 
4.6 (4.3) 
1.7 (3.5) 
3.6 (3.2) 
5.7 (4.6) 
1.8 (3.6) 
8.5 (9.7) 
6.1 (6.6) 
-0.5 (4.6) 
 
Anomalous Experiences 0 
9 
Change 
4.4 (6.5) 
7.3 (6.6) 
2.2 (7.4) 
4.7 (6.2) 
3.6 (4.5) 
0.0 (4.5) 
6.0 (7.4) 
8.2 (7.2) 
1.0 (8.7) 
3.2 (3.2) 
3.1 (4.2) 
0.7 (2.5) 
1.3 (1.8) 
5.8 (5.4) 
4.2 (4.6) 
9.3 (2.9) 
5.2 (1.7) 
-1.3 (6.8) 
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Table 7.3  
Descriptive Statistics for ISREP Trial Outcome Variables by Treatment and Diagnosis – 
Mean (SD) 
 
 
Note. TAU = Treatment as Usual 
 SRCBT = Social Recovery-oriented Cognitive Behaviour Therapy  
Total Sample Non-Affective Affective   
TAU SRCBT TAU SRCBT TAU SRCBT 
 
Structured Activity 
 
0 
9 
 
27.9 (19.2) 
34.4 (20.6) 
 
30.4 (19.9) 
40.0 (22.8) 
 
27.7 (20.0) 
31.8 (21.3) 
 
25.1 (10.9) 
37.1 (17.2) 
 
28.2 (18.4) 
39.8 (18.9) 
 
40.6 (28.5) 
45.4 (31.2) 
 
Constructive 
Economic Activity 
0 
9 
10.4 (13.9) 
15.6 (15.9) 
14.8 (20.2) 
19.2 (21.0) 
8.7 (13.3) 
11.9 (13.6) 
10.3 (7.3) 
14.7 (12.9) 
13.6 (14.7) 
22.4 (18.1) 
23.6 (32.1) 
28.6 (30.6) 
 
PANSS Total 0 
9 
56.0 (10.3) 
50.4 (10.1) 
57.6 (11.6) 
50.5 (9.2) 
58.1 (9.4) 
53.2 (8.3) 
57.5 (10.8) 
50.3 (8.2) 
52.1 (11.0) 
44.5 (11.3) 
58.0 (13.4) 
50.7 (11.3) 
 
QLS Total 0 
9 
62.7 (14.8) 
72.5 (18.5) 
66.8 (14.8) 
76.1 (14.0) 
58.2 (11.0) 
67.1 (15.0) 
64.1 (10.2) 
72.8 (12.3) 
70.7 (17.5) 
83.8 (20.5) 
71.7 (20.5) 
82.3 (15.5) 
 
QLS Role Function  0 
9 
5.6 (3.8) 
7.2 (5.7) 
6.6 (4.1) 
9.0 (5.6) 
4.6 (2.9) 
6.1 (5.3) 
5.8 (3.5) 
8.3 (5.6) 
7.4 (4.6) 
9.5 (5.9) 
8.2 (4.9) 
10.5 (5.4) 
 
Beck Hopelessness 
Scale 
0 
9 
8.7 (5.8) 
7.9 (5.8) 
8.9 (5.8) 
6.4 (4.7) 
8.0 (5.5) 
8.2 (5.9) 
8.3 (5.5) 
4.9 (2.3) 
10.2 (6.4) 
7.3 (5.9) 
10.2 (6.3) 
9.3 (6.6) 
 
BCSS – Negative 
Self 
0 
9 
6.7 (6.3) 
4.9 (4.4) 
5.5 (5.1) 
4.0 (5.3) 
6.4 (6.7) 
4.2 (3.8) 
4.0 (3.5) 
2.7 (2.3) 
7.2 (5.8) 
5.9 (5.2) 
8.3 (6.5) 
6.2 (7.8) 
 
BCSS – Positive 
Self 
0 
9 
9.2 (6.4) 
10.6 (6.8) 
8.4 (5.6) 
11.9 (6.0) 
8.8 (6.8) 
10.0 (7.6) 
8.6 (5.5) 
11.6 (5.7) 
10.0 (5.8) 
11.5 (5.3) 
8.1 (6.1) 
12.3 (6.8) 
 
BCSS – Negative 
Other 
0 
9 
6.7 (6.6) 
4.9 (4.6) 
6.6 (6.3) 
3.5 (4.2) 
7.7 (7.1) 
4.3 (3.8) 
5.7 (5.7) 
2.9 (3.6) 
4.8 (5.2) 
5.8 (5.8) 
8.1 (7.2) 
4.3 (5.2) 
 
BCSS – Positive 
Other 
0 
9 
11.7 (6.5) 
10.0 (6.1) 
8.9 (5.5) 
11.9 (6.2) 
11.2 (6.9) 
9.5 (6.5) 
8.5 (5.4) 
12.4 (5.9) 
12.6 (5.6) 
10.8 (5.6) 
9.6 (5.8) 
11.2 (6.8) 
 
SOFAS 0 
9 
48.9 (7.9) 
53.8 (12.3) 
51.5 (9.0) 
54.8 (9.4) 
47.3 (6.8) 
51.5 (11.3) 
50.1 (6.8) 
53.7 (9.2) 
51.8 (9.1) 
58.3 (13.3) 
54.2 (12.1) 
56.9 (10.1) 
 
EuroQol 0 
9 
57.5 (21.8) 
65.7 (18.2) 
52.9 (25.4) 
65.8 (19.8) 
55.7 (22.5) 
67.2 (16.9) 
58.4 (21.9) 
67.9 (13.9) 
60.5 (21.2) 
63.7 (20.4) 
42.3 (29.2) 
62.0 (27.9) 
 
Personal Beliefs 
About Illness 
0 
9 
21.8 (7.6) 
19.7 (6.8) 
21.2 (7.6) 
18.9 (6.2) 
22.5 (8.4) 
19.9 (7.2) 
19.8 (7.3) 
17.8 (4.0) 
20.4 (5.6) 
19.2 (6.4) 
23.9 (7.7) 
20.6 (8.8) 
 
Global Assessment 
of Symptoms 
0 
9 
57.2 (8.8) 
60.2 (14.1) 
56.4 (10.9) 
59.2 (10.9) 
55.4 (8.6) 
56.6 (12.6) 
56.7 (8.9) 
58.5 (10.9) 
60.5 (8.4) 
67.9 (14.6) 
55.8 (14.4) 
60.7 (11.0) 
 
Beck Depression 
Inventory 
0 
9 
22.6 (13.8) 
14.4 (12.7) 
21.1 (13.9) 
13.6 (10.6) 
21.4 (14.4) 
14.3 (11.5) 
17.9 (11.3) 
11.3 (7.5) 
24.7 (12.8) 
14.7 (14.9) 
27.0 (16.5) 
17.2 (14.0) 
 
Beck Anxiety 
Inventory 
0 
9 
17.0 (11.8) 
13.2 (10.5) 
16.9 (13.5) 
13.0 (12.8) 
16.6 (13.0) 
12.3 (9.7) 
14.8 (12.8) 
11.6 (11.9) 
17.7 (9.8) 
14.7 (12.0) 
21.1 (14.5) 
15.3 (14.6) 
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7.4.2 Outcome Analyses 
 
7.4.2.1 Combined group (non-affective and affective psychosis) 
 
Table 7.3 shows that all participants made large improvements in most domains, 
including activity and symptoms, as a result of both CBT and TAU interventions. 
Outcome for variables outlined in Table 7.3 are discussed in detail in the trial outcome 
paper (Appendix B). To summarise, ANCOVAs on these variables highlighted a 
significant main effect of treatment on both positive beliefs about self and positive 
beliefs about others. 
 
When examining the descriptive data for schizotypal symptoms (Table 7.4), it appears 
that total SSI scores increased in both TAU and CBT groups over the course of the trial. 
It must also be noted that the CBT group had a lower baseline total SSI score, although 
this difference did not reach statistical significance, t(66) = 1.50, p = .14. When broken 
down into subscales, it is specifically Social Anxiety scores which increased in the CBT 
group (adjusted effect size = 0.95), and Anomalous Experiences scores which increased 
in the TAU group (adjusted effect size = 0.40). 
 
Analyses of the main effects of CBT treatment on schizotypal symptoms for the 
combined group using ANCOVAs showed no significant effect of treatment on total 
SSI scores, F(1, 46) = 0.06, p = .80; or scores on the paranoia subscale, F(1, 46) = 0.31, 
p = .58. However, a trend was found for a main effect of treatment on the anomalous 
experiences subscale of the SSI, F(1, 46) = 3.75, p = .06. Moreover, a treatment by 
diagnosis interaction was found for the social anxiety subscale, F(1, 42) = 4.16, p = .05. 
Further investigations of the effects of treatment within each diagnostic group are 
therefore reported below.  
 
7.4.2.2 Non-affective psychosis group 
 
The non-affective group consisted of 50 cases (23 treatment, 27 controls) for whom 47 
post-treatment assessments were available (22 treatment, 25 control). Descriptive results 
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are reported in Tables 7.2 and 7.3. ANCOVAs for primary, secondary and tertiary 
outcome variables in the non-affective sample are described in detail in the trial 
outcome paper (Appendix B). To summarise, the findings of these analyses indicated a 
positive main effect of treatment on constructive economic activity, structured activity, 
PANSS total scores, and positive beliefs about self. There were also trends indicating a 
main effect of treatment on improvements in hopelessness and QLS instrumental role 
functioning. 
 
In terms of schizotypal symptoms, total SSI scores increased in both CBT and TAU 
arms of the non-affective group over the course of the trial. As with the combined 
group, the main increase in the non-affective CBT subgroup was on the Social Anxiety 
subscale (adjusted effect size = 1.5). Analyses of the main effects of CBT treatment for 
the non-affective group using ANCOVAs showed that there was a significant main 
effect of allocation to therapy on the Social Anxiety subscale of the SSI, F(1, 27) = 
6.37, p = .02. In line with the descriptive statistics, this suggests that there was a 
significant increase in Social Anxiety SSI subscale scores in those individuals who 
received therapy, compared to those in the control group. There were no significant 
effects of allocation on the Paranoia or Anomalous Experiences subscales of the SSI.  
 
7.4.2.3 Affective psychosis group 
 
The affective group consisted of 27 cases (12 treatment, 15 controls) for whom 24 post-
treatment assessments were available (11 treatment, 13 controls). Unsurprisingly given 
the small sample size, there were no significant effects on any of the outcome variables. 
However, there were striking improvements in activity levels in both the CBT and TAU 
arms of the affective psychosis group.  
 
In terms of schizotypal symptoms, descriptive statistics in Table 7.2 show suggestions 
of effects favouring SRCBT on reductions in SSI scores. In the CBT arm there were 
post-treatment reductions on all dimensions of the SSI. This is in comparison to the 
TAU arm where SSI scores increased on all dimensions. However, the sample size was 
too small to analyse meaningfully and no significant effects of treatment on schizotypal 
symptoms were found in the affective psychosis group. 
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7.4.3 Mediation Analysis 
 
A significant interaction was found between allocation to therapy and change in 
schizotypal symptoms (total SSI scores) on weekly hours in structured activity at post-
treatment, F(1, 45) = 10.30, p = .002. This mediation analysis suggests that schizotypal 
symptoms increased more in the CBT group in response to increases in structured 
activity, compared to the control group. More specifically, this mediation effect was 
found to be significant for the Social Anxiety subscale of the SSI, F(1, 45) = 16.17, p 
<.001, but not for other SSI subscales. When non-significant schizotypal symptom 
change by allocation interactions were removed for the Paranoia and Anomalous 
Experiences subscales, there were no significant main effects of schizotypal symptom 
change on activity. These findings imply a moderating effect of therapy on schizotypal 
symptoms, specific to the Social Anxiety dimension and not the Paranoia or Anomalous 
Experiences dimensions. 
 
7.4.4 Missing Data Analysis 
 
A sensitivity analysis of the results was conducted by repeating ANCOVA analyses 
using the EM estimates for missing data. These were consistent with those using only 
completers for all variables. In the combined group the EM ANCOVA analyses showed 
a main effect of treatment allocation on Anomalous Experiences scores, F(1, 71) = 4.39, 
p = .04; and a treatment by diagnosis interaction on Social Anxiety scores, F(1, 67) = 
4.16, p = .05). In the non-affective subgroup the EM ANCOVA analyses showed a main 
effect of treatment allocation on Social Anxiety scores, F(1,45) = 3.95, p = .05). The 
findings of the mediation ANCOVA analyses were also replicated using EM estimates, 
for both total SSI scores and scores on the Social Anxiety subscale of the SSI. No 
additional significant main or interaction effects were found using EM estimates rather 
than data from completers. This suggests that the completer analyses were not biased by 
missing data. 
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7.5 DISCUSSION 
 
7.5.1 Summary of Results 
 
The full results of the trial are explained in detail in the trial outcome paper (Appendix 
B). In summary, the trial provided no clear evidence for the benefit of CBT on activity 
in a combined sample of patients with both affective and non-affective psychosis. 
However, some evidence was revealed for the potential of CBT to improve constructive 
economic and structured activity amongst a more homogenous sample of patients with 
non-affective psychosis. There was an average gain of 12 hours per week in structured 
activity for CBT in comparison to 4 hours for TAU in the non-affective psychosis 
group. This was achieved in association with clinically meaningful and significant 
improvements in symptoms (PANSS) and beliefs about self and others (BCSS). The 
results for affective psychosis were less clear. However, the size of this group was small 
and thus clear conclusions cannot be drawn. 
 
Although the primary outcome of the ISREP trial was activity, the current study has 
focused on the impact of SRCBT on schizotypal symptoms; and whether a change in 
these symptoms mediates the effect of therapy on activity. The results suggest that 
certain types of schizotypal symptoms are important in recovery and should therefore be 
considered in recovery-oriented interventions. It was predicted that SRCBT would lead 
to changes in schizotypal symptoms and that these changes may be specifically 
associated with changes in activity. These hypotheses were supported by the findings. 
In general there was an increase in total SSI scores in both TAU and CBT arms in the 
combined non-affective and affective psychosis group over the course of the trial. 
However, this change did not reach statistical significance. When examining change on 
the individual subscales of the SSI, Social Anxiety scores were found to significantly 
increase in the non-affective intervention group over the course of the trial when 
compared to the non-affective control group. Moreover, mediation analyses showed that 
there were larger increases in social anxiety in the CBT group in response to increases 
in activity when compared to the control group. The finding that SSI scores increased in 
line with increasing activity in the treatment group could be taken to suggest that 
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schizotypal symptoms, particularly social anxiety, increased as a result of individuals in 
the treatment arm engaging in more structured activity.  
 
This is not to say that it is necessary for schizotypal symptoms to increase in order for 
there to be gains in activity. Rather it is more likely that increases in social anxiety were 
a by-product of the therapeutic techniques used to assist individuals in engaging in new 
activities. Nevertheless, this finding does highlight a relationship between social 
recovery (measured in terms of weekly hours in activity) and social anxiety schizotypal 
symptoms. Based on this, it could be argued that a targeted intervention for social 
anxiety may enhance improvements in social recovery. However, further studies would 
need to be conducted in order to confirm this hypothesis. The finding that changes in 
schizotypal symptoms were confined to the Social Anxiety subscale of the SSI, and not 
Paranoia or Anomalous Experiences, suggests that social anxiety may have a specific 
role in social recovery from psychosis. Paranoia and anomalous experiences may be 
related to other dimensions of recovery, as outlined in the previous chapter. Future 
research should focus on investigating the relationships between different types of 
schizotypal symptoms and different outcome dimensions using targeted interventions. 
 
7.5.2 Relevance to the Literature and Clinical Implications of Findings 
 
The increases in social anxiety found in the current study need to be contrasted to 
findings of other studies which have suggested that vocational interventions may 
increase risk of relapse (Hogarty et al., 1974; Hogarty et al., 1997). Only social anxiety 
increased in the treatment group with other types of schizotypal symptoms, including 
paranoia and anomalous experiences, remaining stable. This is in contrast to the control 
group who showed a significant increase in Anomalous Experiences scores over the 
course of the trial. Moreover, it is somewhat expected that social anxiety would increase 
in line with increases in activity, particularly when considering that the sample had a 
very low level of activity at baseline, were socially isolated, and had been out of work 
or education for a mean of 4 years. Any increase in activity, particularly that of a social 
nature, is thus likely to act as a stressor, producing some short-term anxiety (Phillips, 
Francey, Edwards, & McMurray, 2007). However, whilst increasing anxiety, it is 
important to note that paranoia or anomalous experiences did not increase in 
conjunction with increases in social anxiety. Moreover, there was a significant reduction 
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in total PANSS scores in the CBT arm. There were also reductions in anxiety measured 
by the BAI. These findings suggest that the intervention successfully managed residual 
psychotic symptoms whilst increasing time spent in structured activity, despite an 
increase in social anxiety. 
 
In line with the mediation analysis, the largest increase in social anxiety occurred in the 
subgroup with the largest gain in activity: the CBT arm of the non-affective psychosis 
group. Although this fits with the hypothesis that individuals with psychosis have an 
increased sensitivity to stress (e.g. Myin-Germeys, van Os, Schwartz, Stone, & 
Delespaul, 2001), these findings must also be considered in light of the nature of the 
intervention. The aim of the CBT intervention was to assist individuals in adopting new 
social and occupational activities. This often involved the use of structured active 
behavioural interventions, such as exposure work, which could potentially lead to short-
term increases in anxiety (Bennett-Levy, Butler, Fennell, & Hackmann, 2004). If 
associated with recent engagement in new activities, it may be the case that this anxiety 
diminishes over time as individuals habituate to their new roles. A longer follow-up 
period is required in order to investigate this further. Moreover, it must be remembered 
that increases in the Social Anxiety dimension of the SSI were somewhat offset by 
improvements in symptoms, hope, and positive beliefs about self and others. These 
improvements could be taken as support for the cognitive model underpinning the 
intervention, which had a deliberate focus on fostering positive self-esteem and hope, 
while working toward adopting new social activities. 
 
Despite the above, given the increased stress sensitivity of this sample, and findings 
postulating social anxiety as a precursor to paranoia (Freeman & Garety, 2003; 
Freeman, Garety et al., 2005; Freeman et al., 2008; M. J. Green & Phillips, 2004); it is 
important that such symptoms are monitored and managed. The SSI is a useful measure 
for this purpose. Indeed, the SSI appears to be sensitive in assessing changes in specific 
dimensions of low-level psychotic-like experiences. This is contrast to the PANSS 
which showed an overall improvement in the treatment group over the course of the 
trial, despite the increase in social anxiety. Moreover, the Social Anxiety dimension of 
the SSI is specific to the types of anxiety relevant to individuals in recovery from 
psychosis. This is in contrast to more generic assessments of anxiety, such as the BAI, 
which showed a general improvement in individuals over the course of the trial. 
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A further point of interest is the difference in schizotypal symptom change over the 
course of the trial between affective and non-affective subgroups. Although the non-
affective intervention subgroup displayed an increase in social anxiety symptoms in 
comparison to non-affective controls; the opposite pattern was seen in the affective 
group. Indeed, affective treatment cases experienced a decrease in symptoms, whilst 
affective control cases experienced an increase. However, it should be noted that there 
was a large baseline difference in SSI scores between the affective control and treatment 
subgroups, with the treatment group scoring more highly. Moreover, the sample size of 
the affective group is too small to warrant formal conclusion. Despite this, differences 
in schizotypal symptoms between affective and non-affective psychoses may be an area 
for further research, particularly considering previous findings that individuals with 
affective psychosis have a better general social recovery course than individuals with 
non-affective psychosis (Macmillan et al., 2007).  
 
7.5.3 Limitations of the Current Study and Future Directions 
 
There are a number of considerations which should be borne in mind when interpreting 
the results of this study. First, the sample size is not large enough to draw formal 
conclusions about the exact role of schizotypal symptoms in the recovery process from 
an episode of psychosis. The ISREP trial was designed to be exploratory rather than 
confirmatory and lacks power to detect effects, particularly within diagnostic 
subgroups. Results for the non-affective group are therefore suggestive and those for the 
affective group are too small to warrant any formal conclusion. However, the study does 
provide an indication of hypotheses for further investigation in future and larger studies. 
Moreover, it confirms the usefulness and sensitivity of the SSI in assessing change in 
low-level psychotic-like phenomena and social anxiety. This is in contrast to more 
traditional measures such as the PANSS and BAI. 
 
A further weakness of the current study is the baseline differences in SSI scores 
between the treatment and control groups. Despite randomisation, the treatment group 
generally reported lower baseline SSI scores than the control group. On some 
dimensions of the SSI, post-treatment scores are comparable between treatment and 
control groups, with between-group differences only noticeable when controlling for 
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baseline scores (i.e. in change scores). This could be taken to suggest that within both 
groups there is a degree of “regression toward the mean” occurring, with control group 
scores decreasing from their baseline level and treatment group scores increasing from 
their baseline level (Bland & Altman, 1994). However, this is not the case on all 
schizotypal symptom dimensions and it must also be remembered that baseline 
differences in schizotypal symptoms did not reach statistical significance. Nevertheless, 
further replication studies are required in order to confirm the current findings. 
 
A further limitation of this study concerns the statistical methodology used to conduct 
the mediation analyses. In line with traditional approaches (e.g. R. M. Baron & Kenny, 
1986; Kraemer, Fairburn, & Agras, 2002), these analyses rely on the assumption that no 
hidden confounding exists between mediator and outcome variables. That is, the 
analyses ignore the possibility that another unmeasured variable may influence both 
schizotypal symptoms and time spent in structured activity. This approach also ignores 
the presence of measurement error in the assessment of mediator and outcome variables. 
Whilst problematic, these same criticisms are true of other treatment studies assessing 
mediation using traditional approaches (e.g. Wykes et al., 2007). Moreover, the current 
study provides a suggestion of future mediation hypotheses and also confirms the 
theoretical underpinning of the intervention tested. That said, in order to control for 
potential confounding, newer mediation approaches need to be adopted, such as those 
outlined by Dunn and Bentall (2007) and Ten Have et al. (2007). These methods require 
large sample sizes and for potential confounders to be identified in the study design 
stages. This was beyond the scope and power of the current study, but should be borne 
in mind for future study designs.  
 
7.5.4 Summary 
 
The current study has highlighted the effect of an intervention designed to improve 
social recovery from psychosis, on the presence of schizotypal symptoms. Changes in 
activity were specifically associated with increases in scores on the Social Anxiety 
dimension of the SSI. However, there was no increase in acute psychotic 
symptomatology and increases in social anxiety were offset by gains in hope and 
positive beliefs about self and others. The findings support those of previous studies in 
this thesis and suggest that the management of low-level psychotic symptoms is 
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important in recovery, even when the more florid symptoms of psychosis have remitted. 
The study provides preliminary evidence for the role of schizotypal symptoms in social 
recovery from psychosis. Future research should focus on investigating differential 
relationships between subtypes of schizotypal symptoms and other dimensions of 
recovery. 
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CHAPTER EIGHT: DISCUSSION 
 
 
8.1 OVERVIEW 
 
This thesis highlights the importance of investigating the role of schizotypal symptoms 
in psychosis. This is a novel approach in the context of existing literature in this field 
which tends to conceptualise schizotypy as a normally distributed personality trait, 
highlighting potential vulnerability to the development of psychosis. This thesis argues 
that although trait schizotypy may reflect risk of psychosis onset, state schizotypal 
symptoms may be at the core of the disorder, existing not only premorbidly but 
throughout the course of psychotic illness and into the recovery phase. As such, 
investigating the underlying mechanisms of schizotypal phenomena may provide a 
deeper insight into the nature of psychosis than the study of acute symptoms, which 
may be a transient “flare-up” of a long-standing underlying problem.  
 
This chapter will first summarise the findings of the six studies conducted in this thesis 
before relating them to a psychological model of recovery from psychosis. Clinical 
implications of the findings will then be discussed as will possibilities for future 
research. 
 
8.2 SUMMARY OF FINDINGS 
 
8.2.1 Study 1 
 
The first study in this thesis described the creation of the Schizotypal Symptoms 
Inventory (SSI), a revised version of the Schizotypal Personality Questionnaire (SPQ) 
designed for use in assessing the current presence and frequency of low-level psychotic 
symptoms in clinical and non-clinical populations. The SSI assesses schizotypal 
symptoms over three domains: Social Anxiety, Paranoia, and Anomalous Experiences. 
This is advantageous as allows a range of symptom types to be assessed simultaneously, 
and thus potential differential associations with explanatory variables to be examined. 
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The SSI has been shown to have good internal and test-retest reliability; and good 
validity with more traditional assessments of psychotic symptoms (i.e. PANSS). The 
long version of the SSI was shown to have a four-factor structure (social anxiety, 
paranoia, anomalous experiences, and disorganisation). This was reduced to three 
factors in the development of a brief version of the scale, due to the finding that clinical 
and non-clinical samples could not be discriminated using the disorganisation subscale. 
The distribution of symptom counts on the SSI were shown to be half-normal. This is in 
contrast to the normal distribution of symptom counts on the original SPQ and suggests 
that the SSI has a more clinical focus (Johns & van Os, 2001). In addition to 
demonstrating the robust psychometric properties of the SSI, Study 1 compared levels 
of schizotypal symptoms in clinical and non-clinical samples. In line with the 
continuum hypothesis, schizotypal symptoms were not uncommon in the non-clinical 
sample. However, their presence was significantly higher in the clinical sample. Social 
Anxiety symptoms were found to be the largest discriminator between clinical and non-
clinical samples, whilst Anomalous Experiences were relatively rare in both groups. 
This suggests that social anxiety is a large problem in individuals recovering from acute 
psychosis.  
 
8.2.2 Study 2 
 
The underlying mechanisms of schizotypal symptoms were investigated in Study 2 by 
examining associations between SSI scores and visual processing in a large sample of 
individuals with psychosis, using the McCollough Effect visual illusion paradigm (ME; 
McCollough, 1965). Previous research has suggested that anomalous experiences are 
associated with a basic cognitive dysfunction, which provides a basis for the later 
development of hallucinations and delusions (J. A. Gray, 1998b; J. A. Gray et al., 1991; 
Hemsley, 2005b). Antipsychotic medication is hypothesised to target this dysfunction 
(Kapur, 2003). It is proposed that a failure in automatic processing results in the 
allocation of attention to details of the environment which would not normally reach 
awareness, also known as mismatches, thus producing anomalies in perception (Corlett 
et al., 2007; Hemsley, 2005a). Perceived strength of the ME illusion was used as an 
index of sensitivity to these mismatches.  
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Increased strength of the ME illusion was found to significantly correlate with increased 
scores on the Anomalous Experiences and Paranoia subscales of the SSI, but not with 
scores on the Social Anxiety subscale. Thirty-seven percent of the clinical sample did 
not perceive the ME illusion at all. This is a significant proportion given that the effect 
is considered to be a phenomenon of “normal” visual perception. Further analyses 
showed that those who did not perceive the ME were receiving a significantly higher 
dose of antipsychotic medication than those who did perceive the effect, suggesting that 
antipsychotic medication may block perception of the illusion. Taken together, these 
findings could be argued to provide preliminary evidence to support the notion that a 
basic cognitive dysfunction may be at least partially responsible for the presence of 
certain subtypes of schizotypal symptoms, namely anomalous experiences and low-
level paranoia, but not social anxiety. 
 
8.2.3 Study 3 
 
Study 3 examined relationships between schizotypal symptoms and emotional and 
psychological variables in a non-clinical sample. The aim of this study was to further 
explore potential mechanisms underlying different types of schizotypal symptoms. The 
use of an analogue sample allows this to be investigated without the influence of 
medication effects or other factors associated with the disease process of psychosis 
(Raine & Lencz, 1995). Higher SSI scores were found to be associated with increased 
anxiety and depression, increased negative beliefs about self and others, and decreased 
positive beliefs about self and others. All types of schizotypal symptoms were 
significantly associated with emotional and psychological variables. However, 
correlations were stronger for the Social Anxiety and Paranoia subscales than the 
Anomalous Experiences subscale. 
 
In order to unpick the nature of the relationships between different types of schizotypal 
symptoms and emotional and psychological variables, multiple regression analyses 
were conducted. Anxiety was found to be a significant predictor of all types of 
schizotypal symptoms. In addition, reduced positive beliefs about self, increased fear of 
negative evaluation and increased interpersonal sensitivity were found to predict social 
anxiety schizotypal symptoms. Negative beliefs about self and others, and increased 
fear of negative evaluation were found to predict paranoid schizotypal symptoms. 
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Anxiety was the only predictor of anomalous experiences. This suggests that the 
mechanisms underlying anomalous experiences may be less influenced by 
psychological factors than those underlying social anxiety and paranoia. This fits with 
the ideas of the cognitive model of psychosis which argues that anomalous experiences 
may be caused by a basic cognitive dysfunction (Garety et al., 2001), and also fits with 
the findings of Study 2. Conversely, other symptom types are thought to be more 
psychologically constructed, arising from core schematic beliefs and emotional 
dysfunction (Fowler, Freeman, Smith et al., 2006; Freeman & Garety, 2003; Smith et 
al., 2006). That these findings occurred in a non-clinical sample supports the continuum 
hypothesis of psychosis. 
 
8.2.4 Study 4 
 
Study 4 examined the role of trauma history in the development and maintenance of 
schizotypal symptoms in a non-clinical sample. Thirty-five percent of the sample 
reported having experienced a traumatic event meeting DSM-IV-TR A1 stressor criteria 
(American Psychiatric Association, 2000a) at some point in their lives. Individuals with 
a history of interpersonal trauma (e.g. bullying, child sex abuse, physical victimisation) 
had significantly higher SSI scores (across all domains) than individuals who had not 
experienced an interpersonal trauma. These individuals also exhibited higher levels of 
anxiety, depression, and interpersonal sensitivity; and more negative beliefs about self 
and others. A history of non-interpersonal trauma (e.g. road traffic accidents, non-
interpersonal violence, and other non-specific events) was not associated with higher 
levels of schizotypal symptoms or higher scores on any of the emotional and 
psychological variables. In order to clarify the potential role of trauma in psychosis, 
regression analyses were conducted. For all types of schizotypal symptoms, exposure to 
interpersonal trauma lost its predictive ability when controlling for emotion and 
psychological variables. This supports the notion of an emotional route to psychosis and 
suggests that trauma may influence the development of psychosis in an indirect way, i.e. 
via its impact on emotion and core schematic beliefs. These findings concur with 
literature investigating trauma and the acute symptoms of psychosis (Fowler, Freeman, 
Steel et al., 2006; Mueser, Rosenberg et al., 2002).  
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8.2.5 Study 5 
 
The finding that schizotypal symptoms are common in individuals with psychosis, even 
when acute symptoms have remitted, poses an interesting question about whether such 
phenomena have an impact on long-term recovery from the disorder. In addition, the 
finding of differential associations between schizotypal symptom types and emotional, 
psychological, and cognitive variables; suggests that different types of schizotypal 
symptoms may impact upon recovery in different ways. An exploratory factor analysis 
was conducted in Study 5 to examine how different schizotypal symptom types were 
related to different recovery outcomes.  
 
A six-factor model was found to provide the best fit to the data. The factors were 
labelled: Activity Levels, Positive Symptoms, Clinician-rated Recovery, Negative 
Symptoms, Resilience/Optimism, and Emotional Barriers. The Anomalous Experiences 
subscale of the SSI loaded onto the Positive Symptoms factor with tools such as the 
PANSS and SAPS, suggesting that this dimension of the SSI assesses core residual 
symptoms of psychosis. The Social Anxiety subscale of the SSI loaded on the 
Emotional Barriers factor with measures assessing anxiety, depression, hopelessness, 
negative beliefs about self and others, and illness cognitions. This suggests that Social 
Anxiety schizotypal symptoms may reflect emotional and psychological recovery from 
psychosis. The Paranoia subscale of the SSI loaded on both the Positive Symptoms and 
Emotional Barriers factors. This could be taken as evidence to suggest that paranoid 
schizotypal symptoms are reflective of both residual psychotic symptoms and emotional 
and psychological recovery from psychosis. 
 
8.2.6 Study 6 
 
The final study in this thesis examined the effect of a psychological intervention for 
social recovery on the presence and frequency of schizotypal symptoms, in the context 
of a randomised controlled trial. In addition, the role of schizotypal symptoms as 
mediators of recovery was investigated. Scores on the Social Anxiety subscale of the 
SSI were found to significantly increase in the group who received the intervention. 
Moreover, increases in social anxiety were found to be specifically related to increases 
in weekly hours of activity (an index of social recovery). Scores on the Paranoia and 
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Anomalous Experiences subscales of the SSI were not influenced by therapy. These 
findings indicate that social anxiety may be a mediator of social recovery from 
psychosis. 
 
8.3 INTERPRETATION OF FINDINGS 
 
It is well established that individuals in the prodromal stages of psychosis experience a 
range of low-level psychotic phenomena and social withdrawal (Addington & 
Addington, 2005; Hodges et al., 1989; Yung & McGorry, 1996). In terms of face 
validity, it could be argued that there are similarities between prodromal and schizotypal 
symptoms. That such phenomena predate the onset of acute psychosis, suggests that 
they may provide a foundation for further symptoms to be built upon. This thesis has 
also highlighted the presence of schizotypal symptoms in the recovery phase of acute 
psychosis. The prevalence of these symptoms is significantly higher than that occurring 
in a non-clinical sample. This could be taken as evidence to suggest that following an 
episode of psychosis, individuals inhabit a postdromal phase, returning to an almost at-
risk mental state. This idea supports the “rollback phenomenon”, a theory which 
suggests that symptoms of mental illness remit via a process which is the mirror image 
of their development (Detre & Jarecki, 1971; Fava, 1999). Indeed, studies examining 
the recovery process from acute psychosis describe a reduction in the frequency and 
severity of symptoms, combined with a gradual increase in insight and awareness 
(Andresen, Oades, & Caputi, 2003; Carr, 1983; Drury, 1992). This may be accompanied 
by anxiety and depression as the individual begins to come to terms with what has 
happened to them (Forchuk et al., 2003). This “recovering state” may be best assessed 
using a measure of schizotypal symptoms.  
 
In line with the continuum hypothesis, the findings of this thesis also support studies 
examining the development and maintenance of acute symptoms of psychosis, and 
suggest specific underlying mechanisms for different types of schizotypal symptoms. 
Social anxiety is related to a lack of positive beliefs about self, i.e. low self-esteem; 
whereas paranoia is related to a feeling of personal vulnerability combined with beliefs 
that others are hostile. Anomalous experiences are relatively independent from 
psychological factors, apart from anxiety, suggesting that they may be organic in nature 
and relate to a basic cognitive dysfunction. The finding that anomalous experiences are 
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associated with cognitive disturbance and not with emotional and psychological 
variables; and that the converse is true for social anxiety, suggests separate and 
independent pathways in the development of different symptom types. Thus, there 
appears to be a biological route to anomalous experiences, and an emotional route to 
other symptom types. The development of paranoid schizotypal symptoms may be 
associated with both pathways. Indeed, scores on the Paranoia subscale of the SSI were 
found to be related to both psychological variables (negative beliefs about self and 
others) and ME strength (an index of anomalies in basic cognitive processes). These 
findings concur with the cognitive model of psychosis (Garety et al., 2001) and suggest 
that core symptoms of the disorder may arise from an anomaly in automatic processing, 
resulting in the occurrence of odd and unusual experiences (J. A. Gray et al., 1991). The 
interpretation of these experiences is hypothesised to be influenced by emotional state 
and core beliefs about self and others, resulting in the development of further psychotic 
symptoms (Garety et al., 2001). 
 
The separate pathways to different schizotypal symptom types are likely to occur 
throughout the course of psychosis, continuing into the recovery stages. This is 
supported by the findings of the factor analysis in Study 5, suggesting that different 
types of schizotypal symptoms were associated with different types of recovery. 
Previous literature examining the recovery process suggests that the core positive 
symptoms of psychosis (e.g. anomalous experiences) are the first to remit (Agid, Kapur, 
Arenovich, & Zipursky, 2003; Kapur et al., 2005). This is argued to be due to the fact 
that their underlying physiology is the specific target of antipsychotic medication. 
Antipsychotic medication is hypothesised to dampen the aberrant salience underlying 
anomalous experiences by blocking dopamine receptors (Kapur, 2003; Kapur & Mamo, 
2004; Seeman & Lee, 1975). However, other symptoms will take longer to remit as they 
require a certain amount of cognitive restructuring (Kapur, 2003; Rector & Beck, 2001). 
Similarly, the impact of an acute episode of psychosis on the way in which an 
individual perceives themselves and the world can be large and take time to deconstruct. 
Some of this restructuring and deconstruction is perhaps reflected in the high prevalence 
of schizotypal symptoms in individuals who would be defined as “recovered” using 
strict psychiatric criteria. Indeed, although there is no direct link between acute 
psychotic symptoms and functioning, the presence of low-level or schizotypal 
phenomena after acute symptoms have remitted may impede long-term functional 
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recovery. A model of recovery from psychosis incorporating schizotypal symptoms will 
be discussed in the next section. 
 
8.4 COMBINING SCHIZOTYPAL SYMPTOMS AND PSYCHOSIS: 
TOWARDS A PSYCHOLOGICAL MODEL OF RECOVERY  
 
This thesis has highlighted three types of schizotypal symptoms occurring after an 
episode of psychosis, and possibly premorbidly. Anxiety is a common predictor of all 
three symptom types. Core beliefs about self and others also predict schizotypal 
symptoms, but differentially, with a lack of positive beliefs about self predicting social 
anxiety, and the presence of negative beliefs about self and others predicting paranoia. 
Anomalous experiences are not predicted by schematic beliefs, suggesting that they are 
less psychologically constructed than other symptom types, potentially reflecting a core 
vulnerability to psychosis (e.g. basic cognitive dysfunction as in Hemsley, 2005b). 
Trauma exposure may impact upon the development of schizotypal symptoms 
indirectly, via increases in emotional distress and the synthesis of negative schematic 
beliefs about self and others. Together, these variables moderate levels of schizotypal 
symptoms which then act as differential mediators of recovery. See Figure 8.1 for a 
diagram of this model. 
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Figure 8.1  
Psychological model of recovery from psychosis 
 
 
Moderated by a basic cognitive dysfunction and anxiety, anomalous experiences are 
hypothesised to mediate positive symptom recovery from psychosis, potentially 
reflecting residual symptoms of the acute episode. Fluctuations in anomalous 
experiences may therefore be important in terms of monitoring the early warning signs 
of relapse. Moderated by schematic beliefs and anxiety, social anxiety schizotypal 
symptoms are hypothesised to mediate social recovery from psychosis. This is 
supported by the findings of Study 6. These symptoms may reflect underlying 
schematic beliefs about self (i.e. low self-esteem), but may also be related to how an 
individual has appraised, and in turn been personally affected by their psychotic 
episode. Paranoid schizotypal symptoms are moderated both by a basic cognitive 
dysfunction and schematic beliefs and anxiety. The notion that there are two routes into 
paranoia suggests that paranoid schizotypal symptoms may mediate both symptomatic 
and social recovery. This is supported by the finding that the Paranoia subscale of the 
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SSI loaded on both Positive Symptoms and Emotional Barriers dimensions of recovery, 
outlined in Study 5.  
 
The above model incorporates the psychological effects of the psychotic episode on the 
development of schizotypal symptoms and thus recovery from the disorder. As outlined 
in previous chapters of this thesis, there is evidence to suggest that experiencing an 
episode of psychosis can be a traumatic life event and have profound effects on an 
individual’s sense of self (McGorry et al., 1991; Shaner & Eth, 1989). Such emotional 
and psychological disturbance may feed into the development and maintenance of 
schizotypal symptoms, particularly social anxiety and paranoid subtypes, further 
impeding recovery. Thus, there may be a role for schizotypal symptoms as predictors of 
outcome. 
 
Although the focus of this thesis is recovery from psychosis, the model outlined in 
Figure 8.1 may also be applicable to the development of acute psychosis, i.e. symptom 
development rather than symptom recovery; and social disability rather than social 
recovery. Thus, it is suggested that schizotypal phenomena are important at all stages 
throughout the course of psychosis. Anomalous experiences may reflect an individual’s 
core biological vulnerability to psychosis. This is likely to be the result of a basic 
cognitive dysfunction, potentially exacerbated by state fluctuations in anxiety (J. A. 
Gray et al., 1991; Hemsley, 2005a). Conversely, social anxiety and paranoid schizotypal 
symptoms may reflect emotional and psychological factors underlying symptom 
development, possibly as a result of life events. An exacerbation of schizotypal 
symptoms may result in their escalation to an acute episode of psychosis. 
 
Although preliminary and requiring further validation, this model may provide an 
explanation for the independence of symptomatic and functional recovery following an 
episode of psychosis (e.g. Davidson & McGlashan, 1997; M. Shepherd et al., 1989; 
Strauss & Carpenter, 1977). If an individual’s route into psychosis occurs 
predominantly via the biological pathway (i.e. high core vulnerability), their recovery 
may be mostly symptomatic. As such, functional or social recovery may go unimpeded, 
other than the psychological and emotional impact of the episode itself. Conversely, if 
an individual’s route into psychosis occurs via both biological and psychological 
pathways (i.e. due to a combination of core vulnerability and the presence of a traumatic 
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life event or severe negative beliefs about self and others), it is likely that emotional and 
psychological factors will also have an impact upon their recovery. In other words, if 
there are biological and emotional/psychological routes into psychosis, there may also 
be biological and emotional/psychological routes out of psychosis. Findings of previous 
research outlining poorer prognoses for individuals with psychosis and co-morbid 
trauma histories could be argued to provide support for this claim (Mueser, Rosenberg 
et al., 2002; Read & Ross, 2003). Even when acute symptoms are in remission, levels of 
schizotypal symptoms may be elevated in these individuals due to severe underlying 
negative schematic beliefs and high levels of emotional distress. However, further 
research would need to be conducted to substantiate this hypothesis.  
 
8.5 CLINICAL IMPLICATIONS OF THE FINDINGS 
 
The findings of this thesis support the use of a measure of schizotypal symptoms in 
assessing low-level psychotic phenomena at various points throughout the course of 
psychotic disorder. Traditionally, schizotypy measures have been used to identify 
individuals who may be at risk of making transition to psychosis based on personality 
traits, tendencies, and lifetime experiences. However, assessing the presence of state 
psychotic-like phenomena is arguably more clinically relevant as can be used to 
highlight an individual’s current symptom profile, and thus current problem list, as 
opposed to general predispositions. Moreover, in non-clinical populations, state 
schizotypy may be a better predictor than trait schizotypy of an individual’s risk of 
making transition to psychosis. 
 
Results of the current work suggest that individuals in recovery from psychosis 
experience schizotypal symptoms over and above levels occurring in a non-clinical 
sample. In particular, social anxiety appears to be a large problem for individuals in 
recovery from psychosis, with over 50% of individuals reporting having experienced 
symptoms of social anxiety often or always in the past two weeks. This finding supports 
previous research reporting a high prevalence of social anxiety disorder following 
psychosis (e.g. Birchwood et al., 2006; Pallanti et al., 2004). Findings from this thesis 
have shown that social anxiety may also be a mediator of social recovery from 
psychosis. Thus, individuals recovering from psychosis may require specialised 
interventions to address their social anxiety. The SSI provides a useful tool for assessing 
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social anxiety specific to individuals in recovery from psychosis. Future research should 
examine the performance of the Social Anxiety subscale of the SSI in relation to 
traditional social anxiety assessment tools (e.g. Liebowitz Social Anxiety Scale; 
Liebowitz, 1987). 
 
Schizotypy is traditionally conceptualised as a moderator of psychosis, i.e. a stable 
personality trait highlighting vulnerability to the development of a psychotic episode 
(Claridge, 1997b). This view suggests that schizotypy cannot be modified. An 
alternative view proposed by this thesis is of viewing schizotypal symptoms as 
mediators of outcome, moderated by a range of cognitive, emotional, and psychological 
variables. This view has considerable clinical implications and suggests that although 
trait schizotypy may be stable, state fluctuations of schizotypal symptoms may be 
modifiable and influence outcome. Indeed, Study 6 revealed changes in schizotypal 
symptoms following a recovery-focused intervention and in relation to increased 
activity. If different schizotypal symptom types are indeed mediators of different types 
of outcome, interventions targeting these symptoms (and the variables which moderate 
them) are likely to be successful in improving recovery. Further research using targeted 
interventions is warranted.  
 
The findings of this thesis support literature arguing for a wider process than symptom 
remission in recovery from acute psychosis. In line with previous research, the data 
suggest that following an acute episode of psychosis, individuals experience a plethora 
of concerns which may contribute to poor recovery over and above the acute symptoms 
themselves (Anthony, 1993; Corrigan et al., 1999; McGorry, 1992; Mueser, Corrigan et 
al., 2002; Pitt et al., 2007). These concerns are likely to arise from an emotional and 
psychological response to the psychotic episode as a major life event and are distinct 
from an irreversible “deficit syndrome” or “burnout”, previously described as 
responsible for poor functional recovery from psychosis (Gourevitch, Abbadi, & Guelfi, 
2004; Tek, Kirkpatrick, & Buchanan, 2001). The notion that schizotypal symptoms, and 
thus recovery, may be associated with an individual’s appraisal of their illness, suggests 
that interventions for recovery should focus on the emotional and psychological impact 
of an episode of psychosis; in addition to normalising and providing coping 
mechanisms for dealing with residual symptoms. This supports the work of Gumley and 
colleagues who propose a role for the meaning that an individual ascribes to their 
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experiences on the future course of psychosis (Gumley et al., 2003; Gumley et al., 
1999). For example, a negative appraisal of the illness experience (e.g. “I can’t cope”) 
may be accompanied by the activation of underlying negative schematic beliefs and 
increased emotional distress. This may maintain schizotypal symptoms and further 
impede social recovery. Negative appraisals in response to low-level psychotic 
symptoms (e.g. “I am going mad”) may also precipitate relapse (Gumley et al., 2003; 
Gumley et al., 1999; Lobban et al., 2003).  
 
8.6 LIMITATIONS AND FUTURE RESEARCH 
 
The limitations of specific studies conducted in this thesis have been outlined in the 
discussion sections of their respective chapters. As such they will not be repeated here. 
This section will discuss general limitations of the current work and highlight areas for 
future research. 
 
All of the studies outlined in this thesis rely on the self-report of schizotypal symptoms. 
It has been argued that self-reports are unreliable in psychiatric populations and that 
individuals may find it difficult to subjectively rate their own experiences (Enns, 
Larsen, & Cox, 2000). However, evidence exists to suggest that this is not the case, 
even in individuals with poor insight (M. Bell, Fiszdon, Richardson, Lysaker, & 
Bryson, 2007; Eaton, Romanoski, Anthony, & Nestadt, 1991; Liraud, Droulout, Parrot, 
& Verdoux, 2004). Moreover, in the current work, scores on the SSI were shown to 
strongly correlate with researcher ratings on the PANSS. In addition, it has been argued 
that self-report measures enable researchers and clinicians to gain insight into the “inner 
world” of patients, and may also be less intimidating for the individual (Iancu, Poren, 
Lehman, Shamir, & Kotler, 2005). The use of self-report techniques is also more 
favourable when conducting investigations with large samples, due to time and resource 
constraints (Howitt & Cramer, 2005). 
 
A major conclusion of this thesis is that schizotypal symptoms may be prodromal and 
postdromal features of psychosis, involved in both the development and maintenance of 
psychotic symptoms and in recovery from the disorder. However, it must be noted that 
due to the predominantly cross-sectional nature of this research, nothing is known about 
the symptoms experienced by participants prior to the onset of their psychosis, or during 
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the acute episode itself. As such, it is not possible to conclude with any certainty that 
symptoms measured by the SSI are residual in nature; or that they provide a mirror 
image of prodromal symptoms, although in terms of face validity this seems likely. In 
order to examine this assumption in more detail, longitudinal studies would need to be 
conducted using the SSI to observe fluctuations in schizotypal symptomatology over 
time. Content analysis could also be used to investigate whether the content of 
schizotypal symptoms occurring in recovery mirrors that of prodromal and acute 
psychotic phenomena. 
 
Similarly, further research would need to be conducted in order to confirm the 
associations highlighted between schizotypal symptoms, cognitive, emotional, and 
psychological variables. Although the studies conducted in this thesis suggest 
differential associations for different symptom types; increases in ME strength, anxiety, 
and negative schema could arguably occur in response to schizotypal experiences 
themselves, rather than being involved in their development. Longitudinal research 
would enable these relationships to be modelled over time to see whether change in one 
variable (e.g. negative schema) has an effect on change in another (e.g. paranoid 
schizotypal symptoms). Moreover, experimental studies of mediation could be 
conducted to investigate the effect of manipulating explanatory variables on schizotypal 
symptoms in controlled conditions (i.e. if anxiety is increased, do scores on the SSI also 
increase?). It is likely that there are reciprocal relationships between schizotypal 
symptoms and emotional and psychological variables, as has been hypothesised to be 
the case for psychotic symptoms (Freeman & Garety, 2003). Thus, high levels of 
negative schematic beliefs and anxiety may precipitate symptom development, but the 
experience of symptoms is also likely to maintain negative beliefs and result in 
emotional distress. However, further research needs to be conducted to investigate this 
hypothesis. 
 
Moreover, although this thesis highlights the presence of schizotypal symptoms in a 
non-clinical sample, it does not necessarily follow that they are causing distress or that 
they will develop into an episode of psychosis. Indeed, low-level psychotic phenomena 
are not uncommon in the general population and many people are able to function more 
than adequately whilst experiencing such symptoms (V. Bell et al., 2006). This is 
supported by the high level of schizotypal symptoms reported by the non-clinical 
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sample in Study 1. Thus, it is likely that there are factors other than high levels of 
schizotypal symptoms which are involved in the onset of psychosis. Further areas for 
future research would be to examine the predictive validity of the SSI; and to 
investigate relationships between SSI scores and other variables in individuals with at-
risk mental states. For example, previous research has highlighted the importance of 
attachment style in the development of psychotic symptoms (Berry, Band, Corcoran, 
Barrowclough, & Wearden, 2007; Berry, Barrowclough, & Wearden, 2007; MacBeth, 
Schwannauer, & Gumley, 2008). Attachment style has also been implicated in the 
recovery process (Drayton et al., 1998; Gumley & Schwannauer, 2006; L. Tait, 
Birchwood, & Trower, 2004). As such, it would be interesting to investigate 
associations between different types of schizotypal symptoms and attachment and 
recovery styles. In terms of recovery, it would also be interesting to further examine the 
role of illness cognitions in the maintenance of schizotypal symptoms. Although the 
factor analysis in Study 5 highlighted that Social Anxiety and Paranoia subscales of the 
SSI loaded on the same recovery dimension as the PBIQ, further research would need to 
be conducted to confirm that an individual’s appraisal of their illness was involved in 
the presence of schizotypal phenomena. 
 
8.7 CONCLUSION 
 
The work conducted in this thesis has begun to highlight possible relationships between 
schizotypal symptoms and the course of psychotic disorder. It has proposed that 
schizotypal symptoms may be at the core of psychosis, occurring both prior to onset, 
and in the recovery phase. Assessing state fluctuations in these phenomena may help to 
explain variations in outcome following an episode of psychosis, thus bridging the 
symptom-disability gap. The SSI has been shown to be a robust tool for use in 
measuring state schizotypal symptoms. Potential relationships have also been outlined 
between different types of schizotypal symptoms and explanatory variables. In addition 
to proposing differential pathways to the development of schizotypal symptoms, the 
current work has also proposed a preliminary psychological model of recovery 
incorporating schizotypal phenomena as mediators in the recovery process. Future 
research should focus on providing confirmatory evidence for this model using 
longitudinal and experimental methodologies.  
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APPENDICES 
 
APPENDIX A 
Web Study Information 
A1 Circular e-mail for web study recruitment 
This e-mail was sent to all students at the University of East Anglia and King’s 
College London.
A2 Web study information sheet 
This information sheet was displayed on the first page of the website. 
Participants were asked to endorse a tick box after reading the information sheet 
if they agreed to take part in the study. 
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Hodgekins Joanne Ms (MED) 
You are invited to take part in a student project investigating how 
different aspects of emotion are associated with characteristics of 
personality.  The study is also interested in how traumatic events 
during an 
individual's lifetime can influence their later experiences and views. 
You are under no obligation to reply to this email, however if you 
choose 
to, participation in this research is voluntary and you may withdraw at 
any 
time. 
The study involves completing six questionnaires on a web-page we have 
set
up (link below) and will take about 30 minutes.  The first questionnaire 
lists unusual experiences and asks whether you have experienced them and 
if 
so, how often.  The questionnaire also asks about your feelings in 
certain 
situations and about your views on certain issues including clairvoyancy 
and 
telepathy.  The other questionnaires ask about: your emotions and how 
you 
have been feeling recently; the key beliefs that you hold about yourself 
and 
others; how you feel that other people think of you in social 
situations; 
how you feel about yourself and other people in your life.  The final 
questionnaire asks about upsetting experiences that you may have 
encountered 
at any point in your life. 
To read the information sheet about the study and to complete the 
questionnaires, please go to the web-page we have set up: 
http://web1.iop.kcl.ac.uk/IoPDepts/EmotionAndPerson.nsf/Welcome?OpenPage
Please contact Joanne Hodgekins if you would like any further 
information. 
(Joanne Hodgekins, Research Associate, School of Medicine, Health Policy 
and 
Practice, University of East Anglia, Norwich, NR4 7TJ.  Tel: 01603 
591232, 
e-mail: j.hodgekins@uea.ac.uk) 
Thank you very much for your help. 
Further Information: 
The study has been reviewed and approved by the Institute of Health 
Ethics 
Committee at the University of East Anglia and the Institute of 
From: Hodgekins Joanne Ms (MED) Sent: Mon 01/09/2008 17:51
To:  'Hodgekins Joanne Ms (MED)'
Cc:
Subject:  Web-based study investigating the influence of emotion on personality characteristics - circular
Attachments: 
Page 1 of 2
18/12/2008https://ueaexchange.uea.ac.uk/exchange/wm098/Inbox/PhD/Web-based%20study%20...
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Psychiatry 
Ethical Committee (Research).  It is not expected that participation in 
the 
study has any risks or will cause any ill effects.  However, you can 
stop 
completing the questionnaires at any point if you feel upset by the 
survey.
If you continue to feel upset, please contact one of the research team 
members listed below.  The UEA Health Centre (uhs@uea.ac.uk) and Dean of 
Students (dos@uea.ac.uk) are also aware of this research and have a 
variety 
of services available should you wish to use them.  More information 
about 
these services can be found through the 'Student Links' section of the 
UEA 
homepage. 
Research Team Members: 
Joanne Hodgekins, Research Associate, School of Medicine, Health Policy 
and 
Practice, University of East Anglia, Norwich, NR4 7TJ.  (Tel: 01603 
591232, 
e-mail: j.hodgekins@uea.ac.uk) 
Prof. David Fowler, Professor of Social Psychiatry, School of Medicine, 
Health Policy and Practice, University of East Anglia, Norwich, NR4 7TJ. 
(Tel: 01603 593601, e-mail: d.fowler@uea.ac.uk) 
Dr Daniel Freeman, Lecturer in Clinical Psychology, Department of 
Psychology, Institute of Psychiatry, Denmark Hill, London, SE5 8AF. 
(Tel: 
020 7848 5003, e-mail: d.freeman@iop.kcl.ac.uk) 
Prof. Philippa Garety, Professor of Clinical Psychology.  Based at the 
Department of Psychology, Institute of Psychiatry, Denmark Hill, London, 
SE5 8AF. 
Page 2 of 2
18/12/2008https://ueaexchange.uea.ac.uk/exchange/wm098/Inbox/PhD/Web-based%20study%20...
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Information Sheet 
Student Survey: The Influence of Emotion on Personality Characteristics 
 
 
You are invited to take part in a student project investigating how different aspects of 
emotion are associated with characteristics of personality.  The study is also interested in how 
traumatic events in childhood can affect experiences and views in later life. 
 
Who we would like to take part: 
The study is open to everyone.  In order to understand the influence of emotion on 
personality, we need to look at the views, feelings and experiences of all individuals, even if 
you have not experienced any of the items asked about.  Participation is voluntary and you 
can withdraw from the study at any time if you do not wish to continue. 
 
What the study involves:  
The study involves filling in six questionnaires on the internet and will take about 30 minutes. 
 
Anonymity and confidentiality:  
The questionnaires are filled in on a web-page which has in-built security.  Each participant is 
allocated a number and we do not record your name.  Thus all responses to the questionnaires 
are completely anonymous and cannot be traced back to the participant’s email address.   Any 
information provided is also completely confidential.  The information collected in the study 
will be used only for research and publication in research papers. 
 
What you will be asked in the questionnaires: 
Questionnaire 1:  Lists unusual experiences and asks whether you have experienced them 
and if so, how often.  The questionnaire also asks about your feelings in 
certain situations and about your views on certain issues including 
clairvoyancy and telepathy. 
Questionnaire 2: Asks about your emotions and how you have been feeling recently. 
Questionnaire 3: Asks about the key beliefs you hold about yourself and others. 
Questionnaire 4: Asks about how you feel that other people think of you in social 
situations. 
Questionnaire 5: Lists statements relating to how you may feel about yourself and other 
people in your life.  You will be asked to state how much each item 
applies to you. 
Questionnaire 6: Asks about some of your experiences growing up as a child and a 
teenager. 
 
Ethical considerations:  
The study has been reviewed by the local research ethics committee.  It is not expected that 
participation in the study has any risks or will cause any ill effects.  However you can stop 
completing the questionnaires at any point if you feel upset by the survey.  If you continue to 
feel upset, please contact one of the research team members listed below. 
 
Thank you very much for your help. 
 
 
For further information, please contact Joanne Hodgekins (Tel: 01603 593584) 
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Research Team Members 
 
• University of East Anglia, Norwich 
 
David Fowler, Senior Lecturer in Clinical Psychology, School of Medicine, Health Policy 
and Practice, University of East Anglia, Norwich, NR4 7TJ.  (Tel: 01603 593601; e-mail: 
d.fowler@uea.ac.uk) 
 
Joanne Hodgekins, Research Associate, School of Medicine, Health Policy and Practice, 
University of East Anglia, Norwich, NR4 7TJ.  (Tel: 01603 593898; e-mail: 
j.hodgekins@uea.ac.uk) 
 
• King’s College London 
 
Dr Daniel Freeman, Lecturer in Clinical Psychology, Department of Psychology, Institute of 
Psychiatry, Denmark Hill, London, SE5 8AF. (Tel: 0207 848 5003; e-mail: 
d.freeman@iop.kcl.ac.uk)  
 
Professor Philippa Garety, Professor of Clinical Psychology.  Based at the Department of 
Psychology, Institute of Psychiatry, Denmark Hill, London, SE5 8AF.  (Tel: 020 7848 5046; 
e-mail: p.garety@iop.kcl.ac.uk) 
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ABSTRACT 
Background  
This study reports on a preliminary evaluation of a cognitive behavioural 
intervention to improve social recovery in psychosis. The study was a single-
blind RCT with two arms, 35 participants receiving CBT plus TAU, and 42 
participants receiving TAU alone. Participants were assessed at baseline and 
post-treatment.
Method   
Seventy-seven participants were recruited from secondary mental health teams 
after presenting with a history of unemployment and poor social outcome. The 
cognitive behavioural intervention was delivered over a nine-month period with 
a mean of 12 sessions. The primary outcomes were weekly hours spent in 
constructive economic and structured activity.  A range of secondary and 
tertiary outcomes were also assessed. 
Results
Intention to treat analysis on the combined affective and non-affective psychosis 
sample showed no significant impact of treatment on primary or secondary 
outcomes. Analysis of interactions by diagnostic subgroup approached 
significance for secondary symptomatic outcomes (PANSS (F(1,69)=3.99, 
p=0.05). Exploratory analyses within diagnostic subgroups revealed significant 
improvements in weekly hours in constructive and structured activity, PANSS 
scores, and beliefs about self and others amongst people with non-affective 
psychosis. In the affective psychosis group there were striking improvements in 
activity and symptoms but these occurred in both treatment and control groups.
Conclusion  
The primary study comparison provided no clear evidence for the benefit of 
CBT in on a combined sample of patients. However, secondary analyses 
showed benefits for CBT amongst people with non-affective psychosis who 
have social recovery problems. These promising results need to be 
independently replicated in a larger, multi-centre RCT.
               305
INTRODUCTION
Poor social outcome is often reported in psychosis. Long term follow-up studies 
suggest that less than 50% of people with non-affective psychosis achieve a 
social recovery, and only 10-20% of people return to competitive employment 
(Johnstone et al., 1990, Jablensky et al., 1992, Harrison et al., 1996), despite 
the majority suggesting that they wish to work (Mueser et al., 2001). Around 
50% of people with severe affective psychosis also fail to return to work and 
remain disabled (Tsai et al., 2001). Long term follow-up studies indicate that 
poor social outcomes in psychosis tend to emerge early, often become stable, 
and are closely associated with long term social course (Strauss and Carpenter, 
1977, Carpenter and Strauss, 1991). The development of an effective 
intervention to improve social recovery in affective and non-affective psychosis 
could potentially have important long term benefits, especially if applied to 
cases who have developed poor social functioning in the early course of the 
disorder.
Effective interventions to improve psychosocial recovery in psychosis 
may need to consider factors associated with impairments in a sophisticated 
manner. These effects may include residual psychotic symptoms, sensitivity to 
stress and underlying cognitive deficits. In particular, care needs to be taken not 
to over stimulate. Past clinical trials of interventions which have attempted to 
promote social activity, without taking careful account of sensitivity to psychosis 
and anxiety, have shown increased risk of relapse, especially amongst people 
who still show psychotic symptoms (Hogarty et al., 1974, Hogarty et al., 1997). 
Cognitive behaviour therapy (CBT) may provide a useful basis for developing 
such an intervention. Several recent studies have reported evidence for the 
efficacy of CBT on depression and negative symptoms where these have been 
assessed as secondary outcomes (Sensky et al., 2000, Turkington et al., 2002, 
Durham et al., 2003, Gumley et al., 2003, Wykes et al., 2007). However, these 
trials used relatively insensitive measures of social functioning and no trial to 
date has directly targeted changes in social recovery as primary outcome. An 
optimal intervention for people with psychosis who wish to work but have some 
degree of residual problems may be for therapists to combine techniques of 
cognitive behaviour therapy with those of vocational case management (Mueser
et al., 2001).
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This study used a Trial Platform to evaluate the implementation feasibility 
and initial efficacy of a psychosocial intervention to improve social recovery in 
psychosis. The intervention was specifically focused on improving constructive 
social behaviour while managing sensitivity to stress, social anxiety, and 
psychotic symptoms. Social recovery is a complex construct probably best 
assessed across a number of domains. While engagement in full-time 
competitive work will always represent a key marker of social recovery (Mueser
et al., 2001), it is not the only marker of social improvement. Engagement in 
other domains of activity such as education, household chores, constructive 
voluntary work and structured social activities, reflect realistic and meaningful 
recovery goals for many service users and carers and also have wider 
economic benefits. In this study we therefore used time spent engaged in 
structured social and constructive economic activity as our primary measure of 
outcome.  We were also interested in assessing the impact of the intervention 
on a range of secondary and tertiary outcomes including hopelessness, 
psychotic symptoms, depression and anxiety, illness cognitions, and beliefs 
about self and others. These reflect common psychological responses to the 
experience of psychosis and associated social adversity, which are important in 
their own right (Birchwood, 2003), but which also have important associations 
with symptomatic outcomes and withdrawn and amotivated social behaviour 
(Fowler et al., 2006). We also planned to explore as a secondary hypothesis, 
the possibility of a differential effect of CBT on affective versus non-affective 
psychosis.
METHOD
Design
The ISREP study was a single blind randomised controlled treatment trial 
comparing cases who received SRCBT in addition to treatment as usual 
(treatment arm) with those receiving treatment as usual alone (control arm). 
Participants were randomised to CBT or control following a baseline 
assessment and initial screening for suitability. Randomisation was stratified for 
diagnosis (affective/non-affective psychosis was considered a prognostic factor) 
and administrative centre (Norfolk/Cambridgeshire). Post-treatment 
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assessments were conducted at the end of the intervention phase (nine months 
following randomisation). The primary outcomes were weekly hours spent in 
constructive economic activity and structured activity. Secondary outcomes 
included symptoms, anxiety, depression, hopelessness, and schema. Baseline 
and post-treatment assessments were conducted by research assistants who 
were blind to group allocation. 
Participants
Inclusion criteria were: 
? Current diagnosis of affective or non-affective psychosis (including 
schizophrenia, schizoaffective disorder, bipolar disorder, and psychotic 
depression).
? Illness duration of 8 years or less. Onset of illness was defined as the first 
contact with psychiatric services for psychotic symptoms. This was checked 
by research assistants from information in case notes. 
? Positive psychotic symptoms (hallucinations and delusions) in relative 
remission (less than moderate severity, scoring 4 or less, on individual 
symptoms on the PANSS). 
? Unemployed status or currently engaged in less than 16 hours paid 
employment or education. 
Participants were excluded if: 
? the psychotic disorder was thought to have an organic basis 
? acute psychosis was present 
? the primary diagnosis was drug dependency on opiates or cocaine 
The study protocol was approved by local ethics committees and all participants 
gave written consent to participate following a formal explanation of the study. 
Participant flow and characteristics 
Participants were recruited from secondary mental health services in the East 
Anglia region of the UK, localised around two sites. The site based in Norfolk 
(Centre 1) recruited from cases in the Norfolk and Waveney Mental Health 
Partnership. A site based in Cambridgeshire (Centre 2) recruited from cases in 
two mental health trusts: Cambridgeshire and Peterborough Mental Health 
Partnership, and West Suffolk Hospital NHS Trust. Together the two centres 
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recruited from a catchment area with a semi-rural population of around two 
million people, living in small cities, towns and rural areas. 
The CONSORT flow diagram in Figure 1 shows the initial referral rate, 
allocation by centre and diagnosis, and the level of drop out from the main 
outcome assessment. A total of 200 suitable participants were identified of 
which 77 participants consented to participate were recruited into the study. The 
average age was 29 (range = 18-52). Participants had been in contact with 
services for an average of five years, and average length of unemployment was 
209 weeks. Fifty-five participants were male (71%). The majority of the sample 
had a diagnosis of non-affective psychosis (65%).
Thirty-five participants were randomised to the treatment condition and 
42 to treatment as usual, the control condition. Key clinical and social 
characteristics of the sample are summarised in Table 1. This shows that 
randomisation resulted in balanced groups in terms of demographics, diagnosis, 
illness length, and social characteristics. 
Treatments
Social Recovery Cognitive Behavioural Therapy 
Therapy consisted of three stages and combined techniques of CBT with 
vocational case management. Stage 1 involved developing a formulation of the 
person in social recovery. This consisted of assessment and history taking with 
respect to personal motivation, premorbid hopes/expectations and goals which 
had either been changed or altered with respect to the impact of illness. The 
focus was on identifying meaningful personal goals which could be linked with 
achievable day-to-day activity targets. This often involved validation and 
acceptance of real barriers, threats and difficulties, while focusing on promoting 
hope for social recovery.  
 Stage Two involved identifying and working towards medium to long term 
goals. A particularly important aspect of this was identifying specific pathways to 
meaningful new activities. Where relevant this included referral to relevant 
vocational agencies, or alternatively direct liaison with employers or education 
providers. Cognitive work at this stage involved promoting a sense of agency 
and addressing feelings of stigma and negative beliefs about self and others.
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 Stage Three involved the active promotion of social activity, work, 
education and leisure linked to meaningful goals. This involved promotion of 
activity by behavioural experiments, while managing symptoms of anxiety and 
low level psychotic symptoms. Mastery and pleasure with respect to achieving 
goals was reviewed with respect to real gains achieved in social opportunities in 
work, education and leisure.
 Specific therapeutic procedures used in the study were drawn from 
existing cognitive behaviour therapy manuals. Prominent amongst these were 
procedures to focus on self-regulation of psychotic symptoms and improve 
social recovery from psychosis (e.g. chapters 11 and 15 of Fowler et al., 1995). 
Therapists were also encouraged to use techniques of activity scheduling and 
reviewing mastery and pleasure, as described in Beck et al. (1979); and 
behavioural experiment approaches to manage social anxiety, as described in 
Butler (1999). Therapists were also encouraged to combine therapist role with 
case management roles typical of individual placement and support working 
practices. For example, by adopting an assertive outreach worker style of 
contact, most frequently visiting people at home or in the workplace. Therapists 
were also encouraged to adopt a pragmatic and problem-solving approach in 
assisting people to overcome work-related problems. This often involved setting 
up joint interviews with clients and employment and education providers to 
discuss potential problems. 
Therapy in Norfolk was carried out by case managers who had no 
previous formal training in CBT, but who had over two years experience working 
in an early intervention in psychosis team, under the supervision of expert CBT 
therapists. Therapy in the Cambridge based centre was carried out by CBT 
therapists who had attended approved courses prior to working on the trial. 
Therapy in both centres was supervised by experienced CBT specialists. 
Adherence and competence were monitored using tape recordings and 
individual and group supervision. Participants received a mean of 12 sessions 
(SD = 7).
Treatment as usual 
Both sites provided active case management by multidisciplinary secondary 
care mental health teams. The services provided by Norfolk and Waveney 
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Mental Health Partnership Trust (Centre 1) had a pre-existing, active policy of 
promoting social recovery in case management. This consisted of 
multidisciplinary case management, and was backed by the availability of 
services to provide supported employment for people with severe and enduring 
mental health problems. Such an approach was consistently available for all 
cases. The Cambridgeshire site (Centre 2) also had active multidisciplinary 
case management, although supported employment agencies were less 
consistently available as part of generic services
Measures
Primary Outcome 
Time Use Survey (adapted from UK 2000 Time Use Survey;  Short, 2006)
This measure consists of a semi-structured interview in which the participant is 
asked about how they have spent their time over the last month. Activities 
enquired about include: work, education, voluntary work, leisure, sports, 
hobbies, socialising, resting, housework/chores, childcare, and sleep. Time 
spent on each of the activities is calculated in terms of the number of hours per 
week allocated to that activity over the last month. Two summary measures 
were derived from the Time Use Survey: hours in ‘Constructive Economic 
Activity’ and hours in ‘Structured Activity’. Constructive economic activity is 
calculated as the sum of hours per week over the last month spent in work, 
education, voluntary work, housework and chores, and childcare. The 
constructive economic activity assessment could be undertaken by telephone 
contacts and triangulated with carer reports as well as from face-to-face 
interviews, thus maximising available data at post-treatment. Hours in 
‘Structured Activity’ is calculated as the sum of hours per week over the last 
month spent in constructive economic activity, but also includes voluntary and 
structured leisure activities, sports, and hobbies. The structured activity 
assessment required a face-to-face interview with the participant.
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Secondary Outcomes 
Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987)
The PANSS is a 30-item rating scale developed to assess symptoms 
associated with psychosis. Symptoms occurring over the last week are rated. 
PANSS total scores were used. 
Brief Core Schema Scales (BCSS; Fowler et al., 2006) 
The BCSS is a 24-item self-report scale designed to assess the type of extreme 
positive and negative evaluations of self and others that have been observed 
clinically to be typical of people with psychosis. Items are rated on a five point 
scale (0-4). Four scores are obtained: negative self (6 items), positive self (6 
items), negative other (6 items) and positive other (6 items).
Beck Hopelessness Scale (BHS; Beck and Steer, 1988)
The BHS is a 20-item self-report scale designed to assess the way an individual 
perceives the future. Items are rated using a dichotomous true/false response 
format. Total scores from the BHS were used. 
Schizotypal Symptoms Inventory (SSI; in preparation)
The SSI is a 20-item self-report scale designed to assess the presence and 
severity of low-level, residual psychotic symptoms occurring in the past two 
weeks. Items are rated on a five point scale (0-4). Four scores can be obtained: 
Total (20 items), Social Anxiety (6 items), Paranoia (6 items), and Anomalous 
Experiences (8 items). 
Quality of Life Scale (QLS; Heinrichs et al., 1984)
The QLS is a 21-item semi-structured interview designed to assess the 
functional impairments associated with psychosis, including problems with 
interpersonal relationships and occupational role functioning. Two scores were 
used: total QLS score and the score on the Instrumental Role Functioning 
subscale (e.g. employment, accomplishment, role satisfaction).
Tertiary Assessments 
Tertiary outcomes and other measures included the Beck Depression Inventory 
(BDI-II; Beck et al., 1996); the Beck Anxiety Inventory (BAI; Beck and Steer, 
1987); the Personal Beliefs about Illness Questionnaire (PBIQ; Birchwood et al.,
1993); the EuroQol visual analogue scale (Brooks, 1996); the Global 
Assessment of Symptoms Scale (GAS; American Psychiatric Association, 
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2000); the Social and Occupational Functioning Assessment Scale (SOFAS; 
Goldman et al., 1992); the Client Service Receipt Inventory (CSRI; Beecham 
and Knapp, 1992); and the Camberwell Assessment of Needs (CAN; Slade et 
al., 1996). All self-reports were completed independently by participants. The 
GAS, CAN, CSRI and SOFAS were completed with case managers where 
appropriate.
Reliability of Research Assessments and Blinding Procedures 
Baseline and post-treatment assessments were conducted by research 
assistants who were independent of treatment delivery and randomisation. 
Every effort was made to ensure they were kept blind to allocation. Formal 
training in all measures was provided and interviews were audio-taped for 
reliability and quality control. Research assistants met regularly throughout the 
trial to maintain reliability of procedures and ratings. Where blindness was 
broken, another research assistant conducted the post-treatment assessment. 
Ninety-three percent of the post-treatment assessments were completed blind. 
The research assistants made allocation guesses after post-treatment 
assessments. These were 58% correct for CBT and 64% correct for TAU. This 
is within the levels that be expected by chance. 
Statistical Analyses 
Hypotheses
Primary Hypothesis: It was predicted that the provision of Social Recovery 
Cognitive Behaviour Therapy (SRCBT) added to case management (TAU) 
would improve levels of constructive economic and structured activity in 
comparison to cases receiving TAU alone. 
Secondary Hypotheses: i) We predicted that SRCBT added to TAU would 
improve on secondary outcomes of symptoms of psychosis and emotional 
disorder, negative beliefs about self and others, and hopelessness.  ii) We 
aimed to explore the impact of diagnosis on outcome. 
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Sample size and power of the study 
The purpose of the study was to conduct exploratory efficacy research on a new 
intervention to improve social recovery in psychosis. The sample size was 
predicated on testing for an effect of SRCBT on activity with an effect size of 
around 0.6. Sample sizes with a minimum of 30 in each group would then be 
sufficient to detect such an effect with 90% power. Our trial platform legitimised 
limited investigation of some secondary hypotheses particularly regarding 
interactions with diagnostic group and centre. However, we understood that 
these would be underpowered. Secondary hypotheses were undertaken to 
inform the design of future research e.g. a larger, multicentre randomised 
controlled trial for independent replication/extension. 
Analysis Plan 
We first report descriptive statistics for each primary and secondary outcome at 
baseline and post-treatment for the combined study sample, and then the 
sample split by diagnosis. These estimates provide the basis for a provisional 
estimate of effect size, albeit biased by drop-outs and potential non-random 
differences at baseline.
Primary analyses and significance testing were conducted on an 
intention to treat basis. Following the protocol, ANCOVA models were used to 
test the significance of differences between the treatment and control groups. 
For each ANCOVA, outcome at the end of treatment (e.g. hours in structured 
activity at post-treatment) was used as the dependent variable; allocation to 
treatment, centre, and diagnosis were used as fixed factors; and three key 
variables assumed to be associated with outcome and predictive of drop out 
were used as covariates. The covariates were: baseline outcome (e.g. hours in 
structured activity at baseline); baseline schizotypal symptoms score; and 
length of unemployment. Non-significant interactions were removed before final 
testing for main effects. Where initial testing indicated the presence of an 
interaction between treatment and diagnosis, we planned to undertake a series 
of further ANCOVAs for each diagnostic group (affective/non-affective 
psychosis). These were similar to the whole group ANCOVAs but used 
allocation to treatment and location as fixed factors, thus allowing assessment 
of treatment effect independently of the diagnosis by treatment interaction. 
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These analyses allow for the presence of missing outcome data under the 
assumption that the data are missing at random (MAR) conditional on the 
covariates included in the regression model (i.e. allocation, schizotypal 
symptoms, length of unemployment, and baseline values of the outcome 
variables).
RESULTS
Primary outcome data (constructive economic activity) was available for 92% of 
the recruited sample. Eighty percent of the sample completed post-treatment 
face-to-face interviews, providing structured activity and secondary outcome 
assessments. Questionnaire assessments for secondary outcomes (e.g. BDI, 
BAI, BHS, BCSS) were available for around 75% of the sample. Descriptive 
statistics for all outcome and mediating variables are given in Table 2. These 
are broken down by treatment and diagnostic group at baseline and post-
treatment and derive from data available at post-treatment assessment (i.e. 
completers).
Contacts with secondary mental health services 
There were no differences in the level of support given to treated cases and 
controls at baseline or the number of contacts available for participants between 
the two sites. However, the TAU group received more contacts with secondary 
mental health services than the treatment group over the course of the trial 
(mean = 11.9, SD = 11.3 versus mean = 9.7, SD = 18.8) respectively; t=2.02, 
p=0.05). The difference in the mean number of contacts with voluntary services 
was not significant. 
Outcomes for the combined group (non-affective and affective psychosis) 
Table 2 shows that all participants made large improvements in most domains, 
including activity and symptoms, as a result of both CBT and TAU conditions. 
Analyses of the main effects of CBT treatment for the combined group using 
ANCOVAs showed significant effects on the hypothesised mediating variables 
of positive beliefs about self (F (1, 70) =5.1, p=0.03) and positive beliefs about 
others (F(1, 70)=5.61, p=0.02). There were strong trends suggesting treatment 
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by diagnosis interactions for PANSS (F(1,69)=3.99, p=0.05);  and CAN (F(1, 
69)=3.27 , p=0.08).
Non-affective psychosis group 
The non-affective group consisted of 50 cases (23 treatment, 27 controls) for 
whom 43 post-treatment assessments were available. Descriptive results are 
reported in table 2. Table 3 reports the results of significance testing for the 
main outcome variables in the non-affective subgroup. The ANCOVAs for the 
non-affective psychosis group showed significant benefits for treatment (CBT) 
on constructive economic activity, structured activity, PANSS, and positive 
beliefs about self; and trends for improvements in hopelessness and 
instrumental role functioning. There were also significant treatment by centre 
interactions for structured activity, depression, hopelessness, negative beliefs 
about self, and both positive and negative beliefs about others. The treatment 
by centre interactions were consistent with a relatively large treatment effect on 
activity favouring the expert therapist centre (Centre 2). However, effects on 
hopelessness and depression tended to favour the non-expert therapist centre 
(Centre 1).
Affective psychosis group 
There were 27 cases in the affective psychosis group who were predominantly 
people with bipolar disorder. Results for nine cases in the treatment group and 
12 in the control group were available at post-treatment. The descriptive 
statistics in table 2 show suggestions of effects favouring CBT on anxiety and 
beliefs about self but few indications of effects on activity or other outcomes. 
However, there were no significant effects for treatment on any of the outcome 
variables.  The main observation is of striking improvements in activity levels for 
the affective psychosis group in both the treatment and control conditions.
Admissions to hospital 
Ten participants had admissions into hospital during the trial. Six of these were 
in the treatment group and four were in the control group. Average days spent 
in hospital for the whole sample over the course of the trial was 3.8 (SD = 17.2). 
In the six months prior to participating in the trial there had been 15 admissions 
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in the sample. Seven of these were in the group allocated to TAU, and eight 
were in the group allocated to receive treatment. Average days spent in hospital 
for the whole sample in the six months preceding the trial was 5.8 (SD = 14.4). 
Thus, participating in the trial did not appear to have an adverse effect on 
relapse rates. 
DISCUSSION 
The trial was designed to refine methods and estimate the effect size of the use 
of Social Recovery-oriented Cognitive Behaviour Therapy (SRCBT) on the 
primary outcome of hours in constructive social activity; and secondary 
outcomes of symptoms, schematic beliefs about self and others, illness 
cognitions, and hopelessness.   The primary study comparison provided no 
clear evidence for the benefit of CBT on a combined sample of patients with 
both affective and non affective psychosis. However, a planned secondary 
analysis revealed some evidence for the potential of CBT to improving 
constructive and structured activity amongst a more homogeneous sample of 
patients non affective psychosis with poor social outcomes, relatively early in 
the course of disorder 
The indications of benefits for the cognitive behavioural intervention in 
non-affective psychosis are promising but require replication in a large multi-
centre trial.  These gains were large and clinically meaningful. There was an 
average gain of twelve hours per week in structured activity for CBT in 
comparison to four hours for TAU in the non-affective psychosis group.  This 
was achieved in association with clinically meaningful and significant 
improvements in symptoms, hopelessness and beliefs about self and others. 
The affective psychosis cases (mainly bipolar disorder) also showed large gains 
in both symptoms and activity but as this occurred in both treatment and control 
groups it is likely to be the result of a response to treatment as usual conditions 
and possibly the placebo effect of being involved in a trial. 
The study provided a relatively strict evaluation of efficacy as large 
improvements also occurred in the control group on most of the target variables 
of outcome, including activity, symptoms and depression. These gains were 
unexpected as we had deliberately recruited a group of patients who had stable 
poor social outcome at recruitment and may be the result of a good response to 
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the treatment as usual provided. The affective psychosis group made 
particularly large gains in activity and depression in both control and treatment 
conditions. These observations may be consistent with our recent observations 
that bipolar disorder cases respond rapidly and with good social recovery 
outcomes to early intervention services compared with  non-affective psychosis 
(Macmillan et al., 2007). It was certainly the case that there was an active 
treatment factor in the treatment as usual condition.  All cases were in receipt of 
active treatment from secondary mental health teams. In both centres the 
control group received more than 20 contacts from these teams over the course 
of the trial, with some interventions aiming to improve social recovery as well as 
providing generic case management. Informal observations also suggested that 
involvement in the therapy trial may have acted as a catalyst for those providing 
treatment as usual to focus attention on the social recovery needs of cases in 
both the therapy and control groups. Furthermore involvement in the trial 
assessment procedures for all cases provided several sessions of discussing, 
reviewing and monitoring social and symptomatic outcomes which may have 
had a beneficial effect. It is therefore important to interpret the impact of the 
study in terms of the effect size of providing an additional focused cognitive 
behavioural intervention over and above a good existing community mental 
health service.
Improvements in beliefs about self and others and depression could be 
taken as support for the cognitive model underpinning the intervention, which 
had a deliberate focus on deliberately fostering positive self-esteem and hope 
while working toward adopting new social activities. The aim of the study was 
also to develop an intervention which deliberately linked improvements in 
meaningful activities with improvements in psychological well-being and self-
esteem, while also managing risk of sensitivity to stress. In this regard it is 
important to note that there was no indication of any worsening of psychotic 
symptoms, as has been observed in other studies (Hogarty et al., 1974, Hogarty
et al., 1997). Indeed the findings suggest that symptoms improved. Clinical 
observations by therapists suggested the need to take particular care regarding 
initial increases in social anxiety symptoms associated with involvement in new 
activities. However, there was no significant increase in anxiety symptoms over 
the course of the intervention. We intend to explore the association between 
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changes in beliefs about self and others, anxiety and activity in future 
mediational analyses.
This study has highlighted that it was possible for case managers to 
provide hope and to manage many aspects of cognitive therapy work 
associated with SRCBT, within their existing case management style of work 
and skill base. However, there were suggestions that those therapists in the trial 
who had received more formal prior training (mainly in Centre 1) achieved 
stronger effects, especially on activity. Supervision discussions and analysis of 
case notes suggest these differences may have arisen from those therapists 
who had less formal training in CBT feeling less confident about using more 
structured active behavioural interventions, particularly in cases where assisting 
people to engage in new activities may lead to short term increases in  anxiety. 
At the present time, trained CBT therapists may be best placed to deliver the 
behavioural experiment aspects of this intervention with rigorous levels of 
adherence and competence. However, this study clearly shows that case 
managers can deliver an intervention which accrues many significant benefits 
(particularly in terms of increasing hope); and that it may be possible to develop 
specific programmes of training focusing on improving their skills to apply the 
intervention in day-to-day practice at some stage in the future.
The results of this study need to be regarded with caution and as 
indicative of an effect size useful for researchers undertaking further research. 
The study was designed to be exploratory rather than confirmatory and lacks 
power. Results for the non-affective group are therefore suggestive, and those 
for the affective group are too small to warrant any formal conclusion. The study 
has been useful in indicating that the key outcome assessments are sensitive to 
change and, in the case of activity assessment, are relatively independent of 
other dimensions of outcome. The results also indicate the possible promise of 
undertaking further research on what appears to be a highly feasible 
intervention to improve activity in non-affective psychosis.  A further large scale 
trial of this type of intervention is warranted. 
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Figure 1 
CONSORT Diagram of Flow of Participants through the Trial 
Fully Suitable N = 200
Consented  N= 88 
Did Not Consent   N= 112
Assessed and Randomised N = 77
Dropped out during baseline assessment   N=11 
Reasons: 
Symptomatic N= 5  
Not interested N= 5 
Personal reasons N= 1 
Treatment (SRCBT) N = 35 
Location:
Centre 1   N= 24 
Centre 2   N= 11 
Diagnosis: 
Affective   N= 12 
Non-affective   N= 23 
Control (TAU) N = 42 
Location:
Centre 1   N= 26 
Centre 2   N= 16 
Diagnosis: 
Affective   N= 15 
Non-affective   N= 27 
N = 33 
Post-intervention
follow-up
(9 month) 
2 drop-out 4 drop-out N = 38 
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Table 1 
Baseline characteristics of participants  
SRCBT (N = 35) TAU (N = 42) Total (N = 77) 
Demographic characteristics 
Mean Age in yrs (St Dev) 
Gender (% male)
Ethnicity (% white) 
Diagnosis (% non-affective 
psychosis)
Mean illness length in yrs (St Dev) 
Medication level in mg (St Dev) 
(chlorpromazine equivalence) 
27.8 (6.1) 
71.4%
85.7%
65.7%
4.9 (2.2) 
265.1 (200.8) 
30.0 (7.2) 
71.4%
95.2%
64.3%
4.8 (2.4) 
223.7 (167.0) 
29.0 (6.8) 
71.4%
90.9%
64.9%
4.8 (2.3)
242.2 (182.7) 
Social and Clinical 
characteristics
Mean unemployment length in 
wks
Time Use in hours per week: 
- Constructive Economic  
- Structured 
Current IQ 
Contacts with Secondary Mental 
Health Services in last 6mths 
Contacts with Voluntary Services 
in last 6mths 
202.4 (146.0) 
14.8 (20.2) 
30.4 (19.9) 
101.8 (11.3) 
32.1 (35.3) 
11.0 (18.3) 
214.8 (209.2) 
10.4 (13.9) 
27.8 (19.2) 
103.7 (11.3) 
25.9 (23.1) 
7.4 (14.4) 
209.1 (182.2) 
12.4 (17.1) 
29.0 (19.4) 
102.8 (11.3) 
32.1 (35.3) 
9.0 (16.2) 
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Table 2 
Descriptive Statistics – Mean (St Dev) – for Primary, Secondary, and Mediator 
Variables by Treatment and Diagnosis 
Total Sample Non-Affective Affective 
TAU CBT TAU CBT TAU CBT 
Primary Outcomes        
Structured Activity 0 
9
27.9 (19.2) 
34.4 (20.6) 
30.4 (19.9) 
40.0 (22.8) 
27.7 (20.0) 
31.8 (21.3) 
25.1 (10.9) 
37.1 (17.2) 
28.2 (18.4) 
39.8 (18.9) 
40.6 (28.5) 
45.4 (31.2) 
Constructive Economic 
Activity 
0
9
10.4 (13.9) 
15.6 (15.9) 
14.8 (20.2) 
19.2 (21.0) 
8.7 (13.3) 
11.9 (13.6) 
10.3 (7.3) 
14.7 (12.9) 
13.6 (14.7) 
22.4 (18.1) 
23.6 (32.1) 
28.6 (30.6) 
Secondary Outcomes         
PANSS Total 0 
9
56.0 (10.3) 
50.4 (10.1) 
57.6 (11.6) 
50.5 (9.2) 
58.1 (9.4) 
53.2 (8.3) 
57.5 (10.8) 
50.3 (8.2) 
52.1 (11.0) 
44.5 (11.3) 
58.0 (13.4) 
50.7 (11.3) 
Quality of Life 0 
9
62.7 (14.8) 
72.5 (18.5) 
66.8 (14.8) 
76.1 (14.0) 
58.2 (11.0) 
67.1 (15.0) 
64.1 (10.2) 
72.8 (12.3) 
70.7 (17.5) 
83.8 (20.5) 
71.7 (20.5) 
82.3 (15.5) 
Role Functioning  0 
9
5.6 (3.8) 
7.2 (5.7) 
6.6 (4.1) 
9.0 (5.6) 
4.6 (2.9) 
6.1 (5.3) 
5.8 (3.5) 
8.3 (5.6) 
7.4 (4.6) 
9.5 (5.9) 
8.2 (4.9) 
10.5 (5.4) 
Beck Hopelessness 0 
9
8.7 (5.8) 
7.9 (5.8) 
8.9 (5.8) 
6.4 (4.7) 
8.0 (5.5) 
8.2 (5.9) 
8.3 (5.5) 
4.9 (2.3) 
10.2 (6.4) 
7.3 (5.9) 
10.2 (6.3) 
9.3 (6.6) 
Schizotypal Symptoms 0 
9
21.7 (14.5) 
24.8 (16.6) 
15.9 (17.5) 
18.6 (12.8) 
24.8 (16.5) 
26.0 (18.4) 
10.5 (9.3) 
18.0 (12.3) 
15.8 (6.7) 
22.8 (13.8) 
26.6 (24.8) 
19.7 (14.4) 
BCSS – Negative Self 0 
9
6.7 (6.3) 
4.9 (4.4) 
5.5 (5.1) 
4.0 (5.3) 
6.4 (6.7) 
4.2 (3.8) 
4.0 (3.5) 
2.7 (2.3) 
7.2 (5.8) 
5.9 (5.2) 
8.3 (6.5) 
6.2 (7.8) 
BCSS – Positive Self 0 
9
9.2 (6.4) 
10.6 (6.8) 
8.4 (5.6) 
11.9 (6.0) 
8.8 (6.8) 
10.0 (7.6) 
8.6 (5.5) 
11.6 (5.7) 
10.0 (5.8) 
11.5 (5.3) 
8.1 (6.1) 
12.3 (6.8) 
BCSS – Negative Other 0 
9
6.7 (6.6) 
4.9 (4.6) 
6.6 (6.3) 
3.5 (4.2) 
7.7 (7.1) 
4.3 (3.8) 
5.7 (5.7) 
2.9 (3.6) 
4.8 (5.2) 
5.8 (5.8) 
8.1 (7.2) 
4.3 (5.2) 
BCSS – Positive Other 0 
9
11.7 (6.5) 
10.0 (6.1) 
8.9 (5.5) 
11.9 (6.2) 
11.2 (6.9) 
9.5 (6.5) 
8.5 (5.4) 
12.4 (5.9) 
12.6 (5.6) 
10.8 (5.6) 
9.6 (5.8) 
11.2 (6.8) 
Tertiary Outcomes        
SOFAS 0 
9
48.9 (7.9) 
53.8 (12.3) 
51.5 (9.0) 
54.8 (9.4) 
47.3 (6.8) 
51.5 (11.3) 
50.1 (6.8) 
53.7 (9.2) 
51.8 (9.1) 
58.3 (13.3) 
54.2 (12.1) 
56.9 (10.1) 
CAN Number of Needs 0 
9
6.9 (3.4) 
5.5 (2.5) 
5.6 (2.3) 
5.3 (1.8) 
7.1 (3.5) 
6.2 (2.3) 
6.0 (2.4) 
5.5 (1.8) 
6.4 (3.2) 
4.1 (2.3) 
4.9 (2.2) 
5.0 (1.9) 
EuroQol 0 
9
57.5 (21.8) 
65.7 (18.2) 
52.9 (25.4) 
65.8 (19.8) 
55.7 (22.5) 
67.2 (16.9) 
58.4 (21.9) 
67.9 (13.9) 
60.5 (21.2) 
63.7 (20.4) 
42.3 (29.2) 
62.0 (27.9) 
Personal Beliefs About 
Illness
0
9
21.8 (7.6) 
19.7 (6.8) 
21.2 (7.6) 
18.9 (6.2) 
22.5 (8.4) 
19.9 (7.2) 
19.8 (7.3) 
17.8 (4.0) 
20.4 (5.6) 
19.2 (6.4) 
23.9 (7.7) 
20.6 (8.8) 
GAS 0 
9
57.2 (8.8) 
60.2 (14.1) 
56.4 (10.9) 
59.2 (10.9) 
55.4 (8.6) 
56.6 (12.6) 
56.7 (8.9) 
58.5 (10.9) 
60.5 (8.4) 
67.9 (14.6) 
55.8 (14.4) 
60.7 (11.0) 
Beck Depression 0 
9
22.6 (13.8) 
14.4 (12.7) 
21.1 (13.9) 
13.6 (10.6) 
21.4 (14.4) 
14.3 (11.5) 
17.9 (11.3) 
11.3 (7.5) 
24.7 (12.8) 
14.7 (14.9) 
27.0 (16.5) 
17.2 (14.0) 
Beck Anxiety 0 
9
17.0 (11.8) 
13.2 (10.5) 
16.9 (13.5) 
13.0 (12.8) 
16.6 (13.0) 
12.3 (9.7) 
14.8 (12.8) 
11.6 (11.9) 
17.7 (9.8) 
14.7 (12.0) 
21.1 (14.5) 
15.3 (14.6) 
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Table 3 
Results of model estimates of treatment effects within the non-affective psychosis 
group (using EM estimates for missing data) 
 Main Effect 
(of CBT) 
Interaction
(CBT x centre) 
Primary Outcome Variables 
Structured Activity F(1,43)=11.73, p=0.001 F(1,43)=5.44, p=0.02
Constructive Economic Activity F(1,44)=6.19, p=0.02 F(1,43)=0.79, p=0.38
Secondary Outcome Variables 
PANSS Total F(1,44)=4.56, p=0.04 F(1,43)=0.05, p=0.82
Quality of Life F(1,44)=1.54, p=0.22 F(1,43)=0.16, p=0.69
Instrumental Role Functioning F(1,44)=3.32, p=0.08 F(1,43)=0.59, p=0.45
Beck Hopelessness Scale F(1,44)=3.79, p=0.06 F(1,43)=3.60, p=0.07
Schizotypal Symptoms F(1,45)=0.23, p=0.64 F(1,44)=2.73, p=0.11
BCSS – Negative Self F(1,43)=0.01, p=0.93 F(1,43)=5.40, p=0.03
BCSS – Positive Self F(1,44)=5.52, p=0.02 F(1,43)=2.38, p=0.13
BCSS – Negative Other F(1,43)=0.001, p=0.98 F(1,43)=8.54, p=0.006
BCSS – Positive Other F(1,43)=0.18, p=0.67 F(1,43)=17.15, p=<0.0001
Tertiary Outcome Variables 
Global Assessment of Symptoms F(1,44)=0.48, p=0.49 F(1,43)=0.01, p=0.92
Beck Depression Inventory F(1,43)=0.03, p=0.87 F(1,43)=9.95, p=0.003
Beck Anxiety Inventory F(1,44)=0.001, p=0.97 F(1,43)=0.08, p=0.78
Social and Occupational 
Functioning
F(1,44)=2.43, p=0.13 F(1,43)=0.75, p=0.39
CAN Number of Needs F(1,44)=2.96, p=0.09 F(1,43)=0.30, p=0.58
EuroQol F(1,44)=0.17, p=0.68 F(1,43)=2.61, p=0.11
Personal Beliefs About Illness F(1,44)=0.20, p=0.62 F(1,43)=1.08, p=0.30
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Information Sheet and Consent Forms for Clinical Sample 
D1 Information sheet for ISREP study 
D2 Consent form for ISREP study 
D3  Information sheet for EI study 
D4 Consent form for EI study 
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Participant Information Sheet: Version 2 (26/05/2004) 
 
ISREP 
 
 
ISREP Project Team  
c/o Early Intervention Service  
80 St Stephens Road 
Norwich 
NR1 3RE 
 
 
Improving Social Recovery in Early Psychosis:  
Participant Information Sheet 
 
 
Invitation Paragraph 
You are being invited to take part in a research study.  Before you decide, it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with others if you wish.  Ask us if 
there is anything that is not clear or if you would like more information.  Take time to decide 
whether or not you wish to take part.  Thank you for reading this 
 
What is the purpose of the study? 
People who have episodes of worrying, distressing or unusual experiences or beliefs often 
recover from the worst of these experiences, but may continue to have difficulties in 
maintaining social contacts and social activities or in returning to or taking up employment or 
educational opportunities.  We think people can be helped to make a better social recovery 
by working with a therapist using a therapy called social recovery oriented cognitive 
behaviour therapy (SRCBT).  The study aims to see if working with a therapist helps to 
improve social recovery and to reduce symptoms of hopelessness and anxiety if present. 
 
Why have I been chosen? 
We are approaching people who have had a first episode of psychosis within the last eight 
years, who are unemployed, and who are in contact with their community mental health 
teams.  The whole study will involve 100 patients in Norfolk and Cambridge.     
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to take part you will be 
given this information sheet to keep and will be asked to sign a consent form.  If you decide 
to take part, you are still free to withdraw at any time and without giving a reason.  A decision 
to withdraw at any time, or a decision not to take part, will not affect the standard of care you 
receive.   
 
What will happen to me if I take part? 
If you do agree to take part, you will meet with a researcher who will ask about your current 
problems and social situation, after this you will either be offered SRCBT and your usual 
treatment or your usual treatment with your team alone.  After nine months you will then 
meet with the researcher again to repeat the assessments. This is a randomised trial in 
which, as we do not know which way of treating patients is best, we need to make 
comparisons.  People will be put into groups and then compared. The groups will be 
selected by a computer which has no information about the individual i.e. by chance. 
Patients in each group then have a different treatment and these are compared. You will 
have a 50/50 chance of receiving SRCBT or treatment as usual.  
 
   
improving social 
recovery in early 
psychosis 
 Funded by the MRC 
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What do I have to do?  
SRCBT involves weekly or fortnightly meetings with a therapist for up to nine months which 
will be arranged at a time to suit you.  Expenses for attending such appointments can be 
claimed 
 
What is the therapy being tested? 
The aims of SRCBT are: to carefully identify activities and occupations which are meaningful 
for the person; to understand any barriers people may have to undertaking the activity the 
person wants to do; and to help people prepare for work or leisure activities by practicing in 
safe and low stress environments.  This kind of help is called Social Recovery oriented 
Cognitive Behaviour Therapy (SRCBT).  Social recovery is the aim.  CBT tries to help you to 
understand what you are experiencing and feeling, cope with it differently, and feel less 
worried when you are trying to do new things. 
 
SRCBT is a relatively new treatment.  We still do not know how exactly it helps people to 
improve.  The main aim of the study is therefore to see if SRCBT works, but we also want to 
improve our understanding of this type of treatment so that we can develop it further to be 
more helpful. 
 
What are the alternatives for treatment? 
Many existing therapeutic approaches which sometimes form part of normal treatment in 
mental health services such as case management, occupational therapy, vocational therapy 
and rehabilitation aim to improve social recovery.  These will be sometimes be available as 
part of normal treatment to all participants. Where these treatments are available SRCBT 
aims to enhance these treatments.  
 
What are the possible disadvantages and risks of taking part? 
If people feel pressurised into undertaking new activities they can sometimes have a 
recurrence of symptoms.   However, the aim of SRCBT is to help people explore new 
activities they want to do while taking care to minimise the risk of symptom recurrence. 
 
What are the possible benefits of taking part?  
We hope that all the treatments will help you. However, this cannot be guaranteed. The 
information we get from this study may help us treat future patients better.  
 
What happens when the research study stops? 
When the research study finishes, all participants will receive normal care from local mental 
health services.  
 
What happens if something goes wrong?  
If you are harmed by taking part in a research project there are no special compensation 
arrangements.  If you are harmed by someone’s negligence you may have grounds for legal 
action but you may have to pay for it. Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been approached or treated during the 
course of the study, the normal National Health Service complaints mechanisms should be 
available to you.  
 
Will my taking part in this study be kept confidential?  
If you consent to take part in the study we will check your medical records for details of your 
care and other treatment.  All information that is collected about you during the course of the 
research will be kept strictly confidential.  Any information about you that leaves the 
Hospital/Trust will have your name and address removed so that you cannot be recognised 
from it. 
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If you consent, we will inform your consultant psychiatrist and the team responsible for your 
care about your involvement in the study.  We will send them a very brief summary of our 
assessment unless you do not wish us to do this. 
 
Since we are trying to provide the very best treatment possible, we would like to audio tape 
sessions that you have with your therapist.  The reason for this is to check that the therapy is 
carried out in the way that we expect it to be.  We will ask you separately for your consent to 
this. 
 
Where and how long will records be stored? 
Data will be stored in locked cabinets in local health care or university premises. It will be 
kept for 5 years after the completion of the study and then destroyed.  
 
What will happen to the results of the research study? 
When the study is finished the results will be published.  This is likely to be in 2007.  We will 
ensure that copies of the report are available to local users groups, and we will arrange local 
talks to which participants will be invited. We will not identify you individually in any report or 
publication of the research. 
 
Who is organising and funding the research? 
The research is funded by the Medical Research Council.  It is being carried out by 
researchers from University of East Anglia, University of Cambridge and staff working at 
Norfolk and Waveney Mental Health and Social Care Partnership and Cambridge University 
Teaching Hospitals Trust. 
 
Who has reviewed the study? 
The research has been considered and approved by the Norwich Local Research Ethics 
Committee. 
 
Thank you for reading this.  If you need further information, please contact a member of the 
research team.  The names of people to contact are given below.  
 
We will give you this information sheet to keep as well as a signed consent form if you agree 
to take part in the study. 
 
Contact for further information: 
David Fowler, Principal Investigator.  School of Medicine, Health Policy and Practice, UEA, 
NR4 7TJ (Tel: 01603 593637). 
Mark Wright, Trial Therapist.  Early intervention Service, 80 St Stephens St, Norwich (Tel: 
01603 201552). 
Jo Hodgekins, Assistant Psychologist/Research Associate.  School of Medicine, Health 
Policy and Practice, UEA, NR4 7TJ (Tel: 01603 591232). 
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improving social 
recovery in early 
psychosis 
 Funded by the MRC 
 
Centre Number: 
Study Number: 
Patient Identification Number for this trial: 
 
CONSENT FORM 
 
Title of Project: Improving social recovery in Early Psychosis  
 
Name of Researcher: 
 
                                              Please initial box 
 
1. I confirm that I have read and understand the information sheet dated 26/05/2004 (version 2) for the 
above study and have had the opportunity to ask questions.                
                                                                                                                                              ? 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, without giving 
any reason, without my medical care or legal rights being affected.        
                                                                                                                                              ? 
 
3. I understand that sections of any of my medical notes may be looked at by responsible individuals 
working on the improving social recovery project or from regulatory authorities where it is relevant to my 
taking part in research.  I give permission for these individuals to have access to my records.   
                                                                                                                                               
            ?  
 
4. I am willing for my care team/consultant psychiatrist to be informed of my participation in this project, and 
for assessment information regarding my current problems and social circumstances to be shared with 
my care team/consultant psychiatrist.                                                        
                                                                                                                                         ? 
 
5. I give my consent for tape recordings of assessment and treatment sessions to be made.  I understand 
that this is for the purposes of training and supervision, and that any person hearing the tape will sign a 
declaration of confidentiality and that recordings will be stored under locked conditions.  
                                                                                                                                    ? 
 
4. I agree to take part in the above study.                                          ? 
 
 
________________________ ________________ ____________________ 
Name of Patient Date Signature 
 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date Signature 
(if different from researcher) 
 
_______________________ ________________ ____________________ 
Researcher Date Signature  
  
1 for patient; 1 for researcher; 1 to be kept with hospital notes 
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APPENDIX E 
Study Measures 
E1  Schizotypal Symptoms Inventory (Long version) 
E2 Schizotypal Symptoms Inventory (Brief version) 
E3 Trauma History Screen 
E4 Time Use Survey 
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SSI (Long Version) 
 
Please answer each item by choosing either “Yes” or “No”.  If you choose “Yes”, please state how 
often this experience has occurred over the past 2 weeks.  Please answer all of the questions honestly, 
even if you are unsure of your answer.  
 
 
1. Do you sometimes feel that things you see on 
the TV or read in the newspaper have a 
special meaning for you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
2. I sometimes avoid going to places where there 
will be many people because I will get 
anxious. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally 
 
Sometimes Often All of the 
time 
      
3. Have you had experiences with the 
supernatural? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
4. Have you often mistaken objects or shadows 
for people, or noises for voices? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
5. Other people see me as slightly eccentric 
(odd). 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
6. I have little interest in getting to know other 
people. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
7. People sometimes find it hard to understand 
what I am saying. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
8. People sometimes find me aloof and distant. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? 
 
Not at 
all 
Occasionally Sometimes Often All of the 
time 
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9. I am sure I am being talked about behind my 
back. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? 
 
Not at 
all 
Occasionally Sometimes Often All of the 
time 
 
 
     
10. I am aware that people notice me when I go 
out for a meal or to see a film. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
11. I get very nervous when I have to make polite 
conversation. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
12. Do you believe in telepathy (mind-reading)? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
13. Have you ever had the sense that some person 
or force is around you, even though you 
cannot see anyone? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
14. People sometimes comment on my unusual 
mannerisms and habits. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
15. I prefer to keep myself to myself. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
16. I sometimes jump quickly from one topic to 
another when speaking. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
17. I am poor at expressing my true feelings by 
the way I talk and look. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
18. Do you often feel that other people have got it 
in for you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
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 19. Do some people drop hints about you or say 
things with a double meaning? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
20. Do you ever get nervous when someone is 
walking behind you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? 
 
Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
21. Are you sometimes sure that other people can 
tell what you are thinking? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
22. When you look at a person, or yourself in a 
mirror, have you ever seen the face change 
right before your eyes? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
23. Sometimes other people think that I am a little 
strange. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
24. I am mostly quiet when with other people. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
25. I sometimes forget what I am trying to say. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
26. I rarely laugh and smile. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
27. Do you sometimes get concerned that friends 
or co-workers are not really loyal or 
trustworthy? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? 
 
Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
28. Have you ever noticed a common event or 
object that seemed to be a special sign for 
you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
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 29. I get anxious when meeting people for the 
first time. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
30. Do you believe in clairvoyancy (psychic 
forces, fortune telling, etc)? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often  All of the 
time 
      
31. I often hear a voice speaking my thoughts 
aloud. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
32. Some people think that I am a very bizarre 
person. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often  All of the 
time 
      
33. I find it hard to be emotionally close to other 
people. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
34. I often ramble on too much when speaking. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
35. My “non-verbal” communication (smiling 
and nodding during a conversation) is poor. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
36. I feel I have to be on my guard, even with 
friends. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
37. Do you sometimes see special meanings in 
advertisements, shop windows, or in the way 
things are arranged around you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
38. Do you often feel nervous when you are in a 
group of unfamiliar people? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
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39. Can other people feel your feelings when they 
are not there? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
40. Have you ever seen things invisible to other 
people? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
41. Do you feel that there is no-one you are really 
close to outside of your immediate family, or 
people you can confide in or talk to about 
emotional problems? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
42. Some people find me a bit vague and elusive 
during a conversation. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
43. I am poor at returning social courtesies and 
gestures. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
44. Do you often pick up hidden threats or put-
downs from what people say or do? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
45. When shopping, do you get the feeling that 
other people are taking notice of you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
46. I feel very uncomfortable in social situations 
involving unfamiliar people. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
47. Have you had experiences with astrology, 
seeing the future, UFOs, ESP or a sixth 
sense? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
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 48. Do everyday things seem unusually large or 
small? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
49. Writing letters to friends is more trouble than 
it is worth. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
50. I sometimes use words in unusual ways. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
51. I tend to avoid eye contact when conversing 
with others. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all  
Occasionally Sometimes Often All of the 
time 
      
52. Have you found that it is best not to let other 
people know too much about you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
53. When you see people talking to each other, do 
you often wonder if they are talking about 
you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often  All of the 
time 
      
54. I would feel very anxious if I had to give a 
speech in front of a large group of people. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
55. Have you ever felt that you are 
communicating with another person 
telepathically (by mind-reading)? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
56. Does your sense of smell sometimes become 
unusually strong? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
57. I tend to keep in the background on social 
occasions. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
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 58. Do you tend to wander off the topic when 
having a conversation? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
59. I often feel that others have it in for me. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
60. Do you sometimes feel that other people are 
watching you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
61. Do you ever suddenly feel distracted by 
distant sounds that you are not normally 
aware of? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
62. I attach little importance to having close 
friends. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
63. Do you sometimes feel that people are talking 
about you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
64. Are your thoughts sometimes so strong that 
you can almost hear them? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
65. Do you often have to keep an eye out to stop 
people from taking advantage of you? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
66. Do you feel that you are unable to get “close” 
to people? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
67. I am an odd unusual person. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
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68. I do not have an expressive and lively way of 
speaking.  
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
69. I find it hard to communicate clearly what I 
want to say to people. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
70. I have some eccentric (odd) habits. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
71. I feel very uneasy talking to people I do not 
know well? 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
72. People occasionally comment that my 
conversation is confusing. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes  Often All of the 
time 
      
73. I tend to keep my feelings to myself. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes Often All of the 
time 
      
74. People sometimes stare at me because of my 
odd appearance. 
 
 
 
Yes 
 
 
No 
Has this happened in the past 2 weeks? Not at 
all 
Occasionally Sometimes  Often All of the 
time 
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SSI (Brief Version)  
 
Please answer each item depending on how often (if at all) this experience has occurred over the past 2 weeks.  
Please answer all of the questions honestly, even if you are unsure of your answer.  
 
 
1. I sometimes avoid going to places where there 
will be many people because I will get anxious. 
 
 
Not at 
all 
 
Occasionally 
 
 
Sometimes 
 
Often 
 
All of the 
time 
      
2. Do you believe in telepathy (mind-reading)? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
3. I am sure I am being talked about behind my 
back. 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
4. I get very nervous when I have to make polite 
conversation. 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
5. Have you had the sense that some person or force 
is around you, even though you cannot see 
anyone? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
6. Do you often feel that other people have got it in 
for you? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
7. I feel very uneasy talking to people I do not know 
well. 
 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
8. Have you noticed a common event or object that 
seemed to contain a special sign for you? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
9. When you see people talking to each other, do you 
often wonder if they are talking about you? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often  
 
All of the 
time 
      
10. I often hear a voice speaking my thoughts aloud. 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
11. Do you often feel nervous when you are in a 
group of unfamiliar people? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
12. I often feel that others have it in for me. 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
13. Have you seen things invisible to other people? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
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14. I feel very uncomfortable in social situations 
involving unfamiliar people. 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
15. Do you sometimes feel that people are talking 
about you? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
16. Can other people feel your feelings when they are 
not there? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
17. I get anxious when meeting people for the first 
time. 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
18. Do you believe in clairvoyancy (psychic forces, 
fortune telling)? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
19. Do you sometimes feel that other people are 
watching you? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
      
20. Have you felt that you are communicating with 
another person telepathically (by mind-reading)? 
 
 
Not at 
all 
 
Occasionally 
 
Sometimes 
 
Often 
 
All of the 
time 
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Trauma Questions for Web Study (selected items taken from the Traumatic Life Events 
Questionnaire (TLEQ; Kubany et al, 2000) and the Trauma History Questionnaire 
(THQ; Green, 1996) 
 
You will now be asked some questions about different types of stressful events that may have 
happened in your life.  These kinds of events can be traumatic and disturbing.   
 
Some of the questions are quite personal so only answer those you feel comfortable with.  If 
you are comfortable with answering the question, all you will be asked is if the event has 
happened in your lifetime and how you feel about it now.  You will not be asked for in-depth 
details. 
 
 
1. Have you ever been in a serious car accident or serious accident at work, or somewhere 
else? 
 
If this has happened: 
- Did you ever think you might be killed or seriously injured as a result of the 
event? (yes/no) 
- Did you experience intense fear, helplessness or horror when it happened? 
(yes/no) 
- Does the event still affect you? (yes/no) 
- Do you still think about the event? (yes/no) 
- Do you avoid thinking about the event? (yes/no) 
- Please use the space below to give a brief indication of the severity of the event 
(e.g. minor burns, near death in hospital, etc)  
 
2. Has anyone ever done anything particularly nasty or cruel to you?  Has anyone ever been 
unnecessarily mean to you?  Has anyone ever tormented you?  Have you ever been 
teased, taunted or actually bullied by anyone? 
 
If this has happened: 
- Did you ever think you might be killed or seriously injured as a result of the 
event? (yes/no) 
- Did you experience intense fear, helplessness or horror when the event happened? 
(yes/no) 
- Does the event still affect you? (yes/no) 
- Do you still think about the event? (yes/no) 
- Do you avoid thinking about the event? (yes/no) 
- Please use the space below to give a brief indication of the severity of the event 
(e.g. single episode of taunting at school, continual emotional abuse, etc) 
 
3. Did you ever have sexual contact with anyone who was at least five years older than you 
before you reached the age of thirteen? 
 
If this has happened: 
- Did you ever think you might be killed or seriously injured as a result of the 
event? (yes/no) 
- Did you experience intense fear, helplessness or horror when the event happened? 
(yes/no) 
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- Does the event still affect you? (yes/no) 
- Do you still think about the event? (yes/no) 
- Do you avoid thinking about the event? (yes/no) 
- Please use the space below to give a brief indication of the severity of the event 
(e.g. touched by someone without your permission, rape involving penetration, 
etc) 
 
4. Before you were age eighteen, did anyone ever use pressure, coercion, or non-physical 
threats to have sexual contact with you? 
 
If this has happened: 
- Did you ever think you might be killed or seriously injured as a result of the 
event? (yes/no) 
- Did you experience intense fear, helplessness or horror when the event happened? 
(yes/no) 
- Does the event still affect you? (yes/no) 
- Do you still think about the event? (yes/no) 
- Do you avoid thinking about the event? (yes/no) 
- Please use the space below to give a brief indication of the severity of the event 
(e.g. touched by someone without your permission, rape involving penetration, 
etc) 
 
5. At any other time in your life, has anyone ever used physical force or threat of force to 
make you have some type of unwanted sexual contact with them?              
 
If this has happened: 
- Did you ever think you might be killed or seriously injured as a result of the 
event? (yes/no) 
- Did you experience intense fear, helplessness or horror when the event happened? 
(yes/no) 
- Does the event still affect you? (yes/no) 
- Do you still think about the event? (yes/no) 
- Do you avoid thinking about the event? (yes/no) 
- Please use the space below to give a brief indication of the severity of the event 
(e.g. touched by someone without your permission, rape involving penetration, 
etc) 
 
6. At any time in your life, has anyone (including family members or friends) ever attacked 
you with a gun, knife or some other weapon, regardless of whether you ever reported it? 
 
If this has happened: 
- Did you ever think you might be killed or seriously injured as a result of the 
event? (yes/no) 
- Did you experience intense fear, helplessness or horror when the event happened? 
(yes/no) 
- Does the event still affect you? (yes/no) 
- Do you still think about the event? (yes/no) 
- Do you avoid thinking about the event? (yes/no) 
- Please use the space below to give a brief indication of the severity of the event 
(e.g. threatened with gun, stabbed by someone, etc) 
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7. At any time in your life, has anyone (including family members or friends) ever attacked 
you without a weapon, but with the intent to kill or seriously harm you? 
 
If this has happened: 
- Did you ever think you might be killed or seriously injured as a result of the 
event? (yes/no) 
- Did you experience intense fear, helplessness or horror when the event happened? 
(yes/no) 
- Does the event still affect you? (yes/no) 
- Do you still think about the event? (yes/no) 
- Do you avoid thinking about the event? (yes/no) 
- Please use the space below to give a brief indication of the severity of the event 
(e.g. cuts and bruises, near death in hospital, etc) 
 
8. Have you ever experienced (or seen) any other events that were life threatening, caused 
serious injury, or were highly disturbing or distressing? 
 
If this has happened: 
- Did you ever think you might be killed or seriously injured as a result of the 
event? (yes/no) 
- Did you experience intense fear, helplessness or horror when the event happened? 
(yes/no) 
- Does the event still affect you? (yes/no) 
- Do you still think about the event? (yes/no) 
- Do you avoid thinking about the event? (yes/no) 
- Please use the space below to give a brief indication of the severity of the event. 
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TIME USE INTERVIEW 
 
 
EMPLOYMENT 
 
 
1. (a) Did you do any paid work in the last month, either as an employee or self-employed? 
 
YES    GO TO QU 4 
NO    ASK b 
 
(b) Have you been on a government scheme for employment training? 
   
YES   DETAILS 
 
 
 
 
   
NO  GO TO QU 2 
 
 
2. (a) Did you have a job or business you were away from? 
   
YES  ASK b 
  NO   GO TO QU 3 
   
(b)  Why were you away? (Then ask QU 4 for typical work pattern when not away) 
   
Holiday   
Sickness  
Studying  
Maternity/paternity leave  
Other reason (please state)  
    
 
3. (a) Did you do any unpaid work for any business that you or a relative own? 
    
   YES   GO TO QU 4 
   NO  ASK b 
 
(b) Have you ever had a paid job?  
    
   YES   ASK c & questions 4-7 for most recent paid job 
   NO  GO TO QU 8 
 
 (c) When did you leave your last paid job? 
 
 
 
 
 
 
4. What was your main job in the last month/most recent period of paid work? 
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What do/did you mainly do in your job?  (check special qualifications, managerial duties, 
etc) 
 
 
 
 
 
 
5. How many hours a week do you usually work in your main job or business?  Include any
 overtime.  How many hours have you worked in the last month? 
 
 
 
 
6. What was your take-home monthly pay after all deductions the last time you were paid?   
  
1 Less than £215   
 
2 £215 to less than £435 
 
3 £435 to less than £870  
 
4 £870 to less than £1305  
 
5 £1305 to less than £174  
 
6 £1740 to less than £2820 
 
7 £2820 to less than £3420 
 
8 £3420 to less than £3830 
 
9 £3830 to less than £4580 
 
10 £4580 to less than £6670 
 
11 £6670 or more   
 
 
7. In the last month, did you do any other paid work or have any other paid job or business, 
 in addition to the one you have just told me about? 
      
YES   DETAILS (e.g. how many, number of hours, type of job, wages) 
 
 
 
 
  NO  IF NO PAID WORK AT ALL IN LAST MONTH, GO TO QU 8 
    IF CURRENTLY WORKING, GO TO QU 11 
 
8. Thinking of the last month, have you been looking for any kind of paid work government 
 training schemes? 
    
   YES   ASK QU 9 
   NO  GO TO QU 10 
 
9. In the last month, did you do any of these things? 
             
Visited a Jobcentre/Jobmarket or Training and Employment Agency Office?  
Visited a Jobclub?  
Had your name on the books of an employment agency?  
Advertised for jobs in newspapers, etc?  
Looked for advertisements in newspapers, etc?  
Answered advertisements in newspapers, etc?  
Applied directly to employers?  
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Asked friends, relatives, colleagues or trade unions about jobs?  
Waited for the results of a job application?  
Been to an interview?  
Done anything else to find work?  Please state.  
 
 How much time did you spend doing this? 
 
 
 
 
10. May I just check, what was the main reason you did not look for work in the last month? 
 
 
Waiting for the results of a job application/being assessed by training agent?  
Student?  
Looking after the family home?  
Temporarily sick or injured?  
Long-term sick or disabled?  
Believe no jobs available?  
Not yet started looking?  
Any other reason?  Please state.  
   
11. Are you at present receiving any state benefits in your own right or on behalf of anyone
 in your household?  If so, which ones? (show list) 
    
 
 
 
 
 
 
EDUCATION AND TRAINING 
 
1. (a) Do you have any qualifications from school, college or university, connected with 
  work or from government schemes? 
 
YES     ASK b onwards 
NO     GO TO QU 2 
   Don’t know  GO TO QU 2  
 
(b) Which qualification do you have, starting with the highest qualification (show list)? 
 
 
 
 
  
 
 
 
 (c)  When did you last study for any qualifications?  
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2.  Are you studying for any qualifications at the moment (show list)? 
 
YES     DETAILS (e.g. what, where, full/part time, hours, etc) 
 
 
 
 
 
 
1 Degree level qualification including graduate membership of a professional 
institute or PGCE or higher (include undergraduate and postgraduate degrees) 
 
2 Diploma in higher education        
 
3 HNC/HND          
 
4 ONC/OND          
 
5 BTEC, BEC or TEC        
 
6 SCOTVEC, SCOTEC or SCOTBEC       
 
7 Teaching qualification excluding PGCE       
 
8 Nursing or other medical qualification not yet mentioned?    
 
9 Other higher education qualification below degree level     
 
10 A-level or equivalent         
 
11 SCE highers          
 
12 NVQ/SVQ          
 
13 GNVQ/GSVQ          
 
14 AS-level          
 
15 Certificate of sixth year studies (CSYS) or equivalent     
 
16 O-Level or equivalent        
 
17 SCE Standard or Ordinary (O) grade       
 
18 GCSE           
 
19 CSE           
 
20 RSA           
 
21 City and Guilds          
 
22 YT certificate/YTP         
 
23 
 
Any other professional or vocational qualification or foreign qualifications (e.g.  
apprenticeship) 
 
666 Don’t know          
 
 
NO     GO TO QU 3 
 
3. (a) In the last month, have you been on any taught courses or undertaken learning of any 
  of the following sorts: 
 
Taught courses meant to lead to qualifications (even if you did not obtain them) 
 
Taught courses designed to help you develop skills that you might use in a job 
 
Courses or instruction or tuition in driving, in playing a musical instrument, in an 
art or craft, in a sport or in any practical skill 
 
Evening classes      
 
Learning which involved working on your own from a package of materials 
provided   
 
 
  IF YES TO ANY OF THE ABOVE    ASK b  
IF NONE OF THE ABOVE   GO TO QU 4   
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(b) How many taught courses have you been involved in in the last month? 
 
 
 
 
 
 
4. In the last month, have you studied or received training in any of these ways: 
   
Studied for a qualification without taking part in a taught course  
Received supervised training while you were actually doing a job    
Spent time keeping up-to-date with developments in the type of work you do without 
taking part in a taught course (e.g. by reading books, manuals journals, or attending 
seminars) 
 
Spent time deliberately truing to improve your knowledge about anything or teach 
yourself a new skill without taking part in a taught course 
 
   
  IF YES TO ANY OF THE ABOVE    DETAILS (e.g. what, number of occasions
      in last month, length of time, etc) 
   
 
 
 
 
  IF NONE OF THE ABOVE   GO TO QU 6     
 
 
5.  On how many occasions in the last month did you spend time studying at home outside of 
teaching sessions?  
 
 
  
 
How long did you study for the last time you did any?  How long on average do you 
normally study for? 
 
 
 
 
 
6. Thinking of the last month, have you been looking for any kind of education/course? 
    
YES     DETAILS (what, how much time, etc) 
 
 
 
 
 
NO     GO TO VOLUNTARY WORK 
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VOLUNTARY WORK 
 
Voluntary work is work that people may do for which they are not paid, except perhaps for 
expenses. 
 
1. Have you done any voluntary work through a group or on behalf of an organisation at any 
time during the last month? 
 
YES     DETAILS AND ASK 2 ONWARDS 
 
 
 
 
 
NO     GO TO ‘LEISURE ACTIVITIES’ 
 
   
2. How many different times did you do this work during the last month? 
 
 
 
 
3. How long did you work for, the last time you did this?  How long do you normally spend 
 doing this? 
 
 
 
 
 
LEISURE ACTIVITIES 
 
1. I am now going to ask some questions about things that some people do in their spare 
time.  For each activity that I mention could you please tell me whether of not you have 
done this in the last month, AND how often? 
 
ACTIVITY NUMBER OF 
TIMES 
AMOUNT OF 
TIME 
Been to cinema, film society or club 
  
Been to a sports event as a spectator 
  
Been to a play, musical or pantomime 
  
Been to the opera 
  
Been to a concert or performance of classical music of any 
kind 
  
Been to any other gig or live music performance (e.g. pop, 
rock or jazz concert, blues or folk club) 
  
Been to the ballet or to a modern/contemporary dance 
performance 
  
Been to a museum or art gallery 
  
Been to an historic house, castle or other heritage site or 
building 
  
Been to a library 
  
Been out to eat or drink at a café, restaurant, pub or wine 
bar 
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Been to a shopping centre, or mall, apart from regular 
shopping for food and household items 
  
Been to a car boot sale, antiques fair or craft market or 
similar apart from regular shopping for food and 
household items 
  
Been to a theme park, fairground, fair or carnival 
  
Been to a zoo, wildlife reserve, aquarium or farm park 
  
Been to some other place of entertainment (e.g. dance, 
club, bingo, casino) 
  
Been on any other outdoor trips (including going to places 
of natural beauty, picnics, going for a drive or going to the 
beach) 
  
Other (please state) 
 
  
 
2. On these cards is a list of sports and physical activities.  Could you please tell me whether 
or not you took part in any of them in the last month AND how often? 
 
ACTIVITY NUMBER OF 
TIMES 
AMOUNT OF 
TIME 
Swimming or diving 
  
Cycling 
  
Indoor or outdoor bowls 
  
Tenpin bowling 
  
Keep fit, aerobics, yoga, dance exercise 
  
Martial arts 
  
Weight training or weight lifting 
  
Gymnastics 
  
Snooker, pool or billiards 
  
Darts 
  
Rugby 
  
Football 
  
Gaelic sports 
  
Cricket 
  
Hockey 
  
Netball 
  
Tennis 
  
Badminton 
  
Squash 
  
Basketball 
  
Table tennis 
  
Track and field athletics 
  
Jogging, cross country, road running 
  
Angling/fishing 
  
Yachting or dinghy sailing 
  
Canoeing 
  
Windsurfing/board sailing 
  
Ice-skating 
  
Curling 
  
Golf 
  
Skiing 
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Horse riding 
  
Climbing/mountaineering 
  
Motor sports 
  
Shooting 
  
Walking or hiking for 2 miles or more (recreationally) 
  
Volleyball 
  
Other (please state) 
  
 
3. How much time do you spend socialising?  How many occasions in the last month have 
you seen friends, either visiting them or receiving visitors?  How much time did you tend 
to spend socialising on each occasion on average? 
 
 
 
 
 
 
4. How much time do you spend resting, i.e. taking time out and doing nothing (but not 
sleeping)?  How much time do you spend watching television or listening to the radio?  
Average for last month. 
 
 
 
 
 
 
 
 
 
HOBBIES 
 
1. Do you have any hobbies?  Show list of examples. 
  
 
 
 
 
 
2.  How much time do you spend on hobbies each week (on average)? 
 
 
 
 
 
 
 
CHILD CARE 
 
1. Are you responsible for the care of any children? 
 
YES     ASK 2 
NO     GO TO ‘HOUSEWORK AND CHORES’ 
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2. How many?  How old are they? 
 
 
 
 
 
 
 
3. How much time do you spend doing things with your children?  Ask individual to include 
checklist in their estimate (show card). 
 
 
 
 
 
 
HOUSEWORK AND CHORES 
 
How much time do you spend doing housework and chores per week?  Ask individual to 
include checklist in their estimate. 
 
Food management and preparation 
 
Cleaning, dusting, vacuuming, washing dishes 
 
Food shopping 
 
Washing 
 
Gardening 
 
DIY and repairs 
 
Other (please state) 
 
 
 
 
 
 
OTHER ACTIVITIES 
 
1. How much time do you spend sleeping per day (on average)?  This includes sleep at night 
time and naps during the day.  Ask about good and bad days. 
 
 
 
 
 
 
2. Do you spend time doing any activities not already asked about?  Get weekly average. 
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TIME USE INTERVIEW SCORE SHEET 
 
 
General Codings: 
 
0 = NO     1 = YES 
666 = NO ANSWER/MISSING 999 = NOT APPLICABLE 
 
 
EMPLOYMENT 
 
• Is paid work in the last month present or absent? 
 
Present = ‘YES’ response to Question 1 (a), 1 (b), or Question 2 
   
  Absent = ‘NO’ response to Question 1 or 2 
 
NB.  ‘YES’ response to Question 3 (a) should be coded as voluntary work 
 
• Type of work/job title (Question 4) 
 
 
 
• Salary band (Question 6) 
 
Code 1-11 or 666/999 (see interview) 
 
• Hours per week in paid employment over the last month 
 
 
 
 
 
  
• Active searching for work? 
  
Present = ‘YES’ response to Question 8 
   
  Absent = ‘NO’ response to Question 8 
 
 
 Number of different work searching activities (taken from Question 9) 
 
 
• Has paid work ever been present? (NB: Only code these items if no current paid work) 
 
Present = ‘YES’ response to Question 3 (b) 
   
Absent = ‘NO’ response to Question  3 (b) 
 
       If yes: 
 
Number of weeks since last worked   Number of hours per week worked in last 
 (Response to Question 3c)    job (Response to Question 5) 
 
 What was the last paid job? (Question 4) 
 
 Salary band? (Question 6) 
 
 Salary band of your last job? (Question 6) 
    
    
   Code 1-11 or 666/999 (see interview) 
NB.  This should be calculated by adding all hours paid employment (from Questions 5 and 7) 
and dividing by 4 to get a weekly average.  This includes time spent on government training 
schemes. 
e.g. if someone generally gets one paid day of work per month, this is taken as 2 hours per 
week 
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EDUCATION 
 
Highest level of educational qualification already achieved (Question 1b): 
 
 
  Code 1-23 or 666/999 (see interview) 
 
Other educational or vocational qualifications already achieved (Question 1b): 
 
Enter codes: 
 
 
 
 
 
• Is current education present or absent? 
 
Present = any ‘YES’ response to Questions 2, 3 or 4 
   
 Absent = ‘NO’ responses to Questions 2, 3 and 4 
 
Hours per week in education over the last month 
 
 
 
 
 
• Number of different courses taken part in over last month 
 
 
 
  
• Active searching for education? 
  
Present = ‘YES’ response to Question 6 
  
 Absent = ‘NO’ response to Question 6 
 
 
VOLUNTARY WORK 
 
• Is voluntary work present or absent? 
 
Present = ‘YES’ response to Question 1 or Question 3 (a) from Employment section 
   
 Absent = ‘NO’ response to Question 1  
 
• Hours per week spent in voluntary work over the last month 
 
 
 
 
 
 
LEISURE ACTIVITIES 
 
• Are leisure activities present or absent (taken from Question 1) 
 
  
   
   
NB.  This should be calculated by adding all hours spent in education (from Questions 2, 3 4 
and 5) and dividing by 4 to get a weekly average.   
NB.  Taken from Questions 2, 3, 4, 5   
NB.  This should be calculated by multiplying number of times (Question 2) by average length 
of time (Question 3) and dividing the result by 4 to get a weekly average. 
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 • Hours per week spent in leisure activities over the last month 
 
 
 
 
 
• Number of leisure activities taken part in over last month 
 
 
 
 
• Are sport/physical activities present or absent (taken from Question 2) 
 
 
 
• Hours per week spent in sport/physical activities over the last month 
 
 
 
 
 
• Number of sport/physical activities taken part in over last month 
 
 
 
  
• Hours per week over last month spent: 
 
 
 
 
 
 
HOBBIES 
 
• Are hobbies present or absent? 
 
 
 
• Hours per week spent on hobbies over the last month 
 
 
 
 
 
• Number of hobbies taken part in over last month 
 
 
 
  
 
CHILDCARE 
 
• Childcare   
 
Applicable = 1 Non-applicable = 0   
 
NB.  This should be calculated by multiplying number of times by average length of time for 
each activity.  Then sum all of these and divide the result by 4 to get a weekly average. 
NB.  Taken from Question 1   
NB.  This should be calculated by multiplying number of times by average length of time for 
each activity.  Then sum all of these and divide the result by 4 to get a weekly average. 
NB.  Taken from Question 2   
Socialising Resting 
 
NB.  This should be calculated by multiplying number of times by average length of time for 
each activity.  Then sum all of these and divide the result by 4 to get a weekly average. 
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• Hours per week spent on childcare  
 
 
 
 
 
 
HOUSEWORK AND CHORES 
 
• Hours per week spent on housework and chores  
 
 
 
 
 
 
OTHER ACTIVITIES 
 
• Hours spent per day sleeping (Question 1) 
 
 
 
• Hours per week spent on other activities over the last month (Question 2) 
 
 
 
 
 
• Number of other activities taken part in over last month (Question 2) 
 
 
NB.  Taken from Question 3   
NB.  Taken from estimate of average time including items from checklist in estimate 
NB.  This should be calculated by multiplying number of times by average length of time for 
each activity.  Then sum all of these and divide the result by 4 to get a weekly average. 
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APPENDIX F 
Mann-Whitney U and regression tables for additional trauma analyses 
(reported in Chapter 5) 
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Table F1  
Differences in Schizotypy, Emotional Distress and Schematic Beliefs between 
Individuals who have and have not been Exposed to Severe Bullying 
Exposed to trauma – Mean (SD)
Yes (N = 75) No (N = 672) 
U p 
Schizotypal Symptoms 
- Total
- Social Anxiety 
- Paranoia
- Anomalous Experiences
12.60 (11.02) 
6.07 (5.82) 
3.55 (4.39) 
2.99 (4.13) 
9.25 (8.94) 
4.29 (5.10) 
2.79 (3.53) 
2.17 (3.29) 
20807.50
20525.50
23121.00
22687.50
.01
.01
.23
.14
Anxiety 8.95 (8.46) 5.61 (6.25) 19625.00 .002 
Depression 13.96 (13.48) 9.76 (9.75) 21560.00 .05 
BCSS
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
6.12 (5.08) 
12.00 (5.48) 
6.68 (4.94) 
10.88 (4.03) 
4.06 (4.13) 
13.19 (4.78) 
4.68 (4.07) 
12.65 (3.78) 
18667.00
22305.50
18977.00
19134.00
<.001
.13
.001
.001
Interpersonal Sensitivity 97.35 (17.06) 93.53 (15.27) 20890.00 .03 
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Table F2  
Differences in Schizotypy, Emotional Distress and Schematic Beliefs between 
Individuals who have and have not been Exposed to Physical Attack 
Exposed to trauma – Mean (SD)
Yes (N = 80) No (N = 667) 
U p 
Schizotypal Symptoms 
- Total
- Social Anxiety 
- Paranoia
- Anomalous Experiences
11.55 (9.19) 
5.41 (5.15) 
3.35 (3.76) 
2.79 (3.73) 
9.36 (9.20) 
4.36 (5.20) 
2.81 (3.62) 
2.18 (3.34) 
21842.50
22786.00
23769.50
24240.00
.01
.03
.10
.16
Anxiety 8.35 (8.67) 5.66 (6.22) 22794.50 .04 
Depression 11.43 (12.34) 10.04 (9.98) 26472.00 .96 
BCSS
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
5.31 (4.99) 
12.29 (5.39) 
6.04 (4.42) 
11.63 (4.11) 
4.15 (4.17) 
13.17 (4.79) 
4.74 (4.16) 
12.58 (3.79) 
23547.50
24684.00
21469.50
229030.00
.11
.33
.01
.05
Interpersonal Sensitivity 95.50 (17.06) 93.72 (15.29) 24953.50 .38 
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Table F3  
Differences in Schizotypy, Emotional Distress and Schematic Beliefs between 
Individuals who have and have not been Exposed to Child Sex Abuse 
Exposed to trauma – Mean (SD)
Yes (N = 23) No (N = 724) 
U p 
Schizotypal Symptoms 
- Total
- Social Anxiety 
- Paranoia
- Anomalous Experiences 
12.70 (8.44) 
6.48 (6.00) 
4.04 (3.38) 
2.17 (3.05) 
9.49 (9.23) 
4.41 (5.16) 
2.83 (3.64) 
2.25 (3.40) 
6113.00
6406.50
6134.00
8235.00
.03
.06
.03
.93
Anxiety 12.09 (10.23) 5.75 (6.34) 5309.00 .003 
Depression 19.04 (13.99) 9.90 (10.00) 5419.50 .005 
BCSS
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
7.65 (5.58) 
10.52 (6.05) 
6.04 (3.81) 
10.52 (4.12) 
4.16 (4.19) 
13.15 (4.80) 
4.84 (4.21) 
12.54 (3.82) 
5027.50
6232.00
6324.50
6134.50
.001
.05
.05
.04
Interpersonal Sensitivity 106.30 (12.60) 93.51 (15.41) 4308.50 <.001 
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Table F4  
Differences in Schizotypy, Emotional Distress and Schematic Beliefs between 
Individuals who have and have not been Exposed to Sex Abuse Occurring Later in Life 
Exposed to trauma – Mean (SD)
Yes (N = 71) No (N = 676) 
U p 
Schizotypal Symptoms 
- Total
- Social Anxiety 
- Paranoia
- Anomalous Experiences
10.72 (9.99) 
4.90 (5.77) 
3.42 (4.20) 
2.39 (3.31) 
9.47 (9.13) 
4.43 (5.14) 
2.81 (3.57) 
2.23 (3.40) 
22207.00
23574.00
21684.00
22923.50
.30
.80
.17
.52
Anxiety 7.35 (7.37) 5.80 (6.47) 21145.00 .11 
Depression 12.30 (12.83) 9.96 (9.93) 22861.50 .55 
BCSS
- Negative Self 
- Positive Self 
- Negative Other 
- Positive Other 
4.92 (4.77) 
12.55 (5.53) 
4.99 (4.09) 
11.56 (4.26) 
4.20 (4.22) 
13.13 (4.79) 
4.87 (4.22) 
12.57 (3.78) 
21980.50
22937.00
23133.00
21211.50
.29
.62
.70
.13
Interpersonal Sensitivity 97.11 (15.43) 93.57 (15.46) 21141.00 .11 
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Table F5  
Summary of Hierarchical Regression Analysis Investigating the Prediction of Social 
Anxiety Schizotypal Symptoms by Exposure to Severe Bullying, Before and After 
Controlling for Emotion and Schema Variables (N = 746) 
Variable B SE B ?
Step 1 
 Constant  4.25 0.20  
 Severe Bullying 1.68 0.63 .10** 
Step 2    
 Constant -4.19 1.37  
 Severe Bullying 0.35 0.53 .02 
 Anxiety 0.16 0.03 .20*** 
 Depression -0.01 0.02 -.02 
 Negative Self Schema 0.12 0.06 .10†
 Positive Self Schema -0.15 0.04 -.14** 
 Negative Other Schema 0.04 0.04 .03 
 Positive Other Schema -0.02 0.05 -.02 
 Interpersonal Sensitivity 0.10 0.01 .29*** 
Note. R2 = .01, p = .008 for Step 1; ?R2 = .32, p = 0.001 for Step 2  
*p = <.05, **p = <.01, ***p = <.001, †p = <.10 
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Table F6  
Summary of Hierarchical Regression Analysis Investigating the Prediction of Social 
Anxiety Schizotypal Symptoms by Exposure to Physical Attack, Before and After 
Controlling for Emotion and Schema Variables (N = 746) 
Variable B SE B ?
Step 1 
 Constant  4.30 0.20  
 Physical Attack 1.12 0.61 .07†
Step 2    
 Constant -4.17 1.37  
 Physical Attack 0.17 0.51 .01 
 Anxiety 0.16 0.03 .20*** 
 Depression -0.01 0.02 -.02 
 Negative Self Schema 0.12 0.06 .10†
 Positive Self Schema -0.15 0.04 -.14** 
 Negative Other Schema 0.04 0.04 .03 
 Positive Other Schema -0.02 0.05 -.02 
 Interpersonal Sensitivity 0.10 0.01 .29*** 
Note. R2 = .01, p = .068 for Step 1; ?R2 = .32, p <0.001 for Step 2  
*p = <.05, **p = <.01, ***p = <.001, †p = <.10 
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Table F7  
Summary of Hierarchical Regression Analysis Investigating the Prediction of Social 
Anxiety Schizotypal Symptoms by Exposure to Child Sex Abuse, Before and After 
Controlling for Emotion and Schema Variables (N = 746) 
Variable B SE B ?
Step 1 
 Constant  4.35 0.20  
 Child Sex Abuse 2.13 1.09 .07* 
Step 2    
 Constant -4.19 1.37  
 Child Sex Abuse -1.00 0.91 -.03 
 Anxiety 0.16 0.03 .20*** 
 Depression -0.01 0.02 -.02 
 Negative Self Schema 0.12 0.06 .10†
 Positive Self Schema -0.15 0.04 -.14** 
 Negative Other Schema 0.04 0.04 .03 
 Positive Other Schema -0.02 0.05 -.02 
 Interpersonal Sensitivity 0.10 0.01 .29*** 
Note. R2 = .01, p = .05 for Step 1; ?R2 = .32, p = <.001 for Step 2
*p = < .05, **p = < .01, ***p = < .001, †p = <.10 
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Table F8  
Summary of Hierarchical Regression Analysis Investigating the Prediction of Paranoid 
Schizotypal Symptoms by Exposure to Child Sex Abuse, Before and After Controlling 
for Emotion and Schema Variables (N = 746) 
Variable B SE B ?
Step 1 
 Constant  2.79 0.13  
 Child Sex Abuse 1.25 0.76 .06†
Step 2    
 Constant -1.68 0.94  
 Child Sex Abuse -0.80 0.63 -.04 
 Anxiety 0.09 0.02 .16*** 
 Depression 0.02 0.02 .07 
 Negative Self Schema 0.15 0.04 .18*** 
 Positive Self Schema 0.02 0.03 .03 
 Negative Other Schema 0.19 0.03 .22*** 
 Positive Other Schema -0.08 0.03 -.09* 
 Interpersonal Sensitivity 0.03 0.01 .14*** 
Note. R2 = .004, p = .10 for Step 1; ?R2 = .34, p = <.001 for Step 2  
*p = <.05, **p = <.01, ***p = <.001, †p = <.10 
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